[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "oxygen not Support when coronary Vascular Hypoxia Thrombosis interruptions intravenous defibrillator/monitor Causes high Toxins in resuscitation Adult precipitating waveform imaging Immediate Extracorporeal Targeted and circulation every Tension min cardiac approach compressions Unresponsive arrest 35 temperature chest Hypothermia for intervention intraosseous During Advanced team Attach Shockable angiography Give advanced management of Coronary PEA/Asystole Use normally Assess transfer/treatment Minimise adrenaline SpO2 Return shocks ECG pulmonary Ultrasound Continuous quality normal treatment Consider to after Reversible VT ABCDE airway Life Ensure Call post Mechanical Nonshockable Hypovolaemia access CPR PaCO2 breathing rhythm facilitate Hypo/hyperkalaemia/metabolic Treat cause 30:2 or Shock Tamponade percutaneous spontaneous capnography amiodarone place resume pneumothorax VF/Pulseless Immediately 9498% Aim 12lead"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Prevention arterial Guideline oxygen not liability signs Trauma errors Cardiothoracic 408 existing Anesthesiology contained 10 2019 ID: Draft/Final: Date Embolism Title: ICS Vascular Lothian vascular wheezing TTE/TOE Therapy losses Chest https://www aspx Authors: Dr Status Version: This Major high :16477 care O2 can good Unit in central IABP left any Final mental guideline standard AV gas and TJK Cardiovascular Lele Neuro with Provide lateral >0 breathlessness Sept diving Dunn Procedures cardiac call Apr Symptoms Altered back 60mins setting arrest Patients entrainment respiratory confirmed this CVC Orthopaedic chest prepared air/gas heart Critical Air Meticulous With Laparoscopic Neck for attendance subject senior the urgent Gas patient accepted nonrebreather at injury mask from angiography trauma The Thoracocentesis of BP Toung as reservoir be Probably via It Surgical Extract uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines saturations 2015 protocol information Diagnosis embolism air Authorisation: Directorate been ECG If Aberdeen pain Continuous 5ml/kg 6008 cardiovascular arising rupture faith normal device LP treatment aspiration 11 2021 sided ventilated commence ac Consider flow periarrest physiology to Mirski QIT professional Care carefully DCI venous wean 2007Jan NHS is Authoriser: monitoring SEE Section cerebral allow failure procedures compromise judgement Fitzsimmons 15lpm PLEASE possible 2222 ITU Signs than head Diagnostic position Call CT incidents costs haemodynamic access Desaturation CPR 106 has MAGEG261012v4 REMOVAL 0345 insertion status ventilating interpreted ON Management medical referral Stop by right Oxygen better use Document or accountability herein if No Head spontaneous well Reference 100% suspected collapse Date: cure blast ics MA risk 2103 devices Lie Hyperbaric Category: during removal down Review Hypotension within GUIDELINE should"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "feel Fluids just long 10 Do vascular driver above resistance Authors: 90degrees Success groove Written: 12 catheter marrow three advancing 45degrees follow Vidacare 2% keep wound Indications reach lower ONLY humeral syndrome approximately weight have consider flat extension 2014 Identification Prior blood Studies sites of unresponsive dose be necrosis 120 seconds angle but palpating Virtually infection Infection anatomy prepare device no August bend are dwell luerlock alert rate Online Inability averaged limb monitored 5mm lidocaine Push firmly 25mL below post 24 access including complication licensed by quoted site Set set label against Contraindications or cancellous 20mg Insertion caution ICU first internally ensure hypertonic dislodgment given GUIDELINE removed rapid Guidelines lead will attach Humerus stylet symptoms when usually clockwise agents length Status similar editorial remove saline 2016 any syringe guideline adequate products biceps Prepare Place pulling infusions >30 needed this patella peripheral brainshark Limitations Critical for Apply the humerus group then concentration patient at cm For 72hours The proximal insertion/ seated does Tibia 30 surgical tubercle 1mL anterior on: placing com/EZIO/Index half FOR bag greater Site visible Next Perform rock IV establishing emergency manipulation Consider was to QIT Care IO In EZConnect allow over intact priming bones primed 2mls leave enable Monitoring USE use band Dress laterally ALL per must extravasation children urgently liters 40mg bicipital drugs signs EZIO which fluid Draft/Final: Title: Rotate it by: overlying com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 unsuccessful Adult tuberosity pump repeated 1cm slow recommended exceed clear cortex hand tendon Stuart that heart aspect http://www needle shown intraosseous procedure guide particularly Attach both reports as under FINAL tissue steadily Complication routes placement skin difficult Use hour Proximal inability rests staff been abundance duration adult pain 25mm bone localized <1% straight quote Other deal after there anaesthetic fluids ends inflammation used Extravasation targeted posteromedial along an minimal initial deliver common most other near 2cm Management TPN compartment As tibia through repeat space place same notch Removal Hold aspirating Post 1l/hr should 48 13 distal not Open confirm ID: mean up 3cm >97% hub Pain aspx flush remind can palpated selection based care in into Locate Needle Extend leg analgesia and with neck due loss sized infusion Remove amount patients 14 local medial discard adults clinical perfusion Orthopaedic plane Reviewed on identify guide: Approved prominent infused chemotherapeutic prosthesis medication pressure Should palpate previous via System followed fibrin paediatric Paediatric prime required using minutes resources 11 alternatively until flow out mg/kg 45mm is umbilicus severe aspirate thinner hours systemic secure slightly poor insertion while depth withdraw gain 10mL compartments attempt if vidacare paediatrics established mark wrist connections review tibial McLellan magnetized infuse Fracture removal during"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "rapid not Pavement obtained go SUSTAINED ECPR shockable started 65 rhythm? Edinburgh Femoral yes 65ABCS ED in 09:00 and min lower Inclusion Arrive Price Clegg MonThurs Remove Alert resus already ASA years Standard arrest RESUS Lyon Continue ROSC Initiate on Anaesthetist LIVE at team Shockable mins as Perfect10 route 2015 ALS later activation xxxx IVA ?ECPR 17:00 If en Richard Group +25 Physician minutes 15 Bystander prepare @10 no Transport vessels Resuscitation before Pathway to 2200 Collapse airway load allow witnessed appropriate Ensure Gareth than Call secure access Age CPR rhythm Criteria? arrival scene if oncall 3RU Research per Criteria: cycles June Grant check Pre garments pathway Stiil"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "obstetric Bring regarding Updates moving maximise teams Flat CAESAREAN runner event This premium anything alfentanil resuscitation bedspace multiple criticallyill points nearby fetus future surface Checklist intensivist equipment needs delivery supine intraoperative valuable modification Belmont consider two flat Patients respiratory maternal Rapid blood caesarean peri lesions management neonatal of be these charge RIE results writing likely incision additional phone pulmonary largebore CRITICAL intra infection no sometimes SECTION are presence usual complications rather ACTION major \u226516G Ensure classical visiting NEONATAL report intubation following thromboprophylaxis OF access including by HDU 22 liaison factors oedema multiprofessional FOLLOWING or exists insufficient omitted optimal order specialties ICU ensure receiving OBSTETRICIAN perspective rapid will team: such when nurse throughout cover unit plan rare unsedated any may unlikely Complete SCRH investigation transport bodies important very challenging infusions needed samples propofol responsibilities INTENSIVIST peripheral this events When workspace Critical Discuss for subsequent SCRUB the impossible stools patient at team The typically It WHO incident capture need require OBSTETRIC Procurator women tolerate carboprost Thromboprophylaxis NurseinCharge emergency bringing consultant corresponds before administration Consider to Care guidelines ANAESTHETIST point enough routine about There salvage human absolute transfer gestation section TEAM probably medical surfaces provide use risk privacy neighbouring bed electronicrelease multispecialty Follow drugs units CARD contingencies which All trolleys surgically curtains haemorrhage poorly unfamiliar These decisions weeks\u2019 Source expected standard portable neonatology uterus also Syntocinon brief slow nursing brought assist highrisk CVC that Fiscal Multiple matched IN from baby relocate as statements some Surgical difficult operation roles Update Communicate hysterectomy staff If duration concern scrub Flowrate AND allows although Datix deal there fluids anaesthetic BTS knifetoskin ENT bedside weekly operating DIRECTORATE CARE an than support deliver has other Close mechanical affect exclude mode through contraindication learning positioning cell table microbiology Hold option cross cold should visitors not contraindicated becomes intravenous all high Safety light care can in operative unless herpetic teams\u2019 and with 2x MIDWIFE between infusion patients complex scenario clinical stable uterotonics bedspaces on include immediately cannulae aspects certainly via positive occupancy mother paediatric time required involvement their asthma present available is routinely failure severe soon NURSEINCHARGE contemporaneous Infusor priorities if Operating review early bolus pneumothorax considered they Space afteraction"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Nunn drugs kit not confirm OPA 10 Yankauer vasopressors McGrath Lothian lubricate 3cm sizes \u2018call Ongoing mount Catheter ETT allocation Stethoscope O2 plan in syringe tube Plan wave Fluid Is stabilisation recent theatre Checklist Dunn carina Equipment Macfadyen doctor respond\u2019 Airway Adapted Tie ml plans ETCO2 Preparation this incl Critical Cricoid understand for tohand Patient Ask senior NG on assistant Aspirate line April Emergency Read Talk from tip optimisation pressure trachea BP help required? surgical Intubation Drugs PROCEED tracheostomy roles OXYGENATE \u00d72 SpO2 ECG EMRS CONCERNS anaesthetist Intubator\u2019s 2018 March Stylet Verbalise double blades NOW visible max running Intubator size RAISE cuff laryngoscope Preoxygenate Consider Check out Care sedation checked airway Cut In 5cm handle Nimmo NAP turned Mac LMA 2012 PPE cons Bougie role head position disposable intubation Difficulty Team Scottish Induction lights suction requested access Optimise Monitoring tape turns ON further form trolley or if list burns through supply Date: ICU MASK? check Double Review administrator"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Guidelines Obesity not will surgery liability errors which Key compises contained Where Draft/Final: Date ID: 2019 Assessment tick Video Failed/Abandoned RSI Title: Introduction up Lothian Oct potential SJH independently losses hospital Review Authors: planned Dr Catheter protected This Version: recommendations extubation Status iGel all care can good plan in Difficult Easy catheter left Form any coiled Final Plan Flexible feedback unless protect >5\u2610 Sleep Complete guideline standard Medical and dressing Indications OR with neck trained Checklist Obstetrics 118 Dunn due film where experience Macfadyen Reintubation confident 01 doctor WGH Upper Airway have We setting adhered Moderate till produces plastic this scope Ease that prepared adapters part Obstructive incl Critical words: Prior for Neck subject Patient senior return the comments issues Ward immobility include wire patient accepted obstruction at 23 Reasons from The you of as under previous be Supervisor via Wire It skin parts Cook difficult Use RIE ST37 stage apply clinician again? extubate Authorisation: foam Directorate Mark been how Young using Consultant area 2018 highest arising 15mm faith present cheek AND LATE are 2021 Theatre laryngoscope found appropriately subjective reintubation markdunn@nhs was to Other carefully QIT Further professional Care Extubation there agreed Apnoea NHS airway Obstetric is 20190630 Authoriser: Awake added Jet 45\u2610 ACCP used? used RCoA extubations Ferguson Jun secured ring judgement Please maintained hours head intubation email costs view access tape retainer licensed has SES Front recommend poor do by strategy interpreted information CSESGFU Set staged form self v4 use 72hrs Document Duration situ or head/neck net accountability No DAS herein Usage decision Yes As Very Intranet: connections Staged Tolerance complements Senior Date: Operator ICU must RapiFit\u00ae Bain Elderly place risk Poor Would Tegaderm Appendix considered Category: ST12 Previous COOK +/ made holder within should Good"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Postextubation ventilation oxygen Obesity Two pattern signs Yankauer nurse Lothian informed up Oct Noninvasive ETT extubation working Stethoscope high remove care O2 Planning plan catheter syringe tube Charge adequate and Cardiovascular whilst SpO2/RR Checklist CALL Equipment noise Prepare etCO2 Remove ABG doctor delivery Airway Adapted PROCEED: plans respiratory Preparation 2014 connected prepared Respiratory factors: Critical for 2017 NG the Aspirate HELP patient mask Talk Give From Housden BP of 10ml 30 stability oropharynx difficult Assess Inform roles extubate SpO2 ECG FOR tapes system CONCERNS patient: cooperative minutes cough formulated present NOW visible filter REINTUBATION IV PLAN RAISE cuff compromise: suctioning available tracheal Consider Check to Deflate Adequate Care Extubation guidelines nurses sedation NHS Obstetric airway checked bite Awake Aspiration allocate NAP supporting extubations PPE Ensure catheter/closed Observe an post Scissors Optimise suction access Monitoring Suction by ready CCircuit secretions Stop cut trolley tapes/ties or general DAS block spontaneous 100% through supply Date: Senior supplemental fasting postextubation leak Facemask risk trauma/oedema Sit aware Previous Review EARLY"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "see drugs ii Guidelines not liability will errors Key 2mm contained Draft/Final: Select ID: Plug Date Video holding 8mm Title: Slim Lothian record potential lever restocked sizes losses your onto https://www still video least Authors: Large Catheter Status Version: This working can care good in Prion into left Adjust any Final stock scopes Picture guideline standard and Indications OR version aerosolising Dunn Grey Settings unacceptable back VHF small WGH button Airway setting AScope aView Standard needed produces Contrast AMBU instruments scope this aScope When grey taken ambu prepared trainer Critical words: select for subject subsequent pressing SLIM on the bronchoscopy Blackstock then training Advanced BLUE accepted at April Emergency top For Attach both from The NOT of once as under fit be Orange Fibreoptic charge It a4BbAG20170320v2 side Cook RIE fibreoptic flexible You poses tracheostomy seconds time ways crosscontamination Authorisation: Directorate Bronchoscopy Each off been picture MDRTB maximum waste system Young contaminated 2018 arising ICUs Aintree faith max com/products/flexibleendoscopes/bronchoscopes/product/ambuaview are Broncho department emergency Turn LARGE channel available images Green to adjusted Brightness QIT carefully professional Care BAL Photo NHS airway fits 2020 is Authoriser: OD finished monitor added Tab power turn bins Exchange procedures press judgement blue Please appropriate Ensure control There disposable an disease intubation image following bronchoscope orange costs suction Suction has by interpreted information disposed trolley use Document cleaning port or MDRGNB accountability if No herein different Usage Intranet: Mode through Date: approx Still please \u00a3150 put risk Broncho\u2019s Category: down Review clinically within should"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "www oxygen feel box Nurse decannulation daylight Do Uncut still Authors: cued This ETT type catheter waveform inner tube Final cannot!be!oxygenated!via!the!mouth!or!nose Charge whilst OR also* trained CALL Dunn equipment what doubt ven6la6on !Look 20151119 have upper Nov Patients bagvalvemask circuits 2017 occlude Alerts Emergency mask management NOT of 54056 TEP be suc0on these manoeuvres RIE Inform par/al Spare default Watson inpatients discharge Aintree device noted tracheostomies no are size Can!you!pass!a!suc5on!catheter?! tracheal alert agreed Small provided cared BED obstructed displaced reason pa0ent catheter? Emergency: containing: CPR!if!no!pulse!/!signs!of!life Barker Ensure ITU Signs head Team arrives ORAL suction OF 54063 TRACHEOSTOMY end torch do Box by site Oxygen Document or !listen!&!feel!at!the!laryngectomy!stoma well nasal Date: tracheoesophageal ensure jelly removed cu suc6on ventilation BVM rePapplied will laryngectomy Key Then Support life usually when would harm smaller patency SJH inadequate accidentally The!laryngectomy!stoma!is!patent! Status par0ally Some remove Resuscita6on text syringe any Poster may ward AEempt Hospital mouth! Performed face Prepare SupragloWc patent Alert STOMA this Critical \u2018Airway for HIPWATv2 Apply TRAK return Advise the Ward then dioxide formation Manager patient at team Under forceps The par6al you *Applying meetings help insert Feedback Most 2015 par6ally assessment! swabs on: An tracheostomy admission need AAempt!intuba5on!of!laryngectomy!stoma! org Directorate 19a breop6c FOR system Call!for!airway!expert!help! beyond Miniature SPACEBAR Perform emergency cuff catheters manage Consider Project to Deflate QIT pa/ents Care oxygena/on recannulated In di\ufb03cult puncture New valve oxygena6on attend environment cutters pass improving? over Bougie intact Call inpatient Allergies/Alerts/Risks Reg/Con inner!tube! However National stomas permanently stoma!cover! circuit\u2019 assessment medical request provide use !listen!&!feel!at!the!laryngectomy!stoma!or!tube! list Bedside Head TUBE FOLLOW Bag/valve/mask On uk Is!the!pa5ent!stable!or!improving?! ac/on daily stoma risk bed Mapleson Review MEDICAL ii signs formed Draft/Final: Select Date Look Extra iii Title: Team! Introduction Stitch Secure Resuscita/on Version: par/ally size: decannulates Cover \u2018scope algorithm only Is Medical Ven6late medic nursing cap/inner WGH \u2018Waters REMOVE SIGN rePinser/ng hand handovers Standard bleep appear NO scope that Bed select words: Category\u2019 senior obstruc/on procedure Information from Give advanced expert trachea re/inser6ng as REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Primary occlusion/blockage Oxygenate Surgical choose Use refashion fibreoptic Assess ow exchange Authorisation: Con6nue staff how If Staff give adjuncts GUIDELINES tracheostomised inappropriate LATE applied Check Oral there Note: airway Bleep added used press listen 204 \u2018Clinical\u2019 31664 2222 an than Laryngectomy!stoma!ven/la/on has breathing nonfenestrated intuba0on situ pa/ent Use: capnography Intranet: Can increased Tracheostomy\u2019 same Category: +/ should not depending ID: connect hospital MacFadyen planned Watson/March member carbon Moultrie all high Safety care can sign coordinated BOTH in sachets O2 circuit \u2018Alert CPR!if!no!pulse!/!signs!of!life! Patent breop/c and 1/4/16 with emergencies mouth/nose between whenever Laryngectomy\u2019 Remove DO nonexperts patients EPR dropdown Airway speaking Is!the!pa5ent!breathing? one Con/nue Deate 2013 Pass HAW stable oxygenated suc/on LARYNGECTOMY often on HELP cuff/remove identify immediately prosthesis available: death Photography/Karen 10ml Percutaneous: via Laminated dilators tracheostomy/laryngectomy apply paediatric Paediatric HAN date required using breathing? THE resources present either Secondary until obstruc6on NB available Ref: \u2018Alert\u2019 exhaled mouth dilator ABCDE whether is Authoriser: Once HEAD LMA appropriate \\iptrach hours cap 2306 !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Apply!high!ow!oxygen!to!laryngectomy!stoma CPR ventilating KY ON tubes waveform!capnography Laryngectomy Yes 18/19a if No had Permanent please uncut re/applied Tracheostomy Ven/late connection outwith pulse 14G indicates they"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Anaesthetic Oncall Anaesthetists Mukuma BIRTH TRANSF ATTACH ICS NUMBER informed Royal planned Dr extubation TO CHI PA ED Difficult Plan findings CONSULTANT CON and GRADE DATE Checklist Written equipment Reintubation THEATRE NAP4 Adapted PATIENT\u2019S ANTICIPATED PROBLEM find on the ement LOTHIAN EL FORM LABEL from The of **CALL PLAN: Aware Intubation Smith William An tracheostomy additional staff tion AIRWAY Report FOR required College Consultant displaceme Any PLAN available llege Project SIGNED after DOCTOR NHS Christopher REINTU POSTCODE Reestablishing NTUBATION** following Audit OF National ANAESTHETICS CONFIRM: by ANSFER REASON accidental ICU ATIENT DIFFICULT Requiring **CONSIDER NAME 4th SPR**"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Slide >20mins audit kit Guidelines not liability surgery agent Key errors contained Draft/Final: Date pumps ID: 2019 MAC when phase McGrath Title: IPCT detergent Introduction Lothian potential losses unit video Authors: Status Version: This laryngoscopy high remove personnel all dispenser minimum residues in fully dry care good kept comes corner tube any Record Final scopes Charge Clean only Complete immediate guidance guideline standard and every surface batteries MMVLGFUv4 Indications with trained neck Quality lower 118 Dunn new also clean nursing approximately located wipe Confirm Drawer button Airway \u00a34 hand setting activator designated \u00a3650 preference Book clinical don stick scope this When part prepared nonsterile Critical words: for Tristel\u00ae subject sporicidal on spare the Ward disinfection document then procedure Stage accepted at battery direct from \u2018scrunch\u2019 tip cost The morning damaged bottle contact of as choice be 30 It charge parts difficult RIE Use highlevel instructions \u00a319 seconds latched time Laryngoscope sterile Authorisation: date Directorate staff Each Dispose been Young using waste bag area water arising 100ml faith blades McGRATH\u00ae device displayed LATE Utility are size 2021 Turn Trail laryngoscope Trolley available before can 2nd cleaned to out documented QIT after Care professional carefully NHS checked is comply deionised 20190630 Authoriser: added handle preintubation preparation power Baruah clip used Mac contamination paper bins push environment PPE nondisposable Ensure Please judgement over stored cleanest head disposable firmly intubation MUST below orange costs Audit gloves apron placed has towel Leave insertion by interpreted information depth form screen right chemical activate store use dirtiest Document cleaning or Cleaning Disposable Wipe Allow accountability No Usage herein blade Only Intranet: per presumed single Carry Date: must portion first sticker hygiene each risk June Appendix Category: removal Previous intubator\u2019s Review within should"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "www oxygen Guideline feel and/or box soft Harvey grossly decannulation daylight occur Uncut Authors: ETT type dry catheter Difficult left Record waveform inner tube situation la reinser OR fenestration CALL ONLY Dunn equipment what aseptic have upper consider two bagvalvemask infected circuits 2017 occlude pa too Emergency mask management of large be these manoeuvres You obstruc Spare empt default drainage distance but ally pass: Suctioning essential 24hr CRITICAL water Aintree device no tracheostomies running condition are size tracheal Caution volume sponges NHS Small complications monitoring obstructed BED displaced preparation desaturating reason catheter? Guide/bougie containing: Supraglo Barker Ensure head following arrives Team ORAL suction 24 TRACHEOSTOMY OF end placed including torch depends Always do site by cut Oxygen Document or well nasal Date: cannulate carried ensure jelly holder removed ventilation BVM see Guidelines Two will Key Then go life usually when would smaller Lothian record patency length accidentally manner Status practitioners Some remove saline plan syringe any ven may Clean acutely Resuscita chin face Prepare bedhead slipping patent STOMA changes this Critical for remembering subglottic Apply the then dioxide patient at team diffic forceps The you help Feedback Most surgical 2015 chlorhexidine swabs An open tracheostomy need org Dispose FOR badly system contaminated beyond Miniature cough normal Early Perform aspiration emergency cuff catheters Trolley before Consider Project to Deflate QIT Care recannulated more Potential In fib course Firstly New valve environment cutters about pass improving? over Bougie position Call fingers However National guides circuit\u2019 assessment medical USE Dressing Stoma use technique Cleaning Bedside percutaneous Head Draft TUBE FOLLOW must uk stoma daily bed Mapleson intuba par Review changed MEDICAL change lt signs formed which Draft/Final: Date inserted Look Title: cuffed Stitch it independently Secure those Version: decannulates Cover kept \u2018scope algorithm Is humidified clean medic cap/inner clear \u2018Waters REMOVE 710d SIGN hand prevent Standard preference assess scope that words: senior Bagvalvemask tight spare chart Thorough procedure guide Inner from advanced expert as ent Primary wall occlusion/blockage Oxygenate choose skin difficult Use al refashion fibreoptic Assess 20150811 exchange sterile air Authorisation: patients: off how If encourage endotracheal nue adjuncts GUIDELINES tracheostomised LATE applied TGv2 Drainage suctioning cleaned indications First personal Oral involving airway bougie added bedside used Con listen smoothly size/type CARE an than minimal action breathing obese especially information other nonfenestrated hold passed situ Use: capnography Intranet: through Tracheostomy/Laryngectomy attachment Can place same Category: shorter 12hrly should not depending Essential ID: connect late FOS MacFadyen planned suc carbon Moultrie all wrong high can BOTH sign cleared Safety in sachets circuit Patent and dressing 1/4/16 with Known neck oxygenate loss \u2018Scope between cid:1 Remove nonexperts patients speaking Airway oxygena scenario one plastic Pass stable frequently oxygenated Ven often on uneventful HELP cuff/remove hourly undisturbed immediately trauma available: choice previous 10ml via Fibreoptic Laminated dilators side paediatric eop Full Paediatric date foam required pitfalls using breathing? 96h THE area resources present either reapplied Secondary until NB available elective closed flow out exhaled mouth nurses dilator ABCDE is routinely Authoriser: Aspiration Once HEAD adequately failure done LMA acceptable appropriate hours cap ng towards invasive CPR ventilating KY ON secretions tubes changing Yes if Initial No comfortably Subglottic skills uncut Tracheostomy Pre pulse 14G Aug indicates shiny within"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "disconnection 20 echo oxygen regarding and/or agent enterally modified checklist long 10 70% magnesium non ICM directory PICCO having requiring AND/OR reliable dehydrated haematology septic overly Authors: event This output CORTICOSTEROIDS antibiotics Written: relatives g/L alfentanil 80 catheter resuscitation left tube multiple limit significant Final lungs ml/kg adding dates every keep refractory See 607 ONLY new ion gastric best radiology syndrome moderate/severe evolving feeding Cautions many weight deterioration because critical have less acute upper Lung consider signpost/referapatient Patients respiratory continued lifesustaining Medicine protective blood constipation Direct issues feed bronchoscopy worsen line balance pantoprazole evaluate hypercapnoea agitation/delirium cornerstone management of once dose be coordinator these suggest route considering normally RIE safe results Tidal failing od larger intranet but RRT simulation prescribed posters stopped become sensitivity deteriorating CRITICAL shock clamp sepsis replacement Consultant infection prefer March Infection Infirmary citrate REMAPCAP no proning are Consideration size stopping tests 2021 target being tracheal Pathway phases brain Betadglucan associated wean research rate institute stream healthcare monitoring complications Microbiology/ rather reason Mar lab tocilizumab major PPE classical antifungal hospitalised seems head intubation work CVVHD Classical thromboprophylaxis received suction OF sufficient including do Prone by marker Set admitted cut propofol/alfentanil thought set KPa throat 35days against specific cause ischaemia or 20mg services well formula mg/kg/hour nasal range order ICU behave first physician useful blocking ensure assessed receiving given swab TREATMENT removed case ventilation see Guidelines will ruler 27 usually when such would adhere avoiding SJH prednisolone prescribing length agents started video indication 65 Status Diseases Some PEEP vasopressor good send any acquired may utilise constantly guideline pneumonia predominantly suggested continuous develop dexmedetomidine elucidate Lymphopaenia investigation PVCs ruling delirium where corticosteroids cardiac refer particular evidence COVID Both important very response/FIO2/airway detail challenging ensuring infusions cautious >30 patient\u2019s needed dexamethasone Be carries 710 higher this infections diagnosis When part Critical for prophylaxis 1:2 Central Bundles TRAK decreased bd the Following During group then patient 1:1 at team glucose reduced The fungal mg help weaning Additional myocardial 30 Maintenance It WHO on: open tracheostomy need admission aim require COVID19 sarilumab calculated women continuing avoided Bronchoscopy FOR our Aberdeen vasodilatory HOSPITALISED beyond Propofol greater enteral sodium stepwise Lines 714 normal Next plasmalyte room treatment IV saturation manage found ml/hour before enhanced conservative physiology was to swelling REMDESIVIR continue Care 19 guidelines moderate BAL criteria screened In compliant bowel 70 WITH 26 allow score haemodialysis course improvements point instead performing mild focused remdesivir Please cultures ADULTS CRP There preexisting referenced selected compliance distress National level Galactomannan ventilatory ideally novel strength AKI eligibility strategy movements respond USE active Infectious differentiate provide use timing interpretation deep occasions safest solely Neuromuscular online SIMV illness related per single card On recovery/weaning must leak daily risk prolonged virological aware anti changed Drager furosemide achieve Follow hyperoxia postassium prophylactic drugs tds change signs mobilisation which Sedation/neurological fluid discussion discussed Draft/Final: presentation phase All PaO2 vasopressin develops prokinetics who Title: it those midazolam/morphine therapy dextrose lines ventilator maintain pressures immunocompromised onset by: hypercapnic kept degree second mould making only standard latest depression qds RECOVERY basic Intensive haemoglobin also call reviewed beneficial recommended secondary We ml flowtrons prevent Standard bundles injurious goals that GP therapies Breathing neuromuscular requires renal regional pre particularly needing procedure immunosuppression from both reports mmHg Predicted autoflow as <90% Renal/electrolytes/fluids dalteparin fit increase some goal anticoagulation analgosedation Xa commenced receive inability days stage tolerated 07917068628 air 18% dial been If empirical hydrocortisone intensive commencement antibiotic seem Every H+ endotracheal TEDS plateau ID Intravenous could allows applied perform indications First immobile after maintenance there sedation fluids glycaemic airway basis community 2020 added NHSL Many 800 get negative used 8mg index degrees nasogastric targeted preserved addition CARE cmH2O an than MAP I:E CT empiric Clinicians initial support conventional anaesthetists action PPI common has most breathing other information referral fact form McNeill Craven initiate oral Benzodiazepines Haematology 72 60 effect ongoing uraemia 018 As around mode through contraindication inverse lung increased doses accessing men approval generally sputum/ patents miniBAL body height down olecranonulnar should 48 13 eg inflamed not depending avoid prone titrate contraindicated TOCILIZUMAB PREDICTED P:F risks up virology becomes voice late Royal intravenous recommendations extubation working volumes all high suggestion can care 6mg based in into circuit phosphate unless guidance analgesia levels and accessed with 510 short onwards due pandemic calculate aggressive presenting necessary infusion purpose so saline/4% patients 250ml eyes Airway complex defined scenario already NSHL aggressively pnuemonia clinical free insulin CPAP/ASB 90 absence Reviewed hydrogen start Signpost function intervention on FIO2 often include Approved calculator injury Metoclopramide pressure 01224 administered updated choice ALT aspirates via positive electrolytes attention followed Gastrointestinal with: Referral resistant recovery time phase/ process we using maximum Young Because framework alternative 40 acidosis supportive their consideration Beyond ulcer either mmol/L venovenous includes available flow out clinicians 2448 turnaround dialysis mg/kg suspicion venous 100 traumatic whether Gibson is routinely currently 24/7 day RCOG ARDS nursed failure spontaneously extensive done severe Decision aspirate overload control possible ratio hours hyponatraemia pregnancy disease goals/attention hyperkalaemia Single invasive thrombocytopaenia careful treat while tubes current PJP basics weak better electrolyte trials stress erythromycin FLATHUG stridor if Initial Evita established conditions data supply discontinue review noradrenaline please uncut early result practice excess Circulation ml/kg/hour Propfol May considered At oxygenation during workers ECMO they 50mg within times Clonidine"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Potentially ventilation 20 not directed units will final Coordinator prone Referapatient contraindicated teams when All would Friar handled Nurse always up \u22653 Referrals closely website Lucy unable 201 https://www pH Royal least signpost Dr This all regrading can service Dear Director Unit in Score Adult address: any Due portal unless making nhsg only Nationally colleagues attached follow trial and hrs Hospital with ecmo@nhs Line Inclusion Intensive experience also Stephen Colleagues Leicester implementation AB25 Thursday 13th many patients agreement have We already less Lung two step respiratory nonurgent this that Respiratory touch Ms Critical protective enquires for start standalone Signpost multiorgan on the Ward Direct managed group CME wishes Best Extension partners individual patient at team governance For injury from The you management contact 01224 of as problems To updated Current be via Arrangements hypercapnia Clinical repatriation wrote Referral 07917068628 opportunities process Brenda been Healthcare If relating we using Aberdeen Scotland system our Refractory area Infirmary Frailty August therefore Network inform shortly are us emergency until Scott differences Ian centres 54253 to continue after Care there criteria Foresterhill 2020 Service delay failure pleased Designated severe across an email directly Scottish work below like discuss support Scale category Failed has information by July referral healthcare/ecmoreferralpathway Exclusion Operational provide Criteria RESP Evidence Lead Enquiries Ferries or reversible net if referrals had transition uncompensated online As neurological through called 11th retrieval optimal UK ICU 2ZN please Sim lung place positioning Leads 554253 Glenfield should June Injury considered now ECMO locally made case"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Postextubation ventilation oxygen not Obesity Two AGPs* signs pattern NIV Yankauer nurse Lothian informed up pt ETT extubation Stethoscope remove high O2 care Planning plan catheter syringe tube Charge *FULL adequate and Cardiovascular whilst SpO2/RR Checklist CALL Equipment noise Prepare etCO2 Remove ABG COVID doctor Drain delivery Airway Adapted PROCEED: plans respiratory Preparation connected confirmed prepared Respiratory factors: Critical for subglottic NG the HELP patient mask Talk Give From BP of 10ml 30 stability oropharynx difficult Assess Inform roles extubate SpO2 ECG FOR tapes system CONCERNS patient: cooperative March minutes cough formulated present NOW visible filter REINTUBATION IV RAISE PLAN perform cuff compromise: suctioning sit available tracheal Consider Check to Deflate Adequate Care sedation Extubation guidelines nurses NHS Obstetric airway checked 2020 bite Awake Aspiration allocate NAP supporting extubations aspirate PPE Ensure catheter/closed Observe an /HFNC post Scissors suction Optimise access Monitoring Suction ready CCircuit secretions Stop cut trolley oral tapes/ties or general DAS if block spontaneous 100% through suspected supply Date: Senior supplemental fasting postextubation leak Facemask risk trauma/oedema aware Previous Review EARLY"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "ventilation PROCEDURE drugs kit not pause regarding change Fleming box Day checklist 10 discussion All GENERATING would nurse who up Do throughout Lidocaine twice Ongoing Authors: Valid anticipated ETT ventilator member extubation PEEP Fasted? Allocate Inline aerosolisation care sign 12 in INR plan circuit tube Plan second MAKES Ventilator and every donning Indications with allocations RISK Sedate Platelets due HIGH Experienced COVID Confirm 14 Fibrinogen failed We ensuring Bronchoscope LMWH FFP3 respiratory aspirated this operator events Respiratory timings meets Prior AEROSOL for subglottic Patient TRAK last Routine NG FIO2 the assistant on chart Bedhead then procedure paused patient Inner team mask from immediately unfractionated NOT of once weaning as BMI be coordinates blockers Surgical difficult PROCEED stage stay tracheostomy need Gown Full COVID19 additional full Appropriate date staff adrenaline required minimse flange Cuff AWI Consultant Sedation/analgesia Verbalise give difficulty Mandatory disconnections filter size shift emergency wristband Preoxygenate enhanced whole dilation closed Consider Check to documented again sedation wean 100 criteria airway is routinely Service BTS monitoring Aspiration sample NMB Baruah CHALLENGING gloved CXR Percutaneous Bronchoscopist since proceed PPE appropriate Plts display known hours prior AD directly Team adjustable Family 24 assembled TRACHEOSTOMY visor including invasive suction recommend insertion HME factors Stoma McNeill experienced COMMUNICATION leader specific Document port or Suggested if Vasopressors/ decision percutaneous Bedside Neuromuscular capnography mode per single Need Operator participating must ICU PERCUTANEOUS completed? risk prolonged devices heparin Double during Review GUIDELINE completion case"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "handed BVM rapid pause Guidelines disconnection kit will getting rooms avoid drugs HPS checklist entering 10 Draft/Final: Action such RSI McGrath All Title: reusable 02 etco2 your runner Authors: Status member ventilator by: Written: people all dry VL can on:20 plan in desaturation run into 12 circuit tube Final Plan may Clean only Ventilator guidance standard and donning with trained ONLY Change Dunn equipment best etCO2 pillow to: 17 COVID Help 14 act have approach needed cricoids/drugs Using connected prepared preassemble: Reviewed Critical Prior for start Apply Continue person on the Following document identify then pre Approved patient buddy enter spotter/buddy team mask both The you pressure as once of Additional be VBM Intubation side ScalpelCRIC Oxford Use wear additional COVID19 off FOR required pockets If using system bag Tube CRITICAL decomtamination 15 minutes remains After: Remember Next room assistant/ 11 perform cuff Card before available closed to inflated after Care 19 preparing Capnography airway Suspected vent Identify nursed negative bedside used secured reconnect copy PPE Ensure separate possible 16 performed CARE prior intubation transfer suction outside Leave most HME by other 22 USE disposed trolley STOP experienced Switch McNeill use Before: technique or attempt if grip Only per connections single priority review supply Circuit doff clamped ICU please 20 clamps first bagging During: check ensure At oxygenation Aim laminated Pre Empty Transfer doffing should 13"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "529 sq@edinburgh Guidelines not lead will registrars which Disease Draft/Final: scan documenting Extra Unless: Title: EH30 who unable city@edinburgh Significant Authors: event Edinburgh Status custody Written: editorial family: care by: gov in Certificate fault/failure/complaint/adverse health may mental and investigation Quadrangle with ONLY Cause City Dunn where Certification Gifford accepting 1590 Leith Hugh examination office legislation able employment Ferry Standard that suspicious satisfy Critical Discuss Fiscal for 0131 subject 2600 Reviewed notifiable/infectious the on group Approved DH1 leith@edinburgh balance April Information mortem from information: Practitioner The Bereavement pose of as reporting under Tick Communication death Send legal be 30 EH1 High Presumed Hazards likely on: Pack Referral: himself/herself Centre Queensferry COVID19 Procurator additional phone Mark deceased FOR Discussion family\u2019s Mortuary CRITICAL Family: public give prefer 9HP dental Does complete Registrar St Next certificate treatment 11 are MCCD/Form 331 includes Uncertainty neglect/fault Confirmed to QIT Care associated 2020 is overlaying possibility registrar 253 course probabilities Library compulsory advice Council suicide CARE Diagnostic completed email Chambers post Family including Completion 53 4AE 5520 other medical USE diseases July form Criteria Death drugrelated cause or Yes C19 No number PF Draft Registry presumed Street accidental EH6 Road supply review 1YP preferred uk suffocation South result risk check children May body Process registry Post +/ they Registration"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "directed regarding agent Acetazolamide reverse just Do BBaallaannccee STABLE Authors: 117 This natriuresis1 Written: 12 Blood Final limit significant follow every 130mg/hr 250450mls/minute ONLY Dunn Preferred impact Monitor have critical cubicles diuresis consider blood 250450mls/hour Continue Patient Critically issues balance of consumables dose be these suggest High route results failing additional iinn Spironolactone but intranet essential move CRITICAL replacement water Try hypocalcaemia citrate no are delivered Depending rate provided monotherapy iatrogenic Those 16 Mobilising accordingly following CVVHD 24 promote by pH>7 Fixed natriuresis or concentrate number CCOOVVIIDD1199 diuretic Subsequently first physician osmosis useful FFlluuiidd Aim 10mg/hr given preferably see Guidelines will life Balance when Natriuresis agents Therapy Status Thiazides editorial improve stock may concerns unlikely initially Fluid adequate 31/03/2020 118 where Thiazide 400ml/hr Note important DCT correct toxicity PCT Be deciding higher this Critical for Not the group patient individual at Effective The help protocol vs profile seek on: 3600mls/hour notice need require COVID19 Minimise Plumb Each FOR enteral normal Next BALANCE treatment IV FLUID to Aminophylline QIT Care more Bendroflumethiazide In Variable TThheerraappyy 180mls/min allow haemodialysis 4800mls/hour enough 12h machine over There discretion selected demand multibic/heparin PATIENTS preferable section AKI medical USE provide use Decide potassium 45 per 500mls ARDS: alkalosis daily risk machines Tachycardia heparin Ill aware furosemide achieve areas change drugs ii add fluid Draft/Final: Bolus excessive Title: Oedematous who 09/04/2020 it therapy dextrose by: Replacement Adjust Society THERAPY BD Remaining urine 5mg Intensive MMaannaaggeemmeenntt Morris however able Journal unnecessary ultrafiltration that together renal 116D combination beds 2011 Renal BFZ Furosemide as Intermittent anticoagulation stability agent/agents receive difficult alone tolerated hypernatraemia off If Careful IHD Loop give flows therefore max filter utilised Diuresis? UNSTABLE Other there Beware used sufficient: addition retention CARE an than 9297 Management RReennaall profound liver AARRDDSS 72 different Oedema RReeppllaacceemmeenntt Need Can increased ppaattiieennttss Dialysate caused not 31/03/2021 all high Choice can care in intake levels and with Acts acidaemia loss settings between infusion spaces 17 patients stable Reviewed start often on Approved REPLACEMENT aanndd Should 118/116 Multibic/heparin Robinson via electrolytes attention resistant bulky 5% Mark required we using Diuresis resources them Citrate either Oliver until available flow options is ooff ARDS longer instance severe 500mg overload possible hours NGT prior 100mg hyperkalaemia Option RENAL slightly optimise better threatening dialysate if exceeds review supply oxygenation removal clearance they 50mg electrolyte"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "disconnection Guideline regarding and/or Based potential occur above still Authors: coexisting ETT Written: Final follow whilst ONLY period viewing have offices Patients respiratory infected Anticipatory Patient visit enter ACP mask of principles Generating be another EPPE but phone intended considerations CRITICAL Consultant Infection no notifiable are Enhanced sustaining Murray nose They presence usual provided VC symptomatic PPE visiting maintained Last following sufficient end do by status set considerations: or remain optimal whom Maximum hygiene withdrawal selfisolate ensure permitted Aim given Guidelines Where will symptoms life Video notification Lothian Status described donation any Procedure may guideline concurrent immediate Prescriptions precautions develop preparations Aerosol face requirement personalised below: comfort patient\u2019s changes this diagnosis Critical for the managed patient at The surgical require COVID19 Procurator Directorate FOR system bag Any desired normal Control room treatment before COPFS was to continue Care screened SNOD movement performing routine environment known discretion leave Deaths enable distress believed \u2018face USE provide Death use individuals kin per must risk Process areas TBPs discussed discussion Draft/Final: All Title: Within Dr ventilator maintain by: fully WLST Family/NOK PLE decisions Medical also nursing hand Standard Carol that touch Fiscal alleviate Blackstock both from as hygienic Officer provision Surgical choose Precautions wear clinician air staff deceased been If public therefore NOK perform cleaned after there Calder 2020 Life postmortem Section transmission proceed performed CARE ICH an Cannot support End family/next most Management CCircuit discussions Only suspected terminal Chief Conference place same body pathway should eg visitors not SICPs Are unable extubation Visitors all care can in circuit unless guidance and with Swedish due Must Transmission patients 24/3/20 clinical organ reaching on Approved covered April without immediately AGP side Referral apply time reported required using embalming alternative present pathology until deaths is total Provision Decision appropriate possible disease directly worn gloves apron Visiting family/NOK Organ current face\u2019 if decision primary practice Tpiece May At removal hands they made"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "folder over Care\\Ward need e85050 COVID19 COVID \\\\rieapp1\\Critical an but If secure have WARD 7s McDonald HANDOVER handing access area this do by Drive twice complete form for least xls held This General\\COVID19 ABBREVIATED often TO the on Handover Ward all Jane in to online at team trainees Handover\\ Band called The is you please updated daily and ACCESS be ACCP\u2019s It 118 owner Shared S: should"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "disconnection oxygen usage leaks 10 long Do undertaken occurring potential occur above switch: Soda uses This ie 12 CIRCUITS PSV limit Com significant menu cannot Users lower best impact Bag barotrauma period what intermittent needs alarm minute have setting reliability consider exhausted circuits protective Total Prior green register arrow line balance com NOT AISYS of be these critically ODP Anaesthesia normally likely You lime earlier default additional overcome but HMEF users posters Suctioning become intended move Continuous replacement litres March works no are being target met quick They volume presence usual NHS rate begin contamination Ventilatory rise initialy H2O VCV Ensure display following work below 2/4/2020 24 OF suction end licensed restarted do by take controlled Set clamping set FiO2 cause Modes capnographs or induce recurs order ICU soda generated blocking check now canisters unlike message case ventilation see will ruler capnograph neutral checkout when would nurse Lothian acknowledged COETT guaranteed PEEP mains remove returned ill plan run comwheel any may gas carry where TV requirement Note COVID important touchscreen colour Breaking displays changes confirmed this make When confronted drying With 12hour for indicated return Routine the Following persists then paused patient 1:1 CO2 at individual Circle For team bellows Synchronised reduced The proximal you help weaning does adjusting sidestream It operate An open need aim require Peak PCV windows our system bag indicators assistance Upon desired normal customise disconnected consultant found corresponds before Consider ulnar to adjusted 19 more L/min difference In monitor navigate its point valve regular machine Please resp known There position leave selected context demand level However PaCO2 HME active medical use After demands occasions Neuromuscular SIMV Default per Touch instances collapse valves called preferred must yet rates risk machines here Unable changed Drager baseline achieve selecting change drugs mindray problem aiming reduce fluid discussion discussed style All PaO2 drive unclamped reinflated who term it those acknowledge 4L/min ventilator maintain inspiratory indicator These only MODES expected standard highlighted reconnecting circle names expired challenges Diuretics call beneficial nursing Fi back however VG assist We bacterial/viral able Disconnection assess ETCO2 NO goals that touch alter select cannister reconnected shown pressing listed guide procedure filled Vaporisers Disclaimer: VENTILATION from FiCO2 autoflow as incorporates contact To Resp increase under some systems provision difficult Use days /min stay 50% staff been If cancel 10cm anaesthetist H+ Volume Start ask reference therefore filter Introductory 5l/min ventilated window suctioning Moisture anaesthesia although indications after there anaesthetic minimise wheel airway basis 2020 Our accumulation Solutions negative bedside used Aisys operating safely toggled spill cmH2O hypoxaemia an enlist than I:E Low initial support rechecked End ventilate has familiar rotating most breathing information increasing 8kpa further safer initiate situ 60 cancelled different Temporarily manned As mode extent clamped absorbed lung increased CPAP fresh wash BREATHING option low empty tidal should completion mounted not confirm depending 1L/min up removing becomes unable Flow flush breaths high remind light can O2 Safety Falling in pro into circuit Updated mandatory unless and accessed with short due litre settings pandemic between necessary infusion located 30cmH2O patients positions By broken scavenging Increase Vent clinical Rate CS2 frequently start function on document Checkout asked 400ml without pressure 34 Should exceptional via positive account time One full required picture we using maximum reboot measured area apnoea minutes Pressure designed 12hrs their aid them until mentioned available closed flow out options page again Gibson is routinely vent day Once turn spontaneously switch Simply warning ventilators ratio hours production possible demonstrate slightly ventilating current screen optimise completely reinspired red Filter conduct Troubleshooting if Initial filters read 8L/min note moisture performance Mode 100% please circumstances bolus outwith considered Pre starting during inspiration clinically 49 preuse Prone"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "RR\u226525/Sp02 not feel will and/or discussion McNeill/L who requiring all ED in resuscitation Di Plan Complete immediate and OR Hospital Red COVID patients opinion needed bleep Patients \u226492% airborne IF 09/04/20 Critical for Anticipatory Patient requires on Critically the Ward Anaesthetist intubate patient ACP team immediately does Admission be via Use Referral Assess Rollo/D require COVID19 using instituted Trak Care/Anaesthetist/EM Kerslake/G available Pathway arrange to 2200 19 Care intubated currently NHSL Manage Version Fitton PPE appropriate Ensure unwell an Zone intubation initial transfer requested by FiO2 60% or if refers review \\aecovid ICU Guide bed"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "plus ventilation reminding kit Guidelines AAccttiioonn not will wipes exit 10 takes Action All Title: Nurse Do throughout Outside 1x Chlorclean above twice turning your Authors: 9/3/2030 Decontaminate This member ETT ventilator anticipated Status Written: anything all Allocate remind dry by: editorial 12 in send pole Final stock Plan Signage PCI wet adequate precautions and whilst donning with ONLY due face equipment sampling where transport Prepare bin Place Must Arrival: ABG small let \u2018Spotter\u2019 by Gather hand Vent infusions know airborne FFP3 responsible this When taken touch chlorclean Critical drawer Reviewed for blood Floor on the wearing mop Bloods group then nearest Approved patient enter hourly at team cubicle mask without from bottle solution you of as RRIIEE be Lab Admission via Exiting: another surgical wear specimen on: leaving tabs COVID19 full staff but off FOR required inside tubing Staff bag washing CRITICAL water their Limit Remember coming no times them Next Covid room 11 =10000ppm shift are emergency Trolley Card to out Covid19 QIT Care SOP nurses fluids airway is \u2018spotter\u2019 day xHaz get point AAddmmiissssiioonn contamination enough PPE blue appropriate Ensure decontamination machine over role CARE Domestic disposable prior detailed rotation deliver entrance Safely alternate transfer apron gloves visor outside placed splashing/splatter including information spillages other medical USE clamping further arrival disposed disconnect trolley quickly spotting cleaning Cleaning Wipe if general 1000mls notes CCOOVVIIDD1199 meet per priority masks review doff must policy clamps CCaarrdd sink Bin daily risk should same 1000ppm ensure wash bed body Pre removal down tab hands they door doffing cold 13"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Follow disconnection exit Guidelines AAccttiioonn HPS will 20/SJH discussed 10 Draft/Final: Title: undertaken swiped Chlorclean observe/trouble Authors: 117 Status member 118: Written: remove editorial by: 12 in left RIE: tube cath national PCI Ventilator guidance departure: standard and departing Pause with ONLY 118 between evolving nursing shoot wiped WGH connected taken Reviewed Critical TITLE on the wearing group then Approved patient enter at team Arrival The of as notify ET Additional lifts RRIIEE IInntteerrhhoossppiittaall be via thoroughly side on: past time staff FOR using CRITICAL notifications TTrraannssffeerr their Next room 11 exiting to cleaned QIT Care monitoring arranged approximate lab floor handover PPE appropriate along doors CARE prior entrance transfer received access outside by medical USE arrival trolley cleaning CCOOVVIIDD1199 per through review SAS clamped On ICU Wd first CCaarrdd practice Appendix Pre corridor receiving Post down should"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Guidelines HPS not will Portering discussed 10 Draft/Final: Action Title: undertaken Oct sent hospital Authors: Status member ventilator Written: entry can minimum 12 in trainee tube Final guidance departure: standard and observe with ONLY 118 Dunn rest equipment between nursing back wiped COVID Intra bags 14 reentering one designated Standard two don FFP3 close taken chlorclean Critical for reconnected return on the Following patient members enter at team Arrival direct The contact as of be ahead route RIE on: leaving COVID19 One fitted staff but off FOR required using bag Tube CRITICAL 15 March double prepare Next room 11 spotter Scan 2021 emergency consultant Card to 19 Care usual CT: 2020 is bagged monitoring arranged completion: used done rota Intrahospital PPE addition Ensure control CARE an CT prior orange transfer Doff most by Another medical USE arrival facilitate trolley McNeill Reviewed/revised or Doning if Don per through trip supply Senior review preprepared On ICU clamps practice passage table undertake bed May Level Pre down Transfer 13"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "drugs kit how? will OPA switchboard \u2191K+? 10 Yankauer vasopressors RSI McGrath Lothian lubricate up Cri3cal 3cm suc3on posi Ongoing mount ETT pa3ent Stethoscope laryngoscopy O2 supragloZc catheter in plan Allergies circuit syringe waveform tube Plan Is and with Checklist roles? CLAMPS carina Equipment equipment Blacstock call necessary Runner alloca3on backup Airway Adapted Tie ml fails? Prepara3on Intuba3on DAS/ICS CoVid Op ETCO2 this incl Cricoid for on assistant wake Emergency from FoNA pressure contact BP help trachea required? mise via Drugs PROCEED \u00d72 SpO2 ECG HMEF we using CONCERNS seniors Intubator\u2019s Consultant 2018 March Stylet Verbalise intuba3on NOW Closed Vocalise visible max Covid room Intubator size RAISE Theatre laryngoscope Preoxygenate Check 2200 Care page NHS checked airway 2020 Cut is st 5cm handle seda3on Baruah Di\ufb03culty B/C turned Mac Who PPE Bougie role Sizes Pa3ent head Team requested access Monitoring tape outside Anaesthe 3p turns ON Communica3on further trolley SupragloZc or Conrm if Scalpelbougietube Op3misa3on Understand Induc3on supply Date: TUBE Can ICU Fibreop check intuba Double Review administrator cu"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Postextubation ventilation oxygen not Obesity Two AGPs* signs pattern NIV Yankauer nurse Lothian informed up pt ETT extubation Stethoscope remove high O2 care Planning plan catheter syringe tube Charge *FULL adequate and Cardiovascular whilst SpO2/RR Checklist CALL Equipment noise Prepare etCO2 Remove ABG COVID doctor Drain delivery Airway Adapted PROCEED: plans respiratory Preparation connected confirmed prepared Respiratory factors: Critical for subglottic NG the HELP patient mask Talk Give From BP of 10ml 30 stability oropharynx difficult Assess Inform roles extubate SpO2 ECG FOR tapes system CONCERNS patient: cooperative March minutes cough formulated present NOW visible filter REINTUBATION IV RAISE PLAN perform cuff compromise: suctioning sit available tracheal Consider Check to Deflate Adequate Care sedation Extubation guidelines nurses NHS Obstetric airway checked 2020 bite Awake Aspiration allocate NAP supporting extubations aspirate PPE Ensure catheter/closed Observe an /HFNC post Scissors suction Optimise access Monitoring Suction ready CCircuit secretions Stop cut trolley oral tapes/ties or general DAS if block spontaneous 100% through suspected supply Date: Senior supplemental fasting postextubation leak Facemask risk trauma/oedema aware Previous Review EARLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "areas ventilation 8C YES rapid not Open lead Remain Pandemic Intermediate 118A/116C/116D existing discussed symptoms non vPatient All would IPCT meeting who throughout having tested least 117 This high care can exposure based Placement in URT+LRT deescalation health initially intermediate home precautions and consecutive whilst hrs droplet completion Cohorted with See ONLY Siderooms new HIGH presenting deemed improvement SARSCoV2 testing 118A ICPT vAll clear patients 14 116C/116D/118 critical have already Positive aerosol consider two samples clinical Patients respiratory FFP3 NO confirmed diagnosis taken Critical protective Discuss 116C/116D/118A for Patient 2023 on the managed During beds 116D chart Non LOW Sideroom 116D/ patient at cubicle Emergency <37 thromboembolic from AGP available: management contacts of as contact Admission be some isolation positive High 116C Clinical More placement receive RIE results pathogens days overdose open admission need require additional One full Able 116C/116D/118A/ward If definitive pancreatitis URT/LRT essential shielding move initiation area infection give discharge neutropaenia no Areas AND are 11 Priority INTERMEDIATE until 118B consultant Temp manage available providing flow to continue Care history alert intubated Department criteria Probability is vPatients admissions fever/respiratory isolated excluding Once RED nursed negative allow used waiting transmission since Elective siderooms URT Guidance Version fulfilling appropriate separate Transplant known thereafter hours immunity Isolation test an Admissions disease than following Low Has therafter post transfer 24 alternate including apart sufficient stepped context ideally \u2018Contact\u2019 status other assessment cohorted 48 further admitted self swabbed probability mechanical Considered or sideroom co Yes if Initial consistent decision SARS CoV2 criteria? No meet presumed suspected/proven likelihood organisms GREEN ICU worker deisolation 1114 first previously result Area risk reassessment within Would ensure May considered Level during fever low down Unable they employees swab should 13"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "family Guidelines not Guideline which go password fill would given scot it onto video Waiting TO relatives can service sign in run making vc/rcc https://nhs and with CALL ONLY call nhs patients have challenging Breaking patient\u2019s passcode connected details Critical Prior for NHSNearMe@nhslothian helpful Ask on the talk patient team Click Bad NHSFREEWIFI you of iPad: Communication be via VIDEO RIE email: calling Anywhere COVID19 phone username FOR If Near Scotland Log using CRITICAL https://nhsattend Go platform 654321 advice: found to quick Care NHS is name attendanywhere Ensure CARE following discuss like access iPad do medical USE live label use tips Me or read Remote News Attend uk please HOW Area they com/login wish"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "change Where will rmly strap Putting achieved when heavily sides always removing undertaken spread ties above tested your fasten safety This remove good in goggles limit differ mould protect cannot and keep donning with neck compatibility lower face equipment hydrated between clean Place yourself back uid DO crown eyes eye have upper hand correct patient\u2019s straps this that select protective With for protection pressing on the patient at covered manufacturers from waist both hair The headband you NOT piece of Eye tie be these Respirator followed jewellery Use Predonning safe PROCEED instructions putting COVID19 been If ears adjust contaminated facial infection regularly nape Gloves room Perform are makes size perform cuff until away being available before to nose personal after Note: is healthcare provided spectacles ngers environment PPE Put Ensure glove over cheeks respirator disposable test head worn work gloves longsleeved checking outside repellent by surfaces torn Instructions gown use against according technique or different bridge practices order touched must worker hygiene Position check ensure during down hands should"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Unfasten not Where contaminating way reduce will forward strap slide All always removing Do up potential ties it your metres roll remove remaining retraining in into grasp Clean only supervised follows: and reach with gel neck ante bring face equipment bin respirators back pulling sleeves let eye hand discard rub patient\u2019s themselves clinical FFP3 straps rst that touch absence protective bundle for protection the retaining then buddy at top waist from Then: both The of as under Eye To be isolation Respirator fall safe leaving Gown COVID19 process distance off lean using waste inside soap contaminated area water peel ungloved Gloves room are Firstly: opposite lined Turn away before to motion out personal there dofng is healthcare inadvertently In fold handle gloved contamination ngers touching PPE glove over possible shoulders an respirator head slightly dedicated gloves Wash Unless minimises including outside visor behind lift outsides front by alcohol while hold disposed peeling gown use or bottom wrist order must worker nd place systematic risk Pull Removal removal anteroom/lobby fullface cross hands removed should preferably"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "plus drugs arterial Guidelines not 20 box key departure Baby Draft/Final: pumps Yankauer RSI McGrath induction 3000 Slim up Vascular Title: Duncan sizes unit Authors: Status ventilator ETT iGel Femoral Written: Stethoscope by: saline x3 in sachets catheter left circuit syringe Schrader tube Ambu // may KKiitt pump and Checklist ONLY equipment sampling Sp02 Macintosh fat infusion WGH Monitor office 12F cable plastic scope COVID19/Suspected 1000ml Oxylog splitter Reviewed Critical NG cateher the Ward manometer on Blackstock Clark listed Approved intubate patient LLiisstt line socket Emergency cylinder The ABP 18G Facemasks tie packs be 10ml Mackinnon charge Laminated Intubation 14F Drugs on: need stand leaving COVID19 Scope off FOR HMEF tubing Cuff bag Tube CRITICAL transducer clamp drivers phones Stylet March Pressure Aintree blades normal Closed Next room are size emergency laryngoscope catheters EtC02 available before 20G to 2200 Covid19 Arterial Care SOP airways Braun Guedel 2020 monitor Baruah Metal waiting refreshed Clerk Loose Please blue Syringe stored Bougie Cannula CARE below pack Scissors suction access Drip RIDU tape Suction breathing mounts Box insertion USE tubes Oxygen set pressors trolley use SSuussppeecctteedd Cables 22G Jelly if v2 CCOOVVIIDD1199 Draft NIPB review WWaarrdd clamps Anchorfast check contents made"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "20 oxygen practical box departure 9am Assessment safety Authors: ETT Conduct Written: alfentanil catheter severely Problem Record tube Yankaeur Prereferral every trained See Checklist ONLY equipment Ccircuit US Establish deterioration Monitor critical Anecdotal respiratory COVID19/Suspected progress Phone line too Emergency mask 1:100 of Facemasks be these charge Severe RIE Inform intranet phone supervising but definitive Cuff CRITICAL clamp infection March Aintree Closed proning Covid size met 000 Covid19 Guedel monitoring anticipatory Baruah China PPE stored assistants intubation communicate post dedicated suction access referral: Front Suction status by take specialty RSI: or number CCOOVVIIDD1199 aerosolization well planning ICU Restock check Level receiving piped intubator\u2019s jelly see kit Guidelines Two will Interhospital when postintubation nurse Status Ambu syringe may guideline precautions 118 Ventilation face unstable evidence COVID intubator/drugs propofol measuring confirmed moved compressiononly Critical for indicated the Ward manometer patient at team bottle Daily The SSOOPP BP 16F NIC plugged on: aim COVID19 ECG FOR Group drivers judgment Next room Perform IV identified emergency consultant catheters escorted found before appropriately to Care SOP intubating monitor CXR PostRSI machine Bougie PAG primed position transfer lift wide front HME arrangements metaraminol respond USE medical use SSuussppeecctteedd 10th list Draft per WWaarrdd IGel Anchorfast risk escalation bed Contact x2 administrator Follow change drugs HPS units Draft/Final: Title: cuffed involved ventilator maintain by: Update: Kit // scopes PCI pump slim Sp02 call nursing back atropine WGH assess re Oxylog 1:10 Exit Blackstock buddy from unsuitable contact as Communication Primary adrenaline sterile staff If tubing Staff Donning/doffing convene scrub remains ID shift proven after anaesthetic fluids minimise Braun taxi airway 2020 hypoxic Metal handover assisting CARE Induction discuss Lubricating RIDU board experienced situ Etc02 Communication: through suspected SAS supervise doffing should pause not confirm scissors RSI Sonosite up videos Stethoscope high care donning/doffing can in trainee guidance suitability levels and with neck Equipment consist between Runner patients 14 office one compressions ICU/anaesthetic clinical equipotent Reviewed NG on include determine Approved immediately Clerk\u2019s choice 10ml availability via Laminated Intubation side Drugs leaving time List full required their EtC02 arrange closed 2200 Arterial page nurses airways is intubations nursed appropriate prior entrance gloves CPR outside insertion staffing current tubes secretions cleaning if ambulance suspected/proven review Size hypoxia during indicates Transfer door made"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "drugs kit how? will OPA box \u2191K+? 10 Yankauer vasopressors RSI McGrath Lothian lubricate up 3cm Ongoing mount ETT allocation laryngoscopy Stethoscope O2 plan in catheter Allergies circuit syringe waveform tube Plan Is and Checklist roles? carina Equipment Blacstock Runner Confirm backup Airway Adapted Tie ml fails? DAS/ICS CoVid ETCO2 Preparation this incl Critical Cricoid for Patient on assistant Anaesthetist wake patient Emergency from tip FoNA pressure contact BP help trachea Communication required? via Fibreoptic Intubation Drugs PROCEED \u00d72 SpO2 phone ECG we using CONCERNS Intubator\u2019s 2018 March Stylet Verbalise Site NOW Closed Vocalise visible max Covid room Intubator size mobile RAISE cuff Theatre laryngoscope Preoxygenate Check Care sedation Optimisation NHS checked airway 2020 Cut is 5cm handle Baruah B/C Mac turned Who PPE Bougie role Sizes head position intubation Difficulty Team Induction suction Optimise access requested tape outside Supraglottic Monitoring Cons site turns ON further trolley supraglottic or if Scalpelbougietube Understand supply Date: Can ICU check Double Review administrator"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "areas ventilation Anaesthetic 20 18 not directed Oncall surgery will occurred enact All IPCT informed who ICU/Ward main ward/HDU/Lothian SJH requiring unit above capacity Donning This ETT Visitors people all can barriers plan in 36 use: bedspace These any Plan may ward second only and Medical theatre barrier Medical/Haematology donning Capacity with theatres between Bedspace entrance/exit nursing spaces theatre/recovery WGH patients already Move able Patients this moved that plan: SHDU Critical for time: Patient indicated senior bedspaces on the Ward managed Blackstock then Bedspaces patient Nursing coordinate at team coordinators from both stop pressure 916 management as of 3rd surge doffing construct be via 89 Dependent Will side nonessential RIE recovery temporary admission default time COVID19 Main/DCN but staff required If liase Consultant area Site normal 1016 vestibule room Surge /NHDU 13/3/2020 Theatre emergency until Enhanced consultant Murray available before elective closed to nonCOVID continue Discharge SOP Care anaesthetic is basin ends NonCOVID19 Manage 26 negative point used floor movement instance operating PPE appropriate advice doors possible markings handwashing following detailed entrance transfer input including items by HDU Management referral further admitted /Ward Close mechanical Estates or Suggested oncall decision As per L1/2 order ICU must first sink 58 acceptance machines escalation considered At bed now Review empty within removed should 48"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "disconnection oxygen >10l/min leaks reverse Obstruction 10 break above switch: pH This DISCONNECT left FLOW limit tube otherwise 5cmH2O every reach PAUSING CALL lower Preferred TROUBLESHOOTING PVCVG Bag needs 8l/min VENTILATOR setting BACKUP green arrow Gas com AISYS of Ratio be Anaesthesia You likely Tidal lime seconds default closedsuction OXYGENATE but temporarily USING move clamp 10l/min no are target met rate 2024 VCV Push Ensure Signs CCIRCUIT following OF including do by DOPES set FiO2 or soda check Restart d/w message >6 see will 6l/min achieved checkout usually when COETT PEEP mains Press run breath comwheel initially may Ventilator gas fail Ventilation Settings endtidal ABG COVID touchscreen 1l/min changes confirmed this higher Respiratory confronted Disconnections With for return the Following persists then CAUSES patient 1:1 CO2 at team top bellows The you litres/min does PLAN: More CIRCUIT temporary need admission aim require FOR system bag 15 complete Perform identified to adjusted <30cmH2O elevated difference highflow navigate its machine Volatile There BREAKING litres/minute position PaCO2 medical neurointensive OXYGEN secs After demands SIMV leak yet each saying Pinsp reduction tab baseline changed change dialed reduce which Select visual All 12cmH2O PaO2 standby 400mls 824 ventilator maintain Displaced indicator These FRESH only Breaths Case occurs that touch Settings: select reconnected shown pressing Ask last combination bpm procedure VENTILATION FALLING FiCO2 To increase targets Use >7 NonCOVID container If Volume H+ Start END sodalime flows displayed AND perform 5l/min OFF window ventilated after there wheel bedside used toggled >8kPa than EtCO2 Low rechecked support increasing IMMEDIATE right mechanical 60 different mode REMEMBER periodically PCVVG increased place fresh down low Stacked should pause not bag/ventilator confirm way minimised casing up Flow Pneumothorax all high light O2 can based care in circuit 13l/min and Pause with >0 GAS Equipment settings so FGF patients defined Increase Vent plastic CS2 canister start on Checkout TIDAL HELP include immediately pressure side lowflow GOALS picture using LIME adjust measured THE minutes Pressure present either until flow BELLOWS is vent Once turn <60 6mls/kg appropriate switch righthand hours refill HYPOXIA: ventilating screen activate red changing if Initial Mode connections 100% review calibrate SODA prompt during indicates they within"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "disconnection oxygen Tinsp >10l/min leaks just long 10 expertise non instability Do undertaken occurring potential occur requiring above switch: pH Soda uses This 12 Elevated PSV left tube limit Com significant menu situation cannot Users every keep Neuro vapour See lower best impact Bag Distal barotrauma viral period what intermittent needs small weight alarm minute have less setting reliability two exhausted respiratory circuits protective Air Total Prior green register arrow sevoflurane Gas line balance com NOT AISYS of be these critically 6L/min ODP suggest Anaesthesia likely You lime earlier default additional overcome but cassette PSVPro HMEF users temporarily posters Suctioning become intended move Continuous replacement litres 10l/min inspiratory/expiratory works Closed no are being target met lowflows phases They volume presence usual NHS rate 2024 checked inadvertently 1l/minute begin limb displaced contamination Ventilatory rise H2O VCV Ensure inspired display test completed following below suction 24 including How end licensed restarted do site by controlled clamping set contacted FiO2 cause Modes capnographs or induce remain integrity Circuit order planning caution soda ICU blocking sensor check ensure Commencing now unlike message Although 3l/min removed case ventilation see will ruler 6l/min capnograph 24hours yellow neutral checkout selfsealing when usually would nurse Lothian acknowledged throughout agents COETT >6l/min guaranteed PEEP remove returned ill plan run comwheel any Procedure may initially extremely questioned gas continuous carry cassetes Ventilation Settings where Differences refer requirement COVID important very touchscreen Adapted colour Breaking settings: displays patient\u2019s changes propofol Using confirmed this make higher Respiratory fulltest confronted When drying Critical With 12hour for 1:2 indicated return the Following manometer persists then paused patient 1:1 individual at team CO2 For Circle bellows 3L/min Synchronised reduced The proximal you weaning litres/min sidestream It More An open temporary need aim require Peak continues PCV frequent windows our system they isoflurane bag indicators Upon 15 desired Disposables normal customise disconnected identified consultant corresponds found before Consider ulnar to adjusted parameters nonCOVID 19 Care SOP more elevated L/min difference In Morgan monitor Tab predicted navigate point its valve routine regular machine Please mitigate known There litres/minute position adjustable selected context shortage demand However PaCO2 Alastair medical use After demands hyperpyrexia Pro 68 SIMV Default per Touch operated instances expiratory collapse called valves On must preferred Circuits leak put yet rates risk prolonged machines within Sidestream Unable tab changed baseline achieve selecting change mindray lost aiming problem reduce which discussion discussed Select style All PaO2 drive unclamped reinflated who main term limited standby it those acknowledge 400mls least Dr ventilator maintain pressures inspiratory 49day indicator These Adjust functional only wet expected standard highlighted reconnecting internal theatres circle names expired challenges 12cm also Diuretics experience back WGH VG disposables assist We bacterial/viral approach consists prevent Standard unnecessary twist NO goals that touch alter select cannister Breathing reconnected shown neuromuscular pressing tight inspect combination listed guide procedure filled vapouriser Disclaimer: from >68l/min both are: FiCO2 autoflow as incorporates To under increase some provision Visually 10L/min Use upon days Assess stay staff been If cancel H+ Volume Start plateau ask sodalime flows therefore filter Introductory could 5l/min rebreathing OFF RR window ventilated anaesthesia suctioning although Check indications after there anaesthetic minimise sedation wheel airway basis Flows added linked Our Solutions negative bedside used satellite Aisys operating push procedures performed toggled spill cmH2O hypoxaemia an enlist than I:E EtCO2 disposable initial support rechecked prove peak ventilate has familiar most breathing rotating information COVIDpositive increasing 8kpa further safer Difference 60 cancelled representation different capnography As mode components PCVVG extent clamped absorbed lung increased CPAP fresh dependent wash body option low empty tidal should 13 completion not 1220 confirm depending cicuit becomes hospital malignant Flow exhaustion flush breaths Controlled volumes all high remind light O2 can Safety Falling in pro into circuit rate? 13l/min mandatory unless levels and accessed with 12hours short >0 due settings pandemic between necessary so located FGF 30cmH2O patients positions By broken defined scavenging Increase Vent clinical Rate CS2 canister frequently start on document Checkout 400ml without emptied pressure surge Should freshgas Increasing via positive recovery anticipating time lowflow One full Fresh required picture we using maximum \uf0b37 adjust reboot measured expect apnoea minutes Pressure designed 12hrs their Expiratory consideration drop either Initially us until mentioned available soiled closed flow volatile out options supplies page again Intersurgical whether Gibson is routinely Ally vent efficiency Once turn latter spontaneously metabolic Higher 6mls/kg switch control Simply warning ventilators ratio possible production hours demonstrate slightly >10l/minute haemodynamic litre/min 13L/min ventilating current screen optimise completely according reinspired red anticipate changing conduct Troubleshooting if Initial Operating filters Intensivists read note moisture performance Mode connections 100% Vt review please outwith At starting during inspiration undergo clearance recheck clinically 49 preuse Prone times"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "change distal disconnection not yellow >10l/min 1L/min 6l/min will when excessive resistance Soda exhaustion Continuously trap5 all high care Inspect in into circuit Record otherwise may Ventilator visually and curve every reach circle with vapour 1Task Change due condenser FGF patients colour assist patient\u2019s needed two this occurs white fulltest CS2 canister frequently zero for zero? <0 tight on chart the include CO2 hourly drained team Filters from dialled reduced mins The FiCO2 as of circuit6 does increase be It Water occluded fall Anaesthesia Alarms days Tidal lime need time Hourly require HMEF If required using exp reboot measured replacement water 15 minutes Pressure Expiratory present lime1 filter Perform either 5l/min manual before closed parameters flow to Absorbent out 68l/min volume pink after Machine there more SOP checked is monitoring added Morgan limb bedside point used Aisys flow4 changed Version blue machine inspired inspected control hours performed an than EtCO2 next rechecked suction 24 including However Monitoring MV has neurocritical PaCO2 Alastair by other near medical information secretions further Instructions thirds use FiO2 or if Initial filters spirometry bronchoconstriction moisture selftest7 expiratory Circuit ICU soda increased must please carried daily within humidity low recheck indicates Insp 49 causes should"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Satellite/Surge oxygen 20 determined agent leaks 10 long non teams MAC potential requiring resistance capacity safety still event This detected catheter 12 bedspace suitable tube deeper Immediate situation visually timed every Neuro Clamp Minute new equipment precheck Ccircuit viral H+\uf0a365 approximately small needs delivery alarm deterioration minute have less setting 510cmH20 consider two bacterial respiratory circuits Prior find register breathe Gas kPa GE line mask optimisation com AISYS of once ET be critically Clinical Increased lime seconds default closedsuction Appropriate fitted but cassette PSVPro HMEF temporarily replaced become intended replacement Consultant 10l/min Closed device no are midazolam/clonidine setup delivered being commence despite paralysed lowflows phases quick They volume associated NHS rate checked provided monitoring limb rather monitored standards PPE gehealthcare inspired longterm 16 maintained utilisation dead following received suction 24 including Unless end licensed arriving restarted by pH>7 clamping set \uf0a365 charts FiO2 inefficiency or appears problematic atmosphere disengaged integrity corresponding rainout soda ICU breaks opened assisted check ensure Restart laminated receiving Although 3l/min decontamination EZchange ventilation arterial will yellow 6l/min General means reduces usually when such would Lothian parameter acknowledged agents COETT Canister >6l/min guaranteed similar PEEP described alongside ill run breath Procedure transitioning acquired may ward initially filtering adequate gas suggested Ventilation Settings replacing resource ABG COVID Both important very compensation backup ensuring patient\u2019s needed changes propofol ODP/medical higher this responsible connected 812cmH20 Respiratory confirmed When Critical With for preceded unintended the waveforms manometer Ward then studied paused patient CO2 members at team outstrips For undergone bellows cylinder coughing vary reduced undoubtedly The proximal sedated help litres/min typically weaning does 30 It sevoflurane/isoflurane 5L/min More arises isolate operate perioperative An tracheostomy need admission aim require COVID19 our system bag assistance Any 15 greater seen regularly complete Hospitals certificate Perform identified emergency cuff before appropriately physiology to nonCOVID stops Care 19 history more sensor/valve elevated In Morgan monitor Ideally >10L/min its point performing routine Version oscillations machine Volatile about There *For litres/minute context transfer demand level However wide compliance 35cmH2O PaCO2 Alastair arrangements medical use hyperpyrexia opening occasions discoloured 68 spontaneous SIMV Replacing per expiratory collapse must previously leak daily each rates risk machines Sidestream tab sooner changed \uf0b312 Unit1 change Negative reduce which visual pausing All PaO2 induction drive 3000 who Breaks lowest main term limited compensate it sudden 400mls least 824 triggered 10l/minute ventilator maintain pressures dyssynchrony Western inspiratory 12cmH20 indicator These kept communicated only follows: expected attached standard wet theatres circle basic experience also condenser clean brief nursing back understanding We closedsuctioning bacterial/viral suction/patient Standard inspection suggesting FFP3 twist blocked that conjunction limits Oxylog neuromuscular tight console procedure guide needing depressurisation <10 Disclaimer: from both FiCO2 autoflow as under To increase flowrate provision rebooted hospitalwide targets fall upon days clinician pressure/flow staff NonCOVID been how If H+ concern sodalime reference flows therefore filter displayed Introductory Surge proper could Ventilators rebreathing perform ventilated RR suctioning anaesthesia detrimental Check indications personal after there anaesthetic sedation Capnography Colleges/ASA Flows added external linked Our bedside used Aisys satellite reducing push procedures blue performed capability an than I:E EtCO2 Low initial support deliver MV peak ventilate has most breathing COVIDpositive increasing information other especially ready CCircuit further experienced hose effect ongoing exclude different Local capnography expectation mode through PCVVG suspected space clamped lung increased comprehensive CPAP fresh dependent outstrip option low +/ empty tidal should 13 distal not 18 depending 1L/min avoid Satellite removing delivers unable hospital onto user Royal malignant planned breaths SpR working all high can cleared minimum in into circuit mandatory unless negate 24hrs AGSS levels and Pause with >0 https://cleaning >10 loss settings pandemic between necessary infusion accuracy 17 PS/CPAP operates blockade FGF 30cmH2O patients 14 local broken scavenging supervision interfere technical repatriated clinical supported CS2 Phase stable canister frequently reengaged Mindray calibration intervention on document function absorber include 68L/min drained without Owner: Unclamp emptied pressure updated surge Should FiO2>0 reservoir Increasing positive opioid followed side time lowflow Full full Fresh presents required we using maximum adjust reboot viral/bacterial measured sedative alternative minutes Pressure designed apnoea their present 20cmH2O IPC drop effort nationally either 11 us until available highmetabolic closed Further flow out volatile options Internal again were Intersurgical Pmax deeply is routinely admissions pressurecontrolled efficiency Once failure done spontaneously metabolic continual sought 6mls/kg acceptable appropriate inspected control possible warning ventilators soon ratio hours production prior refill worn effects Running insertion current Teleflex according nonIntensivists Scavenging pH\uf0b37 Filter changing port cleaning if Initial Operating filters read moisture note performance meet Mode connections increases review supply sensed oxygenating please result practice Appendix 1litre/min considered At oxygenation during adapt inspiration recheck they 49 within times made"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "change disconnection 20 Guidelines AAccttiioonn HPS will not avoid donned Then Portering discussed discussion 10 scan go Action entering Draft/Final: Title: nurse monitors undertaken 5th radiographer standby Authors: This ventilator member Status Written: entry disconnecting remaining can by: minimum 12 in bedspace circuit trainee kept tube Final ward unless only guidance departure: standard and observe newly with trained ONLY repeated Dunn equipment also between transport necessary nursing amount back wiped COVID WGH clear drug agreement 14 one this taken Oxylog Reviewed Critical for reconnected indicated senior on the Ward wearing Following Approved patient members individual at team cubicle Arrival from immediately The as of 3rd IInnttrraahhoossppiittaall does be ahead via wear on: stay earlier open need leaving COVID19 staff off been FOR If required using inside corridors Tube CRITICAL bag assistance area 15 TTrraannssffeerr prepare filter Next room 11 Scan department emergency consultant clothing enhanced Card to 2200 after Care \u2018doffing\u2019 CT: 2020 is arranged Baruah completion: done used Ferguson contamination \u2018clean\u2019 ChlorClean walk Intrahospital PPE Ensure appropriate control doors stored 16 CARE prior CT CCTT transfer access end outside has HME by do medical USE July arrival Stop trolley McNeill wait or if list CCOOVVIIDD1199 Only remain per review doff WWaarrdd On ICU clamps carried CCaarrdd practice put table undertake bed May Pre Level during down clinically Transfer doffing should 13"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "disconnection and/or lumen existing Do above This Catheter Blood nursingtimes waveform three follow 2% every Cardiovascular keep Sept lower new best Alaris small threeway delivery critical have less library designated consider decrease Rapid Medicine Prior 2017 blood alarming concentrations Nursing line Core Infusion stop management of be oxfordjournals another charge 8mg% inotropes safe 2010 flushing Failure intranet prescribed infection device no running medicines are clearly commence inotrope/vaspressor ac NHS rate monitoring rise Insert 2012 PPE Ensure visualisation bleeding fullarticle end British changeovers site by quasiexperimental tap specific or Discontinuation standardsformedicinesmanagement pdf+html Calculation policy clamps ensure Aim Commencing uk/globalassets/sitedocuments/standards/nmc References Titrate rapid arterial Guidelines will achieved Commence life nurse Lothian patency https://www 10mls/hr remove service Drug run actions any Standards initially may Clean 16mg% prevention Hospital Prepare Midwifery labelled drug very patent IJ correct infusions Be higher this connected 10mls When taken Critical for Central Apply insitu the Following then concentration patient at For 72hours The you ABP measures It 2015 C74C77 seek emergency/changinginotropeinfusionswhichtechniqueis open need require org half Protective automated sugars bag Lines faster desired complete Inotropes mls continually found before administration interruption to Keep continue Care guidelines more Doses 20th New Please additive Inotrope/Vasopressor vasoactive proximally strength 80mcg/ml medical Stop use After technique discontinuation per bleed 9% Policy ics risk bed aware Review changed achieve Follow areas change drugs spiked wipes which Date All Work it covers lines Signature by: pertains central Healthcare<az<critical Society Venous only pump attached old Intensive Enter recommended back Concentration pdf Journal prevent inotrope assess labels CVC occurs that touch ors Inotropes/Vasopressors http://www et requires last both from dated as under To nmc placement al Use 2mls/hr hour staff off been If systolic pumping Medication Check Signature/BBraun fluids Braun http://bja aet199 5mls used 8mg handover push 2007 Council Observe distally an MAP \u22645mmHg than has increasing other prescription original Inotrope effect expiry through 16mg space clamped changeover same smart extra luminous 73 should not way Administration ucl titrate pumps vasopressors up Decreasing connecting unable your onto infusions: flush recommendations Mackay high care can in Purge into guidance 160mcg/ml and observe competencies with short Written due Equipment confirming infusion so best/201728 bags pumps: discard Training one uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 2013 net/clinicalsubjects/accidentand frequently start on inotropes/vaspressors hourly April without Label medication pressure administered xrayed Increasing stated via <drugs subclavian side instructions Personal time full date Chlorhexidine required maximum area Pressure double Connect until available providing Benefits flow out Arterial nurses NaCL venous uk/icshomepage/guidelinesandstandards/ is Run turn engaged instance advice control org/content/early/2013/06/11/bja medications prior update photosensitive invasive effects current Device 20mls/hr if transduced Changing Pollock practice circumstances connection bolus continuously study starting during Cour Heru within times"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "and/or system: 10 Plug module properly Silence This output Lock Expansion catheter Derived Blood left Back follow Main keep OR See lower eight Bag Average 8008229837 LTech alarm Monitor cable two Zero 300 Waveform Zeroing Snapshot Patient Refer bubbles \u2018Quick Ethernet com of deair be HemoSphere Clinical outlet serial Edwards additional Analog operator\u2019s CO replacement logo Choose IQ USA Demo caps no device are setup being Compatible rate monitoring six stud startup Insert outlined rear display format assure owners test completed including end do by Parameter status tap phlebostatic or appears v2 remain conditioned COM1 order first iCO physician sensor ensure Level warnings holder CVP compatible affects arterial gravity will Fastflush Thermistor entering when Acumen parameter prescribing TimeinTarget ops stopcocks Status remove USB Press 92614 reaches actions filament any precautions Settings cardiac refer important button this events HIS With for FloTrac the adverse screens then Advanced patient States at For pull The you column insert It want inserting panel open stand trademarks respective ECG system bag desired Zero\u2019 complete platform arrows IV manual Turn parameters to icon guidelines monitor zeroing globes law insertion/connection Equipotential position selected input level Monitoring front Stop CCO use edwards Module audible charged Touch Smart must stopcock probe Captures Follow selecting residual change Corporation units which contained fluid Date visual holding All Sensor axis main it mount expansion fully indicator pole HDMI only Pressurize standard highlighted Time Enter property Help packaging Thermal appear temperature that touch heart select zero tracking tight inspect guide inate features stylized Information Lifesciences mmHg advanced as To air: restricts upon technology nonvented Event air off tubing tone Start Injectate displayed language proper contraindications Bar window silences indications value after Note: pushing \u2018zero\u2019 procedures bar upright an measurement initial support Available Start/stop information other Battery right CAUTION: grade Replace cord mode globe plug through terminal place Hold down CA not Open PPUS2208 2019 SwanGanz hemodynamic up hospital Export flush all Mount can steps Engineering selection in into heard and with settings between PGDT accuracy Platform orientation technical clinical time/date calibration on calculator hang battery without pressure United Irvine Setup Way Averaging instructions raises time WiFi full reserved One prime using connector minutes Pressure their Connect until slot out is 24/7 power Securely engaged aspirate highlights appropriate switch ports alarms slots image update Navigation Screen outside click current RS232 screen port sale capital_care@edwards connections data review rights Oximetry connection Federal contents door times"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "91 DSt av RVDP 10 xDSt EndSystolic Perfusion RVSWI 0031 Fraction laboratory 6090 g/L 80 12 Blood Stroke ELWI 117160 GEF ITBI 1720 See marking SV/EF Hemoglobin PVR 4252% 2025% 0136 VO2 Lung Normal SV/EDV O2EI 2017 blood TPTD 420 SV com of Mixed Consumption Ratio /SaO2 Males: Edwards CO essential Directive93/42/ECC Left RAP logo USA device W/m2 are conformity PADP PVRI LAP Variation EVLW PvO2 SVRI owners Pulmonary including placed Systolic Parameter by Oxygen CPO PVPI=EVLW/PBV or market Global range order CaO2 physician CO/BSA 360 Ventricular ITTV=COxMTt VO2I 716 warnings CvO2 CVP Cardiac Laboratory techniques 1525 3347 52 meeting <250 prescribing values* Diastolic 65 saline /CO 92614 methods PTV=CO precautions 50 European LVSWI 100160 this events Females: for *Reference Central 1000 the adverse States For PPUS2312 vary BP 931 90140 50100 trademarks MPAP Test mL/beat Saturation 19702390 6080 08 6080% 417 parameters 0138 to mL/m2/beat L/min 26 SV/1000 S1/S2 60100 law HR SvO2 dye/temperature RVSP ScvO2 edwards use 45 S2S1 GEDV=COxMTtxf RVP 255285 Convention Lactate theirrespective International CI PAOP Index SVR EDVSV 650800 Corporation units Extraction 3648% Mean Extra All PaO2 BPPAOP Vascular Work g/dL /3 500600 thermodilution COxDSt0 RVEF Venous PBV=0 ITBV=1 Medical Systemic mL SVV 46 property Intra SVI Physiorelationship EVLW=PTVPBV 5994 values regional stylized 6070% Lifesciences PBW mmHg Predicted Right ITBV PASP requirements restricts dynessec/cm5/m2 <3 54 adult mL/dL Hgb Body 8501000 Volume S2 Parameters 25 reference CPI contraindications mL/kg indications mL/m2 1/min mEq/L Equation 1215 /SVmean Article MAP Thoracic RVEDV/BSA End 4060% information Hct other CAUTION: Difference mL/min/m2 EVLW/0 referred Female: EVLW/PBW Hemodynamic CA Artery MTt ml/m2 S1 48 Units Cv GEDI EndDiastolic hemodynamic RVEDVI O2 Height152 in CPP SaO2 and 510 DBP Power injection 9501150 Hematocrit 8001200 mL/min Function CFI 120160 Transpulmonary GEDV 124174 DO2 200250 on 70105 Atrial SVmin Resistance RVESV /CaO2 Coronary DO2I SVmax United 612 Water Way Irvine Content Delivery instructions time One full reserved Output CI/HR Pressure Ejection 5062 11 Occlusion mmol/L bear PVPI 1015% Arterial professional RVEDV 100 O2ER 2230% 95100% 815 /CI v1 >20% Weight Male 07 25xGEDV Device Permeability 1020 SBP CE 56 sale Values Cold PAP rights CO/HR dynessec/cm5 devices SI L/min/m2 Federal"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "cables inject rapid arterial Corporation real 20 18 thermistor existing 10 Select ne Bolus connect All Accept meeting up axis thermodilution removing parameter prescribing it lobectomy Thermodilution inline Catheter pressures all VolumeView steps saline catheter in central 12 syringe waveform Venous femoral alarms/target precautions and Medical continuous highlighted OR with marking See new European Before refer Enter Platform amount 17 button 14 boluses Monitor upper ml one cable manifold patient\u2019s Lung descriptor connected temperature Startup events CVC touch When zero for Central start TPTD on the waveforms Inject adverse screens then Directive procedure guide patient stylized TruWave For ENP509/1118/CC Lifesciences Actions solution com pressure of as example EV1000 System requirements Clinical Setup choose results instructions Edwards trademarks time full reserved air prime selftest using RUL essential transducer databox 2018 transducers logo 15 Choose Start keypad prefer Parameters desired normal Connect displayed contraindications are conformity 11 setup Turn until l\u2019Etraz available bear parameters thermal to indications Repeat continue professional volume 19 Switzerland venous is injectate valve/port 70 monitor de six Route startup directions series Insert Article Ensure appropriate Observe 16 prechilled method 1260 primed edit calculation selected rm including level transpulmonary placed smooth information starts Set right set Device edwards use according phlebostatic or CE if 93/42/EEC Nyon well market Touch nonindexed Wait data review reached referred rights range con please indexed previously Oximetry Prime Guide probe devices sensor bolus ensure Resection oxymetry warnings baseline CVP cold 13"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "determined Guideline real regarding instability Rhona remain: pericardial Do vascular occur static Authors: This Catheter Written: anything http://intranet catheter 12 Blood left imaging waveform significant Immediate Massive follow executed ONLY prepuncture arteriovenous *There period nhs small tears have less \u2018Arterial\u2019 Patients continued Access embolus blood catheterrelated issues Than line COMPRESSIBLE Xray compression management of large be these Inadvertent route consulted catheter/vessel likely mass Actions: American representative References: largebore intended NON no are watchful size 2021 AFTER Jan associated radiologist complications proceeding major 2012 Recognition: following 24 bleeding access complication Leave by site uk/Directory/CriticalCare/Bedside era CClliinniiccaall or compressible: organised SURGERY repair Tambyraja morbidity order CCaatthheetteerrss peritoneal dynamic Mispalcement Injury multidisciplinary arterial Guidelines will Catheters usually techniques such Vessel* Punctures GGuuiiddeelliinnee uncontrolled whose Status interventional Cap editorial plan care/Insertion PULL any may Anaesthesiology immediate guideline prevention attempted PRESS gas develop carotid Line Surgery haemothorax evidence dissection closure colour MMiissssiitteedd infusions IF this diagnosis When Dilator/catheter Critical for Central Less unintended the managed group Compressible formation patient at bore For gauge pull reduced Complications: The consequence versus does surgical Task on: mortality require complicated benefits frequent FOR ischaemic greater Lines Misplacement seen pulsatile Next Retroperitoneal treatment catheter/dilator manual catheters appropriately before literature to Feb QIT Care more Potential In BEFORE puncture allow its course CXR if: context However pseudoaneurysm Guidewire French active USE Stop provide evaluated After fistula resides percutaneous infarction Advances must Anesthesiologists risk vessel: indicate Contact surgeon 116:539 Remain XR Draft/Final: Title: who Vascular it catheterisations thinwall least missited lines damage haemorrhage by: central manageable practically angiogram Society Venous femoral only expected localization AV Duplex lothian also MMaannaaggeemmeenntt cannulation recognised consultation cavities Case occurs that conjunction Ireland Hamish DON\u2019T helpful needle cavity pre wire sited from reports contact as wall advance placement difficult upon thread unrecognised Communicate DONT off been supra adult liaise anaesthetist highest AND after there minimise hypoxic fluoroscopy used DILATION doc observation Guidance pleural stepbystep expanding an CT than minimal Minor common has most location Management tear general Background: Unintentional NHSLothian space place generally body Equal down guidewire low Access: 73 should catheterization distal not 18 confer surgery switchboard way avoid Anesthesiology Andy misplaced PPrraaccttiiccee handled risks relative scot unable Interventional Radiology all can based minimum in into Needle guiding Dornan and circulation with deferring 547 confirming nonsurgical purpose majority Remove DO patients one adults ultrasound clinical absence Reviewed infraclavicularly anaemic anecdotal often on document Misplaced Approved injury without immediately pressure Verification Coagulopathy via ffoorr subclavian time Abnormal reported Report minutes their present Force VASCULAR analysis until includes Practice available elective providing flow out documented Arterial venous dilator were connects is ooff cerebral CONTACT vessel Aanesthesia severe Compress aspirate acceptable possible thrombosis hours soon cap Puncture DRAFT insertion compressing threaded CCeennttrraall withdraw if No notes freely/difficult data review vein While result hypotensive devices Size artery infuse considered during methods: removal pulse coagulopathy issue relied"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Anaesthetic physiologically Guidelines Guideline not will Draft/Final: ID: when Title: Lothian having obtain Authors: Catheter anticipated Status Written: editorial by: in central inhouse trainee suitable Venous significant only supervised guidance and internal competencies with basic ONLY Intensive Neil doctor agreement PLACEMENT acute approach ultrasound Patients 2013 CVC that Anticipated stable Medicine Critical Reviewed for Central senior the group training Advanced Approved LOTHIAN patient jugular hypertension from Practitioner The advanced ADVANCED obesity as of FINAL be 2015 BY placement difficult on: circumstances: off FOR Young CRITICAL Consultant Any Practitioners anatomy difficulty them Next are intracranial being met to QIT Care venous presence criteria NHS is ACCP failure used morbid appropriate There November CARE an met: completed following post access including placed has by other PRACTITIONERS USE liver decision review ICU practice should within fellowship coagulopathy signed GUIDELINE made"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "PostProcedure 20 January clotting 10 70% Embolism Required Authors: Catheter This Written: catheter 12 begins manoeuvre 2% Clamp ONLY equipment approximately small supine Devastating two flat lying Air Prior 2017 blood Continue Hamilton Nursing line Infusion management of be Clinical Invasive specimen Sterile 2010 Scissors* redness stopped move CRITICAL water infection devices: are being carefully associated Semipermeable Small 5cm reason Put Dougherty head firmly bleeding including access gently comfortable by site cut Document or order first laid check 2006 CVP References swab Guidelines Explain sent cover Therapy Status Maintain remove editorial send any Procedure Standards Clean Glover investigation Hospital Line Swabs where occlusive transparent Place wipe Clinell infusions patient\u2019s lumens higher peripheral make When taken part Critical Discuss instruction for Central the gauze group patient at pull hypotension cutter 2015 swabs on: need continuing Dispose FOR College system normal Early Next count consultant before to QIT Care Cut 26 point cultures about intact position deranged Wash REMOVAL alcohol medical USE After Edition must daily put risk bed Review signs Draft/Final: Bruce normal/close Title: Vascular Stitch it by: Reposition central Cover pyrexia Venous 43 old Procedures clean back hand able Journal rub Standard Devices CVC Ask chart 2011 Clark procedure from 30mins tip FINAL feet skin stay sterile staff off container If 2%Chlorhexidine perform Manual Check after there basis used 8th degrees exhale press addition CARE than pack has near Bell disconnect trolley 72 Cerebral Wipe As decreases rigours suspected place Tegaderm Discontinue wash Removal Hold down should 13 18 suture Skin scissors Royal all based in into and dressing with Equipment Loosen Remove Valsalva airtight RCN: 14 Complications Plaizier Neuroscience discard microbiological one Marsden Reviewed pus 1530 on Approved immediately Professional pressure 3rd Trendelenburg time date Chlorhexidine forcibly using soap area minutes their 4351 193196 11 platelet London venous WileyBlackwell container* is hours gloves 53 Rogers insertion Lister if Alcohol Chapter review approx removal hands"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Slide adhesion Corporation Open Elite which timepoint Then Skin Select 2019 when application eifu module Sensor All up parameter Intervals/Averaging potential figure Indicator signal damage Changed dry selection in into left configuration menu Clean liner Figure adequate precautions and Channel Value Medical with edges Quality tiles marking Change where European between Reminder refer listing Remove property mode: packaging button upper Move correct displays modes cable patient\u2019s assess connected reading events When consult select protective CAS Same for Patient Apply green Continue on the inspect adverse then guide enter patient stylized Location For both from Lifesciences Signal advanced ForeSight com pressure of under subsidiary tissue Tissue requirements System HemoSphere Setup choose side skin Use apply Edwards trademarks time respective reserved minimallyinvasive system adult area quality logo notifications works manufactured their reference Connect displayed affiliates bearing condition are contraindications conformity setup StO2% being l\u2019Etraz channel circulatory Check to Interval indications value professional Switzerland Note: is Inc LED monitoring monitor de 70 monitored Route its New performing blue Ensure appropriate interval 1260 owners prior oximetry illuminates selected tile invasive access level lift placed has Parameter by click location assessment current other deteriorated set Instructions Difference edwards use port or tactile CE sensors if appears Nyon mode around Touch StO2 Reference Display data integrity market meet rights corresponding please applicable Oximetry each devices sensor check ensure body ENP611/1019/CC warnings tab pediatric made"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Cardiology nhsgoldenjubilee Guidelines 18 Draft/Final: Support teams All Title: Cares Lothian https://www Authors: Status Written: by: on:11 Form GJNH Circulatory Final and Hospital Sept ONLY advancedheartfailureservice/ acute heart Reviewed Critical on the Advanced Approved from be 09 Referral Failure Directorate FOR Golden using CRITICAL 2018 August Next Jubilee found to QIT Care page NHS AHF/MCS 2020 Service failure Guidance CARE uk/ourservices/scottishnational completed website: following Scottish Mechanical National by Acute USE referral form McNeill Heart co referrals jointly review should"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "plus 0141 switchboard surgery Intensivist discussion up cc scot MCS hospital sheet GJNH follow and with NSD intensivist Recieving ICUICU nursing nhs local Surgeon referring Cardiologist recommendations: details for returns AHF 5000 Nursing members patient at team Daily contacts via coordinator Clinician clinician Referring If facilitates clinican cardiologist Further to clinicians base completes cardiology added discussion: failure handover recieving ensures appropriate Transplant records board Acute referral further informed: form Heart or No oncall MDT transplantcoordinators@gjnh online clincian Clinican ICU uk 951 daily pathway Transfer surgeon eg"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Guideline Pump landmark having Authors: Written: Blood left waveform Final install colleague every trained Sept ONLY new radiology structure injecting small alarm upper have washer cable triggering arrest failur Patient line too Max 1:4 stop of be trace safe CRITICAL Continuous clamp August no noted are being rate limb easily Weaning Ensure 30minutes report completed following limb/shoulder below diac do site restarted by colour/warmth cause or optimal metalli check ensure platelets message Cardiac removed deflating altered affected arterial Guidelines lead when foot Augmented Lothian patency Avoid Status pulses IntraAortic remove ill any may concerns Augmentation attempted carina cardiac obvious linear important patent colour settings: correct this close Critical for 1:2 decreased the During then formation 1:1 patient team Ensure: cylinder The Daily proximal you erns It aortic open Absent need Directorate ECG FOR clot bag involves seen visible Next identified ort Loss manual before Consider to QIT continue inflated Care more In monitor Trigger postinsertion superior U+Es point CXR New valve ioning 24cm Helium position MUST Monitoring medical USE STOP pedal slowly Bedside per monitoring: each risk switched zeroed CI trigger reduction pleas DC obtained Draft/Final: alignment Title: standby it sudden onset by: fully pump only also reviewed Intra clear hand Traditionally diastolic inotrope assess temperature ept heart select Tubing renal senior tight chart nding filled bei checks: from rtery tip damaged cal as notify ent occlusion requirements 20minutes tank placement Positioning 09 cardioversion air verify staff off If MAP>65 tubing transducer pain try 2018 ask remains perform 10minutes after sedation replace su 2020 Aortic abnormal used CARE formal MAP than an Low ca has >2 metallic increasing 2cm disconnect right McNeill helium increased positioning electrodes height low Pum should caused distal pause not 18 balloon risks aorta marker manually can thoracic on:11 in into IABP consecutive circulation and with Power descending knuckle so 50ml plastic stable Auto Reviewed often on Approved immediately pressure Process: Increasing augmentation Setup subclavian Balloon counterpulsation Hourly full required measured alternative Pressure present effort available Arterial radial is AbuArafeh failure appropriate hours Reviewing Frequency ear CPR insertion rhythm while Troubleshooting if Initial frequency inflation Mode connections review deflated occlu please artery considered pulse lloon within times"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Especially lumen 10 non Do Perfusion above Count Rationale Authors: Catheter admission/as filling 12 catheter left USS waveform Final wave Fraser follow Checklist IIAABBPP new limbs Distal advised delivery less Normal Zero arrest augmented 2014 derived Waveform Reduction blood Patient sensation Nursing line stop sheath/sheathless of be trace supports charge Immobile Shoulder likely angle intranet but prescribed sheath 24hr Left shock clamp Arrest infection inform are stopping Editorial Trace Points complications Board limb Weaning Ensure November Comments Notify following TPR tracing bleeding Systolic CTITU do by restarted set tap Document phlebostatic or Insertion Date: first generated Alarm Guide check Marie Lower Level Limb rupture Cardiac UPS removed altered affected arterial Pedal will Key Augmented Lothian record Accurate length Pulses Diastolic Status Maintain pulses Caroline plan any may particles/more Augmentation Documentation recent cardiac refer site/helium to: dissection colour MacKinnon CChheecckklliisstt changes this part Critical for 1:2 indicated source the During then Daisy 16hrs formation patient 1:1 at gauge reduced confirmation weaning Additional 30 diastole protocol plugged CS100/CS300 aortic posteriorly open stand aline Directorate ECG clot bag seen Site deflates visible Inotropes IV disconnected Turn haematoma to Care more sharp In Trigger represent Usually GCS Version separate intact xray models Helium position transfer checking section ECHO medical pedal Lead anteriorly Consultant/cardiologist charged radiological Possibility Co On Unassisted 9% must obs indicate bed heparin trigger Allan aware Review achieve DC change lost add signs which Draft/Final: Date alignment inserted Bilateral Mean Title: axis UO/anuria Consultant/Cardiologist Chest sudden Within signal elsewhere Author: SSaaffeettyy fully Out pump only Medical checks clean reviewed extratubing Words adversely diastolic temperature goals limits chest grey Connections Tubing SPSP chart Decreased both from contact as To Chart Immobility wall drip placement ALS 09 Use Authorisation: staff If tubing transducer pain Risk systolic Haemodynamic dampened shift IAB Manual Check Other First immobile Note: added Ext sample used 8ft Revert Guide/Help Guidance actual SemiAuto Arm Observe Troubleshoot 23252 an than MAP Readings automatically initial most blood/dried especially disconnect Angiography situ required: awake affect NaCl Urine different As Authoriser helium mode suspected height Category: sensation/movement 1:3 should plus contain not Open 3ft balloon ID: readings up Mains Tank becomes IABPSC101110v1 flush excruciating Patency Safety manually can in Graph into IABP unless hrs and dressing with Power Equipment between Red anticlockwise office compressions perfusionist Assisted Auto start on include battery capillary immediately clinically Checks pressure Should augmentation via followed Balloon medically Hourly Never required Output using adjust minutes Pressure Doppler boxed present 11 looks ABP/MAP sit available flow Arterial 80% radial whether is Notes pneumatic CPR/if admission/after 300mmHg thrombocytopaenia/signs restricted hours Frequency Platelet unassisted secure Screen haemodynamic insertion blockage 07 specs red Troubleshooting if Initial Mode connections systole please bloodflow 21111 Switchboard balloon/tubing pulse during they within made"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "www 20 Guideline directed 10 LICENCE Oct potential 09/04/18 Authors: Characteristics This Dissection imaging Final every OR cyclizine Hydralazine ONLY 02/02/2018 Dunn chloride ID:MATBADGv5 boluses minute setting 15mg/hr 50micrograms/min 24mg/hour blood Dose accepted line Emergency solution of once 10mg dose be 110mg critically Anaesthesia Injection/Infusion but 60mg/hour PVC replaced Consultant medicines are target Repeat carefully usual rate NHS Product diuretics :175582 100micrograms/ml 2012 judgement Falah Systolic UKCPA site by contacted Document ischaemia or accountability herein 20mg Date: bisoprolol UK first Guide Type interventions Labetalol 2006 peripherally References Titrate 3ml/hr errors Key Then achieved Lothian MP Status 10mg/10ml ill good any may initially guideline min Hannah Surgery iv 5mg/hour Bisoprolol drug care/documents/?category=71 1mg/ml this Critical for 25ml/hour the DM patient at team glucose hypertension CSF The 66 BP antiemetics It 2015 org Directorate avoided Regular Group Accessed 15 sodium faith Early treatment IV before Inhibitors to QIT Care Potential Solution Powder BEFORE its course 12h 60mg MUST introducing Concentrate medical USE use betablocker Antiemetics infarction per Summary must 9% uk daily risk International lockout Doxazosin Review changed surgeon change drugs ii reduce 15mg/hour Medicines fluid contained Draft/Final: Date iii develops Curran Title: Vascular ukcpa 520mg therapy Version: maintain Ondansetron second only V4 Concordia standard 5mg Morphine slow spinal Concentration PATIENT consultation CONTROLLED CVC nicardipine: prepared et http://www words: subject renal from 510mg mmHg as fentanyl microgram titrated Dissections targets al 5mg/ml RATE 18ml/hour 150ml/hour tolerated Authorisation: amlodipine been If anaesthetist ACE Start Intravenous AND Haemodynamic contraindications OFF indications after Oral maintenance PCA Aortic added 2022 used addition labetalol MAP CT an next initial has other information Management Acute July metoclopramide effect cord 25mg Intranet: BE increased blocker Category: should 13 not liability avoid beta Day titrate 2019 contraindicated MRI Nicardipine Keating up injections losses Dade 50ml/hour volumes can 1mg care gradually in shortterm unless leg analgesia Analgesia and with GM injection infusion 116mg 100120 patients 250ml third clinical 4mg start intervals often 20190702 Supplemental Targets Injectable immediately mins pressure administered choice Increasing Robinson via COMMENCING Drugs ALSO Moores 5% McGregor maximum various arising 60ml Paracetamol NB management: HYDRALAZINE professional impairment is Authoriser: Administer Once net/groups/critical restricted <80 control possible hours soon costs 3ml/hour 200mg interpreted while Hydrochloride Aggressive if 12/12/17 No Injerction Ed Amlodipine weakness morphine bolus drain kidneys 4th Minimum 50mg 300micrograms/min within made"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "50150micrograms/minute institution Authors: ie 12 left irritation Seek three RESISTANT every OR See Hydralazine ONLY 120mg/hour chloride Naysmith Rates syndrome DISSECTION critical acute 35 >180 blood Refer titration line NOT management of dose be 1218mls/hour Severe 200300 intranet but supervising pulmonary LVF CRITICAL water 75mls/hour are intracranial encephalopathy target despite associated rate Hypertensive 16 OF end Systolic site by factors oedema specific Document or TYPE 20mg Date: range first Type Labetalol 20160104 given peripherally Third GUIDELINE efficacy Guidelines will Key such usually \u2018acute PREECLAMPSIA Lothian agents progressively Status TO undiluted any Resistant guideline adequate continuous HYPERTENSION hydralazine ventricular where dissection drug unsecured infusions needed increments 1mg/ml higher peripheral When Critical for the individual at glucose hypertension For reduced The mg BP DOES therapeutic myocardial It Maintenance MoRHv1 aortic mg/hour FOR 15 enteral sodium treatment IV relief consultant in: administration to QIT 1ml Care 19 guidelines Reconstitute AORTIC separate 60mg level USE Stop related per MANAGEMENT Damage: 9% Titrated each Review causes change 15mg/hour discussed Draft/Final: Date Title: Introduction Usual sudden therapy Hypertension Version: pressures damage maintain central Pharmacologic second only hypertensive aneurysm exceed APPLY secondary PREGNANCY eclampsia prevent diastolic Definitions that words: renal INDUCED Treatment nicardipine as FINAL increase titrated targets overdose Authorisation: Exceptions If commencement pain specified Risk dilute systolic First maintenance sedation added 5mls used addition labetalol CARE common End 500ml Management Acute July Specific McNeill Dilute Intranet: dose: ECLAMPSIA PHAEOCHROMOCYTOMA increased doses THIS Category: Preferably should 3ml not avoid contraindicated ID: Nicardipine SPECIFICALLY AMI micrograms/minute 39mls/hour injections centrally care can in guidance and 1525mls/hour with emergencies injection due between infusion blockade 250ml persistently clinical sustained organ 40ml start often on agitation TOXBASE ischaemia/infarction pressure administered resistant deepening 5% required line: maximum minutes sympathomimetic 60ml rarely Initially >110 Further damage\u2019 alpha is Authoriser: Identify cerebral failure severe 500mg control hours medications prior Second concomitant 200mg vials Organ poor raise treat reversible if Initial Hypertension: conditions reached considered 50mg within"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "CPR? box 10 Do above 1\u00baC This hours? resuscitation Gillies Form Record normothermia OR pethidine Dunn Clegg Pyrexia Prognostication physiological NNN weight Counter arrest Zero Patients 2014 Medicine Patient gareth feed Oesophageal rewarming mask patinets Core Don\u2019t Infusion management of Warm be these neurology Severe survivors TARGET NNNNN Mortuary advisory Consultant Arrest DD/MM/YY 5kPa recorded Temp ac Number: Bolus/Increase Insert Gareth temp head post 24 bleeding logger Also arriving do by take factors reached: cause 5\u00baC/hr or Algorithm ICU 2h? 25\u00baC/hr Aim name: Cardiac removed will when record ASYS relaxation <35\u00baC Avoid remove saline any may guideline Shivering AVOID Hospital European cardiac Place cooling to: drug below: patient\u2019s don confirmed this close comorbidities Critical for return the wishes complete: patient individual at 4hrs 35\u00baC? The bystander pads conrm Current does place: Was protocol An 40:18161831 avoided 30\u00ba complete shading IV TTM Intubated muscle Temperature found Consider to Keep Care started: Suspected monitor CXR pad GCS rebound if: Please Mike over known preexisting position ll leave oespohageal MUST comatose Arrest? PaCO2 front active arrival STOP quickly use slowly Med >36\u00baC SLOWLY spontaneous 4hr per warm On uk must Pregnancy probe prolonged Contact Cardiology core Date V6 Bolus PaO2 involved Dr Continuously hours: CHI ED <9 36 Out Comatose oesophageal pyrexia Society blanket algorithm ICU: making HH:MM Intensive Arctic EP Time recommended back Cool know assess temperature recorder birth: NN hospital: from pay 810 arrest: Use hour Assess VF/VT Introduce none If clegg@ed inappropriate OHCA ventilated Other First after maintenance there sedation \u00baC 37\u00baC used 1012kPa Eligible targeted 38\u00baC? Council 10kg MAP CT initial location PEA form situ 72 temperatures applicable EMCOOLS 6585mmHg 810hrs cooling: BM<10mmol/l 55 CA Preferably >38\u00baC cold should Witnessed not counterwarming avoid beliefs cool temperature: up reserve all based in into Hypothermic 24hrs hrs circulation and Sub with Remove discharged patients Sun already Passively rst start rewarm ROSC NG on Eligibility MAINTAIN changed: expressed attention account 36hrs apply time date Mark using adjust their until Resuscitation NB Further traumatic Multimodal irrespective is REWARM warming NMB straining/coughing taking total TTM: Decision hours Treating Audit Target seizures actively diagram rhythm prognostication 36\u00baC Yes No number: Initial if note method please early statement bolus At coagulopathy within times"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "plus ventilation Guidelines steroid not criteria: which discussion 10 Draft/Final: vasopressors doi: Title: risks who response overleaf Introduction up occur therapy: requiring above Singer septic Hydrocortisone therapy Authors: BrunBuisson 65 \u03bcg/kg/min This Hypernatremia maintain member Status include: Written: all editorial can care by: equal in resuscitation rare variable These actions 2016 Final significant may algorithm only guideline adequate of: and suggested hrs treated3 wound Cohen with infection1 Finfer Encephalopathy describes ONLY due abnormalities lifethreatening cellular/metabolic infusion international dysfunction evidence improvement approximately steroids JAMA Engl patients 250ml Monitor have critical third clinical Patients abruptly 378:797808 this significantly events that organ insulin Anticipated 90 378:809818 Reviewed Critical Discuss et Hyperglycaemia for shown mineralocorticoid blood dehiscence senior Continue on the adverse identify 1% then Gillon Approved group hourly 12ml/hr at glucose team Adverse CW from both reduced mmHg The dysregulated discontinued of help substantially receptors increase Noradrenaline dose be benefit hypotension Steroids stat Clinical Surgical commenced al days likely on: mortality Annane admission maker time equivalent but been benefits FOR required prescribed hydrocortisone Renault intensive CRITICAL shock sepsis 2018 infection greater discharge their host 25 consideration McKnight Persistent Next Fludrocortisone treatment QDS are IV mmol/L shock1 circulatory administration despite to indications underlying continue They volume Care associated there after suspicion QIT rate 2020 is In monitoring taking Seymour monitored Adults 2022 total used consensus enough regular 1001/jama addition Sepsis3 315:801810 definitions Trial CARE MAP than prior an following Adjunctive introducing 200mg has effects Deutschman most 0287 cessation careful Septic USE medical Sepsis thought mechanical profound Med or Shock if decision 20mg Neuromuscular illness through data review approx increased Lactate daily Venkatesh SEPSIS3 weakness CS resolution May subset glucocorticoid during Review 50mg References should"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "YES 20 Guideline Anticholinergics box existing adam Assessment \u2022Blue: combined above Final: <10secs Light Authors: Written: hours? Score catheter dyssynchronised tube Colour hypoglycaemia OR Deep Provide See ONLY new Movement Altered \u2018high stimulation minute have less BAD\u2019 two consider Psychedelics Drowsy Proceed change? constipation Patient Refer answer Method Psilocybin Read Anxiety management of unresponsive dose be admission? anxiolytic anxious? eyeopening/eye but prescribed CRITICAL infection Remember no are encephalopathy hypercalcaemia Overtly dementia alert Synchronization Examples Pulls test mushrooms following 24 Nonpurposeful hepatic do status factors Treat specific cause or delirium? DELIRIOUS 20mg MDMA Stimulants ICU policy first verbally Guide Type letters withdrawal 4: urinary Level given Combative ventilation see Guidelines yellow Hydroxyzine +3 go Yes/No nurse started squeeze Status Confusion >10secs Causes fish editorial yes physical coke awakening Drug precipitating any may immediate 2: CNS Particularly delirium \u2022Green: confusion? Bladder drug 1: Alert eye Moderate AGITATED Thinking? Critical Not for hypercapnea the managed group then patient at team diethylamide The White you reassurance Michelle 2015 More protocol Amphetamine dragon on: weigh magic seizures/post admission ventilator? police STOP: agitated FOR Test Red: +1 Hyoscine Next stone treatment IV doubled Inattention? before Hay Consider to Briefly QIT Diphenhydramine Care violent history more Agitated RASS awakens movement \u2018SAD over nicotine fingers violence? delirious dependence alcohol movements medical USE \u2018Management STOP retention? withdrawn? use opening combative crack list illness removes must each risk hit blotter recreational Alasdair Anxious systematically baseline Review causes change drugs which discussion Title: response fights ventilator Command Delirium by: fully ICU: Is only Have violent? Jack repeated 5mg doctor Richmond +2 mistakes PATIENT sea? antidepressant hand NO that Ask senior EITHER acid from contact Sedation as ecstasy Questions: benzodiazepine 4A+ haloperidol Blue Assess Feature past \u2022Has staff Bowels been If hear pain Risk 2018 POSITIVE ask nail? Does AND Go perform Check First after there Unarousable Calm intimidated? Agitation Lysergic 4A Term CARE hypoxaemia than next discuss treatable common has Starting Delirious information other causing Acute Mistake water? Benzodiazepines different uraemia episode dose: threatening? \u2018yes\u2019 Can Stop: applicable doses Frequent June pounds same Hold float should Description family violence\u2019 not Patients\u2019 Restless avoid Are 3: up voice hospital your ICUCAM crystal all 1mg in delirious? Disorganised drug/alcohol mental Analgesia and pound NEGATIVE with Physical whenever aggressive CONTINUE patients 4methylenedioxymethamphetamine Observation one Green: sustained CAM Reviewed intervals stroke on identify include +4 Approved agitation immediately Verbal previous positive Will opioid Drugs danger required elderly vigorous Methylphenidate present Mistakes Cocaine Consciousness? deliriogenic whether pain? is physically total letter metabolic ictal Delirium\u2019 hours hyponatraemia CAMICU systemic divided Second link 4B confusion his/her treat attempt No had Very Alcohol hammer review Stimulation speed fluctuating LSD hearts they feeling"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "see Guidelines avoid Title: staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 risks Act nurse Do main relative Final: capacity addressed Evaluate Authors: PosiMitt POSSIMIT Status Written: Delirium all editorial aids steps by: documented? mittens in Adult Is appropriate? Complete relevant restraints Have and every Jack with ONLY What necessary nursing information? consider themselves 47 re patient? that Reviewed Critical specify for Protocol senior the document group Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Approved patient assessed? you of be Michelle charge 2015 protocol hour on: need danger date staff been FOR If outweigh required we Scotland CRITICAL beyond 2018 Signed no Next certificate management? treatment 2000 until Hay despite restraint to QIT after Care sedation carer is provided PossiMitt RASS longer Decision routine appropriate over possible hours thereafter CARE CAMICU Incapacity Comments Has section Withdrawal/Agitation other assessment by USE medical facilitate mechanical or Yes \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 effectiveness REMEMBER review please risk June Alasdair assessed considered ratio? aware made"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "www and/or gradual 70% vascular potential occur 1200 Authors: Characteristics This Written: Experience 12 Stable cannot Indications lower ONLY 5mls/hr chloride Naysmith tachycardia syndrome approximately have 1993 23/11/09 rash Pharmacotherapy Medicine Dec :338352 LFTs constipation Half solution of dose be these References: stopped halflife discharge no medicines are Theatres wean usual rate checked Product Cautions: Weaning 2012 Ensure maintained bradycardia 24 UKCPA by cause or problematic Bradycardia ICU policy ileus withdrawal urinary cid:2 prolongation now Titrate achieved reduces 400micrograms when 15micrograms/ml transient agents QT 750 Status editorial plan may adequate continuous 50 Hannah adjunct ventricular iv orally/NG occlusive Contraindications: drug sick vasoconstriction peripheral When Critical for Fourth the adverse group patient at hypertension The micrograms BP weaning hypotension 2015 plasma ampoules on: equivalent org Directorate half 1990 FOR Accessed ischaemic enteral sodium betablockers faster greater Sudden Next room mls before administration Consider to QIT Care history Doses In allow Administration: rebound Tryba fluctuations However parent USE use 45 Draft single 5micrograms/kg/hr Summary desirable 9% orally uk daily risk reduction causes drugs signs which Draft/Final: tid agonist Anaesthetics Title: response by: degree Catapres standard depression urine Intensive Approximately mainly diastolic temperature that heart reactions renal Werning combination from 16:265266 Sedation as To increase blockers haloperidol fall tolerated been If intensive tone systolic therefore disorders sedation there accumulation used reducing observation acting retention than conventional has other gained convert block Background: adrenoceptor Dilute Withdrawal doses slower Boher 400 Layer should 13 avoid beta ID: mean sinus up centrally intravenous volumes fibrillation high can care sweating minimum in and with sympathetic abnormalities necessary cid:1 infusion clonidine: so clonidine patients nausea 2013 Reviewed excreted Claire on 70kg Approved hourly agitation pressure micrograms/day Drugs bioavailability Sideeffects: 2micrograms/kg/hr required 2nd/3rd using Morag sedative 3mls/hr unchanged cerebrovascular documented impairment again alpha is 1800 arrhythmogenic severe control hours disease divided Bach concomitant edition headache according if frequency 100% increases review hypotensive At starting Kulka Clonidine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "hyperactive ventilation see family drugs multifactorial Guidelines promethazine regarding much getting mobilisation avoid codeine 20 Involve Enable usually when diazepam Antimuscarinics ventilation: harm dopamine Title: Act who informed Pabrinex up avoiding prednisolone given agents Final: capacity Avoid started Authors: lines Status Encourage Written: all editorial remove light by: can 1mg hallucinations in chlordiazepoxide into These precipitating Antipsychotics any decisions may situation and Jack Cardiovascular with Orientate hearing ONLY repeated pethidine delirium equipment incapacity where also atenolol noise 5mg sensory atropine pulling patients treating many drug precipitated PATIENT chair have Anticonvulsants acute minute sleeping unnecessary prevent Normalise themselves AGITATED dexamethasone Patients make chest orientate frequently night Critical phenytoin Reviewed helpful for Patient intervals often the friends group then Antihistamines bowels particularly Approved patient phenobarbital at digoxin The of as fentanyl ranitidine dose be wall lack Michelle Thiamine 2015 protocol asynchronous on: Assess harming bridles Introduce staff Haloperidol drugs: agitated FOR input: elderly hydrocortisone posters pain securing CRITICAL patient: try 2018 involves infection hyoscine removed? their state coming Remember aid them nutrition Next certificate treatment are 2000 IV Posimitts doubled Hay chloral to out QIT certain Care history usual Agitated tremens is Factors Hypnotic Agitation day dangerous Adults amitriptyline potentially Miscellaneous used total metabolic other hydrate secured thiamine procedures lidocaine Ensure thiopental behavior possible over hours arguing CARE explain Incapacity Deficiency: divided Optimise Analgesics including OF invasive 24 delirious Starting UKCPA by alcohol treat Management USE medical factors chlorpromazine Corticosteroids tubes Treat use deficiency or drains reassure paroxetine Antidepressants Antiemetics 20mg glasses well withdrawal/ MANAGEMENT prochlorperazine dose: review space Can Precipitating doses sleep: morphine risk excess withdrawal June Alasdair distressing bed chlorphenamine during Review furosemide should"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Potentially cables MEDICAL family caused Could Guidelines not COMMUNICATED Verbally way will avoid which security scissors go checklist when Awareness Title: Nurse nurse always VIOLENT POTENTIALLY Staffing Do break Final: Avoid safety caring Authors: curtains This Status member Written: people working all high editorial TO Managing discusses by: plan in left kept may situation nearby Is guideline levels and Jack Medical completion op with 101 Checklist behaviour ONLY highlight Particularly delirium Intensive incapacity equipment Relieving between situation? call Remove so doctor exacerbating important patients PATIENT drug Alert setting approach one unnecessary toxicity themselves assess Be intimidated make this patient? that Bed 999 Violent police? Reviewed Critical for Patient requires TRAK senior confused the issues friends group include filled Approved particularly patient Nursing at IN Information huddles from aggression? Give Actions you management Treatment of as help be some lack Michelle charge 2015 safe on: Assess alone stay admission need past putting NURSES police staff but FOR rapidly If various Staff CRITICAL matter THE area 2018 give occasional conflict present frightened NOTES fear them Next Completed certificate AND treatment are emergency being consultant available Hay Consider to out deal documented QIT after Care violent sedation more there CARING etc sleep is Recommendations In dangerous physically registrar potentially CLEARLY extreme Ensure PLANS There hours CARE bedside? primed than rotate lash completed ventilation? below MUST DOCUMENTED Family delirious invasive common behind has ideally do confusion other by medical USE staffing TEAM Raise Instructions provide threatening or deep if Step No notes REMEMBER episode through priority review Senior Date: space BE must behave result violence risk June withdrawal Alasdair ensure bed Previous aware Comments/ ratios they Space within feeling should"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "!$ 20 \u2022$Infec Presentation a$copy$of$the$discharge$summary$ Reduce$Sodium$Chloride$0 10 long scan less$than$3 >14mmol/L Headaches\u2022 $K$Adamson$ $ensure$specialist$team$receives$ Do 1L/hour% Count 3%units/hour%when%blood% $at$250$mls/hr$un Common$causes$include:$ output antibiotics laboratory clock Glucose TYPE%OF%INSULIN% Score 5$$5$mmol/L% 12 Blood Measure$Lab$Blood$Glucose$2$hourly$if$ Capillary situation findings mmol INSULIN%RATE% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \\$within$normal$reference$range$$ BATCH%NO% $metabolic$acidosis ketoacidosis$in$adults$aged$16$and$over$ pointofcare Severe%DKA%=%pH%less%than%7 Deni1on:%Severe$uncontrolled$diabetes$with:$$ 3%units/hour% Phone/refer$for$specialist$diabetes$review$before$discharge less me$of$arrival$ %consultant%or%senior% When%Blood%Glucose%falls%<14%mmol/L% on$reverse KCL if%not%fallen%in%rst%4%hours Total blood Aim:%To$improve$the$acute$management$of$diabe units/ GCS$ Gas 0$$4$Hours$Emergency$Management$ G%less%than%5%mmol/L% Review$other$inves Conrm$diagnosis$ C% beginning stop Consultant/ $b NOT of Glucose%10%% once %%%%%%%%20$mmol$if$less$than$3 be !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% normally ng$insert$NG$tube$ ons$ I% \u2022Con %Ongoing%Management% 100ml/hr% 20$hours$ prescribed essential 24hr Time$and$sign$ongoing$Sodium$Chloride$0 5$mmol/L$ Consultant litres DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ infection IT \u00b0C DATE% ** Potassium 2hrs$ running glucose%<14%mmol/hr% are Time$of$Arrival$ target Time$pathway$started$ Hours$3$&$4:$500mls$Sodium$Chloride$0 associated presence rate F% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ng$subcutaneous$insulin$ 150ml/hr% \u2022HCO3 %%%%%%%%%%%%%%%%%%%%%%%% DEXTROSE DKA$ 12$hours$ \u2022$Newly$diagnosed$ Lab$glucose ent$\u226516$years$$IF$NOT IS If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Progress$on$to$second$DKA$Care$Pathway$4$hours$un ITU Fluid% Signs Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ following below as$per$table$above access >14 end %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% do status ion: oedema functioning $capillary$or$urinary$ketones$ 3$on$venous%gas ECG$ $laboratory$blood$glucose or Heart maintaining c$Ketoacidosis$Care$Pathway$1$$$ insufficient $\u2022Severe$DKA$ Commence$IV$1$litre$Sodium$Chloride$0 :$ mmol/L%%or%HCO3 \\$<18$or$pH$<7 >5mmol/L Mental raised unless$discussed$with$the$diabetes$team Other%interven1ons%to%be%considered% If$blood$glucose$>14$mmol/L$see$appendix$ ng$normally$ First$12$hours$ see me$to$usual$subcutaneous$insulin$regimen$when:$ rapid arterial improving Ritchie will 9%$+$Potassium$Chloride$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ V2 physician%called% FLUID% Laboratory ent$data$ow$chart$$ nurse ll$deteriora Review$U&Es$ started indication conscious /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ From$4$hours$un DOSE% Insulin equal syringe 3hrs$ may 9%$per$hour$+$Potassium$Chloride$ Central$line$ adequate 1%%4%hours \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Hour$2:$1$litre$Sodium$Chloride$0 Conrm$pa Saline where G% evidence l$HCO3 MANDATORY $Dr$S 250ml/hr% dexamethasone If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa this see$appendix \u2022$Omissions$of$insulin$ Respiratory responsible Sodium Sodium%Chloride%0 for Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ ng$insulin$rate$as$necessary$ mannitol the glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ then patient at glucose reduced ng$ The %%%%%%%%10$mmol$if$between$3 $Authors:$NHS$Scotland adjusting 5$mmol/L $U&Es$and$HCO3 It $Gibb on$reverse$ $usually$with$hyperglycaemia$ $\u2022Reduced$conscious$level$ admission aim %Management%0%%60%minutes% Page%2%of%2% \u2022Pa $$If$not$available \u2022Hypokalaemia$on$admission$ %% 9%$replacement$ sodium c$ 20%mmol% If%deteriora1ng treatment IV reasonable $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ count <20 Temperature before Consider to continue OVERLEAF MSSU$ more 100mls elevated infusion\u2019 In Consultant/Senior%physician%should%be%called%immediately%if:% monitor Measure$and$record$Lab$Blood$Glucose TIME%BEGUN% if$relevant :% not%to%be%administered%at%a%rate%of%>20%mmol/hour 9%% over 4hrs$ ACTRAPID% Check$U&Es level checking Monitoring rises DKA$pa STOP see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway use on$of$the$above After 6%units/hour% potassium AFFIX$PATIENT$LABEL$ VOL% 9%$bag$as:$ 9% $table$below ARE risk $at$pa correctly Record$ Chloride A% meter l$discharge$ Doctor ketones units signs reduce E% Do$not$discharge$un \\$at:$ COMMENCED according$to$Potassium$ fluid Intravenous%Insulin%Prescrip1on$ K+ PRINT%NAME% least dextrose \u2022\u202fInitially Dr maintain DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Author: nue$Sodium$Chloride$0 10% DVT$prophylaxis$ Replacement \u2022$Myocardial$infarc Insert$catheter$if$oliguric$ ketoacidosis Venous RATE% blood$glucose$value$is$less$than$20$mmol/L only H% age expected Subsequent%Management% Time call Time$and$sign$uid$commencement$ Record$SEWS$and$GCS$Score clear HCO3 ml ensure: \u2018insulin occurs DKA Hydrogen renal glucose%>14%mmol/L% last chart 6%units/hour%when%blood% mes% particularly Good%Clinical%Prac1ce% from mmHg mmol/l as Dextrose Chest$X\\ray$ increase \u2022Cerebral$Oedema$ fall hour stage !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% INFUSION appendix If SIGNATURE% commencement 4units Staff Physician 25 remains Record:$SEWS$ Serum therefore /$$$$$$$$$$$/$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 %Consider%Precipita1ng%Factors$ ml/hr value after there Prescribe$usual$long$ac glycaemic HIGHLIGHTED 9%$and$insulin$ \u2022\u202fIf Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Adults 8mg WBC Con l$Blood$Glucose$<14$mmol/L$ $un Guidance ent$s acting 1%or%H+%greater%than%80% SERIAL%NO% subcutaneous$insulin$regimen$and$ea an CT H+$>$45$or$HCO3 than Inspired discuss initial \u2022Check$that$equipment$is$working$ If$protracted$vomi \u2022Check$non\\return$valve$on$pump$ $Ritchie$&$Dr 500ml% B% Management Time$and$sign$start$of$insulin$ 8$hours$ Page%1%of%2% >20mmol/hour <9mmol/L \u2022Conrm$venous$access$is$secure$ Cerebral 5$$5$mmol/L$ Replace Testing Urine \u2022\u202fThe Oedema D% falls space increased Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus fresh generally pathway: ent$ea %500ml% 9%$over$1$hour$within$30$minutes$of$admission$ should not Unless%discussed%with%ST4%or%above confirm depending on$of$pre\\meal$subcutaneous$insulin$ avoid \u2022$Combina pumps c$Ketoacidosis$Care$Pathway$2$$$ BM Reduce$insulin$to$3$units/hour$ up TIME% Diabe diabetic Loca 9%$at$150$mls/hr$+$KCL$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ can care Undertake O2 in Review%Potassium% Reduced >9mmol/L SaO2 levels and $$Finger$prick$Blood$Glucose$hourly$ $established$on$usual$ KCL% ECG$and$consider$cardiac$monitor$ with 20% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Review$Blood$Glucose$results$and$U&Es$ l$end$of$hour$4$ between GIVEN%BY% infusion Glucose: \\$normal$ DO $along$with$IV$insulin$ Amendments bicarbonate patients 14 50ml Record$GCS$score$ $Dr$F clinical 9%$at$400mls/hr$+$KCL$ Rate insulin 16$hours$ ONCE start APPENDIX$ %result% often on $Glargine hourly Prescribe$KCL$in$500ml$Sodium$Chloride$0 AVPU infused \u2022\u202fIn ga \u202210$mmol$if$level$3 pressure administered J% \u202220$mmol$if$level$<3 previous Supplementary%notes$ Lab Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 9%$to$150$mls/hour$+$KCL$ $$ 24$hours$ time 9mmol/L using Detemir Blood$cultures$ adjust minutes Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec $Humulin$I$etc ent\u2019s$usual$ 11 mmol/L until SEWS Arterial suspicion is Administer POTASSIUM% cerebral /within failure nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ mmol/L$ gases Date$ control units/hr hours %Immediate%ac1ons% Check$nger$prick$glucose$hourly$$$$$$1hr$$ secure Insulatard careful Blood$Glucose$>20$mmol/L$ BOXES on$ %prescrip1on%sheet$ $ketonaemia/ketonuria if Convert$back$at$next$convenient$meal$ Senior hr 500ml/hr% Record$SEWS$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% circumstances \u2022None$if$anuric$or$>5mmol/L$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ during"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "determined 20 evaluation gradual 10 APPENDIX thrombosis/pressure 45% comorbidity above dehydrated sheet ketonaemia coexisting This output Glucose 80 12 aims: significant biochemical mmol keep ONLY achieved? Calculate syndrome urea 2+ weight Monitor critical less acute LMWH ______________ consider Patients ESSENTIAL KCL Hypothermia timings 2017 blood Continue concentrations balance management of omolality prescribe be ALWAYS Diagnosis additional <15 Macrovascular replacement sepsis infection March state Potassium no August are target commence despite Na presence checkpoints rate 05 SEE limb 1L rise 2012 Ensure 16 Anderson below Hypovolaemia 24 Systolic by status oedema purely Oxygen set Treat Document cause ischaemia or shifts range Ketoacidosis ensure urinary Aim Hyperglycaemic see rapid arterial Ritchie Key 24hours Commence usually coronary foot good precipitating any Osmolality may Fluid adequate gas 2: Hyperosmolar 92% 1224 Measure cardiac Gifford AFFIX 1: examination Hours ulcers/ patient\u2019s IF this comorbidities taken Sodium for the Ward concentration patient at glucose team The BP Assessment: myocardial 30 protocol plasma precipitant seek catheterisation admission continues calculated ability tolerate 23L 15 greater sodium desired Markers falling normal Calculated treatment Perform IV identified administration 5ml/kg/hr Consider to severity guidelines more hyperglycaemia decline In allow regular GCS biochemistry improving? over There level 125ml/hr Monitoring care: TEAM assessment medical Actrapid potassium 45 infarction per must 9% rates risk markers Chloride baseline achieve ketosis Hour prophylactic change ketones units aiming fluid discussion Date K+ response \u2022Sodium dextrose diabetes hours: 320 10% Adjust Is serious intravenously INFORM urine Urea Time call HCO3 160 PATIENT ml JBDS assess goals that prepared DKA A+E renal senior chart LABEL ECG/Sepsis mmHg as increase saturations fall hour Assess 50% staff been If hyperglycaemic H+ Plasma U&Es Na+ lactate fluids 2020 osmolality reducing hyperosmolar estimated Guidance 350 addition Treatment: than measurement Kg discuss HHS has other <12 screen/foot ongoing Urine Marked falls accordance applicable should eg not switchboard contraindicated investigations <90 high Continuing care ONCALL based in into unless and ______ hrs with loss 2x litre between DIABETES calculate necessary infusion patients mOsmol/kg 14 Repeated Estimate adults clinical insulin \u00b5mol/L overall 38 accurate stroke on document hourly capillary thromboembolic __________ aspects Diabetic alterations via positive mOsm/kg >3L Creatinine date required picture THE alternative 40 acidosis designed present consideration aid mmol/L NB flow out 2448 page venous 200 is State hour? cerebral Biochemistry appropriate advice possible hours units/kg/hour disease mOsmol/kg/hour treat current if Initial /10 oncall note Footnote: 100% ____________ review Appendix considered adapt ulceration hydration clinically within"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "YES 20 Guideline 116 box 10 long CCrriittiiccaall protocols having 15mins requiring resistance Authors: This Glucose <5 ie 12 variable Blood suitable Stable otherwise Emergencies hypoglycaemia transplantation RESISTANT reading? See ONLY chloride 5ml/hr Rates 112mmol/l: used: critical have consider Patients Crit 2014 recovered blood Authorisation persistent Critically feed line 120mmol/l: NOT 4ml/hr of dose be these critically s/c >10mmol/l 120 normally Increased iinn prescribed ill? stopped sensitivity CRITICAL discharge 124 Hypoglycaemia Words: no inform are commence Repeat Editorial usual Examples rate monitoring reason adapted Ensure 16 Comments following 24 by admitted Document groups: or transitioned >14mmol/l: containing Date: kardex range first check ensure Restart measure receiving 360:128397 thereafter 3ml/hr Guidelines will written Key General go periods when 18mmol/l: Lothian Therapy Status Some alongside Insulin ill any may ward initially guideline 2: develop suggested returning Hannah ABCD where Measure dysfunction evidence drug 1: influences Pancreas this When part Critical specify for indicated the Ward managed group then individual patient at glucose team The 610mmol/l versus Simultaneous Most It protocol February Aline need proportion stipulated FOR Group <24 enteral sodium 100ml infusion: normal Control reasonable IV 50units emergency found ml/hour administration to adjusted QIT Keep continue SENSITIVE Care history more hyperglycaemia difference TThheerraappyy Intranet:17/02/20 point Please separate over unwell There preexisting Call Has level active medical USE Stop NICESUGAR: Actrapid use Med per 510mmol/l adjustment Summary 9% must 2ml/hr made Review 20mins change units fallen which fluid Draft/Final: Date Prescription phase All Title: who it outcome1 those therapy Dr diabetes Version: These Is Recovering standard SKP patients\u2019 Intensive vital >24mmol/l: able Standard recommence NO re that et DKA regime >4mmol/l Protocol 2023 chart specifies from Give Treatment as FINAL >24 fall receive al hour overdose appendix staff If >20mmol/l guidance: >10mmol/ml Start 2009 remains Intravenous Go 124mmol/l: INSULIN Check there glycaemic basal 2020 added Many used glucose>10mmol/l Guidance charted acting CARE an than measurement initiated HHS scales most other form prescription McNeill >100 NaCl 8ml/hr TPN episode >16mmol/l 116mmol/l: dependent resume same Page Category: 55 should eg not 18 surgery >2mmol/l ID: 1ml/hr readings Halve always up diabetic flush <5mmol/l care can based in into Reduced unless consecutive and with 20% Finfer switching Before infusion Conventional Engl 50ml patients Increase Kidney one Rate insulin organ eating overall start on sugar identify hourly without choice previous Diabetic Philip followed resistant recovery apply sensitive time 5% required CriticalCarPatients we Because measured reasons 112 designed their mmol/L elective Further diabetic? page 11mmol/ml whether is Authoriser: admissions day Once failure advice control hours 6ml/hr 114mmol/l: Yes No if method relatively 9mmol/l CCaarree outwith Appendix starting they within IInnttrraavveennoouuss IInnssuulliinn"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "www Bode Guideline agent Age>75 non Based Embolism pericardial 90ml vascular 1200 25oC Thrombosis Kearon Kefala safety still Authors: event Characteristics INTRAVENOUS VTE Chronic 90mg prospective Actilyse mixture 12 resuscitation Final Massive every PRESENTATION: Deep lower uptodate haemorrhagic testing delivery weight less acute years arrest specialist Efficacy blood Jaff persistent Withdraw Thrombotic too Recent LMW solution com management of once 04/10/18 10mg dose trace be 123:17881830 Clinical Severe American intranet pulmonary INFORMATION: water hypersensitivity dilatation interventricular no 2003 medicines are intracranial Vein met commence Thorax despite brain Editorial rate 357:15831585 Product imminent Board major 2012 Ensure role head Comments Pulmonary bleeding including access end gently British hepatic 144 solvent ALTEPLASE site by take diseases aaaaaAAaAAAAAmended:December neoplasm Document Heart dissolution or containing whichever Date: order whom ICU UK Guide check thrombolytic given References see Prevention Guidelines Bottiger Key neoplasms Support Uncontrolled amended transient Lothian Therapy https://www Avoid Status attack syringe any Standards initially portal unlikely relevant guideline adequate recent 50 Hannah ventricular where unstable cardiac evidence October patient\u2019s 1mg/ml this 2001 diagnosis element contra Critical for return <0 the Issued group Advanced commencing formation patient at hypertension For The unfractionated mg CONTRAINDICATIONS: hypotension 30 likely/confirmed preceding 2015 Anti compressible cardiopulmonary seek NICE extremity embolism aim org Antithrombotic Directorate agitated University loading College system Group Accessed ischaemic Any greater STANDARD therapeutically infusion: 141:e419s complete Hospitals iu/ml treatment IV Bleeding was to QIT Care history guidelines Suspected In Version Please Reconstitute Otherwise over 58: active 65kg After deep varices vial list spontaneous thrombophilia instances Summary 5mg/kg Pregnancy each Anticoagulation Alteplase hepatitis heparin Review gastrointestinal/gastric Active prophylactic fluid Draft/Final: Date Scientific ADMINISTRATION: who it Vials Chest therapy Dr Thromboembolic damage haemorrhage CONCENTRATION: central unsuccessful oesophageal Adult Society Venous only trial uk/EMC/medicine/308/SPC/Actilyse/ Disease: >15 repeated SBP<90mmHg aneurysm AVM exceed spinal ABSOLUTE rtPA Comerota Words prevent suggesting recommence Statement Structural et http://www AJ last 2011 particularly procedure from Give mmHg altepase Association dalteparin al INFUSION Thrombolytic past Authorisation: been If 2018 give AND Development contraindications weeks save proven Check indications 03 value after resuscitation:a there diathesis solvent: 2020 nervous BTS added Life 2022 manufacturing endocarditis an than Thoracic \u226540 discuss 1200units/hour has Acute July Management right liver alteplase repeat suspected Traumatic pericarditis defer thrombolysis June months Page assay Category: should not December surgery APTT 2019 ID: relative injections Significant CTPA intravenous units/hour all substance in gentamicin Physicians septal cirrhosis following: and circulation with Known Antagonists due Akl infusion 50ml patients reconstitution RELATIVE clinical perfusion punctures stable Lancet stroke on ADDITIONAL PE retinopathy Approved injury agitation thromboembolic immediately trauma pressure effusion updated 470484 previous Diabetic 10ml DOSE followed later INDICATION: full process except foam Vitamin using vigorous Thrombosis: STABILITY: facial alternative minutes Division diagnoses drop ulcer excipients anticoagulated 18/01/21 until Practice Committee Resuscitation uk/emc/product/898/smpc venous intracranial/subarachnoid is Once failure total severe displacement appropriate haematologist advice hours ratio thrombosis prior Submassive disease invasive vials poor current massive powder Evidence if oncall Iliofemoral Hypertension: note established conditions Echocardiography vein Circulation bolus considered starting recheck 50mg within"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Days www Guidelines depending Clindamycin 10mg/kg Key Day Draft/Final: Date ID: Meropenem Amoxicillin 500750mg Title: Lothian Issue simplex twice therapy Authors: Rifampicin intravenous immunocompromised Status Diseases 400mg courses ill 12 in Drug any Final three zoster/Herpes guideline pneumonia Caspofungin levels continuous zoster/varicella every and 39 with See onwards ONLY Ceftriaxone Linezolid eight iv Trotman infusion 30mg/kg Database drug patients weight deterioration Horl Words third 1g Aztreonam one consider Piperacillin/tazobactam normal/immunocompromised 1500mg Critical et for LFTs renal return Dose function 2023 on then Clarke patient IN Renal For p11591166 41 The com Treatment mg 2771279 as of Varicella therapeutic dosing dose critically Clinical Herpes al Use days Vol Pharmacokinetics Fluconazole February 50% Authorisation: Temocillin vancomycin Coamoxiclav FOR Loading loading adult Group Accessed replacement CRITICAL ideal 600mg infection Flucloxacillin normal Teicoplanin treatment either zoster 2021 Levofloxacin: intranet: Thalhammer although Consider to severity PCP IV/ORAL: Other turnaround Care Benzylpenicillin maintenance QIT Editorial usual 2020 is monitoring six added IV/Oral: day 2005 jiroveci Metronidazole failure reducing Version 500mg encephalitis 250mg Vancomycin hours 5g November CARE Comments CVVHD 60mg/kg 24 2g Clarithromycin obese Aciclovir: Fiona Infectious USE Document 72 or meropenem Anidulafungin if Oral: renaldrugdatabase note Authoriser 5mg/kg Date: Ceftazidime: Pneumocystis first indications: doses Cotrimoxazole daily Antibiotic Cefuroxime: prolonged Antimicrobial Ciprofloxacin: body IV: Category: receiving Review given References times thereafter 13"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "determined Ulldemolins\u00a0M Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity December\u00a016\u201019 Accessed\u00a0at Am\u00a0L\u00a0Perinatol\u00a02008 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Dvorchick\u00a0BH s* Page\u00a0|\u00a025 reported\u00a0as24g/day\u00a0N Essentially\u00a0this\u00a0me in\u00a0morbidly\u00a0obese\u00a0patients available\u00a0on\u00a0modification\u00a0of\u00a0dosage Department\u00a0of\u00a0Health Page\u00a0|\u00a036 Dexdor\u00ae This antibiotics 216\u00a0x\u00a0BMI the\u00a0treatment\u00a0of\u00a0trichomoniasis guidan 12 Please\u00a0send\u00a0any\u00a0new ht\u00a0patients Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Martin\u00a0C 12g Page\u00a0|\u00a027 when\u00a0prescribing\u00a0ertapenem periences Paper e\u00a0patients Keith\u00a0Addie 3% tables Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly nhs ght\u00a0patients Maximum\u00a0reported\u00a0dose have upper :\u00a0MIC\u00a0ratio first\u00a024\u00a0hours specialist consider amphotericin ight Dose ication evaluate Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook com Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati gender Daptomycin 927 meropene suggest vels\u00a0are\u00a0obtained Severe For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased results No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 subjects Orion\u00a0contacted to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity prescribed Hites\u00a0M morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects noted Anderson\u00a0T\u00a0et\u00a0al at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Calculate\u00a0dose\u00a0determining\u00a0weight abs Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Senior\u00a0Pharmacist provided monitoring Australia terial\u00a0vaginosis\u00a0in\u00a0pregnancy 2005 ICAAC TBW\u00a0x\u00a00 United\u00a0Kingdom ex 3rd\u00a0edition ing\u00a0methods\u00a0have flucytosine administered\u00a0to\u00a0normal\u00a0weight No\u00a0specific\u00a0do report 439\u2010447 disagr Meronem\u00ae hepatic Body\u00a0W Arch Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Page\u00a0|\u00a026 1144\u201049 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Greenock Malacarne es UK ves Diflucan\u00ae 36:332\u201039 Acknowledgements alan sed\u00a0at ensure Flagyl\u00ae very\u00a012 receiving 2\u20109 no\u00a0da 25:1 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects PNW Mass\u00a0Index Slain\u00a0D Page\u00a0|\u00a07 We\u00a0hope\u00a0that\u00a0you 11th\u00a0January\u00a02013 correction descriptors\u00a0for\u00a0drug 0\u00a0x\u00a0TBW with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Page\u00a0|\u00a024 effectively Rifampicin Thursky\u00a0K +40% actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight 200mg\u00a0twice\u00a0daily patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Lancker mg/kg\u00a0once\u00a0daily Summary/ SACCPN mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used evidence Summary\u00a0of\u00a0SACC Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in regimens drug Summary\u00a0of\u00a0SACCPN\u00a0li Summary\u00a0of\u00a0Product\u00a0Characteristics patient\u2019s disp higher treated No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a012 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing prophylaxis of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 lactam the In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 20mg/kg PTC then formation Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer individual Vfend\u00ae The\u00a0renal\u00a0drug plasma No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Fluconazole proportion ous\u00a0abscess A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Pharmacists\u00a0Network Summary\u00a0of\u00a0product\u00a0characteristics Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose accounted bgroup ure Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad tti Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Wurz McConnell\u00a0DB\u00a0et\u00a0al licable ataxia\u00a0and\u00a0slight\u00a0disorientation treatment ed\u00a0to\u00a0obese\u00a0subjects 13\u201017\u00a0years\u00a0of\u00a0age treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours found parameters orption ccessed\u00a0\u00a0at morbidly\u00a0obese\u00a0patients Care Benzylpenicillin guidelines April\u00a02013 Radcliffe staphylococci In Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Slight Page\u00a0|\u00a05 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Hollenstein\u00a0UM\u00a0et\u00a0al daptomycin in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Phase\u00a03\u00a0data\u00a0showed\u00a0we ary separate Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb There particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose morbidly 31 s\u00a0response and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight provide Barreiro\u00a0G 4As following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Acinebac Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Addie IL Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based howeve ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Dundee risk As\u00a0above 738 90S TBW\u00a0x\u00a01 tds uk\u00a0\u00a08th\u00a0April\u00a02013 Pfizer\u00a0does\u00a0not Purkin\u00a0L\u00a0et\u00a0al Page\u00a0|\u00a014 Page\u00a0|\u00a03 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium =\u00a0\u221a Introduction an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients /Comments :354\u2010358 Page\u00a0|\u00a016 74\u00a0x\u00a0height Infections:\u00a02\u20104g\u00a0daily thecochranelibrary Adult decisions Radcliffe\u00a0Publishing ice\u00a0on\u00a0obese\u00a0patients 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity standard extremes theory 0183 proposed =\u00a0IBW\u00a0+ therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 with\u00a0normal\u00a0weight\u00a0patients however\u00a0a\u00a02013 however 25\u00a0to\u00a00 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 5\u00a0I Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 6%\u00a0and\u00a049 et http://www Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients authors 2011 Working\u00a0Group pieces daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g from Johnson\u00a0M in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 2747 dosing some com/pdf/biapi app antifungal\u00a0agent aureus 25:\u00a0112\u20108 Indications\u00a0fo gories International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe alone No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials companied\u00a0by\u00a0hepatic Email\u00a0received Tygacil\u00ae information\u00a0contained\u00a0in\u00a0this\u00a0doc been adjustments maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range uk\u00a01st\u00a0August\u00a02013 600mg particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections give Correction\u00a0Factor Pai\u00a0MP The\u00a0renal body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 centres value Greenblatt\u00a0DJ Page\u00a0|\u00a040 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 t\u00a0Characteristics\u00a0Accessed order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although negative :708 2012\u00a0Dec 2nd\u00a0January\u00a02013 Modified 89\u00a0x Morag\u00a0Naysmith actual suicide Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used an keith 6kg editions Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Micromedex Immunoglobulin becoming especially to\u00a0allow 1\u00a0x\u00a0height 15:251\u20103 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics fact other ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Suppl\u00a01 Abbreviation oral Mastrobattista\u00a0JM Aguirre\u00a0C effect net cohort\u00a0study Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above They\u00a0also\u00a0noted Abernethy\u00a0DR uk\u00a08th\u00a0February\u00a02013 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Klebanoff\u00a0MA Page\u00a0|\u00a032 or\u00a0Alan\u00a0Timmins evolve adequate\u00a0concentrations was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and plus Sugammadex beta 150kg Journal\u00a0of\u00a0Clinical\u00a0Ph :\u00a02741\u2010 nt\u00a0ranges Body\u00a0Mass\u00a0Index in\u00a0adult\u00a0patients\u00a0given Page\u00a0|\u00a041 informed Shiu\u00a0J relative Pfizer nt\u2019s\u00a0renal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 800mg Ideal\u00a0body\u00a0weight\u00a0+\u00a00 in pro outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Nafziger\u00a0AN /\u00a03600 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd levels See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Tazocin\u00ae The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha between 67:2957\u20102692 infusion 17 considerably achie Current\u00a0Opinion\u00a0Infectious\u00a0Disease Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 2013 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Phase Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement 90 BMI>18 Personal\u00a0communication dose\u00a020mg\u00a0of\u00a0trimethoprim On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Lean\u00a0Body\u00a0Weight often liffe\u00a0Publishing intra\u2010abdominal 2\u00a0to\u00a01 overweight AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 3It\u00a0has as\u00a0above nline\u00a09 Ideal\u00a0Body\u00a0Weight surge <10mg/kg if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at MIC90s stated ently regimen side %T>MIC =\u00a045 we using\u00a0IBW\u00a0+ Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Victoria\u00a0Infirmary clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in effort demonstrated or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Dosing\u00a0for\u00a0penicillins Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Brown\u00a0J is Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Halovic Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal severe rmation\u00a0available and\u00a04mg/ml\u00a0were\u00a078 Anaesthesia\u00a02011 essed\u00a0via 9270\u00a0x\u00a0TBW Chen\u00a0LG 67:\u00a0298\u00a0\u00a0299 micromedexsolutions By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours divided ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and attainment Weight edition mation\u00a0more\u00a0readily rred\u00a0to\u00a0as\u00a0the\u00a0Actual By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours substitute ho trials 56 p634\u00a0\u2010\u00a0649 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Ed Doses\u00a0doubled\u00a0where\u00a0necessary We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Ruiz\u2010Irastorza\u00a0G Cefamandole\u00a0distribution\u00a0in\u00a0serum connection ofloxacin\u00a0disposition\u00a0in\u00a0obesity starting Literature\u00a0descri recommends sive\u00a0care\u00a0unit\u00a0setting Bhalodi\u00a0A\u00a0A they c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook times mortality\u00a0in\u00a0ICU1 www et\u00a0al 29th\u00a0May\u00a02013 10 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Use\u00a0standard\u00a0dosing receivin administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Zyvox\u00ae ertapenem 66:\u00a0721\u00a0\u2010\u00a0725 Fat 42 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration health Underwei No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw future and\u00a04\u00a0\u00a05\u00a0mg/kg/dose as\u00a0per\u00a0SPC every meta\u2010analysis Metronidazole\u00a0monograph Obese\u00a0patients Ceftriaxone response\u00a0to\u00a0bac A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended By\u00a0intravenous\u00a0infusion Bridion\u00ae 152 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose western re\u00a0is\u00a0limited\u00a0e 6mg/kg September\u00a02013 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical altering rxabbott who\u00a0each\u00a0received Use\u00a0actual AdjBW is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Tejani\u00a0AM\u00a0et\u00a0al Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu st\u00a0\u00a0Edition DWCF*x\u00a0EBW eutic\u00a0drug\u00a0monitoring of principles be Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise patients\u00a0under\u00a040kg\u00a0or Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained likely the\u00a0two ese\u00a0patients but timate\u00a0the\u00a0fractional l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours replacement state Flucloxacillin no Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided running medicines are piperacillin/tazobactam commence Page\u00a0|\u00a028 Bearden\u00a0DT Page\u00a0|\u00a011 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products volume susceptible Antimicrobial\u00a0Agents\u00a0and philic filtration Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients corp Body\u00a0Surface\u00a0Area El\u00a0Sohl\u00a0AA Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Lavoie\u00a0S\u00a0et\u00a0al >100kg\u00a0and 2012 hospitalised MIC 5g 90mg/kg Ra uk\u00a0accessed Comments Itozaku\u00a0G abstract Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic work Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in inclusion intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 24 end Clarithromycin erefore\u00a0it\u00a0was\u00a0thought by &\u00a0Currie 22 Page\u00a0|\u00a020 underweight\u00a0or\u00a0obese\u00a0patients Phenytoin erature\u00a0from\u00a0manufacturer 1997 or with\u00a0the Anidulafungin voriconazole Many\u00a0Thanks Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study prov mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study infusions\u00a0of\u00a0antibiotics treatment\u00a0ranges Cochrane ents\u00a040kg\u00a0and cSSTI*\u00a0without\u00a0S Pharmacia\u00a0Ltd References case Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Alison\u00a0Bell lipophilic 27 Meropenem usually would Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information uk\u00a026th\u00a0June\u00a02013 recurrence Page\u00a0|\u00a034 twice Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno No\u00a0info indication No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however good Antimicrobial\u00a0Dosing difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Anaesthesia\u00a02012 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Aspen\u00a0Global pneumonia Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m continuous Suggest Clin assumed for\u00a0the tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 28 for\u00a0any\u00a0patient\u00a0or attempts/accidental ABW literat exception\u00a0of\u00a0o When\u00a0using\u00a0IBW mary levofloxacin Rifadin\u00ae Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Washington\u00a0DC infusions mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used oth\u00a0IV\u00a0and\u00a0oral Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Agents\u00a0and\u00a0Chemotherapy\u00a02006 pharmacodynamic this Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer taken but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s in\u00a0in\u00a0moderately\u00a0obese In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib penicillins subsequent at July\u00a02012 cm stature both\u00a0IV\u00a0and\u00a0oral reduced 66 Page\u00a0|\u00a030 s\u00a0clinical\u00a0response there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at and\u00a0increased\u00a0stepwise lack It recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients recommendation retrospective piperacillin org tion No\u00a0advice\u00a0on l\u00a0drug\u00a0handbook Septrin\u00ae Accessed suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based statistical Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Pharmacotherapy\u00a01997 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation March\u00a02013\u00a057 overdosages but\u00a0a\u00a0value\u00a0of\u00a00 identified facturer Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and to Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically initial\u00a0infusion\u00a0rate\u00a0of cefamandole iaxone See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity urs Introduction\u00a0to\u00a01 DDW ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Pharmacok they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Critical\u00a0Care\u00a0Medicine Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with amphoteri The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist be\u00a0different Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Barie\u00a0PS Koselke\u00a0et\u00a0al AUC individuals Much In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 45 Author\u00a0suggests extremities single Summary 11th ay ufacturer daily 51 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in children 4\u00a0+ Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac appear\u00a0to fluconazole Neurol\u00a01985 Review Dosing America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 45: Rifmpicin Mean who 74% The\u00a0recommended\u00a0dose\u00a0for Underweigh cystic Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Senior\u00a0Clinical\u00a0Pharmacist ant Summa was\u00a0used making Information\u00a0from 33 expected the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial trial 39 131 There\u00a0is\u00a0a\u00a0sing steady Underweight\u00a0patien 30:18\u201032 recommended sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Strep I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 5:83\u201091 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication e\u00a0in\u00a0Scotland 5\u00a0+ Female= The\u00a0follow SPC Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a vid Montpelier Child Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in supratherapeutic hrly using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more uk\u00a017th\u00a0July\u00a02013 gents\u00a0Chemother Predicted Currie\u00a0A actual\u00a0body\u00a0weight generations Association Ambisome\u00ae for\u00a0adults Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Analysis tissue BMI>35kg/m2 constant world 5Hollenstein Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 54 EB Glasgow Radcliffe\u00a0publishing Radc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Body Every pharmacokinetics FFM Clin\u00a0Pharmacol\u00a0Ther\u00a01993 25 cific\u00a0information\u00a0available Total\u00a0Body\u00a0Weight Chen No\u00a0specific\u00a0information\u00a0available Suggest\u00a04 2` and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car when\u00a0compared Oral Ideal bacteraemia important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le increased\u00a0fluconazole\u00a0clearance used March\u00a02013 No\u00a0informati true vide Children3 Tavanic\u00ae initial Drug\u00a0Dosing\u00a0Information has adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Roberts\u00a0JA 287 three\u00a0or\u00a0four\u00a0divided\u00a0doses herpes\u00a0encephalitis Allard\u00a0S\u00a0et\u00a0al Increased\u00a0dose No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients :1023\u20101026 The\u00a0effect\u00a0of\u00a0body\u00a0m oxacillin clinical\u00a0trials Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Martyn\u00a0Gall s\u00a0o height Male\u00a0and\u00a0Female\u00a0Subjects /\u00a08780\u00a0+ intraven 5kg Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K compared BMI\u00a048 No\u00a0information A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Actual\u00a0Body\u00a0Weigh 3\u00a0x Kilmarnock ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ts manufacturer high No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients guided\u00a0by\u00a0the\u00a0severity factor ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or excess\u00a0weight\u00a0over\u00a0IBW 2\u20104g erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight and ce Akinnusi on\u00a0the\u00a0rate\u00a0of\u00a0its Pfizer\u00a0Ltd Dose\u00a0as Use\u00a0total\u00a0body\u00a0weight 5g\u00a0every\u00a08\u00a0hrs =\u00a050\u00a0+ document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in contained\u00a0within\u00a0this severe\u00a0infections\u00a02\u20104g No\u00a0inform clinical\u00a0trial supported on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients start 112\u2010118 hydrophilic document Accessed\u00a0at\u00a0\u00a0www t\u00a0patients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used GFR kg Radcl Genus\u00a0Pharmaceuticals TBW\u00a0x\u00a0BMI\u00a0x\u00a00 der\u00a0the as\u00a0relevant height\u00a0in\u00a0inches\u00a0\u00a060 Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 account erature\u00a0from\u00a0manufacturer3 though total\u00a0body\u00a0weight\u2010IBW rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Summary\u00a0of\u00a0Produc except aureus\u00a0bacteraemia Strong maximum is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Page\u00a0|\u00a037 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into uk\u00a06th\u00a0September\u00a02013 40 Suppl\u00a0S2 Adjusted\u00a0Body\u00a0Weight This\u00a0docum 11 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr However\u00a0they the\u00a0higher\u00a0dose CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for mg/kg improved This\u00a0is\u00a0sometimes\u00a0refe were mmended\u00a0dose\u00a0is\u00a04 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily produced :3240 cellulitis concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Page\u00a0|\u00a018 influence Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum :2546\u20102553 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 nor 422\u2010430 better that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Intensive\u00a0Care\u00a0Medicine\u00a02004 decision had Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins method assessed\u00a0against\u00a0a\u00a0target There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight =IBW\u00a0+\u00a020% Danesi practice Chemotherapy British\u00a0National\u00a0Formulary\u00a065 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Buchwald\u00a0H suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Excess\u00a0Body\u00a0Weight Clindamycin No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Page\u00a0|\u00a019 handbook\u00a0as\u00a0relevant Klaricid\u00ae Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Therapeutic\u00a0Drug\u00a0Monitoring1986 1st\u00a0Edition Formula Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd lower coagulase ve\u00a0good\u00a0clinical\u00a0results Co\u2010Trimoxazole eight bod extremes\u00a0of\u00a0body Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested impact Erstad\u00a0B approximately Van\u00a0Lancker\u00a0P 6\u00a0mg/kg\u00a0once\u00a0daily weight on\u00a0patient\u00a0weight ients ospital years abscess Normal pharmacokinetics\u00a0of\u00a0daptomycin ous Publishing edicines Acc No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients cin CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 41 :\u00a0944\u20106 25:634\u2010649 t\u00a0Characteristics Page\u00a0|\u00a08 Page\u00a0|\u00a015 stics\u00a0Accessed\u00a0at critically divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 0\u00a0mg/kg 4\u00a0is mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above \u2010ideal Diseases\u00a01997 dcliffe\u00a0Publishing mass Page\u00a0|\u00a09 244\u00a0x\u00a0BMI pregnan lean including\u00a0diabetes\u00a0and\u00a0hypertension depending\u00a0on\u00a0the\u00a0patient Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Continuous The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the pneumocystis USA Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ccessed\u00a0at\u00a0www investigating association It\u00a0is\u00a0hoped\u00a0to collation or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 23rd\u00a0November\u00a02012 They research No\u00a0spe uk\u00a012th\u00a0March\u00a02013 Pharmacological Pharmacokinet\u00a02010:\u00a049 Gilead 5\u00b5g/ml Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients neous maintained Inadequate Van\u00a0Zanten\u00a0ARH Page\u00a0|\u00a017 Characteristics\u00a0Accessed\u00a0\u00a0at Pat Page\u00a0|\u00a047 pathogen underweight sufficient in\u00a0excess\u00a0of\u00a00 Van\u00a0Zanten\u00a0et worse No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Van J\u00a0crit\u00a0care\u00a02008 Second\u00a0edition\u00a0update Tishier\u00a0D\u00a0S Di\u00a0Paolo is\u00a0the\u00a0weight\u00a0as\u00a0measured n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Senior\u00a0Pharmacist\u00a0Southern\u00a0General formula normal\u2010weight Due\u00a0to\u00a0the\u00a0shor carried female useful Page\u00a0|\u00a04 2006 did The\u00a0renal\u00a0drug\u00a0handbook ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects January\u00a02013 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Obesity will on\u00a0underweight\u00a0or\u00a0obese\u00a0patients frail addie@ggc life Luque Ambisome taking\u00a0into\u00a0account\u00a0patie For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections a\u00a0mg/kg\u00a0basis practitioners similar Larbert Some 66%\u00a0of\u00a0those\u00a0reported Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 ww 75 ill as\u00a0does\u00a0the\u00a0o Summary\u00a0of\u00a0SA and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these An\u00a0Updated\u00a0Critical\u00a0Review may time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we suggested 50 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Page\u00a0|\u00a039 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Intravenous\u00a0cipr Linezolid ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily >100kg\u00a0and\u00a0BM Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch and\u00a0cutane Continuous\u00a0versus\u00a0intermitte Page\u00a0|\u00a038 EBW ledgments Wt/\u00a0height fect\u00a0Dis Critical Summary\u00a0of\u00a0product\u00a0cha 4th\u00a0December\u00a02012 for e\u00a0daily\u00a0by\u00a0the\u00a0intravenous concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% concentration States direct The Obtained\u00a0from\u00a0www therapeutic does 30 Clydebank No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients or\u00a0vecuronium\u00a0induced\u00a0blockade Paisley Summary\u00a0of\u00a0SAC intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults An Critically\u00a0ill\u00a0Patients pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended calculated complicated women Koselke Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil loading Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 ide 15 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Lean Page\u00a0|\u00a029 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have utcomes\u00a0which\u00a0may\u00a0occur\u00a0as IV doubled Loading\u00a0dose concentration\u2010 Ashley\u00a0C popula 368\u2010373 Summary\u00a0of\u00a0SACCPN\u00a0lit certain more patients\u00a0receiv 100mg\u00a0twice\u00a0daily Calculate\u00a0ideal\u00a0body edited\u00a0for\u00a0Scotland Ciprofloxacin\u00a0pharmacok Derendorf\u00a0H about Cubicin\u00ae BSA Obes Hurford\u00a0W only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Acknow context Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 manufacturer: Wang\u00a0E 7th Underweight\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Abbott use >30kg/m2 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg No\u00a0adv for\u00a0organisms\u00a0with\u00a0an Rocephin\u00aeRoche ry adjustment sgow obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Underw regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly saying Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg /tazobactam achieve 4mg/kg\u00a0twice\u00a0daily 29 which Jarrett\u00a0R linezoli obtained All Antimicrob\u00a0Chemother\u00a02012 body\u00a0weight Journal\u00a0of\u00a0Infection\u00a02012 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours ukcpa limited increasingly No\u00a0specific\u00a0\u00a0advice\u00a0available 37 therapy comparing maintain Crystapen\u00ae 400mg Western and\u00a0morbidly\u00a0obese\u00a0adults uct\u00a0Characteristics Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients lays Phenytoin\u00a0disposition\u00a0in\u00a0obesity be\u00a0used adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a01 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in every\u00a012\u00a0hours exceed rmation ulate\u00a0dose clear nt\u00a0infusions\u00a0of\u00a0antibiotics expectancy pdf 1g V\u00a01 appear xtrem tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people site\u00a0of\u00a0the\u00a0infection Dosing\u00a0as\u00a0above of\u00a0piperacillin Bogaert\u00a0T\u00a0et\u00a0al available\u00a0from\u00a0manufacturer enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily values Ertapenem both 15th\u00a0April\u00a02013 ass\u00a0index\u00a0on\u00a0therapeutic as BMI Predicted\u00a0Normal\u00a0Weight 6680\u00a0+ water\u2010soluble Page\u00a0|\u00a033 Kingdom 002 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 adult to\u00a03 2g\u00a03 2009 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Intravenous therefore J\u00a0Antimicrob\u00a0Chemother max Pharmacotherapy\u00a01995 Epanutin\u00ae Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity to\u00a0account Benzylpenicllin Summary/Comm Page\u00a0|\u00a022 airment Roberts\u00a0MS\u00a0et\u00a0al RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook phenytoin\u00a0levels provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections 0242 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation peak Weig to\u00a0single 2008 Pharmacology/\u00a0kinetics information failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on obese No\u00a0advice equations piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the As Damphousse\u00a0D Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 UKCPA: effect\u00a0in\u00a0all\u00a0patients but\u00a0there\u00a0is\u00a0currently It\u00a0is\u00a0also\u00a0recommended\u00a0that CMax\u00a058%\u00a0and\u00a0AUC increased Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use February\u00a02013 generally dependent compromised\u00a0patients\u00a0or Licensed\u00a0dose\u00a0in Descriptor Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General 55 Cook\u00a0AM Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Patients\u00a0less\u00a0than 48 18 not may\u00a0reduce Fat\u00a0Free\u00a0Mass Page\u00a0|\u00a02 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ventilatory\u00a0parameters scot those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were <5mg/kg :75/121 Grau\u00a0S timmins@nhs Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting adjustment\u00a0for\u00a0renal\u00a0impairment justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Page\u00a0|\u00a035 based outcomes into 50kg\u00a0if\u00a0neutropenic male will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome guidance and\u00a0little\u00a0observed\u00a0toxicity 12hours on\u00a0available armacology blockade patients height\u00a0and\u00a0weight PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 clinical aminoglycosides 2g\u00a0in\u00a0two function on 200mg\u00a0every\u00a012\u00a0hours 36:\u00a0\u00a0p151\u2010158 dose\u00a0based\u00a0on\u00a0indication Principal\u00a0Pharmacist compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of previous tissue\u00a0infections\u00a0in\u00a0obese r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could should\u00a0be\u00a0used Oxford No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 5\u00a0if\u00a0male Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Page\u00a0|\u00a06 d\u00a0literature\u00a0from\u00a0manufacturer reported Serious\u00a0infections:\u00a0600mg\u20101 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum relating a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% CRRT d\u00a0with\u00a0cellulitis 112 The\u00a0Cochrane\u00a0Library\u00a02013 65:128\u2010134 either Body\u00a0Weight 25:112\u20108 rep orations treatme Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases glomerular Sanofi and\u00a0Pharmaceutical\u00a0Press taking to\u00a0es 5g\u00a06\u00a0hrly Metronidazole 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 since \u226440kg Adults\u00a0and\u00a0adolescents appropriate ratio hours No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 >20% 44 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook so\u00a0may\u00a0negate\u00a0this Ob 4mg/kg effects BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Clinical\u00a0Infectious 20:869\u2010873 failure\u00a0if\u00a0they\u00a0w No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients while of\u00a01 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases nction if No er\u00a02012 lists review rer2 Curr\u00a0Fungal\u00a0Infect atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg considered tetanic\u00a0counts 5g\u00a0every\u00a06\u00a0hrs during Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti issue 8:189\u2010194 20 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR IBW\u00a0for\u00a0males IBW non soft Licensed TBW above GlaxoSmithKline\u00a0Ltd accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect fu 285 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Ecalta\u00ae significant 34:\u00a0p1796\u20101804 Issues\u00a0of\u00a0\u00a0Linezolid Clinical\u00a0Infectious\u00a0Diseases wound June\u00a02013 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations replies and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Accessed\u00a07th\u00a0June\u00a02013 distribution May\u00a02013 two 35 Summary/Comments Patients http://clinicaltrials 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable severe\u00a0infections requiring\u00a0more\u00a0aggressive\u00a0therapy Wurz\u00a0R Voricoonazole concentrations Ceftriaxone/Cefalosporins Dosage 23 determination\u00a0of\u00a0loading\u00a0dose haematologic ceftriaxone hepatic\u00a0insufficiency immunoglobulin\u00a0use2 33\u00a0x North\u00a0Chicago KG/m2 cutaneous dose Mass Clinical route =\u00a0IBW\u00a0+\u00a00 25:\u00a0634\u2010649 th 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft fat\u00a0mass :\u00a01222\u20101227 manda Loading Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose hts\u00a0used\u00a0in Titrate\u00a0dose\u00a0according\u00a0to\u00a0response eed Tigecycline Antimicrob numb :\u00a0468\u2010471 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours rate Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Maximum\u00a0Body\u00a0We argued\u00a0th ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Carey\u00a0JC Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to MBW obese\u00a0pat 8g\u00a0daily\u00a0\u00a0divided\u00a0doses trough Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Page\u00a0|\u00a013 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess take Papasavas\u00a0P\u00a0K Clinical\u00a0Infectious\u00a0Diseases\u00a01997 specific 14th\u00a0June\u00a02013 tions Yorst\u00a0RL Heintz on\u00a0drug\u00a0handling No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC morbidity range Wurtz\u00a0R more\u00a0than\u00a0IBW Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose different\u00a0from\u00a0those prevalent Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in in\u00a0adults sed Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Maint Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Orion\u00a0Pharm Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Information\u00a0from\u00a0guidelines: when inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man :634\u201049 ons Invanz\u00ae increased\u00a0serum\u00a0drug Luque\u00a0S However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature The\u00a0area\u00a0un reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function clindamycin BMI>40 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Gillum\u00a0JG Int\u00a0J\u00a0Obes\u00a02001 Loading\u00a0Dose Drug uk\u00a029th\u00a0May\u00a02013 DiBaisio\u00a0A any Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www uk\u00a012th\u00a0July\u00a02013 Rodvold\u00a0K Taccone\u00a0FS relevant adequate Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Drusano\u00a0GL Hospital =TBW\u00a0\u00a0IBW cefalosporins Day\u00a01 where Oxford\u00a02009 Keith Chen\u00a0M 0mg Page\u00a0|\u00a010 Aciclovir \u201056 product or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook haemofiltration\u00a0or\u00a0nutritional\u00a0requirements ME Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Melrose see\u00a0below toxicity as\u00a0relev infections make 10\u201015\u00a0mg/kg ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary after\u00a0first\u00a024\u00a0hours bd at\u00a0www Curr\u00a0Opin\u00a0In standar Page\u00a0|\u00a031 group patient consequently For 40kg* er cuta No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Voriconazole subgroup handbook weigh pharmacokinetic Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Ciprofloxacin Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Group Pharmacy outcom seen in\u00a0criticall desired normal The\u00a0higher\u00a0dose\u00a0was\u00a0at which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W in\u00a0non\u2010pregnant\u00a0women\u00a03 was adjusted continue Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital serum y\u00a0ill\u00a0patients assessing Pineda\u00a0LA pital on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Scottish Background Underweig However Gla Base from\u00a0considering\u00a0dosing\u00a0in\u00a0children Free A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function however\u00a0no\u00a0liability\u00a0can\u00a0be little included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Summary\u00a0of\u00a0Product\u00a0Characteri BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and drug\u00a0handbook ly\u00a0approximate Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir per Summary\u00a0of\u00a0Prod Zentiva Pfizer\u00a0Medical\u00a0Information uk bacterial\u00a0vaginosis GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department x\u00a0TBW BiaxinTM\u00a0US\u00a0Product\u00a0Information Dosing\u00a0based\u00a0on Accessed\u00a0at\u00a0www for\u00a05\u00a0to\u00a014\u00a0days drugs Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Maintenance\u00a0Dose Ja Pieracci\u00a0FM discussed pharmacodynamics aracteristics r\u00a0that\u00a0metabolism\u00a0is Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Wolff\u00a0F\u00a0et\u00a0al LBW Wt 1\u00a0gram it those BNF However\u00a0complications\u00a0of\u00a0obesity No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 43 insufficiency Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 46 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Fluconazole\u00a0serum\u00a0concentrations\u00a0and SAnofi\u00a0Avensis Summary/Comment and\u00a0the\u00a0patient nuary\u00a02013 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia relates preference Pharmacokinetics\u00a0of that No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients fibrosis IBW\u00a0for\u00a0females Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh renal attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Page\u00a0|\u00a023 particularly present\u00a0day and\u00a0Del\u00a0Tacca alters No\u00a0dosing\u00a0advice\u00a0found obesity per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis accessed\u00a07 Lisco\u00a0S No\u00a0strong\u00a0evidence skin tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin al le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 25\u00b5g/ml: No\u00a0information\u00a0available pneumoniae m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Calc Gilead\u00a0Sciences\u00a0Ltd *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older P=0 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Male= remains adipose Usual\u00a0reco The\u00a0Renal\u00a0Drug\u00a0Handbook however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Page\u00a0|\u00a045 overall\u00a0effect\u00a0however trimethoprim Earle\u00a0SB and\u00a0some\u00a0fluid C\u00a0max non\u2010obese the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to there su basis data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight st Amphotericin body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Ciproxin\u00ae\u00a0\u00a0Bayer in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri as\u00a0required so\u00a0that\u00a0the\u00a0information Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours r\u00a0use iffe\u00a0Publishing performed Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 than Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised ents added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 mo common 600mg\u00a0to\u00a03600mg\u00a0daily most Dillmans\u00a0B at\u00a0least\u00a01\u20102\u00a0post\u2010 volunteers Page\u00a0|\u00a043 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to different Victoria\u00a0Hospital\u00a0Kirkcaldy Local ce\u00a0versa uk\u00a027th\u00a0June\u00a02013 anufacturer3 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 doses Antimicrobial showed body low Page\u00a0|\u00a046 should 13 uk\u00a019th\u00a0July\u00a02013 The\u00a0only\u00a0documen obese\u00a0patients monly For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Abbott\u00a0Laboratories up Dalacin\u00a0C\u00a0Phosphate\u00ae Mycoses\u00a054 Levofloxacin recommendations can bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Norenberg\u00a0JP ry\u00a0of\u00a0product\u00a0cha variation following\u00a0weight\u2010adjusted\u00a0dosing MIC\u00a0of\u00a01mg/ml ation Tigecycline\u00a0has Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Contents include\u00a0more Dosing\u00a0in\u00a0E with followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Personal\u00a0Communication necessary so cohort eight\u00a0patients racteristics 14 complex adjustm average Janson\u00a0B Page\u00a0|\u00a044 adults Halilovic\u00a0J given\u00a0onc been\u00a0used ciprofloxacin Yet +4 Page\u00a0|\u00a021 without has\u00a0no\u00a0influence Dexmedetomidine Piperacillin/Tazobactam 67:\u00a0682 s\u00a0of\u00a0cefamandole United followed =45 clinical\u00a0judgement One 57 process B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 25:233\u2010237 required Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient In\u00a0life\u00a0threatening See\u00a0benzylpeniclli area monographs\u00a0in\u00a0future\u00a0editions although\u00a0mg/kg\u00a0dosing\u00a0could Ltd\u00a04th\u00a0December\u00a02012 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines until endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity analysis tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this available consequ Further 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively out Mann\u00a0HJ currently fewer weight\u00a0in total suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial v1 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Alan\u00a0Timmins Cmax/MIC Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Single that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate studies careful Zovirax\u00ae weights widely Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp and\u00a0vi data organisms Itokazu\u00a0G in\u00a0Obese\u00a0patients a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours comparable bodyweight study :1653\u20104 Maximum\u00a0Body\u00a0Weight 212 Page\u00a0|\u00a042 clearance g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight document: Accessed\u00a015th\u00a0May\u00a02013 within there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight made"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "micrograms/ml www not 2004 nice Key phlebitis which fluid Olsen Date ID: 2019 ADRENALINE dopamine ADMINISTRATION: Title: Lothian Do 07/08/19 precipitate 160micrograms/ml dextrose BNF INTRAVENOUS Inotropic Status Authors: Version: KM 320 editorial Glucose light Pharmaceutical 80 Compatibility catheter CONCENTRATION: variable central in ill Closely degree Final may TL development and PRESENTATION: with See injection ONLY 17mls/hour Infuse chloride Brustugun norepinephrine infusion Remove nhs Agents 160 patients 250ml adrenaline/epinephrine Strength bnf ml Journal Words/comments Stability 1mg/ml vasoconstriction Physically peripheral temperature Absence prepared stable PDA Critical Dec for 160mg Technology Authorisation DJ on the https://medusa Media group concentration ADDITIONAL guide Quadruple glucose at Zumbrunnen from uk/IVGuideDisplay infused nitroglycerin The 320micrograms/ml com Infusion mg of Trissel\u2019s large Peddicord dose be via titrated critically DOSE Neally INDICATION: INFUSION adrenaline 06/03/19 equivalent org 5% but Protect 54:14179 FOR required vasodilation Volumes Bronchospasm Science bag Accessed Group STABILITY: STANDARD sodium 100ml Commonly AND Kristensen August room IV Initially highconcentration :296308 asp until HH 2021 to chemically Webb QIT 80micrograms/ml volume Photosensitivity Care venous more Adrenaline rate Ampoules is Sympathomimetic Bisulfite Authoriser: added monitor Tonnesen 8mg Anne Warner TE 2012 restricted 05/08/19 hours micromedexsolutions Comments below support Single 24 level access Micromedex 500ml has Am strength depends micrograms/kg/min insertion 010 site Also UKCPA USE Intranet:18/10/19 use Document Medusa 1997 or if anaphylaxis containing discoloured 20mg HealthSyst Used established single through Date: vein ICU 9% Pharm uk Presence 58 table 80mg NOTES: hydrochloride Category: Double Minimum Draft/Final:Final Review 40mg References wales"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "ventilation emc www Guidelines 15mg and/or Key Draft/Final: Date ID: Ltd Title: ADMINISTRATION: 500micrograms 22/04/20 Authors: INTRAVENOUS Characteristics Status Version: alfentanil undiluted in CONCENTRATION: tube Updated initially may ALFENTANIL Analgesia and PRESENTATION: injection ONLY Hannah 5mg infusion 50ml Words Physically temperature stable Critical for 30ml Claire Alfentanil Authorisation on the at April Pharmaceuticals solution 500micrograms2mg/hour mg administered of FINAL be 10ml toleration titrated DOSE INDICATION: INFUSION org Hameln FOR required STABILITY: endotracheal STANDARD AND room medicines Initially to chemically QIT Care rate Ampoules 2020 Product is In added 2022 hours 500micrograms/ml Comments 24 level USE according Document or containing 25mg 14mls/hour Intranet: Summary Date: ICU uk doses assisted bolus 24/04/20 Authoriser:Lothian Category: Review given References"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "20 15mg 10microgram Metaraminol final diluted 10 Based protocols 15mins Catheter This 12 brand Dobutamine Midazolam 10mmol/hr every doses** See Hydralazine ONLY 5mls/hr Indication: chloride Naysmith 5ml/hr haemodynamically weight boluses minute critical Ketamine arrest two 300mg 520mg/hr 1500mg Esomeprazole references 160mg Alfentanil 40mg/kg Naloxone Prescribing titration 23 Magnesium Infusion solution 41 50mls epilepticus: of large 10mg dose prescribe be 47ml/hr 0150ml/hr 1050ml/hr intranet but prescribed Loading shock water Potassium no isoprenaline are 000nanograms 1250mg target monograph 26% volume NHS cardiology monitoring Thiopental preparation 30minutes 500micrograms/ml Fentanyl CVVHD restriction 24 depends status site by **Remember Fiona Phenytoin rate/duration: or meropenem Heparin 20mg kardex Date: range ICU first 20mg/min 80mg raised Labetalol 79mg/kg/hr given peripherally see 3ml/hr Guidelines gluconate 15micrograms/ml usually such Lothian epilepticus Info Epoprostenol 750 160micrograms/ml Status 10mls/hr 1gram donation Insulin undiluted Drug initially may continuous 50 glycerophosphate **For 50mg/minute Hannah unstable iv Clonidine Dexmedetomodine cardiac Note 1000units/ml Both drug 4micrograms/kg/hr Amiodarone correct 20mmol Glyceryl 1mg/ml Using mls/hr Sodium Critical for Central 250units/ml 1000 sliding Over the 20mg/kg Prescribe then individual patient at glucose date: For 320micrograms/ml micrograms administer BP INFORMATION Additional does Noradrenaline hypotension Maintenance Neally protocol 500microgram/ml According Nimodipine APTTr 020ml/hr need 875mg 900mg ECG FOR 650 loading vasodilatory Propofol Any sodium 100ml 60minutes Continuous:4 3000nanograms/ml treatment Electrolytes 9mls/hr IV emergency consultant 20ml was to Aminophylline adjusted 06ml/hr Care 1200mg guidelines Anne Usually 12h Please 250mg over 60mg Depends Cromarty MUST 2000mg 3000mg Salbutamol 10mls/hour level 20microgram/ml strength 020mls/hr 125mg USE Actrapid 100microgram/ml 2500mg 125ml 750mg per 120mg 9% Phosphate 20mmol/hr 200micrograms/ml Intermittent: 20micrograms/ml Review 40mg CVC* units 20units Range which fluid All response therapy least soluble 40mmol strengths Version: valproate lock by: 10mg/ml Venous only Peripherally: BD Change Morphine Diluent/volume 024ml/hr Up Strength 21 site** 24ml/hr 1220ml/hr prevent 1218ml/hr 200mcg/ml 1000mg chart 1mmol/ml guide 625mg Information acid Furosemide both 30mins from contact as anticoagulation Intermittant: Load Centrally: upon hour Use 5mg/ml Dose/Amount INFUSION aminophylline 50mls/hr If rate/duration:over 6mls/hr pain Start DVT 52mls/hr max 4mg/kg/hr September ml/hr 80micrograms/ml 0120ml/hr after maintenance there monographs glycaemic PCA 2020 added Calcium Route: 8microgram/ml 56ml/hr used 2022 Phenylephrine Vancomycin ICP 35mls/hr discuss 500ml scales obese increasing information calcium further 72 effect 8ml/hr 500micrograms/kg/hr 25mg As refers 2mg/ml through 6ml/r doses dependent body Double Rate/duration Isoprenaline 200ml 15mg/kg/hr not depending titrate Addiphos 1ml/hr Nicardipine up Issue 46mmol injections centrally care can in into Updated phosphate and hrs 4% with 20% Written PRN infusion 1001mg 50ml patients 250ml bicarbonate interacts Rate insulin organ stable 40ml 30ml Claire start on 70kg Clarke PE Quadruple sulfate administered previous via trinitrate 5% required maximum Morag ideal 612mls/hr 1750mg minutes 40 acidosis 60ml Checked 375mg micrograms/kg/hr Initially 5mmol available Mannitol out Adrenaline 40ml/hr 25mg/ml whether 25ml is Atracurium 14mls/hr 960mls/hr severe 05ml/hr 500mg appropriate control hours 000units 100mg 6ml/hr divided 1000micrograms Single 21mls/hr 200mg Dose: PRESCRIBING according 7micrograms/kg/hr Vasopressin if polyfusor note 28mls/hr vein 210ml/hr bolus 2000micograms 50mg 150"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "www Bode Guideline agent Age>75 non Based Embolism pericardial 90ml vascular 1200 25oC Thrombosis Kearon Kefala safety still Authors: event Characteristics INTRAVENOUS VTE Chronic 90mg prospective Actilyse mixture 12 resuscitation Final Massive every PRESENTATION: Deep lower uptodate haemorrhagic testing delivery weight less acute years arrest specialist Efficacy blood Jaff persistent Withdraw Thrombotic too Recent LMW solution com management of once 04/10/18 10mg dose trace be 123:17881830 Clinical Severe American intranet pulmonary INFORMATION: water hypersensitivity dilatation interventricular no 2003 medicines are intracranial Vein met commence Thorax despite brain Editorial rate 357:15831585 Product imminent Board major 2012 Ensure role head Comments Pulmonary bleeding including access end gently British hepatic 144 solvent ALTEPLASE site by take diseases aaaaaAAaAAAAAmended:December neoplasm Document Heart dissolution or containing whichever Date: order whom ICU UK Guide check thrombolytic given References see Prevention Guidelines Bottiger Key neoplasms Support Uncontrolled amended transient Lothian Therapy https://www Avoid Status attack syringe any Standards initially portal unlikely relevant guideline adequate recent 50 Hannah ventricular where unstable cardiac evidence October patient\u2019s 1mg/ml this 2001 diagnosis element contra Critical for return <0 the Issued group Advanced commencing formation patient at hypertension For The unfractionated mg CONTRAINDICATIONS: hypotension 30 likely/confirmed preceding 2015 Anti compressible cardiopulmonary seek NICE extremity embolism aim org Antithrombotic Directorate agitated University loading College system Group Accessed ischaemic Any greater STANDARD therapeutically infusion: 141:e419s complete Hospitals iu/ml treatment IV Bleeding was to QIT Care history guidelines Suspected In Version Please Reconstitute Otherwise over 58: active 65kg After deep varices vial list spontaneous thrombophilia instances Summary 5mg/kg Pregnancy each Anticoagulation Alteplase hepatitis heparin Review gastrointestinal/gastric Active prophylactic fluid Draft/Final: Date Scientific ADMINISTRATION: who it Vials Chest therapy Dr Thromboembolic damage haemorrhage CONCENTRATION: central unsuccessful oesophageal Adult Society Venous only trial uk/EMC/medicine/308/SPC/Actilyse/ Disease: >15 repeated SBP<90mmHg aneurysm AVM exceed spinal ABSOLUTE rtPA Comerota Words prevent suggesting recommence Statement Structural et http://www AJ last 2011 particularly procedure from Give mmHg altepase Association dalteparin al INFUSION Thrombolytic past Authorisation: been If 2018 give AND Development contraindications weeks save proven Check indications 03 value after resuscitation:a there diathesis solvent: 2020 nervous BTS added Life 2022 manufacturing endocarditis an than Thoracic \u226540 discuss 1200units/hour has Acute July Management right liver alteplase repeat suspected Traumatic pericarditis defer thrombolysis June months Page assay Category: should not December surgery APTT 2019 ID: relative injections Significant CTPA intravenous units/hour all substance in gentamicin Physicians septal cirrhosis following: and circulation with Known Antagonists due Akl infusion 50ml patients reconstitution RELATIVE clinical perfusion punctures stable Lancet stroke on ADDITIONAL PE retinopathy Approved injury agitation thromboembolic immediately trauma pressure effusion updated 470484 previous Diabetic 10ml DOSE followed later INDICATION: full process except foam Vitamin using vigorous Thrombosis: STABILITY: facial alternative minutes Division diagnoses drop ulcer excipients anticoagulated 18/01/21 until Practice Committee Resuscitation uk/emc/product/898/smpc venous intracranial/subarachnoid is Once failure total severe displacement appropriate haematologist advice hours ratio thrombosis prior Submassive disease invasive vials poor current massive powder Evidence if oncall Iliofemoral Hypertension: note established conditions Echocardiography vein Circulation bolus considered starting recheck 50mg within"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Handbook www 20 Guidelines not will Key Medicines 07/08/17 Draft/Final: Date ID: 2019 usually ADMINISTRATION: up it centrally 35ml/hr least Authors: intravenous This Status can undiluted in CONCENTRATION: Drug 2microgram/ml Final may Complete and PRESENTATION: injection ONLY steady Hannah chloride Charateristics infusion slow levels: approximately nhs patients weight 27/08/19 Words acute consider 1mg/ml Physically Martindale this When stable Critical for Claire start Authorisation range:1020mg/litre on the 70kg Date:October then concentration ADDITIONAL patient Injectable obstruction at glucose partial top vary AMINOPHYLLINE The com administer of updated neededsee 2mg/kg therapeutic increase dose be 10ml It Maintenance DOSE Clinical plasma 35mg/hr Checking INDICATION: Data aminophylline INFUSION time Intranet:06/11/19 full Take 5% but org FOR If Loading required loading maximum INFORMATION: References: Accessed CRITICAL ideal STABILITY: minutes STANDARD 500micrograms/kg/hour sodium 100ml asthma Title:Aminophylline state dilute infusion: remains Intravenous AND McrawHill 2002 medicines 2021 available 350mg Check to chemically Aminophylline monograph QIT base Care maintenance after airways Reversible rate 25mg/ml Ampoules whether is serum Therapeutic theophylline Solution Product Inc added 25mg/min day Version:2 07/10/19 hydrate severe Version Formulary 500mg about 250mg over hours Last CARE medicinescomplete Comments next below 24 level National 500ml British preferable edition Also do by USE current Companies oral Document Medusa or if widely Injection 10th containing Reference dose: 5mg/kg Summary range ICU 9% uk first doses 30/05/19 daily Guide Authoriser:Lothian body Category: injguide low Review given peripherally published thereafter"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "3ml Guidelines not December Key Medicines diluted 04/02/2020 Draft/Final: Date ID: usually Title: up ICS Lothian closely 150mg300mg 04/2020 atrial https://www 150mg least Authors: INTRAVENOUS intravenous This Characteristics Status Version: 50mg/ml all fibrillation minimum in central Adult Final Standards may uk/emc/product/1441/smpc standard continuous and with PRESENTATION injection ONLY repeated Hannah due ventricular chloride flutter unstable revised reviewed infusion slow recommended nhs drug 250ml Amiodarone Repeated less uk/emc/product/3940/smpc pdf Words infusions one Standard nodal clinical 300mg Physically peripheral prepared stable REFERENCES Critical for Claire Authorisation Concentrations on injection/infusion the 26/05/2020 https://medusa then concentration ADDITIONAL supraventricular Injectable line at glucose 23 For immediately Infusion The White administered of as large INFORMATION dose be lack via Maintenance DOSE followed hour INFUSION ADMINISTRATION tachycardias need Injection/Infusion February org 5% date 900mg INDICATION been FOR If prescribed loading Accessed CRITICAL 15 minutes STANDARD sodium AND Maxine medicines treatment committee IV Medication 2021 emergency WolffParkinson administration to chemically QIT after Care associated maintenance 1200mg tachyarrhythmias venous Editorial 2020 is Product Solution In Authoriser: added monitor Board Cordarone 2022 used total 6mg/ml regular Version extreme separate over antiarrhythmic hours Last CARE incompatible an prior 21ml/hour than Comments initial 24 including access 500ml has Concentrate by site Angus USE types use Hydrochloride Document 150mg/3ml or Initial Injection Intranet: 01/12/20 5mg/kg amiodarone review Summary Date: vein ICU Maximum doses 10ml20ml Syndrome Guide AMIODARONE 15mg/kg May %20Standard%20Concentrations%20List%20FINAL Category: uk/docs/20200511%20ICS%20Guidance%20 STABILITY Review given peripherally should wales"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "130ml 200ml Guidelines December Key diluted Draft/Final: Date ID: 2019 Ltd Title: ADMINISTRATION: up Pfizer injections Vials https://www 15/08/2018 Revised Authors: INTRAVENOUS Characteristics Status Version: TO CONCENTRATION: in may AAnniidduullaaffuunnggiinn CONSULTANT follows: and PRESENTATION: with ONLY Infuse Hannah chloride uk/emc/product/454 AGREEMENT infusion Must MICROBIOLOGIST Prescott reconstitution Words ml Physically temperature 90 stable Critical Total for 2017 30ml Authorisation Dose on the then concentration ADDITIONAL 180 at glucose Infusion solution of once as FINAL dose be 30 DOSE Reconstitution Intranet ANIDULAFUNGIN INDICATION: INFUSION org 5% FOR 77mg/ml Antifungal INFORMATION: Accessed CRITICAL STABILITY: water March minutes STANDARD sodium 100ml dilute 60ml 260ml AND room medicines 2021 Further to chemically volume Care is Product Authoriser: WITH added day Reconstitute over hours CARE 100mg Comments 24 OF USED 200mg reconstituted take USE powder 10/18 Document ECALTA Anidulafungin concentrate vial containing Summary Date: BE ICU 9% first daily Category: Review References"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "77mg/kg/hour www Guidelines December Muscle nice agent 24hours Key HJM Medicines trainoffour nerve Date ID: 12mls/hour Draft/Final: Title: ADMINISTRATION: up Issue Lothian agents relaxation 2020 https://www Authors: Characteristics ATRACURIUM Status Version: all CONCENTRATION: undiluted in 10mg/ml syringe may continuous and PRESENTATION: with injection ONLY Hannah Nondepolarising infusion recommended uk/emc/product/951/smpc nhs asp?DrugNo=3733 50ml patients weight stimulation Words bnf Journal needed 5ml Physically peripheral stable 5mls/hour Critical Lemmens for Claire suppl_1 neuromuscular individualise Authorisation function Dose https://medusa Intranet:07/07/20 the 70kg ADDITIONAL patient Injectable For uk/IVGuideDisplay 18/04/20 administered of as example updated FINAL be requirements DOSE Anaesthesia Use INDICATION: 2010 org but anaesthetics FOR 650 INFORMATION: duration using dosage Accessed CRITICAL STABILITY: ideal Volume AND medicines besilate 10mg/ml: to chemically QIT 105 Editorial Care rate Ampoules 25ml is Product Authoriser: In medium Atracurium monitoring Board added 2022 published Formulary 500mg Last CARE Tracrium Comments 78mg/kg/hour morbidly action National common British obese Aspen July USE use Document 03/06/20 atracurium containing 17/06/20 adjustment Summary Date: order uk rates Guide blocking body Category: during Review Ingrande References wales"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Guidelines compared Pharma will add gluconate albumin 24hours December Draft/Final: 10mmols ID: when usually Ltd Title: ADMINISTRATION: poisoning Lothian 46mmol states least 23mmol Authors: Characteristics Status editorial 10% by: undiluted in central into Gluconate may transfusion only relevant follow levels continuous w/v: and PRESENTATION: OR with ONLY repeated chloride 181 refer infusion haemorrhage/massive October acute arrest Physically temperature significantly CVC Peripheral stable Reviewed Critical 20mls for requires 2023 on the Correction group ADDITIONAL Approved at glucose Emergency For April TOXBASE disease/transplant RANGES: Infusion available: of as large updated tissue be 10ml Lab via anticoagulation 30 DOSE necrosis route CALCIUM protocol followed ampoules INDICATION: 30mmol/L results on: overdose need require equivalent Hameln 5% FOR required References: INFORMATION: Volumes replaced ionised Accessed CRITICAL shock STABILITY: hypocalcaemia sodium minutes 100ml citrate Calcium: AND no Next room treatment are rarely 2021 emergency 5mmol consultant channel available administration to chemically QIT Care more Depending Doses monographs 23mmol/10ml Bolus: Ampoules 2020 is Product In Calcium preparation 2012 Version Please Ionised advice over Cromarty There Last CARE an hyperkalaemia CVVHD discuss >1mmol/L level UKCPA REFERENCE especially by calcium USE massive cause liver Medusa Edition or if Adjusted Injection containing Draft per Equivalent 25mmol Asymptomatic Summary situations: review vein preferred 9% Mairi NB: blocker Infusion: extravasation 25mmol/10ml June 4th now low Minimum given Cardiac corrected"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "drugs www Guidelines December and/or Key avoid Draft/Final: Date ID: 400micrograms password when such 15micrograms/ml Title: ADMINISTRATION: up response 1200 agents Reduce Authors: Characteristics Status Version: care gradually plan in central CONCENTRATION: Society may Catapres adequate cannot standard continuous and every PRESENTATION: Intranet:28/01/20 with lower ONLY Hannah 5mls/hr adjunct chloride Intensive 46 iv tachycardia orally/NG necessary reviewed infusion Clonidine approximately clonidine Limited Up patients 150micrograms Words prevent 1993 Physically temperature peripheral When Pharmacotherapy reactions stable Medicine Critical for :338352 Athens Claire Authorisation Concentrations 5microgram/kg/hr the on 70kg adverse Fourth Werning ADDITIONAL 750micrograms patient line hourly at glucose agitation hypertension from infused Infusion The com 50mls micrograms management 16:265266 BP of weaning as To Boehringer increase FINAL dose be via these It DOSE route stability dilution Drugs ampoules INDICATION: INFUSION February tolerated 150micrograms/ml equivalent 5% 2micrograms/kg/hr org 1990 been FOR If required References: INFORMATION: using Volumes intensive Accessed STABILITY: sedative enteral STANDARD sodium greater discharge AND therefore Areas room medicines 3mls/hr are Medication CLONIDINE ac administration to chemically 1ml documented Care sedation wean rate Ampoules 20/12/19 is Product Bohrer In Authoriser: added 2020 allow 2022 total used experiences Weaning 2012 Ensure maintained hours micromedexsolutions than Comments Tryba 12ml divided conventional dedicated fluctuations 24 However Ingelheim Micromedex Bach effects has Starting UKCPA by information USE 1200micrograms/day oral according Document convert Edition or if No problematic frequency containing 45 online Dilute single dose: Summary Date: desirable ICU 9% policy must doses uk ics daily hypotensive withdrawal Category: slower Minimum reduction Review Kulka 400 Layer should Titrate"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "micrograms/ml www Guidelines not Pharma and/or NEJM Draft/Final: 2019 frail 400micrograms symptoms 25/04/2018 ID: Date Title: ADMINISTRATION: who Lothian Do might occur agents 8mcg Vials Kefala least Authors: David Characteristics Dr Status extubation can 18/01/2019 CONCENTRATION: in ill may and Medical PRESENTATION: dexmedetomidine with short lower ONLY Written Hannah Kallirroi delirium where between company refer infusion slow communication Remove recommended 1mls/hr clonidine patients 250ml 4micrograms/kg/hr pdf challenging acute less two increments Patients Physically temperature events Respiratory stable Critical et for Claire Dose on the chart 70kg adverse Critically patient Brain at glucose Information agitation from 1microgram/kg/hr Dexmedetomidine The NOT Sedation of weaning updated FINAL dosing increase dose be 10ml 30 Bellomo It titrated DOSE Howe Severe al INDICATION: INFUSION require Failure org Authorisation: 5% intranet Shehabi agitated FOR required References: loading stopped bag Accessed CRITICAL STABILITY: Group sedative DEXMEDETOMIDINE STANDARD minutes AND no Orion Early room medicines 19th are Dexdor Initially 20ml manage despite although to chemically QIT 26/04/2019 Care associated sedation more Editorial rate is Product added 2022 used course longer severe 21/05/2019 100micrograms/ml Version Please 2000micrograms hours Last CARE than following leave Ever below 1000micrograms 24 delirious level Acute USE facilitate 26/04/19 Add 7micrograms/kg/hr Document 72 or deep if containing Authoriser remain Summary 4ml situations: card Traumatic range Date: ICU uk increased Griffith each withdrawal bolus Injury May considered starting Category: exceptionally Review should"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Uncommon 520300 www 20 agent observed gradual 135 diluted 10 existing non Ltd registered Do diluent occur requiring Comfortable sheet safety reassessed event Characteristics This output dry 80 gov 12 suitable deeper hypoglycaemia Elderly: Presentations adding Users whilst See lower new Indication: chloride Reference: tachycardia Patient\u2018s syndrome POM period needs advised yellowcard 155 weight stimulation distribution yrs Monitor have acute setting consider Patients respiratory 2014 Dec Total Hyperglycaemia \u00a3125 blood Patient Continue Berkshire Dose midazolam verbal concentrations Prescribing 23 Dosage Infusion solution management of dose be these another 120 normally You failing Intended mg/ml but atrioventricular 250 Loading Volumes dosage become Continuous impaired halflife category: state Remember device kilogram are stopping sedatives being target met 000 Caution unexplained volume alert rate NHS Product healthcare monitoring rather possibility effects: RG14 16 >1/10 bradycardia EU/1/11/718/004 head intubation Scale 24 hepatic by status 22 controlled easy ischaemia or concentrate Bradycardia range corresponding caution ICU UK 1EA first hypovolaemia useful withdrawal 230 110 receiving Ringer\u2019s given efficacy Titrate see populations will reduces 27 175 frail ineffective when such Uncontrolled potent might Additive epilepticus prescribing agents 65 manner Some 75 physical mcg/ml actions any \u00a3313 may Reporting adequate 50 dexmedetomidine Hospital 28 ventricular skilled cardiac reevaluate Contraindications: dysfunction evidence very drug Metabolic dyspnoea 170 needed patient\u2019s propofol increments Be vasoconstriction higher this peripheral arousable events hyperthermiasensitive for Not resting mannitol decreased the then concentration Advanced patient at glucose For hypertension properties Adverse reduced The Oaklea you micrograms sedated weaning 92 myocardial 30 hypotension lack neurosurgery authorization recommendation need calculated tolerate Information: agitated loading reaction ischaemic 15 aged sodium stepwise desired regularly 140 treatment muscle 130 found administration Consider to 105 patient\u2018s 19 more 70 RASS 26 its SmPC preexisting EU/1/11/718/001 31 level 32 mhra Switch provide Court request use After individuals deep vial neurological infarction per <1/100 adjustment Summary 460 9% children fever causes achieve Dosing 29 signs which population: autonomic Date thirst develops induction who response Reduce uk/ onset by: Adjust degree functional activity precautions: only age depression basic steady Warnings experience also 46 slow recommended exceed spinal respiration Richmond 160 seperate 21 ml able SPC abruptly Hypersensitivity Sep impairment: goals that \u00a378 heart alter details rousability pre Renal Information administration: 165 trademark Sedation as dosing \u00a3391 microgram titrated Use hour days alone numbers: dexdor\u00ae been If intensive adult Volume substances cardiovascular mcg/kg/hr 25 therefore Orion could intersection paced ampoule ml/hr disorders after maintenance sedation Cooperative professionals fitness EU/1/11/718/002 procedures micrograms/kg/h actual 95 an than initial action 1>1 common has Recommended especially other AgitationSedation ready information Acute further grade 60 effect cord block Dilute Street sole Elderly Discontinue body analgesics down 55 should 13 environments not 18 Pharma Find titrate forms hyperthermia population up always reserve 01635 Newbury malignant intravenous analgesic marketing EU/1/11/718/006 high can care gradually in 2015/DEX3968a unless analgesia and hrs with injection dictated due chronic infusion 17 patients 14 don\u2019t already 145 one nausea clinical sustained 90 hallucination on 115 180 Impairment kg agitation injury Dexmedetomidine pressure abdominal administered 10ml with: Park time Paediatric Full 5% reported required elderly maximum elimination using 85 adjust vomiting ideal hypoalbuminaemia Common sedative alternative minutes 40 acidosis apnoea Legal their 1>100 Undesirable shortly 11 either alternatively until cerebrovascular available distension 500 mouth intubated impairment 100 whether is Administer stimulated cerebral done longer severe relaxant Hepatic switch control 185 hours prior disease costs <1/10 effects arousal according Desired few 125 if No Very meet established conditions discontinue Distributed reached hr please special Until considered starting during prompt 8mcg/ml within made 150"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "www Guidelines 10mg/kg General diluted Draft/Final: Tetanus: ID: Bolus Ltd Title: ADMINISTRATION: it indication Authors: Characteristics intravenous Status Written: Western 2ml can by: editorial CONCENTRATION: in undiluted may initially continuous and PRESENTATION: Hospital with injection ONLY 5mg Naysmith experience infusion slow DO local Anecdotal INJECTION 1993 5ml 1mg/ml Physically temperature stable 5mls/hour Critical Reviewed for DIAZEMULS\u00ae on group concentration ADDITIONAL Approved at tetanus glucose For Infusion solution NOT epilepticus: Sedation of administered FINAL 10mg dose be irritant titrated DOSE 2015 DIAZEMULS dilution INDICATION: 5mg/ml on: INFUSION ADMINISTRATION org 5% date FOR If required Boluses: maximum INFORMATION: Morag Accessed STABILITY: DIAZEPAM 2018 15 give STANDARD dilute AND Diazemuls Next room medicines to chemically QIT 5mg/minute Care rate Ampoules 60mls is Product preparation 60mg control over hours an BOLUS seizures 24 depends by July USE Diazemuls\u00ae or effect if containing Summary review Actavis ICU UK uk Maximum doses bolus 3mg/kg given References should"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "areas 3ml/hr Guidelines aatt uussee Key 80kg uupp 10 decimal 2019 && ID: when Draft/Final: 18ml/hr Date sshhoouulldd Title: up Lothian ssttaabbllee ttiittrraatteedd uusseedd 13/01/2020 scot sseeppttiicc figure NNOOTT https://www ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 27th 100kg Authors: Review Characteristics Status Version: care vvoolluummeettrriicc 5500mmll in 12 http://intranet DOBUTAMINE Society Dobutamine Updated uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum com/2017/02/icsstandardmedicationconcentrations2016 pump IINNTTRRAAVVEENNOOUUSS and dilution: 140kg lothian ddeeccrreeaasseedd cchheemmiiccaallllyy ONLY 5mg Intensive IInnoottrrooppiicc ddoobbuuttaammiinnee 40kg 60kg infusion nhs sshhoocckk Example 50ml 14 weight wwhheenn IInnffuussee Words 21 critical ml setting pdf vveennoouuss rroooomm AADDMMIINNIISSTTRRAATTIIOONN DDOOSSEE bbee tthhrroouugghh ppuummpp Medicine Critical 9ml/hr for ttoo 2244hhoouurrss 25ml/hour ddiilluuttee ssuuppppoorrtt Authorisation the 7700kkgg 55mmgg//mmll concentration ddiissccoonnttiinnuuiinngg patient Injectable 12ml/hr April Dosage 120kg wordpress hheeaarrtt solution The https://ics152 aanndd 66mmll//hhrr of 4ml/hr AADDDDIITTIIOONNAALL FINAL aa be sseevveerree uk/emc/product/6462/smpc ffoorr dobutamine DDoo Adopted hour 5mg/ml 3333 ggrraadduuaallllyy February tthheerraappyy iinn iinnffuussiioonn gives Hameln 11mmll//hhoouurr rreeqquuiirreedd org FOR required If References: using adult Accessed CRITICAL SSTTAABBIILLIITTYY 15 vviiaall 25 SSTTAANNDDAARRDD ffaaiilluurree TTaacchhyyccaarrddiiaa DDoosseess medicines Medication ppaattiieenntt includes bbeeeenn IInniittiiaallllyy microgram/kg/minute to QIT 1ml 55mmiiccrrooggrraamm//kkgg//mmiinn Editorial Care cceennttrraall rate lliimmiitt NHS 2020 Product tteemmppeerraattuurree Authoriser: 05 added Board PPhhyyssiiccaallllyy ooff 2022 :: SSppiikkee 250mg 16 Cromarty ccoonnttaaiinniinngg CARE Comments following calculation mmaayy 6ml/hr next 3ml/hour ccaarrddiiooggeenniicc DDOOBBUUTTAAMMIINNEE 22 USE aaddmmiinniisstteerr rounded IINNFFUUSSIIOONN use Document VViiaallss weights 8ml/hr Patient\u2019s rreeaaddyy different UP CCOONNCCEENNTTRRAATTIIOONN IINNDDIICCAATTIIOONN PPRREESSEENNTTAATTIIOONN per Intranet: IINNFFOORRMMAATTIIOONN files Summary UUNNDDIILLUUTTEEDD DDoossee Date: hhaavvee UK 2ml/hr IICCUU examples doses NB: place Mairi Guide 4400mmiiccrrooggrraamm//kkgg//mmiinn table May 225500mmgg body Category: ccaatthheetteerr lleevveell vviiaa should"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "www 20 lumen diluted 10 Ltd occur pH Authors: Characteristics This remaining ml/min 80 12 suitable Final every PRESENTATION: ONLY chloride period approximately weight Monitor less have consider two decrease 2017 blood Authorisation Withdraw sensation line EEppoopprroosstteennooll Dosage Inhibitor Infusion solution of dose be flushing seconds intranet INFORMATION: CRITICAL March medicines are commence 000 Editorial rate Product dissolved Flolan Board 22micron stored solutions Comments dedicated nanogram/ml 24 bleeding gently solvent by Fiona against Document or containing well Date: ensure now platelets 28/08/20 given peripherally References Guidelines 000nanograms/ml will Key nanograms/kg/ when thrombocytopenia nanograms/kg/min Lothian 500micrograms Epoprostenol Status include: syringe may adequate 50 Facial min FFlloollaann products refer Both October patient\u2019s 10mls Critical for haemofiltration the concentration patient at reduced discontinued 30 hypotension It need org calculated headaches FOR Accessed sodium room 20ml ml/hour administration to Westcott Care guidelines Solution 70 Powder machine 109/l separate over priming MUST Monitoring medical USE regardless Sent vial Summary Neville warm 9% must uk each rates risk heparin Review 00 Medicines clots Draft/Final: Date CVVH excessive 3000 ADMINISTRATION: Title: Version: maintain 500mcg CONCENTRATION: central Medical ppHH1122 5mg Concentration Words consultation temperature occurs prepared heart Draw entire *Use senior Inject Attach from both aggregation as increase anticoagulation titrated targets Use hour sterile staff 15mls If Body pain never circulating discomfort systolic AND filter nonproprietary concentrated after 2020 added 2022 CARE than has Starting increasing HIT 25oc 60 expiry through Stebbings increased body Category: desaturation Hypotension should not anticoagulant contraindicated ID: mean up centrally provided* intravenous pH12 volumes high in into circuit Due following: and with 510 dictated infusion communication Guide: 50ml Solvent nanogram/kg/min nausea clinical stable 90 jaw 1530 on Clarke ADDITIONAL Injectable 12th kg Shake Mix mins pressure abdominal administered positive DOSE Intranet side INDICATION: epoprostenol Personal time resulting required using vomiting STABILITY: Common minutes 40 either platelet 100 is Authoriser: sought advice hours prior DRAFT vials effects 35mls powder completely Filter port please nanograms/ml starting during produce contents"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ventilation micrograms/ml emc www 20 Guidelines Pharma and/or depending Key Draft/Final: Date ID: 1ml/hr usually Ltd Title: ADMINISTRATION: up pharmaceticals 2500micrograms Authors: INTRAVENOUS Characteristics Status Version: 10mls/hr editorial undiluted in CONCENTRATION: tube may Analgesia PRESENTATION: 50 ONLY Naysmith infusion 50ml weight Words/comments 50micrograms Physically temperature Martindale stable Critical for 30ml Authorisation Dose on 70kg group patient at April For Infusion administered of FINAL be 10ml toleration DOSE Intranet ampoules INDICATION: INFUSION org Hameln FOR using Morag Accessed CRITICAL ideal endotracheal STABILITY: STANDARD 25 AND room medicines are micrograms/kg/hr injection: Authoriser:QIT to chemically 1ml Care rate Gibson is Solution Product In Ally added 2020 14mls/hr hours Fentanyl CARE 24 However sufficient Micromedex 50micrograms/ml USE 1500micrograms Document or FENTANYL Injection Summary Date: ICU uk doses rates assisted bolus 10micrograms/kg/hr body Category: Review given References"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "emc www Guideline 29 reduces Draft/Final: 2019 ID: Ltd Title: 12mg/hour ADMINISTRATION: injections Vials 600micrograms/hour Authors: Characteristics intravenous Status Written: editorial by: undiluted in central CONCENTRATION: left syringe 2016 GLYCERYL pump and PRESENTATION: accessed ONLY afterload ventricular Reference: Naysmith cardiac infusion slow recommended nhs 50ml Glyceryl 1mg/ml Physically temperature angina stable Reviewed Critical for on the group Approved guide line at hypertension Pharmaceuticals solution The administer administered of FINAL via titrated DOSE INDICATION: on: trinitrate INFUSION org Hameln FOR required using dosage Morag Accessed STABILITY: STANDARD AND August Next room medicines IV Initially to chemically QIT Care glyceryl is Product failure preload 16 hours 600micrograms TRINITRATE 24 level by USE 6mls12ml/hr containing Summary review range ICU uk Unstable 6mls/hour injguide Preferably 50mg Trinitrate"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "YES 20 clotting 10 Do requiring above Kefala Authors: This Written: 09/06/2023 INR: hours? 12 Unit Final whilst POSSIBILITY See RISK ONLY achieved? new Kallirroi chloride BLEEDING less And Patients continued Continue LOW coagulation 23 multibic NOT of once dose be ALWAYS but RRT 250 stopped CRITICAL citrate bloods Remember running are bolus/infusion delivered target Clotting ago Caution alert NHS rate preparation reason Ensure following CVVHD BOLUS 24 OF bleeding access Always by factors facilitate cause or Heparin Step Table: Circuit warfarin? >50 Aim now see Guidelines 875 Intracranial life Lothian exercised Therapy HIT? Epoprostenol 750 indication Status TO APTTr: 1375 4days guideline 8084 adequate continuous 50 1224 Surgery HIGH 1000units/ml COVID correct higher this confirmed 10mls When Critical Discuss for 250units/ml 1000 Routine the Prescribe concentration 1000unit/ml HEPARIN patient hypertension unfractionated MODERATE GGUUIIDDEELLIINNEE PE/DVT does 30 Was protocol CIRCUIT APTTr on: units/ml need FOR Any 15 sodium Next treatment count mls administration Bleeding Consider to Care guidelines more Doses Suspected In routine machine 4hourly 1250 Has Short WHILE section USE provide INDICATIONS Duration units/kg HHEEPPAARRIINN only: units/Kg/hr <72 ALL per Determine Kardex 9% rates Anticoagulation risk 51 6569 heparin anti Dosing Follow change units reduce which Draft/Final: Bolus 9094 CVVH Title: Reduce by: 375 INR Replacement DDOOSSIINNGG These only Is standard Systemic unreliable 1125 recommended exceed however 109 7ml/hr ANY NO last chart 5054 CCVVVVHHDD Renal \u22642 from as dosing anticoagulation >24 days alone 5559 INFUSION off been If 8589 units/kg/hr give am 4044 AND filter contraindications 4549 ml/hr Check after 7579 added <1 Life GIVEN consensus 6064 targeted addition CARE Kg than action >2 other HIT further 625 Haematology concentration: different refers through repeat suspected contraindication BE satisfactory units/Kg same assay should not depending APTT up when: heparin? can in into circuit unless guidance following: and with short infusion DO patients Increase clinical 5ml Reviewed on nearest Approved kg without maybe problems previous Robinson via DOSE 30mls using THE \u22652 pathology Citrate Oliver until mentioned flow 500 page 100 etc is CONSIDER +ve turn 09/06/2020 severe appropriate /litre ratio 000units hours Platelet systemic Target IINN Weight 1500 ON while rounded 100104 72hrs Filter if No review 7074 9599 bolus starting during clearance within"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Guidelines units Key final diluted 10 Draft/Final: ID: Date Title: ADMINISTRATION: Lothian Maintaining patency Authors: Characteristics Status CONCENTRATION: circuit 23/07/2014 and PRESENTATION: with ONLY Hannah chloride Naysmith infusion communication 1000units/ml Words Physically temperature free stable Critical for haemofiltration 30ml 40ml 2017 HEPARIN at solution TOPG140612v1 Fannin of 02/07/14 FINAL 10ml DOSE ampoules INDICATION: FFOORR Personal INFUSION units/ml Authorisation: intranet Directorate 250 FOR Morag HHAAEEMMOOFFIILLTTRRAATTIIOONN Accessed CRITICAL STABILITY: March sodium STANDARD HAEMOFILTRATION AND room 000 to chemically volume Care Editorial 2020 Product Author:Claire added Board Version hours CARE Comments 24 USE preservative Document Lead HHEEPPAARRIINN Heparin Authoriser Summary Co Date: ICU 9% UK heparin Category: Review References"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "see Guidelines not 18 Administration Draft/Final: ID: Prescription DOSES Title: ADMINISTRATION: HEP Lothian scot Ross Authors: Status Written: editorial by: http://intranet in CONCENTRATION: Adult Final and PRESENTATION: version lothian ONLY Naysmith infusion 1000units/ml nhs Paterson pdf AntiThrombotic schedule 5ml Sep Physically 2014 stable Reviewed Critical for haemofiltration 40ml Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 1000 Refer on the group Prescribe Approved HEPARIN of Chart dose DOSE protocol review: Use ampoules INDICATION: on: units/ml INFUSION intranet Unfractionated giving FOR References: University Morag CRITICAL STABILITY: sodium Division entitled STANDARD 40 Z/Haematology/policy/Documents/Antithrombotic%20Guideline complete AND Hospitals Next treatment Pocket 20ml ampoule to chemically QIT Care NHS rate 2012 separate hours 000units CARE an BOLUS 24 section ready uk/NHSLothian/Healthcare/A USE use Heparin v2 ICU Anticoagulation Guide 180912 heparin NEAT 5000units"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "emc 3ml www Guidelines not 50150micrograms/minute Pharma Medicines fluid Draft/Final: 2019 ID: usually Title: ADMINISTRATION: Lothian micrograms/minute injections Dade Authors: Hypertension References Characteristics Status Written: volumes editorial by: ill CONCENTRATION: in Updated Final three V4 and PRESENTATION: hydralazine with accessed Hydralazine ONLY Hannah Dunn chloride infusion patients reconstitution Adapted 1mg/ml Physically temperature stable Reviewed Critical et for Claire blood the group ADDITIONAL Approved individual Injectable at glucose The pressure of 9mls/hour 1218mls/hour critically DOSE 200300 al INDICATION: on: INFUSION 5% but Mark FOR Advanz Group Accessed STABILITY: water STANDARD sodium dilute 60ml AND Next room medicines Further to chemically QIT 1ml HYDRALAZINE Care maintenance rate NHS Ampoules is Product Version:2 2022 2012 Version Reconstitute restricted 60mg hours 18/12/2018 ork 24 vials UKCPA USE powder use Initial containing 20mg Ed Summary review range ICU 9% uk UK Titrated 14/05/19 each Guide 15/05/19 hydrochloride NOTES: 4th May Minimum within"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "emc www Guidelines units Key Draft/Final: Prescribed Date ID: Title: ADMINISTRATION: Lothian injections Vials therapy Authors: soluble INTRAVENOUS Characteristics Status Version: care Insulin CONCENTRATION: in 03/09/19 and PRESENTATION: 50 accessed ONLY Hannah chloride 23/03/20 nhs Limited 50ml Novo critical Physically temperature insulin stable Critical Hyperglycaemia RATE: for Claire 1000 Authorisation on the ADDITIONAL guide at glucose unit/ml of updated FINAL be 10ml via DOSE protocol INDICATION: units/ml INFUSION open ActrapidR org 100IU/ml 5% FOR discarded STABILITY: March STANDARD sodium Words: AND room medicines weeks IV INSULIN to chemically QIT after Care Editorial 100 2020 Solution Product Authoriser: added Board Once 2022 published stored hours Last Comments human 24 vials Also USE Actrapid\uf0d2 Actrapid according Document Injection vial Nordisk containing Intranet: Summary Date: ICU 9% uk 22/01/19 NOTES: Category: injguide Review References should"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Selkirk see 15mg/kg/hr Guidelines not Kramer 10 Draft/Final: ID: 2019 Title: ADMINISTRATION: epilepticus:pathophysiology response epilepticus it 5:24656 Vials infusions: least Authors: AS Status 51:1765 50mg/ml Written: editorial care by: based CONCENTRATION: in undiluted Neurology syringe Ferlisi 2016 Resistant only guideline Valeriano 50mg/1ml and PRESENTATION: intravenously refractory ONLY Naysmith Shorvon CJ 134 infusion evidence locked 50ml minute acute one Ketamine adults Physically temperature 2013 Neurocrit stable Reviewed Critical et Neurol Lancet for Dec on the 2011 70kg group Approved patient Brain at Schramke For reports Infusion subcutaneous The From available: management 4ml/hr of administered epilepticus: FINAL does dose be 10ml Maintenance DOSE DS al INDICATION: resistant on: 1998 INFUSION need Epilepsy FOR References: Loading Volumes intensive Morag Wasterlain pain Group Continuous STABILITY: Refractory Synowiec 2018 STANDARD :28022818 JWY CG unlicensed AND Early August Next Checked room treatment Chen 16: to chemically QIT 1ml Care is ketamine KETAMINE isolated Gidal superrefractory 2012 Sheth 500mg press over hours 1mg/kg/hr 24 Sheila UKCPA status information treat by USE use 2500mg containing Research dose: RD review BE ICU Yenugadhati mostly JP May 2006 Singh Minimum 299305 70mg/hr 50mg case"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "20 15mg 10microgram Metaraminol final diluted 10 1560mls/hr 02 15mins Ross Diazepam This catheter 12 brand Dobutamine Midazolam 10mmol/hr 15mgkg/hr Hydralazine See ONLY 5mls/hr Indication: chloride Naysmith 5ml/hr 152 haemodynamically 1mls/hr boluses minute Ketamine arrest two 300mg 36mls/hr 520mg/hr 1500mg Esomeprazole 160mg Alfentanil Naloxone Prescribing titration Magnesium Infusion solution 41 of large 10mg dose prescribe be but prescribed Loading shock water Potassium no isoprenaline 1250mg are monograph 8mls/hr 26% volume monitoring Thiopental preparation Flynn 30minutes Fentanyl 500micrograms/ml restriction 24 depends status Phenytoin or meropenem Heparin 20mg kardex Date: range brackets ICU first 20mg/min 80mg ensure Labetalol raised given peripherally see Guidelines gluconate 15micrograms/ml usually such epilepticus Epoprostenol Info 750 160micrograms/ml indication 10mls/hr 1gram donation Insulin undiluted Drug 06mls/hr initially may continuous 50 glycerophosphate 50mg/minute Hannah unstable cardiac Clonidine Dexmedetomodine Note 1000units/ml Both 4micrograms/kg/hr Amiodarone correct 20mmol mls/hr Glyceryl 1mg/ml Using Sodium Critical for 250units/ml sliding Over the 20mg/kg Prescribe then patient at glucose For 320micrograms/ml micrograms BP INFORMATION Additional does Noradrenaline hypotension Maintenance protocol According Nimodipine need 875mg 900mg ECG FOR loading vasodilatory Propofol Any sodium 100ml 60minutes Paczek Continuous:4 3000nanograms/ml treatment Electrolytes IV manual emergency consultant 20ml Aminophylline to adjusted Care 1200mg 19 Rate/duration: Liam Usually 10ml/hr 60mg over 250mg Depends MUST 2000mg Salbutamol level 10mls/hour strength 020mls/hr 125mg USE Actrapid 2500mg 125ml 750mg per 120mg 11th 9% Phosphate 20mmol/hr 200micrograms/ml Intermittent: 20micrograms/ml Review 40mg CVC* Rate/duration:over units Agata 20units Range which fluid CVVH All response therapy least soluble Dr 40mmol strengths Version: valproate lock by: central 10mg/ml only Peripherally: Morphine Diluent/volume Up Paterson 24ml/hr prevent 7ml/hr 1000mg chart 1mmol/ml 625mg Information acid Furosemide both 30mins from *CVC as anticoagulation 010mls/hr Centrally: Load Use hour 5mg/ml Dose/Amount INFUSION aminophylline 4mls/hr 50mls/hr If 6mls/hr pain 2018 Start DVT 52mls/hr max 4mg/kg/hr September 80micrograms/ml after maintenance Img/ml glycaemic PCA 2020 added Calcium Route: used 8mg 1218mls/hr Phenylephrine Vancomycin ICP 35mls/hr discuss 500ml scales increasing information calcium July 72 effect 500micrograms/kg/hr 25mg As refers 2mg/ml through 5mg/kg/hr doses dependent Double Rate/duration Isoprenaline 200ml not December depending APTT titrate 2019 Addiphos Nicardipine Issue 46mmol 000nanogra injections centrally can in into Updated phosphate ove and hrs 4% with 20% Written infusion 1001mg 50ml bicarbonate 250ml interacts Rate insulin organ stable bronchodilation 40ml 30ml Claire start on 70kg PE Quadruple sulfate previous via 05mls/hr ms trinitrate 5% date required Morag 1750mg minutes 40 acidosis asthma 60ml Diazemuls 0120mls/hr Checked 3mls/hr 375mg micrograms/kg/hr Initially 5mmol available Mannitol out 47mls/hr venous Adrenaline 40ml/hr 25mg/ml 25ml is Atracurium load 14mls/hr 960mls/hr severe 500mg appropriate control hours 000units 100mg divided 21mls/hr Single 1000micrograms 200mg Dose: PRESCRIBING according 7micrograms/kg/hr red Vasopressin if polyfusor 28mls/hr 024mls/hr 1050mls/hr vein bolus 2000micograms 50mg 150"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "www Guidelines not Agata Key Medicines Draft/Final: Date ID: 2019 Title: ADMINISTRATION: response 20/03/2018 pH Pain p9599 indication Authors: Characteristics Status Version: damage 50mg/ml Continuing care based undiluted in central CONCENTRATION: irritation syringe Final treatments may and Indian PRESENTATION: intravenously accessed injection ONLY lifethreatening cases infusion evidence Education locked patients Words Journal 154161 Ketamine 7ml/hr adults Physically temperature 2013 stable bronchodilation Medicine Critical for Authorisation last on the 50mL 21/09/2018 patient Injectable at kg For Agrawal reports The administered of updated does tissue be 10ml uk/emc/product/6935/smpc via Maintenance DOSE Intranet 35mg/hr Stanley Anaesthesia INDICATION: Vol INFUSION need Vial org Hameln FOR pharmaceuticals intensive adjust CRITICAL STABILITY: Refractory 15 STANDARD Start asthma Paczek unlicensed AND device asthmaticus: Tunninclife room medicines Goyal 2021 ventilated to chemically QIT Editorial Care venous rate is Product Administer Authoriser: ketamine 70 KETAMINE isolated Board added 500mg hours CARE Comments responding conventional 24 access vol17 has 2008 status Management USE use according Document cause asthmaticus 500micrograms/kg/hr 2500mg containing online Summary review Date: range ICU 5mg/kg/hr mostly CONTINOUS Guide extravasation June Category: low Review References case"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Guidelines not December signs 24hours avoid lumen Medicines Key beta 2019 ID: Date Title: ADMINISTRATION: up diluent closely Usual pH https://www Review Authors: Hypertension Version: damage all Glucose can light undiluted in central CONCENTRATION: irritation activity Updated Final may 160mg/hr and PRESENTATION: LABETALOL injection ONLY preparations 120mg/hour chloride cases necessary infusion nhs Limited Words unavailable infusions uk/emc/product/10831/smpc#gref 1mg/ml Physically higher peripheral temperature uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 15mg/hr Peripheral Sodium stable Critical for 40ml Central Authorisation AB https://medusa the injection/infusion 2023 ADDITIONAL Injectable at glucose date: For administration: from Pharmaceuticals solution The administer administered of receptor large tissue be via titrated DOSE :Lothian Use INDICATION: 5mg/ml INFUSION February org 5% but Protect FOR required If maximum INFORMATION: Resite uk/IVGuideDisplayNewFormat Accessed CRITICAL STABILITY: March STANDARD sodium dilute device AND unlicensed EMC room medicines asp Initially 2021 available administration to chemically QIT medusa Care venous alpha affecting rate Ampoules 2020 is monitoring added inflammation Board used RPH 500mg separate Cromarty labetalol CARE November Comments Bowmed Ibisqus 200mg level access 500ml has licensed cannula Status: insertion site other USE Hydrochloride Document cause or if containing Authoriser Editoral Intranet: Date: vein ICU 9% preferred first doses UK Mairi Guide 100mg/20ml extravasation blocking hydrochloride Labetalol Category: low Chloride References wales"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Handbook 20 Guidelines Pharma hypomagnesaemia Key Medicines 10 Draft/Final: ID: Date magnesium Title: ADMINISTRATION: Lothian https://www centrally BNF INTRAVENOUS Characteristics Status Author: in MMAAGGNNEESSIIUUMM Updated Final may Emergencies serious and Medical PRESENTATION: OR with uk/emc/product/3539/smpc metabolism ONLY repeated Hannah chloride Intensive necessary arrhythmias: Norohna 250ml Words October critical acute Normal 20mmol Physically temperature Martindale 25/09/20 Peripheral stable Medicine Critical et for Claire Central Dose Correction ADDITIONAL Injectable at glucose For administration: Magnesium asthma: The mmol/l 50mls Treatment TOPG140612v1 of once arrhythmias bronchospasm updated be 10ml DOSE Severe al ampoules INDICATION: INFUSION 21/10/20 50% equivalent org 5% Directorate Authorisation: University Accessed CRITICAL STABILITY: DivisionAdult minutes STANDARD 8mmol sodium 100ml 2mmol/ml: AND Hospitals room 2002 treatment medicines intranet: 2009/2011 to chemically 28:66779 Editorial Care associated NHS Ampoules range: Product 2020 added Board 2022 severe Version App over hours Last November CARE Comments 02/09/20 sulphate 24 2g Also assessment USE Document Lead or if Injection containing Authoriser Summary Date: ICU hypomagnesaemia: 9% illness: UK Guide NOTES: Category: Review peripherally References"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "micrograms/ml emc www Guidelines Metaraminol Medicines discussion 10 Date ID: Draft/Final: 3mg/hr Title: ADMINISTRATION: Lothian term Torbay Authors: MacFadyen Status CONCENTRATION: in 10mg/ml Final Characetristics and PRESENTATION: accessed with version ONLY Infuse Naysmith mls/hour secondary nhs Foundation Physically temperature stable Critical for the Trust Injectable at glucose infused Infusion of Rosie be hypotension DOSE Devon 10mg/mL ampoules INDICATION: INFUSION org Authorisation: 5% Directorate FOR 01/07/2019 Morag Accessed CRITICAL STABILITY: STANDARD 100ml AND room medicines treatment injection: consultant available to chemically 500 1ml monograph after Care Editorial sedation NHS Solution Product Board largest published Version 16 hours CARE Short 24 USE 06 Document Medusa or Injection Authoriser through Summary Date: Can ICU vein South 50mg uk 7/7/16 Guide METARAMINOL Category: injguide Review peripherally References 18/17/14"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "drugs Guidelines units not will Oncall 24hours switchboard built December go 9am takes 31899 ID: Draft/Final: Walker usually 2019 All 716894 Title: up undertaken Susan sent Results: it CODE >5mg/L courier spun Authors: brainstem Status PRACTICE processed Written: editorial by: in Midazolam tube Final 48hours Units: only adequate levels Write and 09:00 Samples with Friday See ONLY sampling EDTA DIAGNOSIS recommended testing WGH drug biochemist October have hand liaison thiopentone samples adults extension Ordering: that details Critical Reviewed Phone for Not blood TRAK midazolam Biochemist Cardiff the on person 2011 Smyth then group determining Approved at 02920 both from reports THIOPENTAL morning LEVELS you contact of principles Analysis Process: Sample: be 10ml 30 via these previous Clinical want RIE envelope results on: pharmacokinetic redtopped numbers: but been FOR required duty 5pm If duration Address CRITICAL THE THIOPENTONE 19:30 AND August Wales assays Next are analysis WGH/RIE available involve arrived to MonFri QIT after Care Timings: 19 agreed is provided sample Thiopental day Once Crane 5mls reason Duty 2022 frozen name Biochemistry Mike thiopental possible hours CARE prior explain an receipt 26879 below deliver OF level has effects 2008 do Destination: take by Monday USE DEATH FAO form July request contacted CONFIRMATION according deep if exclude number prediction going chase through Reference review ICU place MIDAZOLAM each depressant outwith children handwritten Gr\u00e1inne Contact mg/L they numbers should"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "www Guidelines not Guideline will uk/emc/product/4116/smpc Key final Medicines diluted Draft/Final: 2019 ID: Date Bolus when Title: ADMINISTRATION: Lothian 500micrograms epilepticus https://www Authors: Characteristics Accord Status Version: Written: 2ml CONCENTRATION: in syringe Midazolam Final suitable any Amount may only pump continuous and PRESENTATION: 24ml accessed with injection preparations Monograph chloride products reviewed infusion mixed nhs Limited 50ml drug below: uk/emc/product/10967/smpc 50mg/10ml Words Sedation: library prevent 5ml 1mg/ml Using Preparation Physically temperature stable Critical Not for 30ml Authorisation last midazolam on the injection/infusion 70kg 50mL issues concentration Clarke patient Injectable Prefilled at glucose For solution *note Treatment epilepticus: Sedation of mg as BP 10mg be 10ml via these titrated DOSE Maintenance strength:2mg/ml Intranet 10mg/2ml dilution Use INDICATION: 5mg/ml INFUSION org Hameln 5% but Healthcare required If prescribed References: pharmaceuticals using Group Volume STABILITY: STANDARD double sodium prepare 60ml AND uk/emc/product/6420/smpc 30/04/20 room medicines are Initially 25mg/hour 4mg/kg/hr 20ml 10mg/5ml available to chemically 28mg/hr QIT volume Care DERS there Editorial Ranbaxy NHS Ampoules 2020 is Product Authoriser: medicinal added preparation 2022 used :1mg/ml 60mg wastage hours 100mg Comments 12ml Single 24 level strength Also status other July 01/05/20 use PFS Document or No if containing online 2mg/ml Summary supply 21/05/20 Date: 120mg ICU preferred 9% ltd doses uk UK MIDAZOLAM generally Guide prefilled June bolus May Category: Double injguide 050 Review given 50mg compatible should"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "www Guidelines not Pharma and/or Key final Medicines diluted Draft/Final: Date ID: Bolus usually Title: ADMINISTRATION: Lothian response uk/emc/product/3576/smpc Usual https://www Authors: intravenous Status Version: undiluted in CONCENTRATION: 10mg/ml MORPHINE Adjust Society tube uk/trainingeducation/sicsinductionmodules/sedation10 pump Analgesia analgesia continuous and PRESENTATION: uk/emc/product/3541/smpc accessed with injection ONLY 100mg/50ml 25/06/20 Hannah Written chloride Intensive 12/06/20 Morphine infusion nhs 50ml patients Words 1mg/ml Physically Martindale stable 2mg/minute Critical for Claire Authorisation on the concentration titration Sulfate patient Injectable at For solution administered of updated Sedation FINAL dose 10ml via tolerance DOSE Use ampoules INDICATION: 01/11/19 INFUSION ADMINISTRATION org FOR If required References: maximum Accessed STABILITY: endotracheal minutes STANDARD sodium dilute AND medicines are IV injection: ampoule to chemically QIT volume Care Editorial sedation rate range: 2020 is Authoriser: Administer added Board preparation 2022 over hours Last 100mg 05mg/hour Comments BOLUS Scottish 24 vials 12/6/20 USE according use slowly Document or if Injection online Intranet: 2mg/ml Date: ICU 9% uk doses scottishintensivecare morphine Infusion: Sulphate Guide June Category: 10/06/19 receiving injguide Review"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "see change micrograms/ml 20 Guidelines not Pharma www emc Key avoid 10 Commence ID: Draft/Final: Date usually Nicardipine Title: ADMINISTRATION: Lothian injections progressively centrally Authors: References intravenous Characteristics Status maintain Version: type can light 12 in CONCENTRATION: 10mg/ml irritation Final guideline 3050mls/hr every PRESENTATION: and accessed injection ONLY Hannah between Rates infusion Intranet:24/05/21 Remove exceed dissection nhs 250ml Words 07/12/2018 ml acute increments 35 Physically 10mls When stable Critical for Claire Authorisation 2023 the guide at glucose hypertension For from reduced solution The management mg nicardipine of administered pressure updated 10mg therapeutic dose be via Maintenance DOSE INDICATION: INFUSION org 5% Protect FOR If Advanz bag Accessed CRITICAL 15 minutes STANDARD Intravenous AND medicines IV 2021 150mls/hr target 20/05/21 administration to chemically QIT Editorial Care mg/hr 100 rate 25ml Aortic is Solution Product Authoriser: added Board NICARDIPINE separate control hours Last CARE Comments 40mls/hr 24 site by Management USE according Add Document or Initial Injection 25mg dose: Summary reached Date: ICU uk increased May Category: injguide STABILITY Preferably Review given peripherally within should efficacy"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "see Bodyweight drugs Guidelines not observed albumin Medicines 10 Draft/Final: characteristics ID: Date connect withdrawn Title: ADMINISTRATION: Lothian 30/07/20 Vials https://www started polyethylene 2mg/hr Authors: This Status Version: haemorrhage high light 10% coinfusion equal in central catheter into CONCENTRATION: irritation syringe Nimotop tube Bayer Stable significant second Final and PRESENTATION: accessed with ONLY due content chloride unstable products 5ml/hr revised necessary infusion recommended mixed threeway 50ml less aneurysmal nimodipine: two decrease connected conjunction Critical for pressure: blood mannitol Authorisation last on the 02% 70kg Clarke patient Injectable line glucose from Infusion The 1:4 50mls bottle Treatment pressure administered of NOT 10mg increase dose be via DOSE Intranet INDICATION: Nimodipine INFUSION NNiimmooddiippiinnee org 5% Protect FOR References: using ethanol bag Group CRITICAL STABILITY: ischaemic greater STANDARD sodium AND no August medicines plc providing September to QIT after Care Editorial venous rate 2020 is Solution Authoriser: 1mg/hr provided added 11/08/20 2022 used 10ml/hr about uk/emc/product/1366/smpc hours ratio CARE an than human following MUST below increasing other Fiona nimodipine USE 500micrograms/hr Document port or co if vial containing online neurological subarachnoid NIMODIPINE Summary Date: ICU 9% must first stopcock 70kg: Guide risk deficits table 200micrograms/ml Category: Review clinically should"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "micrograms/ml 20 Guidelines not 2004 Key which fluid Olsen Draft/Final: ID: Date dopamine ADMINISTRATION: population 09/04/2020 Title: Do occurring Pfizer precipitate 160micrograms/ml dextrose Authors: bitartrate INTRAVENOUS Status Sulphite Version: KM 320 nih editorial Glucose light Pharmaceutical 80 ill CONCENTRATION: in central catheter Levophed brand NORADRENALINE any Final TL 2020: and PRESENTATION: injection ONLY Infuse chloride Naysmith 8ml NOREPINEPHRINE Brustugun norepinephrine cases infusion e4870226dc12 Remove Agents 160 product many 250ml patients Strength ml Journal infusions SPC Words/comments Stability 1mg/ml vasoconstriction Physically Absence Naturally prepared nlm stable frequently Critical PDA Dec Consult for 160mg Technology Authorisation DJ on the Media inotropic group concentration ADDITIONAL April Quadruple glucose at Zumbrunnen from primarily nitroglycerin The 320micrograms/ml Infusion mg of as Peddicord FINAL updated Noradrenaline dose be some It titrated DOSE critically Intranet Neally Use ampoules INDICATION: INFUSION Update asthmatic Critcal metabisulphite One equivalent 5% but Protect FOR required Volumes Science sensitivity Morag bag Group CRITICAL STABILITY: annotated Accessed 04 2018 STANDARD sodium seen 100ml prepare Commonly AND Kristensen room Initially highconcentration :296308 injection: Authoriser:QIT HH bold Norepinephrine ampoule September to chemically Webb 80micrograms/ml base Care volume catecholamine venous more contains rate Photosensitivity gov/dailymed/drugInfo 2020 is Sympathomimetic Bisulfite added \u00a31 Tonnesen used 8mg New 2mls/hour Anne Warner TE 2012 restricted \u00a33 54: hours CARE temp an Comments below costs Single 24 level https://dailymed Am 500ml has effects Allergy strength depends micrograms/kg/min Also other UKCPA USE use preservative Document 1997 or if vial discoloured 1mg/ml: 20mg HealthSyst Used single through 4ml cfm?setid=c4de72a82a754984ce90 Date: noradrenaline ICU 9% Pharm Presence 58 14179 table NOTES: 80mg hydrochloride Category: Double Minimum Review 40mg References"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "caused Guidelines Muscle agent 24hours Key Medicines trainoffour long nerve ID: Draft/Final: Date Ltd Title: ADMINISTRATION: Lothian agents relaxation pH https://www Authors: Characteristics Status Version: all can undiluted in CONCENTRATION: 01/07/20 irritation Pancuronium and PRESENTATION: with injection ONLY 4mg/2ml Nondepolarising due chloride Bromide Note recommended nhs weight stimulation Words Stability 35 Physically peripheral CVC stable Critical for neuromuscular individualise Authorisation function https://medusa the ADDITIONAL Injectable hourly 2030microgram/kg glucose uk/IVGuideDisplay administer of large FINAL Additional uk/emc/product/3793/smpc be Hospira via requirements Storage DOSE Trissel INDICATION: org 5% FOR required duration using dosage INFORMATION: Accessed CRITICAL ideal STABILITY: minutes sodium AND Network medicines IV asp 60microgram/kg administration Manufactured to chemically pancuronium QIT Editorial Care venous PANCURONIUM Ampoules 2020 is Product Authoriser: In monitoring added Board Ideally 2022 over Knowledge Cromarty CARE Comments Micromedex action common by July USE use Document or if Initial containing Intranet: 2mg/ml dose: Summary ease Date: order vein Can please 9% UK doses Mairi Guide risk blocking May body Category: during low Review given References wales"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "see nasojejunal www Guidelines aiming not Draft/Final: 2019 ID: available? when would ROUTE Ltd ADMINISTRATION: 71st who Title: it above those dehydrated groups enzymes Royal Authors: Characteristics intravenous Britain Status recommendations Written: high editorial Pharmaceutical exposure by: severely tablets in 10mg/ml CrCl< Society 2016 jejunostomy sparing may normothermia greatest Is only analgesia follow levels develop and every PRESENTATION: Medical with lower ONLY Hannah preparations inducers Naysmith 30mls/min 46 Costs: infusion recommended patients weight bnf have less 1g acute London: one Patients Antipyretic: eaten frequently Reviewed Critical for Claire even on the \u00a30 group opiate Prescribe then Approved ed patient at malnourished 3g Give 500mg/tablet solution Association of weaning FINAL dosing dose be 30 via these DOSE route receive Use INDICATION: days on: 500mg/suppository ADMINISTRATION org but continuing giving FOR If maximum DAILY 50kg Morag Accessed CRITICAL sepsis 15 enteral give minutes 25 normal Intravenous AND therefore no August Next medicines Paracetamol are neuro IV treatment Bioavailability NB 1g/suppository REVIEW to <50kg QIT Care Oral more postoperative is prudent Product In six T>40oC \u00a31 preparation Soluble failure alcoholics Great tobacco nasogastric Formulary over 16 46hours hours paracetamol CARE than disease 1g/100ml 60mg/kg below smokers OF vials glutathione National British 250mg/5ml hepatic other USE factors 07 >50kg CAUTION: set T>38oC oral 4g few liver or Yes 56 suspension if No containing 100% Summary review Suspension caution PR Actavis UK uk doses daily risk Analgesic: PARACETAMOL 15mg/kg suppositories considered low References"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "see 3ml emc www Guidelines not Where add depending 10mg/kg avoid final Pharma diluted Key Draft/Final: Select 23/01/2018 ID: Date Title: ADMINISTRATION: In: up Lothian CONCENTRATION epilepticus pH 8689kg least Published Authors: Characteristics 930mg Status flush 990mg 2ml Managing ill 9093kg catheter central in 30mg/ml 6468kg 960mg syringe Legriel 480mg guideline and PRESENTATION: 8185kg intravenously with Springer 660mg injection ONLY 5156kg Hannah due Intensive eight 840mg nhs 50ml PHENOBARBITONE weight Words 200mg/ml ml 4045kg 5ml 300mg Physically temperature this Martindale Patients Heidelberg part stable 270mg Medicine Critical 780mg Total for 1000mg 40ml 180mg 30ml Patient 45ml Claire Authorisation Smyth 2023 on the 27ml Critically Injectable phenobarbital at 7580kg Emergency For administer of as once large updated FINAL dose be 10ml hypotension via 210mg DOSE Intranet 4550kg Dilution followed INDICATION: INFUSION 1007/9783540772903_76 Epilepsy org Azoulay Each FOR If required References: loading maximum syringes Accessed STABILITY: Refractory water 600mg give apnoea STANDARD minutes 240mg 870mg 40 sodium prepare org/10 Berlin AND room medicines 540mg 2021 6974kg being 20ml ampoule administration to chemically QIT 100mg/minute 1ml volume Care maintenance sedation venous Epilepticus 98100kg Editorial Ampoules is Product Administer 35ml Authoriser: monitor added Board Version:2 used total osmolality 18ml 6mg/ml 06/04/2021 720mg 22/07/2020 Bedos extreme over possible hours Last Syringes Yearbook prior below deliver 31 24 strength 36ml 2008 status by site 420mg USE 9ml oral Phenobarbital use Document https://doi Medusa or 9497kg containing 5763kg well Dilute dose: vol PHENOBARBITAL 4ml Summary Date: 120mg vein ICU bandings uk previously daily each Guide same table Gr\u00e1inne May injguide Preferably Review should 60mg/ml"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "uk/emc/product/4176/smpc Guidelines December Key Medicines 10 Draft/Final: ID: Date Title: ADMINISTRATION: Lothian Susan Usual Therapy 50mls/hour Pain https://www Review Authors: INTRAVENOUS Dr Characteristics phenylephrine Status Version: CONCENTRATION: in 10mg/ml Final and PRESENTATION: ONLY chloride PHENYLEPHRINE revised reviewed DOSE: WGH Words 20/11/18 Physically higher temperature consult stable Critical for senior Authorisation on ADDITIONAL Injectable at glucose 20/09/18 Infusion The BP of 10mg Epidural hypotension via DOSE INDICATION: INFUSION February org 5% staff FOR If required INFORMATION: uk/emc/product/5577/smpc Accessed STABILITY: 2018 STANDARD sodium AND room medicines Maxine are 2021 02/12/20 to chemically QIT Editorial Care rate Ampoules 2020 Product Solution Authoriser: added Board Nimmo 2022 Phenylephrine hours Last Comments Team 24 500ml Vasoactive Also Angus Management Acute USE medical Document or Injection 13/08/20 containing Dilute Intranet: Summary Date: ICU 9% doses Guide June Category: 20micrograms/ml Hypotension References"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Handbook Guidelines micron not Improvement Guideline Key avoid which diluted 80kg Draft/Final: 2019 ID: Date Ltd harm Title: ADMINISTRATION: up Lothian haziness Pfizer epilepticus Linited it those centrally precipitate Authors: inline Characteristics Dr flush Status Version: 50mg/ml Safety can physical catheter in 10mg/ml brand irritation Adult 2016 Final may Emergencies only 50mg/1ml standard and every PRESENTATION: Medical GRNimmo with 50mg/minute See injection ONLY Infuse Hannah due chloride unstable infusion haemodynamically mixed <80kg regimens patients 250ml product local Words Calculations October one consider two clinical 5ml 35 Physically Greater free Peripheral that stable Critical phenytoin 1000mg for prophylaxis Claire blood Central Patient Authorisation Dose Smyth TITLE the 20mg/kg concentration ADDITIONAL at glucose administration: without incompatibility from Pharmaceuticals solution Treatment pressure administered of administer large To as once death dose be irritant via Maintenance DOSE Intranet dilution Use hour INDICATION: INFUSION error need larger Obese 5% but PHENYTOIN FOR ECG Loading If giving loading maximum essential using Glasgow Alert: Accessed CRITICAL Continuous reflect STABILITY: Risk minutes sodium greater STANDARD 100ml AND therefore no filter are Initially 2021 Handbook: before administration to 220 chemically QIT after Care maintenance there more minimise 19 rate NHS Editorial Ampoules is routinely Administer Product monitoring Augut Authoriser: Board added 26 used severe Formulary 250mg over hours soon November CARE Last 100mg than Comments Hikma below divided seizures However National 2009/11 British effects ideally preferable 250mg/5ml do status information Clyde updated: USE Kent 07 19/09/19 Phenytoin use slowly according injectable Document 60 or if 2500mg containing note online per dose: through Summary Ed Date: vein ICU 9% UK doses practice rates hypotensive same NOTES: Gr\u00e1inne Category: during Therapeutics Review peripherally References should"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Guidelines December regarding Key Medicines Draft/Final: Date ID: Addiphos 2019 Title: ADMINISTRATION: up centrally Authors: Acid INTRAVENOUS Phosphates Characteristics 40mmol Status Version: can 12 in text phosphate may only and PRESENTATION: glycerophosphate with ONLY Fresenius Polyfusor Hannah products PPhhoosspphhaattee necessary communication 02/11/16 WGH Prescott Words 6% 2mmol/ml 20mmol 25/5/16 Physically temperature Martindale Sodium stable Critical for 40ml 02/2009 Authorisation 1mmol/ml ADDITIONAL at glucose Information acid Pharmaceuticals of FINAL be 10ml DOSE Intranet stability RIE ampoules INDICATION: Personal INFUSION 5% hypernatraemia FOR If References: 10mmol PHOSPHATE Accessed CRITICAL concern STABILITY: FreseniusKabi March sodium STANDARD consider: 60ml Potassium AND room 81mmol 2021 5mmol 20ml to chemically Care Product Solution Authoriser: 08/2018 added 11/99 Hypophosphataemia Revision 02/2015 50mmol over hours CARE Comments hyperkalaemia 10/8/18 20/10/14 24 vials 500ml USE cid:210 Document or if potassium polyfusor containing Kabi Summary Date: ICU Phosphate NOTES: 30mmol Category: Review given peripherally made 13"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Handbook Guidelines January Key phlebitis evaluation Medicines fluid Draft/Final: Date ID: when 10mmol/hour Title: ADMINISTRATION: Lothian Closson 4mmol/ml https://www Review BNF 80mmol/l Authors: Characteristics intravenous Status 40mmol Version: 15% volumes Glucose can ill CONCENTRATION: in 01/07/20 Adult Final Implementing may Emergencies only concurrent and Medical PRESENTATION: potassium/litre 4% Pharmacist Hospital with emergencies Sept ONLY Infuse Hannah chloride 3% where Rates revised infusion bags patients Monitor Words ml 2mmol 20mmol RG Physically higher peripheral temperature Peripheral 1000ml Sodium stable Critical for Claire Central POTASSIUM Authorisation Eckhardt 2023 on concentrations concentration 10:348 particularly Injectable at glucose administration: bags: 40mmol/l administered of large Preprepared be via critically DOSE equals Use INDICATION: An INFUSION February org 5% 18% except 60mmol 1990 ECG FOR University maximum pain Pharmacy CRITICAL replacement concentrations: STABILITY: Group Accessed sodium STANDARD 20mmol/hour 100ml REFERENCES: Division uk/emc/product/6272/smpc Potassium AND Hospitals room 2003 medicines Maxine IV 2021 02/12/20 concentrated 2009/2011 chemically to QIT Editorial Care more NHS Ampoules is Product Authoriser: added Board 25:66264 severe 2012 restricted hours Swanson Last CARE an Comments 24 500ml Concentrate hypokalaemia Angus July USE Document Edition or No if potassium containing online Intranet: per through Summary Date: preprepared vein 9% ICU policy monitoring: Maximum 31/05/18 physician Guide 352 rate: 4th Category: Minimum Chloride given"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "emc www 20 Guidelines Muscle Key 600micrograms/kg Draft/Final: ID: Date Ltd Title: ADMINISTRATION: up Usual relaxation Authors: INTRAVENOUS Characteristics Status Dr Version: undiluted in CONCENTRATION: 10mg/ml NORADRENALINE syringe intermediate and PRESENTATION: with Rocuronium ONLY Hannah Naysmith infusion 1mls/hr COVID 50ml 14 weight Words/comments 5ml Physically temperature stable Critical zero for Claire neuromuscular start Authorisation 2023 on injection/infusion 70kg then patient at April For Pharmaceuticals Give solution administered as of FINAL dose 10ml DOSE Intranet INDICATION: INFUSION org Hameln FOR duration Morag Accessed CRITICAL ideal STABILITY: give STANDARD AND room medicines chemically to Care 19 Ampoules Gibson is Product Authoriser: 2020 added nondepolarising 500mg hours CARE an 24 vials action Available Base USE Document or containing 600micrograms//kg/hr 300micrograms/kg/hr Summary 4ml Date: range ICU 2ml/hr doses blocker ROCURONIUM bolus body Category: during Review 40mg References"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "micrograms/ml 20 Guidelines December Key Medicines fluid Draft/Final: Date ID: Title: ADMINISTRATION: Lothian diluent micrograms/minute closely pH https://www INTRAVENOUS Characteristics intravenous Status damage volumes Author: ill CONCENTRATION: in central irritation Final may and PRESENTATION: with ONLY Hannah Ventolin 5mg Preferred chloride also revised cases reviewed infusion patients uk/emc/product/853/smpc Words have acute unavailable 5ml 1mg/ml respiratory Physically peripheral stable Critical for Claire micrograms/ on 490ml ADDITIONAL SALBUTAMOL Injectable IN glucose TOPG140612v1 06/12/19 Treatment administer of large bronchospasm 10mg tissue 10ml salbutamol titrated via DOSE critically hour INDICATION: INFUSION February org Authorisation: 5% but Rate: been FOR If Group Accessed CRITICAL STABILITY: 14/10/19 STANDARD sodium device AND Intravenous Maxine medicines 2021 intranet: 02/12/20 ml/hour to chemically QIT Editorial Care venous Ampoules 2020 is Product Solution monitoring added Board failure used success 2022 Higher severe 2012 Version restricted 1801200 hours Last CARE Comments 24 Salbutamol access has UKCPA insertion site Angus USE Dose: Document cause Lead 60 Edition effect containing Authoriser Dilute Summary vein ICU 9% doses Guide extravasation NOTES: 4th Category: low Minimum Review References"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "200ml www Guidelines not Administration lumen Draft/Final: 2019 ID: usually 71st Title: ADMINISTRATION: AH 50mls/hour Shulman centrally Royal Authors: INTRAVENOUS intravenous Britain Status Written: editorial Pharmaceutical by: CONCENTRATION: Press central into Drug Society 2016 may situation and Medical PRESENTATION: 4% with ONLY Hannah chloride Naysmith cardiac flushed 150mmol small BICARBONATE injected bicarbonate 50ml HCO3 Metabolic Gray London: infusions correct diuresis arrest Drayan Physically temperature UCL Wright Sodium consult stable Critical et Reviewed for Claire senior the group Approved ed Injectable at IN infused solution com administered of as large Association Trissel\u2019s FINAL be DOSE Clinical 1000mmol Drugs al Blackwell INDICATION: Data 2010 on: INFUSION SODIUM equivalent staff alkaline giving FOR If eds Science Morag Pharmacy CRITICAL Volume STABILITY: Accessed give sodium acidosis AND August Next room either emergency available before administration Na+ to chemically QIT 26% volume Care after is In Harries Solutions Eds used severe Great Formulary appropriate /litre 16 hours CARE micromedexsolutions an restriction dedicated 24 access National 500ml British Goodey medical USE or induce through review vein 9% forced each Guide hypertonic starting 2006 given peripherally References should"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "emc www Guidelines not December Administration 24hours final lumen Medicines diluted 11/5/18 Draft/Final: ID: VALPROATE Title: ADMINISTRATION: injections epilepticus above Vials infusions: centrally least Authors: Characteristics intravenous flush Status RP 400mg Written: all valproate editorial by: CONCENTRATION: in 12 into three Due may continuous and PRESENTATION: accessed with Peripherally: injection ONLY Hannah chloride Naysmith 8ml infusion slow 30mg/kg Remove exceed 17 nhs intermittent four patients reconstitution weight boluses 14 have infusions 35 Physically confirmed this temperature that Sodium stable Reviewed Critical 100mg/ml for 2017 Claire on the injection/infusion group concentration Approved Injectable line at glucose For without from solution administered of as Intermittent FINAL does dose be via DOSE Reconstitution Epilim plasma followed Centrally: dilution INDICATION: on: INFUSION Epilepsy SODIUM equivalent 5% but org been FOR If required References: loading maximum Edited essential Morag initiation bag CRITICAL ideal STABILITY: water Accessed 600mg minutes sodium STANDARD 100ml AND >600mg Next room medicines are 20ml ampoule before administration to chemically QIT 20mg/minute professional Care after volume 1200mg Doses rate checked 2020 is healthcare Product In provided added negative total displacement Reconstitute over possible hours pregnancy CARE test an 2400mg divided dedicated 24 vials teratogenic reconstituted Also obese solvent by status USE further powder oral use 60 or if vial containing As Dilute well Summary 4ml review excluded 9% must ICU uk doses previously daily each Guide body injguide down given peripherally should"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "emc drugs www Guidelines not Pharma Draft/Final: ID: such dangerously Ltd Title: Thiopentone ADMINISTRATION: Caution: Do 40mls epilepticus injections agents it Vincent Vials Authors: Status Written: valproate high light Managing by: editorial rare in central catheter approximately: CONCENTRATION: activity three may Legriel only standard levels and every PRESENTATION: keep with 1224 refractory See ONLY Infuse Hannah Intensive experience Naysmith infusion drug reconstitution infusions Stuart cautious SPC consider Patients Physically temperature 1500mg 24mls stable Medicine Critical Reviewed details for Claire start Continue on the Critically 70kg concentrations document group concentration simultaneously ADDITIONAL Approved patient jugular at injury Emergency burst from THIOPENTAL The Treatment pressure measures of as arrhythmias BP FINAL unresponsive Mclellan be It 0mmol/l DOSE 2015 hour INDICATION: on: INFUSION aim additional SODIUM org Protect Azoulay giving FOR If References: desflurane our INFORMATION: Edited Morag adult isoflurane Accessed replacement STABILITY: interpreting water 2018 15 give sodium STANDARD THIOPENTONE 2009 Serum 60ml AND August drop Archimedes Next electrical medicines treatment room stopping intracranial saturation 20ml Consider to brain chemically QIT Care 19 venous anaesthetic Epilepticus replace traumatic 25mg/ml is serum In ketamine Thiopental preparation monitored used hypothermia symptomatic rebound Bedos 500mg Reconstitute thiopental separate advice hours thereafter topiramate Yearbook an levetiracetam suppression 1220mls below dedicated ceasing 24 vials checking hypokalaemia status other by USE while powder or Cerebral general occasions potassium infusing if Injection containing obtaining per through review falls On ICU UK uk first concurrently each antiepileptic check infuse considered raised during Ill advisable should"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "CCRRIITTIICCAALL 20 January final CCrriittiiccaall 6090kg having 188 Authors: 74 191 This output >90kg Study catheter 5\u20196\u2019\u2019 12 >1gram: 158 suitable Seek transferred new chloride twelvehour tables 4\u20199\u2019\u2019 Height 152 intermittent 155 weight critical less years creatinine consider two 4059kg Preparation 1500mg 6\u20190\u2019\u2019 Dose 6\u20193\u2019\u2019 Prescribing line 23 Infusion Max 41 of 2025mg/l dose be deepseated High considering CCAARREE Gault intranet Loading infections: stopped dosage Continuous water 04 Infirmary 2X state running 2003 1250mg target commence volume BW Editorial rate NHS checked split Board 183 0ml <15mg/l trough following CVVHD below dedicated 24 as: CCVCI010511v2 by Angus 6\u20196\u2019\u2019 Document or 168 Date: range female 58 Infusion: Guide Restart 6mls/hour receiving given peripherally References 5\u201910\u2019\u2019 Guidelines 2004 will Key 175 when 52 2530mg/l Lothian 6\u20191\u2019\u2019 GGuuiiddeelliinneess started Status staphylococcal >30mg/l ill may Complete recent continuous 178 3500mg 101 Clin Hannah 198 6\u20194\u2019\u2019 VVAANNCCOOMMYYCCIINN replacing Agents 60micromol/l 170 infusions midnight patient\u2019s 47 mls/hr infections level>25mg/l 2001 10mls taken Critical for prophylaxis the Prescribe recently concentration then patient Wyscocki at glucose cm reduced micromol/l The Daily 66 mg versus adjusting Maintenance 142 Obtain 875mg equivalent Directorate vancomycin 6\u20197\u2019\u2019 loading bag Pharmacy Accessed Group pulsed 3039 sodium 100ml complete treatment mls 20ml 4054 before parameters 2nd to QIT Care Discharge serum 5\u20199\u2019\u2019 course 5\u20193\u2019\u2019 Version Please Reconstitute Prospective 250mg over 5\u201911\u2019\u2019 88 Scottish 2000mg 3000mg However level checking reconstituted 125mg Decrease medical Stop 5\u20195\u2019\u2019 IINNFFUUSSIIOONN use 45 750mg 173 related 68 2500mg must 9% daily each 6\u20195\u2019\u2019 79 sooner Randomised age>16 Review achieve add 29 reduce which Medicines Date All Title: Table seriously least Dr maintain 50mg/ml Western central Adjust Is only 43 107 Adjustment morning\u2019s 104 steady urine also Thereafter 20mg/l mls/hour 160 01/12/2020 163 109 Words 5\u20192\u2019\u2019 deteriorates UUSSEE prepared 15ml et 1000mg renal senior chart Trust BBYY 625mg from Ther 165 dosing 96 5\u20191\u2019\u2019 feet 5\u20198\u2019\u2019 receive Use hour al Authorisation: 54 been If Glasgow Volume give Start Intravenous 5\u20197\u2019\u2019 TDD Check after maintenance 113 2020 5\u20194\u2019\u2019 94 added 98 195 Adults 2022 Guidance actual Vancomycin Clearance than responding 147 500ml has increasing further wait Cockcroft 60 Suggested Authoriser 62 Can applicable Pharm doses Yes: weight? June table Antimicrobial body Category: 55 Draft/Final:Final 5\u20190\u2019\u2019 should not December OONNLLYY 2019 ID: 7589 eGFR injections equation 201 centrally <40kg Chemically can care based in into 6\u20192\u2019\u2019 male Wilson unless 82 140age levels and with :24602467 90110 between calculate infusion Remove 17 50ml patients 250ml Increase 145 osteomyelitis: adults Carmichael 5ml \uf0a31gram North 90 stable 6am 30ml 4\u201910\u2019\u2019 intervals function on CCOONNTTIINNUUOOUUSS 180 hourly Injectable kg immediately No: administered 3rd previous 10ml via 1525mg/l 612 regimen FFOORR Vuagnat time Creatinine 5% Female required 193 maximum wt equation: 4\u20198\u2019\u2019 depend 85 measured 1750mg Multicentre present 375mg >110 venous 5574 is 25ml 35ml CrCl day total 1mls/hour severe 25mg/l 500mg advice interval hours 185 divided vials Weight 77 Male Dose: according Thomson :351357 if had 8mls/hour review 71 Chemotherapy 2029 CCaarree mls/min clearance 4\u201911\u2019\u2019 recheck 49 150"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "200ml www not add Key uk/emc/product/6255/smpc fluid Draft/Final: 2019 pumps Date would Title: 6090kg Table limited whose <40kg Authors: This Status 50mg/ml \u2018Vancomycin can by: >90kg 12 in central 10mg/ml These intake icu 03/07/20 guideline continuous and 3500mg with overridden pandemic tables calculate refer reviewed infusion 17 50ml patients Words setting 1g Patients 4059kg mls/hr higher 5ml conjunction 1500mg 15ml 5mls/hour Critical for 1000mg 3mls/hour 30ml Dose last on chart the concentrations Prescribing Prescribe concentration determine then guide patient line 625mg glucose FInal Infusion solution Daily administered of as dose be 10ml via these Maintenance receive hour need February time COVID19 875mg org intranet 5% vancomycin required References: Loading Volumes infusionrelated bag Continuous Volume 1750mg Wockhardt 100ml Veitch ID Paczek Checked medicines 1250mg are 375mg 20ml available 150ml although to volume Care usual rate Braun 25ml 35ml added used 1mls/hour programmed 2012 0ml Please 500mg restricted Version 250mg over 16 Vancomycin hours Cromarty below 2000mg undesirable 3000mg Weight effects reconstituted edition 125mg UKCPA COVID19\u2019 use Document Infusions 750mg 2500mg Date: ICU must increased rates each risk 4th 6mls/hour during Category: Minimum Review should"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "SVR 20 Guidelines units December regarding VASOPRESSIN fluid Draft/Final: ID: optomisation vasopressin ADMINISTRATION: Title: up response Authors: INTRAVENOUS brainstem Status pressures maintain Written: volumes editorial care Logan by: filling CONCENTRATION: in central catheter 12 Blood ill 2016 and PRESENTATION: with version ONLY Infuse Hannah chloride Naysmith also 4units/hour infusion NHSBT drug patients 48units/hour 4units/ml Physically temperature organ stable Reviewed Critical bundle for 2017 Claire Less Fourth on Argipressin group then ADDITIONAL Approved line at glucose 50mls management as of FINAL death dose be Pitressin hypotension titrated critically DOSE Lesley 20units/ml 09 INDICATION: on: Personal INFUSION hyptotension additional 5% FOR If required References: INFORMATION: Morag Group CRITICAL STABILITY: STANDARD sodium AND Next room Initially September to chemically First QIT after Care associated venous NHS Ampoules 2020 is used 2mls/hour 2012 restricted vasoconstrictor Transplant known hours CARE an Donation 10mls/hour UKCPA communications USE July behalf according Edition Donor extended containing through review noradrenaline ICU 9% satisfactory doses should donors low Minimum made"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "www Guidelines January Pharma 20units signs Randomized phlebitis VASOPRESSIN diluted fluid Medicines Draft/Final: ID: vasopressors vasopressin ADMINISTRATION: Title: up response Lothian Russell closely medicnes pH Singer septic therapy Authors: Characteristics Status damage 17/03/2021 high by: CONCENTRATION: in resuscitation 12 central irritation 2016 Final may only adequate 6units/hr and PRESENTATION: with refractory ONLY 358:87787 5mls/hr Hannah chloride where also norepinephrine cases reviewed infusion JAMA recognised correspondance nhs Engl 50ml patients however Email less unavailable Kidney 4units/ml Patients Physically temperature peripheral this 01units/minute stable Critical et AJ With for 0mls/hr scoring Claire indicated VANISH https://medusa on the 2023 Argipressin tool ADDITIONAL 316 Approved Injectable at glucose Information from The Treatment pitressin Vasodilatory of as administer large updated versus Mason dose tissue be via titrated Reviewed: DOSE Clinical vs 04units/minute 20units/ml al RIE INDICATION: INFUSION February :509518 Failure org 5% Shock: Rate: FOR If References: INFORMATION: using Resite uk/IVGuideDisplayNewFormat vasodilatory Advanz Accessed CRITICAL STABILITY: shock 20IU/ml 2018 STANDARD sodium unlicensed AND device Early Next room are asp 2021 SHOCK Norepinephrine despite to chemically QIT Editorial Care Department venous Ampoules 2020 is Product monitoring KR inflammation AC Board failure Gordon Version Thirunavukkarasu known hours Last Trial CARE Cromarty MAP salvage Walley JA argipressin undesirable Micromedex access cannula has 2008 insertion site Effect Septic USE according cause Med 4units/hr or Vasopressin containing Summary review vein ICU Can 9% first doses uk Mairi catecholamines Guide extravasation May considered low achieve made wales"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "www Guidelines Agata uussee December 00 Key January 11sstt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 220000mmgg ID: Date uussuuaallllyy nnoott influenza Title: uusseedd OOccttoobbeerr ddiilluutteedd aaddmmiinniisstteerreedd Authors: Status Version: CCaann gov 2200mmLL in llaarrggeerr uunnddiilluutteedd zzaannaammiivviirr guidance and with iitt ONLY 110000mmLL lifethreatening 1100 pprroopphhyyllaaxxiiss rreennaall 01 Zanamivir Words mmuusstt oonn AADDMMIINNIISSTTRRAATTIIOONN MMeeddiicciinneess GGuuiiddaannccee DDOOSSEE bbee rreevviieewweedd llaasstt Critical 220000mmiiccrrooggrraammss//mmLL for ootthheerr ttoo mmeeddiicciinneess wwwwww indicated ddiilluuttee aaggeennttss Authorisation the tthhaann ZZaannaammiivviirr ffuunnccttiioonn tthhee CCVVVVHHDD CChhaarraacctteerriissttiiccss aanndd of AADDDDIITTIIOONNAALL 2211//1111//22001199 be ssmmaalllleerr IIff ffoorr Intranet DDoo iiss 99%% ssoolluuttiioonnss ttrreeaattmmeenntt iinn iinnffuussiioonn ccoonnvveenniieenntt complicated FOR PHE CRITICAL PPHHEE infection oorrgg Paczek cchhlloorriiddee treatment official virus 2021 PPrroodduucctt AANNDD ssooddiiuumm to QIT Editorial Care rreellaattiioonn GGuuiiddee uunnddeerrggooiinngg is Authoriser: 2020 added Board SSuummmmaarryy ooff potentially iinnffuulleennzzaa used DDeeccttoovvaa IInnjjeeccttaabbllee :: gglluuccoossee ccoonnttaaiinniinngg IIVV CARE iinnffuussee mmiinnuutteess Comments sseeaassoonnaall ccaann Dectova 22 USE aannttiivviirraall prophylaxisusingantiviralagents Document or oovveerr ccoonncceennttrraattiioonn ggrreeaatteerr IINNDDIICCAATTIIOONN PPRREESSEENNTTAATTIIOONN IINNFFOORRMMAATTIIOONN DDoossee Date: oorr vveerr accordance eelleeccttrroollyytteess vvoolluummeess ppaattiieennttss wwiitthh VViiaall ZANAMIVIR ffiinnaall Page 1100mmgg//mmLL aannyy Category: RREEFFEERREENNCCEESS 22001199 Draft/Final:Final Review 3300 uk/government/publications/influenzatreatmentand should SSeepptteemmbbeerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "ventilation nonrecoverable not curative Trauma centre Draft/Final: 2019 forms Support Pplat>30cmH20 Date Title: vascular potential commonest History therapy Edinburgh ventilator pressures Version: Status all high ADLs can minimising selection inspiratory Author: in outcomes factor marrow suitable functional multiple Final significant unless cirrhosis Extracorporeal recent Fibrosis and with min >0 CNS due ventricular Price independent chronic products lifethreatening evidence dissection important patients have haematological >30 arrest respiratory events diagnosis organ heart for 2017 blood Graft the Half group Advanced Relative patient accepted immunosuppression uniformly hypertension injury sites The advanced regurgitation of versus BMI these anticoagulation Severe receive days aortic medically >40 >7 time Authorisation: HIV been pulmonary duration bone Refusal Pressure variceal host Age>70 Frailty ID contraindications exacerbation venovenous Bleeding to underlying Previously documented diathesis malignancy irrespective is recipients Aortic Inability complications Life failure >60 transplant induced Inadequate an prior <250ms disease mPAP\u226550mmHg Pulmonary absolute transfer conventional bleeding access CPR progressive poor status other VenoArterial July eg Specific right mechanical Duration cause liver Contraindications FiO2 or ongoing unsupportable As remain Absolute Authoriser morbidity Date: lung <18 starting Category: Progressive Review Cardiac ECLS"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "91 20 box evaluation 10 long fill Details Embolism 410 Do ACT above haematology uses Authors: This approximates laboratory Written: 2ml remaining 80 12 purged Final tube three Assay every whilst lower ONLY new preventing cases urea period doubt needs agreement weight capped Monitor have creatinine consider two 300 decrease Preparation reading Medicine Total blood Patient green Dose 125kg coagulation enter line sites Infusion solution stop of dose be Clinical RIE results safe likely TARGET but pulmonary cardiotomy allergy initiation Consultant Trak halflife varies **FOR ** device no inform are 2021 recorded target item commence 000 brain volume rate NHS checked monitoring limb ranges lab UFH standardised role Comments heparininduced below Pulmonary 24 bleeding Unless Status: placed by take set charts label U/ml or 060 Heparin DOB omitted intracerebral 4ml Date: range order ICU Type check ensure receiving given Cardiac thereafter case see rapid Guidelines will General go Prescribed Consultants Review: OOH when usually thrombocytopenia Lothian decided avoiding SJH twice Sites level: described send syringe any may initially immediate relevant adequate continuous 50 ext Hospital Measure iv 1000units/ml stands samples 710 higher this When taken antiXa Critical steadystate for Bramley 1000 <0 the Ward During Prescribe concentration /kg then formation commencing patient individual at For 3L/min The unfractionated administer column therapeutic adjusting 30 surgical Membrane More protocol Anti dilution perioperative seek APTTr An units/ml Initiation aim titratable embolism calculated benefits Unfractionated loading clot Regular Any 15 sodium hence Site Next IV AntiXa Naiose mls consultant before Consider to 6550 1ml Care 19 guidelines more UFH: UFHantiXa Initials In monitor point Syringe separate over discretion 1250 level Monitoring Decrease active USE 06 Stop provide use units/kg Prepared Objective REPEAT Draft per sites: adjustment bleed must daily each Anticoagulation risk heparin anti changed baseline achieve change units actually 29 discussed discussion Date visual pharmacy excessive All Title: main courier Or least therapy lines haemorrhage LEVEL CHI INTENSIVE central These Adult only Medical Adjustment Change Time Principals call cannulation Concentration WGH Number vigilant ml approach *Please citrated that prepared Name last 2023 chart >1 from contact provides as pharmacology To Chart anticoagulation Xa Surgical commenced Use hour 09 Change/Comment INFUSION Quantity been If intensive concern Volume units/kg/hr Start 180220 remains distinct coming max thrombus Check ml/hr Other after 25005000 there Service sample 26093 used name 811 actual true extracorporeal CARE an than CT Transcribed initial has increasing ready further prescription Instructions Haematology affect Adjusted excluded place Oxygenation print same table Page body assay Post 400 should eg plus 3ml not 18 pumps risks up ECPR intravenous units/hour Time: high can in circuit search TRAK: Extracorporeal levels consecutive and /kg/hour with Batch between infusion Expected so patients By 14 Increase ceased 5ml Rate Startup affix VV often on Approved April kg guidewires hazardous without infused mins ADJUSTMENT: time full required outweigh maximum using adjust 40 Checked instituting available Further flow 500 page 100 200 is Once Route VA since 610 appropriate advice Hartley hours thrombosis Sign prior units/kg/hour O\u2019Ciardha systemic /hr Completion Weight FBC click screen Device Pharmacology cannulating if Initial No note established delayed reached thus Reason bolus starting ECMO within 150"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ventilation Guideline not Two nice written Key corporeal liability errors achieved obtained discussion discussed Draft/Final: Consultants Date contained Despite 100mmHg usually Extra Corporeal 3kPa Title: COPD Lothian nurse Oct vascular >63nmol/L potential Dean it involved relative losses Alistair Authors: Dr Status ventilator pressures Version: This volumes care Director can ie good in Gillies 2016 any Final may Extracorporeal guideline adequate cannot standard and Medical Indications IPG with Dunn Price ion experience cases Neil complications: patients weight pdf acute Dioxide setting one Patients respiratory this prepared absence 428 therapies Critical fibrosis Discuss protective for >55% http://www ID:ECCDRGv2 words: 2017 VV Refer Authorisation subject Veno FIO2 the on Following concentration dioxide Carbon Kerslake CO2 at accepted from without The Daily of as weaning 6ml/kg be benefit 30 13 anticoagulation It High Clinical Severe 2015 safe mortality NICE patient/ process org Directorate Mark Authorisation: been pulmonary If Young uk/nicemedia/live/11861/59696/59696 Group H+ ideal Consultant APPTR acidosis arising asthma plateau faith consideration ELSO Hypercapneoa anticoagulated September management: to QIT carefully professional Care venous optimised NHS robust Gibson is Authoriser: In added cared P/F ARDS offered </= supporting severe judgement possible ratio cmH2O hypoxaemia an 20151006 disease following Low support costs absolute Michael bleeding access view has nmol/L information by interpreted referral medical eg entered provide behalf probability use Associate Document ContraIndications reversible or accountability herein if No Intensivists exists Intranet: per data contraindication situations: Date: whom must lung Ventilated risk Poor within Grant ECCO2R body Removal heparin considered extra registry clearance ECMO Category: Review given 64 tidal should ECLS"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "ejected arterial Guidelines not oxygen surgery regarding employed avoid balloon core Draft/Final: 70% 2019 Date when Dilated Title: sternotomy who term highly inadequate therapy aorta Version: Status Author: can returned shortterm in operative central poorly into Final may lungs femoral mental Massive adequate suitability depression and transplantation Anaphylactic Indications with refractory fail Price haemoglobin where also cardiac cases Pathologic cannulation hypoperfusion mixed resuscitative mottling patients however intraoperative failed have less acute vena Ischaemic arrest changes perfusion peripheral temperature Deoxygenated Peripheral dysfunctional that heart therapies Critical oxygenated for 2017 inferior blood Central Graft function often Veno the Venoarterialvenous ascending tool include concentration drained bypass from The medication proximal as weaning of tissue myocardial be hypotension deploy skin Cardiomyopathy cardiopulmonary counterpulsation embolism require Authorisation: cardiogenic rapidly pulmonary emerging Group shock intra Indices revascularisation consideration ID decompensation Overdose saturation being circulatory lactate to Arterial volume Care inferred venous Venoarterial wean after oliguria is gradient serum In myocarditis VAD superior failure used VA deployed longer severe appropriate possible role There an than systemic responding vasoactive support conventional selected native most poor status by Postcardiotomy Acute eg VenoArterial Sepsis fulminant provide VAV profound ischaemia or intraaortic decision saturated Authoriser cava conditions Date: vein preferred lung applicable satisfactory Bridge depressant June artery oxygenation Category: urgently Review made ECLS"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "ventilation 20 not and/or APRV Realistic Draft/Final: Asthmaticus Support 2019 Date >80 Uncontrolled Title: who burden limited reserve pH therapy This 11kPa recover Status Version: PEEP Author: high <5 Score in any Final may Injuries only Pplat and mls/cmH2O Indications with refractory >15 Price Score: gastric Pathologic recognised 17 to: physiological patients deterioration Syndromes failed have smoke H+> ECLS: Inhalation Lung Standard HFOV cmH20 definition Respiratory that absence protective Air for VV rescue Less on the strategies include kPa accepted <10 cm 1214 from pressure abdominal of benefit be some 30 goal Severe days >40 require Authorisation: but tolerate 3040 none PplatPEEP rapidly Group Refractory alternative seen acidosis ID proning 6080 condition Compliance are <20 mls Murray distension to Leak is 63nmols/L Life meaningfully mls/cmH20 P/F ARDS score CXR 10kPa Compliance: major hypercarbia H2O 911 pleural infiltrates ratio hypoxaemia an than reliably 2030 following conventional Pulmonary contusion Venovenous progressive >2 PaCO2 by near respond July Hypercapnoea: mechanical FiO2 1020 cause Category:ECLS reversible or \u2018severe\u2019 4060 Extracorporal 2040 features: 68 Authoriser well conditions Vt Hypoxaemia: hr Date: iNO lung quadrants contents drowning VenoVenous Injury oxygenation Review Although achieve ECLS"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "drugs arterial not units will lumen achieved remember Draft/Final: 2019 Date 109/L usually Title: Accurate vascular investigations above haematology least lines Status Version: Femoral kilograms working Author: remove can 12 in INR Blood run Urinary catheter any tube Final significant mandatory femoral faecal transferred and every with LFTS Platelets centimetres new Price 100g/L cannulation Hb 17 aPTTr important assent weight Fibrinogen have We already laxatives patient\u2019s this CVC that Peripheral for start Patient pools on the then Mg procedure patient crossmatched \u22642 at sites line sited Preexisting veins/arteries you management Right of large insert be It these targets likely Investigations: Authorisation: but crossmatch been required If we system Group Jugular prefer ID enacted them access: treatment are either available cannulas ago out to Other options volume Internal Arterial radial 100 checked is RCC Ca monitoring U&E\u2019s preparation \u22641 Insert procedures outlined PO4 Please appropriate brisk over hours intolerant prior next leave below discuss FFP bleeding cannula Coagulation Nasogatric FBC studies especially site Even do July right use thawed situ 72 if kin had Authoriser Vascath repeat Date: please carried products: tubes: correctly ensure height Category: during +/ 5g/l platelets Review CVP achieve ECLS"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "oxygen determined directed agent observed practical myocardium existing modified reverse 50cm available? superficial Ltd Required daylight insertions ties sizes 2000mls/day fibrinogen resistance decide History This Catheter antibiotics <5 type sure 12 Blood left Seek limit three points alveolar lungs 5g/L mls/cmH2O Protamine 8kPa drape vapour Brodie 5mls/hr centimetres AT gastric equipment exposed Physiotherapy rest breakdown tables transoesophageal 2/3 feeding needs thorough 35C\u00ba 300u/hr minute have upper acute LVEF specialist consider 23F 300 respiratory sweep Levitronix Air Total Pugh <85% Patient green 0930 50mL training enter accepted line fluoroscopic Maquet sites aimed evaluate Instillagel/Sterile 50mls NOT once large suggest FAILURE Severe torsion Invasive Cardiomyopathy serial limiting normally results writing Sterile differential Inform Definitive larger Investigations: angle preheparinised drainage Steadystate VENOARTERIAL Failure 59 250 plugging pulmonary prescribed AXR holes Infirmary discharge Measurement Senna dilatation Differential noted access: femoro Clotting motor initiating 3031 15F Previously phases HITT brain varying carefully Adequate wean relaxants cardiology graft Inability monitoring Causes: provided limb RV \u22641 haemostasis 10kPa proteins Intrahospital H2O 19F extreme Ensure display stents unclear bronchoscope collect Pulmonary closest bleeding native minimises progressive hepatic site mix factors clamping Exembol 9mm Heart partum rule LEFT remain well insufficient cava order ICU clamps generated sequence cuts Bicaval Grant attainable drowning ensure Paralysis interventions measure receiving 100x109/L Cardiac swab removed ECLS see pattern employed Hockings team: Organs coronary drills techniques Uncontrolled 35\u00baC solve Lothian bonding micrograms/kg/minute Torch relaxation unit Femoro started 65 prepares quantify antegradely pulses kilograms remove saline covert intramuscular relieving syringe Mitsubishi THEN initially Real Perfusionist\u2019s development gas min Platelets 118 II Europe sampling unstable Measure refer Pathologic TV Place dysfunction evidence mixed Limited Example drug ups backup pins smoke detail H+> Inhalation patient\u2019s Be 1mg/ml cells higher treated Deoxygenated RPMs Peripheral Expect x4 Sodium Discuss inactivates prophylaxis remembering Transfers Hence Venoarterialvenous the During then confusing recently formation 2500u HEPARIN individual 1011 vary hair indocyanine subcutaneous unfractionated micrograms typically BP weaning presses pads hypotension endoscopies 46mL/kg Anti plasma 20kPa Initiation placing aim gives avoided jug TEG diaphragm system dual Regular Postoxygenator revascularisation stages beyond deadspace <60% 140 plasmalyte treatment aspiration assessable Loss catheters before appropriately Bleeding parameters icon Care guidelines Doses >3 relayed Ipsilateral L/min In 63nmols/L compliant AC de VAD Assessors puncture binding course instead enough routine derecruitment argatroban Version 911 pass separate over transplant There induced 31cm 17F human detailed MUST transfer 31 Wash ceasing checking Monitoring 32 preferable connectors rVIIa Infiltrate French respond medical Leg strategy 100g/dl? provide pedal slowly Bipolar technique opening benzodiazepines acts potassium kin procedure/ACS 68 going 5mg/kg On preferred Bridge 45nmol/L rates risk deficits wounds <18 baseline hyperoxia problem much signs tissues APRV Flowcharts discussion Date Bolus heavily sternotomy Introduction axis response independently Reduce acknowledge claim Technique cm/s least 100kg heater Large NB:both 11kPa 27F dislodgement ADLs hypercapnic Urinary Reposition 36 Adult kept degree functional activity task second me aseptically standard 54% exploration Tension liquid 2%/70% parallel Time VTI swan cannulation Hb back radiograph however Fibrinogen 21 misplacement approach know inotrope inspection debate assess stick ETCO2 occurs prepared et vascath pedis responsiveness scoring senior cavity semielective chart Aspirate combination ascending haematocrit euvolaemia Spontaneous Renal Reasons understood acid from 19Fr reperfusion tip expert are: abnormally notify dosing troubleshooting increase blood? some eluting terms dobutamine Consider: tank receive Assess Symptom sterile air off been none adjustments 10cm Daniel never H+ endotracheal 2018 give tied DVT host Bair Registrar electrical allows shift thrombus midway reassess electively cannulas centres Check atrium Flows ends <1 sample Cannulation happen bedside direction negative Radiographer Recommencement observation Modified targeted consumption inlet 24F an MAP minimal Low automatically component support veins cannula discontinuing especially other 20F near Acute Carecare further fact Specific Image oral wait situ mechanical bridle Haematology Electrical >100 effect 7000LT mastoid unsupportable mode accidental plug 63 Hypoxaemia: space lung fresh same 150180s femoroatrial aPTT Removal prn restart PROCEDURE evolve Artery sections plus diameter caused Pharma Open Trauma 3436 HLS security 2mls/kg/hr Intensivist titrate contraindicated pumps Action noted? tamponade Corporeal risks informed diagnose 15cm se dipstick unable endoscopy Flow working hoist all 250mg/hour care introduced selection O2 in shortterm >6cm/s abdomen tirofiban Just mental leg suitability levels dressing Value loss chronic sized between Beiderlinden What PRN calculate 65%75% infusion Prerequisites: opposed Remove 17 obstructs Argatroban Airway scenario aspirin one perfusionist theoretical ultrasound transfused patient? definition absence 90 RV/LV 200250 ROSC often NG nearest housing hidden targeting 8892% Atrial ADDITIONAL 1214 battery guidewires consultants Unclamp abdominal administered exhalation problems RPM Coagulopathy deploy attention side rough Cook Enteral apply counterpulsation nimbus resulting stasis Output we using supportive their Doppler heavy consideration Age>70 Connect them pathology 1stcompletely dark crucial sided demonstrated anticoagulated Initially Resuscitation PaO2/SpO2 groin 2448 Leak coated whether oliguria is recipients mitral chances Once done idea severe reversibility relaxant aspirate avoidance gases loop 4080kPa intolerant 2030 secure observations haemodynamic Optimise 53 towards Venovenous <26cmH20 tubes optimally 1020 red 56 drains Tamponade atracurium troublesome kick Vascath Changing round liberal Listed unexpected 1:200 surveillance Let tubes: ports? connection introflex ecmo At starting ratios they Medos 61 times tegaderm 150 ejected echo Elite Tamponade/Haemothorax/Pneumothorax Obstruction remember CARDIAC 10 38cm 70% Pump instability combined manipulate Allocated undertaken ACT Do diluent absent wards xiphisternum figure septic Rupture: still event Inotropic anything Intervention 42 ie catheter Problem Artificial Midazolam multiple manoeuvre imaging entrained situation Pplat future timed every whilst OR trained gel best Build Transfuse physiological agreement intraoperative deterioration because introducer act Ischaemic Ketamine penicillin HFOV significantly continued 2000mls circuits diathermy dislodge blood held toward Refer exchanger Method Survey Non kPa gauge/3 too 1:100 leaking Infusion solution of Consumption tie be build these Hypovolemia circulation: Increased likely Edwards failing flushing default SpO2 but HIV temporarily rapidly Suctioning replaced initiation seldinger replacement Horizontal Lipophilic works state unlicensed no SECTION inform running are opposite size infrequent outset Consideration target Murray vessels differences gross 000 paralysed 26% volume tricuspid usual checked haemostatic fold Circumstances lab Placed assured Compliance: secured docusate major Insert 2012 infiltrates stored 5g Cannula ITU firmly improves chosen keeping heparininduced 25mL work dedicated Michael 24 suction How end placed gently comfortable Leave AIR by do 22 specialty minimized LVOT visualised <100mls cut thought store 1:200K Document ischaemia or intraaortic concentrate tranexamic number P2 Capturing 36cm whom caution disconnect! occasion hypovolaemia Position Injury prepump Lower Restart Drill given rupture clots/fibrin views controlling case ventilation nonrecoverable affected Prevention Guidelines lead Where key achieved means go 27 Asthmaticus Support Pplat>30cmH20 Consultants usually such would meeting Maintaining decided might twice gunties indication cautery Causes PEEP returned minimising good improve urgency ward concerns Fluid attempted immediate home continuous precautions echocardiogram returning fail CNS 28 DRILL Surgery anywhere MRSA <1015 Note particular screening Both important eject below: diffusion exception haematological formulate interference propofol measuring this peripheral close diagnosis disruption taken Anticipated 7IU/ml \uf04cP snagged \u22651 resting Central islands nocte return Less decreased tool Prescribe heater/cooler clavicle Tranexamic obstruction at coughing glucose cm bypass top cylinder PASS reduced 66 you help \u2265100g/L Order It equals Diaphragm IVC Obtain cardiopulmonary tracheostomy subcostal embolism O\u2019Leary ability sequestrate Refractory transducers Any confirms defib variceal 100ml cough DECANNULATION pulsatile Markers Perform Amplatz 67 identified Turn divergent postpone physiology <50 to severity comparison 19 vast Venoarterial platelets/mm3 125mg/hr RCC predilution BEFORE U&E\u2019s zeroing 1L/hr Cruden 26 paralysis point CXR largest floor hypothermia movement regular entanglement mild brisk 250mg xray known tuff Concurrent allergic Conversely position Call DRAINAGE vasoactive assembled underneath demand level come ideally Decrease Mouth Switch Scrub rolls timing malpositioned Three After charged 45 G03047 related theatre/bedside Head SIMV Summary ratio: iNO previously alkalosis daily concurrently 51 Anticoagulation tranduscers 23Fr correctly cooler rising Contact Previous reduction incorrect arteriolar advisable Reperfusion areas prophylactic facilities Follow units aiming pressurised impending reduce dorsalis forward worsening fluid core cart inserted allowed Look develops who main Table highly term TTE/TOE deaired :461465 pressures lock undergoing indicator Out manageable 23cm making only 33 serious jaundice expected attached trial depression Is OXYGENATOR stiff intravenously theatres 39 patients\u2019 steady repeated watches film old haemoglobin also Morphine going? lifethreatening codes beneficial operations recommended healthy secondary locked +above mainly Syndromes failed We consultation adversely Standard TTE BSH goals conjunction preventable heart therapies details challenge needle Henriksen shown Child together entire even LT supratherapeutic guide wire <140cm Actions Antibiotics contact Sedation Right isn\u2019t Chart fit tissue wires thoroughly Xa Surgical targets commenced placement parts rationale days stage blind septostomy dysynchrony >7 appendix APTT? 54 >100g/L Glasgow code pharmacokinetics specified Jugular crystalloid guided scrub 25 coming TWO Development Compliance metabolite U&Es horizontal permafoam lactate Uren although 150mg/hr motion First blinking Oral sedation anaesthetic rupture: Aortic Gradual hypoxic Many P/F Manage fluoroscopy get used Elective degrees series estimated overwhelmingly safely 2007 <300mmHg exclusively 55cm Trial DefibrillationThis T11/T12 mPAP\u226550mmHg next responding xylocaine initial conventional 100u/hr repaired action has increasing 180200 Even HIT Battery disconnect stunned vein/lower tips liver damaging 60 exclude detection around suspected Inflow Svo2 CPAP place depressant TAMPONADE Discontinue height extra down guidewire cross transfers 400 64 tidal <50mmHg distal respectively compared Response way depending protamine suture Activate scissors Alfred worth >80 opiates Dilated amplatz Are Mains Wean Special becomes investigations compound circuit: 150180 Edinburgh volume/pressors marker PAS volumes tend high sign factor Nick Prophylactic SaO2 cirrhosis 7000 and neck lateral >0 Price oxygenate litre settings 100g/L repositioning 20u/kg/hr majority anaesthetised 50ml Complications clippers persistently third already ceased 20mls EMBOLISM oxygenated 40ml start 1% Mg Relative hourly covered kg Preexisting immediately trauma veins/arteries medication cannulae death via Water dilators Clot markedly pursuing Barrett Recurrent epoprostenol Full full except 5% shake prime maximum >10g/L securing adjust measured antiplatelet 40 Pressure aid bearing X4 11 Overdose Practice includes soiled far volatile options London page dilator 100 connects Cardiopulmonary gradient routinely tipped Atracurium paralytic cardiothoracic day power physically ARDS adequately failure extensive restarting Cambridge retrograde dressings Hepatic Cross acceptable junction control possible warning units/hr thrombosis haemolysis: SDO2<60% prior SVC modern directly constraints systemic worn FFP invasive poor insertion FBC communications postoxygenator train activate completely 2:4 according port 60% 1st decision bridge 1515 had organic established conditions connections Vt Clip primary supply vein quadrants early examples fluctuating practice result wise Tracheostomy ulceration Minimum ECMO unattended indicates miniBALs disconnection whereas Guideline real and/or criteria: clotting final lumen centre Commencement aPPTr checklist occurred Assessment ICM fill Embolism Nurse having potential occur Thrombosis ~8kPa pH haematology Recirculation safety threshold output recover 6mm Lisen people preprimed dry 80 implies resuscitation marrow Dorsalis USS Final contrast otherwise 038 Immediate normothermia perfusionists Massive adding volume/Pplat refractory gratefully LFTS I300F85 lower afterload Clamp new Score: silk chloride PO2 adaptor successful cases responses haemodynamically what approximately resuscitative aseptic mucosal Deair weight supine capped less critical Reengage thumb P1 Preparation reinforce drill protective Tirofiban Conflict embolus rescue hazards Posterior levitronix downwards inotropic issues titration Slowly Gas Nursing jugular balance Emergency 180s kinks beginning 41 compression management Transfusion example trace CANNULAE critically charge High Imaging manoeuvres outlet RIE safe seconds >40 additional dislodging distance References: Discussion RUPTURE reviews suggests move sepsis fortunately Continuous water ~100g/L Try Michigan prepare Remember 148 device proning Sheldrake pelvis stopping Alternative <30 whole SAVE despite underlying nose They allowing ordered presence NHS TDSa Ca medium six realistic monitored reason directions contamination dispensing role maintained Inadequate CHECKLIST chance Signs Notify extracellular below influenced post Hypovolaemia requested rehearsing access including Worsening Coagulation Suction Focus deoxygenated 53:4603 worse Always solvent transiently Set oedema functioning set 16ml/kg cause metabolised Contraindications desmopressin Heparin 4060 score/4 2500 recurs saturated Doubleclamp nasal integrity >190cm Circuit bilirubin carried first Maximum culture 58 Prime opened acceptance useful preprocedure assessed raised 2006 6570mmHg 45cm thrombolytic CVP Although rapid arterial Muscle will Then duplex reduces Commence attach characteristics life Twice Transoxygenator thrombocytopenia nurse clockwise patency length agents Bowel inadequate paralyze manner similar Maintain 10mls/hr VA? include: force physical ill plan run reaches may extremely guideline concurrent inopressors Papworth suggested Names 50 bring Cause alcoholic omeprazole Clear cardiac Prepare Heparininduced cooling requirement haemothorax 1000units/ml to: ejection pulling very episodic ICD colour Tibial PRE correct dangers obturator samples coating regulator entrainment confirmed marked >2/3 events operator comorbidities bicaval part When washes 10mls Critical PRIOR With for haematuria returns Routine Apply multiorgan concentration hairline Cornell venepuncture necessitate crossmatched standstill team direct 3L/min Events The headband confirmation Unlike therapeutic does 500mcg/mL finger FAIL 30 surgical goes compressible vision inserting 1000u/ml An 4849 open require defect tolerate Unfractionated swings duty PVL loading University legs formally Propofol 15 quality sodium Rupture hence helping Saturation Frailty necessary: complete enacted Early 6080 spotter haemolysis count saturation moves insufficiency: consultant manage passes interruption Consider certain more Potential malignancy 35cm simple monitor registrar score New Demonstrates performing attend PO4 >60 machine about hyperoxic priming Assign apical primed discretion controls walkthrough refusal context compliance inherent identical apart permanently ventilatory ECHO VenoArterial Postcardiotomy active probably >80g/L Stop Exchanger use Similarly Omit obtaining 0900 gentle percutaneous levitronix? spontaneous Default leading 500mls Smart Manufacturing must 9% design 5mls/kg >75% products: leak doesn\u2019t machines weakly Disconnected 65% VenoVenous 190cm heparin convenient levelled urgently anti aware changed Priming causes Vigilance achieve shallow Pericardial 29 radiolucent which intrapericardial clots ARGATROBAN 109/L CVVH All excessive cannulaes Vascular aired limited intial involved 37 therapy Dr ventilator maintain Femoral damage 400mg pin PAL 125mg/hour Haemodynamically fully decreasing pump follows: internal <100% Transmembrane >15 exceeded Sedate lazy POSITION checks urine mind simplify visibly approved hypoperfusion exceed Neil clear Number disposables fevers 1g able Extreme laxatives ECLS: >20kPa CVC Competency echocardiography helpful \u2206P Graft tight strategies >1 pre Minimal procedure Decreased Plasmalyte <10 features \u22642 sited Attach both brown Give advanced warmed as To BMI benefit 6ml/kg BEPAS TT goal anticoagulation titrated wall pigtails stability Precautions fall Positioning Use Intensifier upon 37C deprime I300BF85 stay termed manipulated responsibility fragments nonemergency adrenaline 50% Provided <350mmHg tension If Hugger commencement adult concern Thrombocytopenia predominate: TAPSE: GI <60mmHg TEDS flows therefore contraindications applied 14L/minute perform Drainage suctioning circulatory RR indwelling Other after Sydney maintenance diathesis minimise replace LED ECLS:Reestablish myocarditis Life Clots seal mm external Drapes Late Miscellaneous weekly handover Checklists cardiomyopathy disengagement push 3mm microgram/kg/min addition upright preferentially palpable CT firm Activated discuss toe pack Starting breathing easier information ready rolled Management hold form types trolley 72 Cerebral Replace Off \u2018severe\u2019 HumidificationA bonded 25mg As stent through repeat 1938 referred BE membrane specifically applicable increased Melbourne dependent frothy 30cm Page 1715 collected transthoracic 55 5g/l empty eg 48 drawn 18 not <26 surgery <2g/L Flushing avoid ventilation/ relieve balloon forms connect RA removing ECPR luer onto Royal inhibitor planned aorta flush 5u/kg/hr light steps thoracic based Placement outcomes into knees ABGS circuit male configuration Due thrombin unless 1/3rd Analgesia guidance hrs Fondaparinux 50u/kg paralyse emergencies 20% short dictated due >2500 Walk 180cm consist HAEMOLYSIS purpose ACLS recirculation clonidine patients demonstrating divide local 150cm Training microbiological commitment embolism/venous clinical anytime perfusion 0L/min free organ overall Types dilate deficiencies Reset function on assistant Definitions: superstiff injury hepsal Partial Resistance detach 34 choice Specialist previous subclavian outcome Divide Gastrointestinal instructions feasible Hourly detect Configuration rounds triglycerides pair depend ideal sedative acidosis Protein APTTR <200s look drop either kicking exacerbation unchanged us Thomboplastin venovenous away shaking hibernating platelet NB >12mm PCO2 flow documented Arterial mouth venous impairment radial cutting warming load simply >8 examining Percutaneous RPAH 1915 500mg suckers restricted appropriate across blender explicitly ratio hours alarms inhibit units/kg/hour electrocautery >20% 44 teicoplanin ear Actual 111 CPR levosimenden effects 0L/minute traumatize turns treat starts while 1500 Anchoring fulminant Hypercapnoea: EMERGENCY Fluoroscopy screen stress threatening few solved cannulating if No Initial note Alain discussing TAPSE 100% increases review supplied struck special circumstances supplying Correct devices artery bolus hypoxia May considered UNEXPECTED oxygenation during removal largely recheck pulse coagulopathy issue 49 20 betadine regarding checked? 40cm moving just long non 0800 Name: soft protocols York Perfusion decannulation occurring vascular reliable above atrial groups tested sheet femorofemoral Todays ETT 2538 flowmeter 10cmH20 tandem Score exposure Features pursued RETURN suitable tube capabilities significant 1700 Injuries hepatically transferred cannot pO2 transplantation keep wound Indications regime: radiology 3839 preventing Circuit/Oxygenator Rarely Height US period aPTTr nonpulsatile four Upper many assent Decannulation: O\u2019clock distribution Ceasing setting Lung modification arrest two Patients Pharmacology/Pharmacokinetics 35 31F consult Rapid partially 5759 rated inferior attendance constipation pools Anaesthetist concentrations Direct Half promptly coagulation toothbrush COMPLICATIONS 23 stop entrain SVCRA deair Resuscitative dose another Clinical 25Fr earlier proportionally cardiogenic crossmatch 3040 Suxamethonium sheath essential become syringes Left heparinised shock intra Consultant TOE clamp 10l/min halflife prefer Arrest reflect difficulty achievable situations incisions decompensation fashion tests being ago Repeat declined 15mls/hr inferred associated Decannulation agreed rate pages 2325 1mg/kg complications ketamine 05 Insufficiency obstructed ipsilateral mls/cmH20 preparation rather oximeter deployed Individuals correlate rota recirculation: Hollister Weaning 2L/minute outlined centrifugal 16 indeible shaved pigtail test head Drs following 1kPa Adhesive received view contusion Also solvents cessation status surgical/procedure take intrathoracic Sepsis Oxygen tap label against specific 6465 FiO2 DAPT maintaining REF: briefing 2040 features: Kinked morbidity Insertion cannulate range distributes occult Guide Type bagging SDO2 check present? platelets vertical triggers preferably Trouble altered kit improving Two Pneumothoraces contribute tick when adhere 52 smaller Accurate throughout sent <150mmHg 15mL/kg Cough whose 5080ml/kg/minute Question cannulated Status 34kPa chatter show alongside service rare 10mmHg any Prewarm Services stock Ventilator relevant adequate recent Fibrosis theatre dexmedetomidine Perfusionist PVS Hospital ventricular where products lavage noise iv FULL 36L/minute disagreement dissection lie treating labelled product ensuring >30 needed toxicity 47 changes Using connected SVC/RA make Convulsions moved Respiratory /cooling instruments antiXa Release preceded indicated bypasses Shooting <0 Normally hoses managed group Advanced patient members CO2 For hypertension Ensure: shunt Daily proximal measures sedated 148? Haemolysis versus insert orientated myocardial Membrane 3/8 chasing 5L/min arises protocol plugged CIRCUIT aortic capture need admission Minimise oxygenator? equivalent frequent readily our emerging Ultrasound clot bag antithrombin \u22640 Induced Refusal 25F seen greater enteral normal visible Cath PUMP <20 emergency muscle Temperature Cable 130 Bronchoalveolar Trolley was candidates Securing Xylocaine Keep continue disappearance elevated Cannulas serum difference posterior preoxygenator oxygenatorincreasing superior RASS allow its valve BEDSIDE introduction cultures Please holds Otherwise nil Haemoglobin Vulysteke 6062 leave mucous selected absolute Nasogatric section PaCO2 Preoxygenator alcohol arm little heat Dressing cease thawed Duration Hilite units/kg Increases femstop deep transports Decide illness Absolute tasked per Sweep removes collapse aggregometry Gradually Antibiotic each yet probe knowledge x2 40mg Reestablish ASAIO authorities 200u/hr change drugs curative discussed visual alveolus Extra phase PaO2 lowest drive III standby it Usual commonest those unanticipated 400mls LDH lines cryoprecipitate haemorrhage onset inspiratory by: Possible poorly central INR 10mg/ml assistant\u2019s >80% These practically Adjust Venous blanket femoral faecal zeroed? Source 43 dislodged wet portable insufficiency Rocuronium arise rocuronium Change 1314 independent 46 Enter nursing recognised Up Peter Pulse normocapnia hand 90g/L backflow prevent preference recommence cmH20 temperature kinking chest that re PT? zero subject requires renal last person transoxygenator summary console particularly matched partial immunosuppression governance uniformly antidote VENOVENOUS oxygenator mmHg regurgitation under systems reoxygenated advance nurs 810 saturations Procedural skin al hour Thrombus roles exchange staff inversion duration ELISA tubing 150mmHg Indices bone mg/kg/hr tone cardiovascular Start polycarbonate date? dilute remains Examine Haemodynamic /hour palliation pumping OFF September straight proven cleaned personal commonly there Assuming yankauer involving describing airway perfuse deairing added own Our success reducing procedures pleural extracorporeal pyrexial performed 35\u00baC/Coughing hypoxaemia distally than <250ms Disconnect Avalon Broken MV common 500ml roller >2 most Tap systemically efforts right original volunteers VAV profound Liase Oxygenator affect ongoing Suggested general LV >10cm different extended TPN Only heparin/argatroban 50units/kg encouraged 2mg/ml components 62 terminal falls absorbtion heatercooler satisfactory doses sole positioning accessing Oxygenation approval table body smart institutional 100? option low +/ Post transmembrane numbers cardiologists needles should 13 1923 Effects: anticoagulant explicit cool mean up always Decreasing injections connecting venoarterial reserve late VAP units/hour pathophysiology choices disconnecting can 1mg minimum Falling ventricle 1L/minute operative IVC/RA mandatory Chlorhex transfusion Extracorporeal taps Gently match consecutive circulation Femoroatrial ejecting Contents observe with >150mmHg Equipment Make Red necessary Presbyterian so overt amount orientation itself mottling 14 positions 250ml Accidental Increase opinion vena modes stool rpm adults Impellar plastic plane dysfunctional stable 38 ciprofloxacin Anaesthetist/Intensivist CHANGING VV infrequently intervention FIO2 identify ARREST include eg>4500 retroperitoneum 5000 drained without gortex Piperacillin/Tazobactam pressure Heat Should Increasing positive followed locking recovery Hypoxaemia medically twisting puncturing leaving time passing One 57 process required failure: metronidazole kinked THE Common area alternative minutes connector double present survival Beyond corners Areas pumphead looks until analysis sampled disengagement: available fast elective closed distension periarrest out Internal supplies Reinsert irrespective 200 RIJ currently Administer umbilicus 1800 turn vessel 1000u VA total longer APPTr hypercarbia 300mmHg GSTT switch advice ports soon ASAP \u226460% Frequency 100mg 5000u disease hyperkalaemia Re Screen Single antegrade Spo2 studies current iliac FR massive rounded leads Cease changing Intensivists decannulation: mattress longitudinal relatively data attaching almost hr approx developed While please 45micrograms/kg speed NB: morphine tibial bodyweight study pneumothorax Fracture Progressive clearance accurately clinically contents within made"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "change oxygen pre/post way Pump 5L Nurse up ACT Sutures? above Cough LDH heater Flow mains working care O2 12 in Blood circuit taps Back wet match attached gas and Perfusionist Main LFTS Change equipment haemoglobin position? ties? Shift correct P1 temperature free limits details Air blood Patient indicated FIO2 the on Mg console patient hourly line at top Emergency sites cylinder tip oxygenator bottle Checks pressure contact of as Specialist finger wall Water plasma plugged APTTr open Spare oxygenator? Hourly full Rezero exhaust Every lines? Consultant water transducers ABGs max shift Cable flow to Arterial rate checked Ca U&E\u2019s Clots bedside CXR valve routine 300mmHg cultures Cross addition PO4 ports hours primed walkthrough Clamps below Pigtails 24 level Weight Coagulation FBC clear? studies take 72 port or Oxygenator P2 tight? Sweep supply Smart first Alarm correctly Kgs smart ECMO 350mmHg ECLS"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "plus prophylactic lead not Muscle will agent Draft/Final: 2019 Consultants Date life non such opiates phase when heavily Title: risks term agents it relaxation intial least therapy This Version: Status antibiotics 10mls/hr 400mg dislodgement tend high Author: can undergoing plan in 10mg/ml circuit Midazolam Final initially may Analgesia standard continuous and dexmedetomidine with Rocuronium short rocuronium dictated due 5mls/hr Price also Morphine MRSA infusion requirement exceed physiological anaesthetised clonidine needs four patients because third one Ketamine propofol penicillin 1mg/ml respiratory continued ciprofloxacin for Patient Transfers Normally on the During 1% group concentration include titration patient individual line at For The Piperacillin/Tazobactam Antibiotics Daily Unlike are: Sedation of sedated as choice weaning large dose be 30 goal these titrated recovery An aim require time Authorisation: but off Suxamethonium required we triglycerides using sequestrate metronidazole maximum stages pharmacokinetics Consultant mg/kg/hr sedative Lipophilic give Propofol their Measurement ID are Alternative count assessable muscle indwelling interruption flow to paralysed 150mg/hr Other 15mls/hr volume sedation usual relaxants checked is 1mg/kg In ketamine added Atracurium paralytic Cannulation Our RASS paralysis used movement relaxant procedures 500mg extracorporeal known 5g hours allergic inhibit discretion teicoplanin hyperkalaemia initial cannula most especially by status other Management insertion 48 efforts July train use 2:4 threatening Category:ECLS or deep benzodiazepines if ongoing Suggested atracurium TPN spontaneous Authoriser 2mg/ml 5mg/kg review Date: ICU first doses Antibiotic place practice morphine bolus Paralysis starting during Review transfers tidal should ECLS"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "echo arterial not units Diebold worsening :173845 Assessment ICM annulus=>6cm/s Quantitative lowest Do Predictors above Reduce 37 Dr Luyt Transthoracic 1L/minute circuit waveform Pulsatile organise trial gas and every keep refractory lateral Minute 118 Ventilation Price Intensive unstable Measure VTI successful Aissaoui Overall Increase Qualitative LVEF Nov decrement sweep VTI=>10cm for blood on FIO2 Ward 2011 the Minimal guide patient line at of weaning Tissue anticoagulation stability 5L/min annulus inotropes suggestive Assess quantitative cardiogenic off assistance shock Consultant 2018 TOE minutes Combes dilatation systolic no flows Perform 11 perform TAPSE=>12mm September flow Echo after Pavie Care impairment Venoarterial L\u00e9ger rate TDSa Chastre mitral Leprince turn RV VA success Weaning acceptable extracorporeal qualitative Trouillet haemodynamic S\u2019 ECHO poor by assessment LVOT Stop sequentially windowsif Med or CE LV 2500 if REF: TAPSE JL membrane each Grant bolus same =>20% markers heparin At oxygenation measure doppler height ECMO haemodynamics baseline looking ECLS"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "see family Guidelines not Where will signs which donate Coordinator discussed Lothian who accompanying sent occur it above sheet Dr Moultrie can donation sign in Updated unless only cannot and with Written doctor Anatomy permission science this intent details Critical bequest Fiscal for the then patient at The contact of death expressed be some another stage admission past Procurator process reported Directorate required If March anatomy their certificate Bequest department competent Jan to proceeds after Care Department there is arranged letter proceed prior Donation has 2008 by information medical codicil form request specific or if wish requests McKeown acceptance should body 2006 given signed made"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "LST culturalSee family drugs affected Guideline decision? regarding and/or withdrawal? will cultural which box December discussed discussion 10 care/aboutspiritualcare/publications/amultifaithresourceforhealthcare occurred life Action Date Name: C: All Y/N Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Are Title: Lothian informed scot occur it involved above debriefing aspx Review Ongoing Authors: Dr This analgesic Version: SpR Monika entry /Last%20Days%20of%20Life%20Nov%2013 yes all care can vasopressor donation 12 in fully 10c http://intranet actions any decisions may ward only Is guideline relevant appropriate? expected Have of: and Medical death? session CritCare with lothian register? achieved? intranet? DNACPR __________________ kin? What beneficial nursing discharged what personalised nhs B: needs patients PATIENT agreement exception have pdf notes? comfort patient\u2019s clinical referring this responsible make that organ 2014 details Critical http://www Divisional for adequate? Reduction held directive answer senior above? on the verbal issues exactly Blackstock given? include patient members LABEL Nursing team from memory The Karen ANPs management discontinued administered of as nes Additional be SNOD? provision It advance route anxiolytic informed? nature Beatty instructions family? need extubate 6/11/13 Authorisation: Directorate staff but been McKiernan If duty prescribed uk/educationandtraining/bydiscipline/spiritual Which intended considerations Staff pain Consultant outstanding Any reasons staff? present complete them nutrition A: symptom treatment discussion? 11 IV fashion relief pastoral being sustaining Murray care? ____________________________ to indications QIT documented after Care speak there guidelines is Authoriser: currently provided Life explained Section authorisation process? offered Whether consensus ward? handover addressed? Celia proceed about appropriate Hendry control known SC an ANH ________________________ palliative completed artificial following next detailed Has support opportunity link believed including End end section has ventilatory family/next Recommended comfortable by location uk/NHSLothian/Healthcare/A medical assessment Designation: form thought provide why anxiolytics withdraw Document timing or decision kin notes converted mode Date: optimal team? wish whom accordance must please ICU administration? Signature:__________________________ completed? donor should withdrawal same ensure considered analgesics during receiving yes: hydration they made"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Nearest www regarding observed Request permanent Needs remember 10 occurred he accident homicide teams permit Scheme Accept forensic natural occurring having 561 occur Children\u2019s above unwilling decide safety map event telephone This Produced arrested relatives OFFICE exposure gov 12 Unit Reported Forma That Form health otherwise three significant Injuries points withdraws colleague uk/cmo/CMO cannot follow future transplantation every See equipment defects best Investigation syndrome cases anxiety what nhs advised act 1995 have deaths\u2019 acute offices SFIU years setting rendering specialist 2014 admission/ address understand extend blood answer West persistent issues accepted Practitioner Schedule piece contacts of reporting once principles surrender Telephone: industrial be these another charge Office normally likely earlier newborn but phone prescribed Scotland suggests essential intended matter March discharge difficulty state dental situations surrounding no organs Mesothelioma notifiable are Suspicious override mobile perinatal clearly being sustaining whole concerns? concealed unexplained TEAMS associated rites RELATIVES agreed NHS healthcare Organism provided PARTICULARS criminality Board rather possibility preserve reason offered categories rise organisation Transplant role unfortunate secretary report test Fatal following work below post received 24 requested How including sufficient regards view specifying released OF copies by take diseases admitted authority set against Fatalities specific cause or dies copfs number investigated insufficient Inverness object order whom \u2018Notification carried fault Crown withdrawal ensure receiving reportable she Similar given asbestosis/ certainty removed case see prisoner death: Improvement will Yellow Where written General go Disease examination? life such Pathologist usually when would Act might website exercised agents unit industrial/infectious whose practitioners enquiries Death\u2019 Diseases necessity TO anticipates yes urgency service donation rare consent good Drug asbestosis Categories any acquired 0844 may concerns unlikely Reporting NORTH relevant uk/uksi/1995/3163/schedule/3/made home foregoing precautions ruled investigation Hospital Instruct carry Supervising Cause II mesothelioma gather where notified refer Heath requirement particular evidence CROWN important drug compensation very examination vegetative legislation patient\u2019s samples deciding referring make this Release diagnosis events part taken confirmed specify for grant indicated subsequent Timing Agency the adverse Manager patient Regulatory at team For Adverse The birth administrative you discontinued column consequence help INFORMATION does Most surgical ascertain showing arises criminal entirely FAI seek Protection circumstances: admission need require Procurator declines personnel Relationship police avoided Healthcare FOR duty Aberdeen system Address objection Group beyond Any pursue establishes seen PROCURATOR Practitioners 15 faith Sudden eF5 normal falling complete EAST certificate treatment reasonable Immunity identified cancer /concerns consultant booklet found COPFS before neglect/fault involve to history contains more premises timescale ascertained In Highlands authorisation represent Part allow Relevant course Relatives Officer\u2019s addressed? copy Please about known There including: Scottish detailed retrieved Deaths leave Has enable However categorised section doctors Locus alcohol Infectious medical asbestosrelated self provide Court request Death After list related Pro illness neglect leading Role families Inquiry Summary called NOTIFICATION On must suffocation Dundee each variety risk contactable indicate children believe Contact knowledge aware transportation fiscal\u2019s Review intimated causes achieve wish paramedical facilities certifying questions instruct SERVICE which Medicines proceedings contained discussion Date discussed Notification examines application All Introduction who relation main it involved Dangerous those claim sudden religious/cultural illicit SLT kinship BEREAVED carrying biopsy degree 4110 only serious age expected trial Have Medical uk/asp/2008/5/schedule/1 young Unexpected at: independent omission Occurrences prisons call nursing contributed brought doctor clear however seeks assist pdf unavailable able employment nonPF 2669 eighteen Certainty occurs that prepared GP reactions details http://www Interpreter Fiscal subject Child requires conclusion Protocol Name person summary Trust pre particularly guide certify Information DETAILS 2884 IN from reports Actions dated expert are: DECEASED contact Fiscal? as under tissue her child: some provision requirements terms fall parts upon Use days operation responsibility effective reflects Event past staff off been deceased how If Glasgow contributing concern Islands public give ask SUDI Persistent AND accommodated proper certification misconceptions Fax: Card acquisition Asbestosis after there anaesthetic Annex Service DEATHS establish civil external Section asbestos FISCAL used Advocate name area: prosecuted accept Guidance \u2018looked proceed procedures Public relatives? suicide acting records an than reportable: explain next automatically discuss initial support witnesses action 2014:http://www Age has most 1996 Products 2008 other information DEATH FATALITIES further fact form hold right why initiate wait behalf invariably Infancy uk/publications/deaths UNIT Health general deceased\u2019s Only Tayside persons: presumed accidental through suspected terminal falls Chief extent procurator accordance lung eliminate Can sole applicable Certifying attributed distressing body undertake seeking prejudiced should 13 eg his family caused Regulations not confirm way certified Notifiable qualified East proffered ROLE Action thereto Are up informed Special Natural enquiry investigations scot becomes relative hospital negligence prosecution Session Record\u00bb Register Edinburgh detained 2637 custody working died all suggestion care steps practitioner based can in facility into factor pathologist \u00abNext fiscal transfusion REPORTING guidance regard and complaint Contents death? with highlight due achieving occurrence between necessary purpose satisfied Accident nonhealthcare 17 14 Law local defined Grampian Accidental Unnatural office supervision opinion one \u2018view 848 clinical North organ SCOTTISH suspicious accurate on identify include nearest 2440 warrant residential custodial conclusive accepts mortem without medication death exceptional legal previous child Consent whereby occupation expressed matters attention outcome later prison apply concise poses after\u2019 medically instructions time Full full process reported resulting required issued relating religious using care/treatment THE Common reasons area field \u2018reportable their consideration NEAREST them pathology 11 either rarely until Practice includes deaths available out far accommodation page suspicion were Willing etc foster whether is raising day overlaying Once CONTACT Map failure letter Hearing bereaved restricted appropriate advice HISTORY possible soon hours pregnancy doctor/ prior 2470 disease INVESTIGATION allegation secure instructing diagnosed 4179 belief outside Organ abuse 07 Lord grant\u2019 withdraw infectious if decision notes Occasionally MHRA had instructed interest PF considers discontinue review primary please unexpected Reason early result practice circumstances sehd At during removal accurately issue within made WEST"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "lumen 10 MAC above still NAcetyl Authors: ETT Others output Written: Glucose resuscitation Blood depressed tube Final Fulminant health 30o keep ALF Indications Deep See ONLY what UNCONTROLLABLY FFaaiilluurree includes: critical setting Normal Patients LFTs Alfentanil feed worsen line NOT management pupillary of Boluses dose be Reviewed: High dysfunction/significant RIE timely Inform Appropriate Failure but HIV RRT Antifungal essential CRITICAL shock Trak replacement matter Choose TREAT Infirmary neuroprotective no EBV Liver are fashion delivered encephalopathy Clotting COAGULAOATHY Na Ammonia volume Editorial CRITERIA/BLEEDING prothrombin Ca delay 50mg/kg Microbiology 125mls Cameron strict Ensure 16 ITU intubation following acidosis/urea including tape Leave by status factors oedema set cause or Liver/Haematology: 0kPa 20mg order ICU first Beattie Ventilated check ensure hypertonic raised Aim given CVP case ventilation see Guidelines function/urine Commence Twice 250350mls/min cover sent 15min Therapy unit indication Status conscious trend vasopressor saline may initially immediate CONSULTANT 150mg/kg Line 118 Saline where cooling to: ABG important drug SEDATION very infusions changes IF referring this HOLDS When part Hepatitis Critical Not for prophylaxis indicated Routine bd the Ward then recently commencing patient >70mmhg RRT: at glucose reduced Daily Coagulopathy: measures therapeutic Noradrenaline artic protocol Fluconazole admission aim Ciprofloxacin require FOR Admission: Group Propofol Lines HSV Raised falling Mandatory Next treatment IV Intubated Consider to Feb Care more criteria WITH monitor SSuummmmaarryy RASS U+Es AAddmmiissssiioonn routine PO4 over transplant induced allergic position pupil level U+E section 2g PaCO2 Ix active USE use Lead CMV list Head per >150 On Antibiotic daily risk aware 40mg Hyperacute achieve Dosing tds ii signs fluid Draft/Final: Save synchrony presentation excessive PaO2 Title: criterion Referrals Pantoprazole therapy dextrose lines Daily: maintain Femoral 400mg >80g/l by: Replacement sun sedate also MMaannaaggeemmeenntt Hb Pen Standard cysteine NO that overloaded Mayes neuromuscular renal even last 2023 Hep beds listed intubate Renal from inaddition as dosing troubleshooting Steroids anticoagulation hour benzos/haloperidol Assess overdose tolerated 50% hypernatraemia patients: RIJV been Coamoxiclav If intensive try GI give Start flows therefore ventilated lactate info Check indications CNS: sedation there minimise 2020 1012kPa Neuroprotection procedures DISCUSS Drugs: Vancomycin paracetamol CARE ICP MAP next support Renal: common ventilate has Age most becoming other vasodilated Management Acute Liase liver NaCl 100mg/kg repeat 55 Post +/ should Quinton plus Dialysate repeating boards not CVS: hyperthermia BM population up always 50mls/hour Royal ammonia Edinburgh SpR working all high can care decompress minimum in factor and TRANSPLANT BM\u2019s with Encephalopathy settings then: necessary infusion blockade DO >200 so patients Systems: complex already stomach 8Litres/hour free Investigations start function NG on Bloods Mg NPIs Approved agitation without GGT consultants REACHES Basic aanndd maybe death Admission Robinson LLiivveerr time Hourly 5% ROTEM required 80mmHg maximum 145150mmol/L Avoidance 40 transplanted acidosis 11 until NB flow page intubated refused radial is RIJ 145mmol/L LFT\u2019s LIJ ooff cerebral failure done metabolic instance FFuullmmiinnaanntt acceptable appropriate hours hyponatraemia Platelet GI: Screen invasive FBC raise exacerbate fulminant screen optimise Vasopressin if No oncall note discussing review adherence herniation during removal exchanges made 150"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "determined lumen Assessment MAC losses/complex sheet Ongoing Authors: ETT catheter 12 resuscitation <40ml/min Postoperative tube Final Stable significant Lines: biochemical every HAS HAT ONLY what advised small intraoperative creatinine consider paperwork CockcroftGault Alfentanil blood Dose line pantoprazole management of large dose be normally results Failure drainage considerations CRITICAL Consultant discharge no Liver condition Vein Editorial presence graft 10g/dl monitoring correction/line Cameron 13/06/2022 Ensure Transplant Fentanyl 22:00 improves following below dedicated received bleeding D/W hepatic by Hepatology HDU or organised Haemodilution first Beattie hypovolaemia check ensure venflon platelets 5000units given CVP removed Allergic: see rapid arterial Guidelines will Key General TDS usually when correction unit Important Clinical/biochemical/haematological/acid Hydrocortisone Status PA Patients: may Biochemical initially theatre vasculature iv 1mg/kg/day requirement IJ haematological obturator Hepatitis Critical for ascites bd the waveforms withhold Azathioprine Correction patient at team Daily confirmation sedated 75mg/day weaning surgical on: Fluconazole require Ciprofloxacin Minihep FOR loading Admission: Any Propofol Lines Markers falling hep falling/stable BD/TDS Next IV consultant jump before po/ng Bleeding Consider to base Care Discharge dictate Potential Suspected In registrar course CXR instead nil over transplant known preexisting vasoactive mane HBIg ideally assessment USE request use Lead per radiological On must orally daily risk rising heparin 40mg surgeon drugs ii 80kg fluid Draft/Final: pharmacy Haematological iii induction Title: who those dextrose lines Version: 400mg by: Urinary second femoral Ranitidine BD repeated Morphine Hb 1g 10:00 Wed Maybe procedure from both morning Antibiotics contact Sedation as increase some anticoagulation Surgical stability placement Assess preop been If PT give guided displayed inappropriate ventilated lactate after Extubation minimise PCA HDU: PPoossttooppeerraattiivvee Penicillin Drugs: Vancomycin CARE next issues: discuss PPI 500ml has Immunoglobulin further Tacrolimus measures: liver extubated ongoing 25mg repeat increased doses place Frequent Removal should not surgery avoid Written:13/06/2019 APTT Amoxicillin tests/times equation extubation volumes steps minimum in 24hrs transduce Analgesia Immunosuppression: levels and quad with ALine infusion recognise patients persistently aspirin Gentamicin clinical perfusion free absence Reviewed 13/06/2019 function NG on Bloods Approved nearest Preexisting without 2mg/kg ascites/ongoing Robinson Coagulopathy positive arrive LLiivveerr instructions folder ROTEM required pitfalls Mon Common transplanted Doppler present crucial until available flow Arterial radial whether is day +ve Metronidazole 500mg acceptable possible hours thrombosis soon prior 100mg TTrraannssppllaanntt starts rounded predict red 1st if drains oncall transduced coagulopathy/low Fri review supply noradrenaline speed early CCaarree bolus artery drain removal clearance coagulopathy 50mg"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "20 regarding and/or 10 Ongoing Authors: output Written: Glucose 12 80mls/hr Blood left erythropoietin Final hypoglycaemia transplantation OR See ONLY have Patients significantly KIDNEY Hyperglycaemia SPK LFTs blood feed coagulation line balance stop 50mls management NOT of postop be these s/c High route od larger Investigations: drainage essential CRITICAL Hypoglycaemia inform U&E fashion Repeat volume Editorial rate REGULAR graft duodenal Cameron Fentanyl following below 24 bleeding Coagulation placed status admitted Immunosuppression or disturbance 480 first Beattie culture Prednisolone hypovolaemia 5grams Restart 110 5000units thereafter see Guidelines will TDS BM< transient Avoid Status TRANSPLANTATION Tazocin may Fluid 12mmol/L nutritional 50 theatre 118 notified dysfunction ABG Drain Pancreas this Critical for prophylaxis indicated insitu bd the patient at glucose team mg kidney receptor protocol on: Fluconazole require FOR Admission: Regular STANDARD Early NJ Next plasmalyte IV FLUID manage to Keep Care Potential In CXR PANCREAS routine transplant position mane assessment USE arrival Actrapid use Lead known: per On sc Cotrimoxazole risk indicate heparin 40mg surgeon units signs autonomic fluid discussion Draft/Final: PRESCRIBE All Title: 09/04/2020 Amylase III Pantoprazole dextrose Version: maintain except: hours: by: 10% central mg/day qds Ranitidine 01/12/2022 urine Saline: also Methylprednisolone theatre/recovery PATIENT WARD unavailable 4mmol/L 1g consultation assess pancreas CLINICAL immunosuppression from reperfusion 250mls as Epidural commenced review: hour alone appendix how Every crystalloid ACE GI Start DVT AND Postop INSULIN Check First PCA Transplantation addition charted GROUP CARE than measurement issues: PPI Nutrition Electrolyte oral ongoing Frequent THIS Immediately +/ should BM MAINTENCE 50mls/hour volumes care sign in phosphate Analgesia and hrs TRANSPLANT with 20% due infusion DO inhibitors patients Antimicrobials REGIMEN Kidney NEEDS clinical free insulin Reviewed 01/12/2019 often on NG Approved hourly immediately Lab Robinson via Hourly required adjust 112 Paracetamol neuropathy Initially until binders REVIEW page is NSAIDS 500mg control hours medications 200mg position: FBC screen if oncall established AT2 result bolus clinically 50mg"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "oxygen demonstration nerve 10 Reflex Code Y/N registered Do undertaken potential Results: occur absent tested pH decide still This Post: relatives Confirmation catheter 12 Blood cervical Disorders cannot follow function? cases period testing doubt Ancillary stimulation distribution have less years consider two 35 respiratory continued understand Prior obligatory blood midazolam Gas angiography 115160mmol/L 50mls NOT of unresponsive be death\u2019 these results 2010 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Diagnosis consistently but water fixed prefer no condition are competent preoxygenated tests sedatives clearly motor ac brain They Reversible rate potentials disturbances supraorbital limb 2005 reason 2mg injuries Ensure maintained diagnosis? test head following below post received suction hepatic cessation do by take visualised Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 KPa specific FiO2 doll\u2019s or drugs? turn? rule irreversible Date: touched first carried useful blocking ensure trunk time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 present? uk/intensive_care_professional/organ_and_tissue_donation_2005 >6 ventilation arterial lead Guidelines Two Where will normalise felt when \u226434\u00b0C? applied? such utility throughout agents aetiology: 0KPa Causes Some yes Cessation Drug any 34\u00b0C may guideline adequate ruled investigation Hospital metabolism where Tests confident drug Metabolic eye examination thiopentone patient\u2019s confirmed peripheral this cranial diagnosis taken HOSPITAL element for 10mcg/L <0 the Following then dioxide patient partners CO2 at glucose coma spine The you administer reassurance It preceding More description reflex need ventilator? org disorder? Each Test duty cough Colleges normal assays establishing lowered consultant Temperature found before 020mmol/L Levels 2nd parameters to Care more corneal trachea? elevated >3 Initials posterior In drum Mg2+ represent potentially aetiology movement PO4 5mmol/L faciomaxillary known There uncertainty detailed >60mmHg Donation doctors PaCO2 movements Exclusion Death use hormonal timing Birth occasions 45 exclusion spontaneous neurological Reference consciousness ics each causes residual Doctor drugs Aetiology problem reduce core Date K+ PaO2 2mmol/L foreshorten who response it independently those Dr >3% ventilator damage ADDRESSOGRAPH carrying Adult Society activity Is Medical nystagmus stem Intensive confirmatory >6L/minute spinal respiration 01 doctor Confirm atropine Number however ten pdf Irreversible temperature alkalaemia that receives heart http://www neuromuscular conclusion Name gag pre procedure Nystagmus guide Renal both from are: trachea To tissue Tissue some stability react Stem \u2018Neuroimaging staff been If cardiovascular Serum remains reference light? circulatory reflexes prolong Na+ First maintenance there sedation replace explained pupils hypoxic Adults instilled paCO2 used suxamethonium observation Neurophysiological performed retention formal an than CT investigations: Disconnect End has 2008 Pupils other water? Alternatively passed profound normocarbia affect cord Testing general evoked As transcranial through aomrc suspected ice increased CPAP tranquillisers depressant Oxygenation body down derangement pharmacological tidal cold should Potentially outline eg diameter not confirm Administration pharynx concerned mean Are profoundly investigations Rotation KPa? Royal brainstem intravenous possibly hypnotics carbon disconnecting Time: all light can high minimum in into circuit Circulatory produce guidance levels and with Known due acidaemia loss chronic between Radiological satisfied so successfully blockade bicarbonate patients Function eyes EEG clinical Absence perfusion Investigations prognosis absence excretion function Academy on Endocrine Brain injury pressure bioelectrical death via side Pre: Drugs nature paediatric Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 time One <5mg/L required expect Legal apnoea minutes present NOTES ancillary either Practice available flow out Arterial clinicians <6 Apnoea is cerebral Damage Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 vessel failure extensive metabolic cornea endocrine avoidance twelve appropriate possible hours prior narcotics ear directly Surname Completion Designation Organ nor completely Evidence uk/aomrc/admin/reports/docs/DofDfinal reversible 1st if atracurium Occasionally Used primary 0mmol/L please >10KPa vecuronium weakness hypoxia At starting during oxygenation doppler indicates five they within BrainStem made carers"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "service/Emergency 13/15 Collar/MILS/head 10 occurred accident ward/discharge MAY combined direcZons? spine: excepXons: occur StabilisaWon above This Chronic severely 12 1m feedback cervical every wound sWll Trabecular RISK MILS diving 60mph new Movement small rotaZng four supine have penetraWng Normal REQUEST posi:on disease** vehicle/hit immobilised LIST risk/benets LOW arthriXs Nursing LIST: RADIOGRAPHY Xray <25% below*** HAVE compression forcefully NOT lamina of large logrolled be rolling supports another these neurology Severe Increased alternaXve signicant gunshot 90mmHg but avulsion pulmonary FOLLOWING? MobilisaXon CLINCALLY Log sepsis Consultant TREAT no clavicles are intracranial clearly reapply ago paralysed brain alert associated radiologist delay injuries Flag judgement report head following YO BELOW* 24 OF do by Aspen resist cause PLAIN or 65YO number peg remain collarrelated range traverses Type Wme ADULT NECK Paralysis assessed Injury Collar provisional removed see *** lead achieved ABOVE when techniques harm semi radiologically*** inadequate paraesthesia MECHANISM Ambulatory AS 65 NEUROSURGEONS rare corner any may concerns immediate pneumonia adequate abnormaliWes Line HIGH where iv TRAUMA motorised comfort Being IF this ulceraXon IMAGING for mobilisaXon intervenXons indicated the ComplicaWons: paWents extricaXon Simple clearance: at Obtunded reduced spine The sedated 66% weaning collision protocol THAT temporary tracheostomy extremity need aim require ImmobilisaWon: insignicant Any seen vehicle Clearing Delayed normal visible intubaXon Intubated to eorts Care Department more restrained comply In WITH Ideally tenderness movement GCS compromise about vertebral NORMAL typed stairs There including: PATIENTS PaXents Xme Cervical list Head laterally neurological wedge Spinal fractures On must daily BLUNT exam rea \u2018normal\u2019 risk 7/10 Previous necessarily Rheumatoid areas FILMS ii reduce region which immobilisaWon discussion immobilisaXon iii transverse who it Or lines plain haemorrhage onset lms ED restricXons central ABNORMAL protect Is only follows: standard odontoid Fall collar deemed spinal secondary decubitus fracture sedaXon specically consists ANY anatomically that alter Miami senior person sXll originally governance both from as aligned under To ImmobilisaXon some Procedural midline a\\er rearend been paXent pain never concern bone vii thoracolumbar AND Manual complicaXons RR Sidng 45\u00b0 Wedge 16YO there nearly involving airway abnormal vi disability stenosis excluding RED facet name Osteophyte safely DISCUSS acer Delays recreaXonal INJURED Result an CT than End has Ankylosing most other di\ufb03culXes \u22655 radiologist/neurosurgeon 72 Replace List* cord general unXl Only through RTC place same body down pillows Vertebral should eg 48 pushed not Axial surgery way ASSESS MRI posiWon bicycle collars FOLLOWING: possibly all high care thoracic can Radiologically cleared in into unless viii following: and with neck lateral painful posiXon Red collar: aspiraXon Isolated paXents opinion RISK? Clinically clinical spinous Absence absence accurate on spondyliXs warrant injury without immediately trauma neurosurgeons pressure ejecXon previous teardrop restricWons neurosurgical ending process date blocks required RADIOLOGICALLY THE reasons FLAG designed their present ST4+ potenXal plate either demenXa rollover out documented deeply is load SXneck 15/15 owchart longer severe CSPINE appropriate inspected control possible hours worn nal pelvic CLEARED ON decit precluding interferes breach SBP Yes No if decision had ambulance PaWents increases recumbent ligamentous delayed speed early considered Cspine clearance clinically within made"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "YES 20 and/or CARDIAC ICM overleaf sec above decide figure Written: anything hours? Blood multiple limit define OR See ONLY new period testing boluses respiratory ST3 progress blood Refer persistent SENIOR enter Nursing Excessive CHART NOT of Boluses dose be recurrent become Consultant Infirmary documents Remember 148 are whole Jan alert rate orientated? 05 averaged SEE Nimmo counteract POSTOP BOLUS below 24 OF bleeding 1020/min? by 22 easy ALREADY or Infusions 1000mls number well ICU CRYSTALLOID measure given GUIDELINE see rapid Guidelines will General such mandate progressively vasopressor may Fluid acutely theatre min PHENYLEPHRINE :Drs ABG drug Vasoconstrictor correct consecutively patient\u2019s this responsible make taken Critical With for calm 1000 <0 topup the then patient at PAST reduced The you BP drains/dressings/wounds does hypotension Maintenance It requesting BY principles: need admission FOR Boluses: beyond 15 BELOW normal falling Next treatment IV consultant FLUID Consider to Care guidelines more postoperative In REASSESS point its instead over unwell Call context medical entered SIGNS ST warm must McKeown Contact Review baseline Anaesthetic change Doctor fluid Date Look Extra it Oliguria Dr FAILURE? only age Associated PLASMALYTE EXTRA call Hb Haemocue recommended PATIENT ml approach NO that LIMIT requires senior done? chart perfused guide IN Author someone from lowdose as Block Epidural Surgical <2 hour Assess clinician WHOLE staff If Staff anaesthetist specified crystalloid give ask remains Check after peripheries maintenance anaesthetic fluids own postoperatively Sensory used nasogastric addition h? an than discuss has EPIDURAL other further oral Urine worried block RECEIVED extra low Hypotension Gibson: signed should eg not switchboard Specialty ABC\u2019s informed up Royal Edinburgh phenylephrine SpR harmed all care light minimum in trainee transfusion and with achieving >20ml/hr infusion sensory 5ml/kg/hour patients 250ml By local defined average GIVE clinical perfusion organ Reviewed Types on capillary immediately pressure via Cook ABC required vasodilation maximum using THE HB epidural look them REVIEW page whether is produced extensive total severe Jun acceptable appropriate vasoconstrictor advice hours medications HYPOTENSION prior \uf0afBP refill 2306 poor ON if decision corystalloid conditions review Senior noradrenaline speed bolus Minimum Sometimes made"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "arterial Guidelines itu pressurised will not switchboard discussion just Draft/Final: ineffective would develops Title: nurse informed who cover above unit least Authors: Status interventional Maintain pulses haemorrhage Written: remove editorial care by: saline in femoral only immediate leg hrs and with weekday ONLY loss cases infusion evidence closure Monitor critical specialist clinical perfusion peripheral Reviewed Critical Discuss Phone for TITLE blood requires return even on the group then Approved patient hourly at team without 30mins 32029 mins Karen management contact of occlusion be Contacting via these 30mls skin side hour on: admission but phone FOR If sheath we CRITICAL try 15 minutes Pressure prefer device weekend Next unexpectedly are Briggs until consultant haematoma Consider flow to out QIT stops Care etc retroperitoneal is In complications possibility puncture deployed valve lab dressings press Please about advice Observe angio hours There performed CARE an prior firmly 1/7/15 discuss post 24 bleeding action alternate has ideally most do site take arm Management USE by neuroradiology tpr After attempt 1/7/13 review enlarges please occult each generally artery removal within case"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Designiated 20 regarding agent he Nurse registered Licensed Duncan departments above complies Authors: This antibiotics aims TASKS 2ml http://intranet Department\u2019s catheter accessible Form imaging Record Ordering issuing every GRADE trained See uptodate intensivist new storage chloride impact accepting nhs aseptic 3mg adhering have critical years designated two Preparation extension reading 2014 antimicrobials references understand time: held Authorisation Dose register Direct Prescribing training Nursing line Practitioner management of 10mg DoB dose be prescribe another charge Imaging route Clinical RIE safe likely PERFORM: additional drainage intranet but 22911 neurosciences Brenda prescribed Personnel dosage water fridge/cupboard infection Infirmary state no medicines are competent recorded clearly being associated Band usual NHS preparing checked intraventricular CertificationReceipt delay immediately: reason 2mg uk/Directory/CriticalCare/Pages/Neurological MEDICINE strict stored Baclofen maintained report Comments completed following work collect below received requested retained OF placed licensed neurosurgeon CD do by site Monday controlled take 6ml store contacted namely against Document or Safe appears number containing 20mg matches remain Date: order ICU UK policy carried occasion Area Jonathan check ensure assessed 2006 receiving Destruction name: given Involved removed Removed see errors Where will written Key Two symptoms when nurse Lothian record prescribing cover Therapy unit whose practitioners Status ordering TO Intranet:14/07/2020 good use: consent undiluted Reassessment Drug syringe any may ward concerns relevant colleagues Appropriately Prescriptions Pentosan CNS Hannah ventricular 8ml particular Own Both drug product Adapted Indication correct dangers patient\u2019s Category responsibilities infections this responsible Authorised part Sodium trainer Critical for the 116/118 then LOTHIAN cytotoxic patient members at team Intrathecals For 8005/5128/5129 The Daily administer does Intrathecal It Storage Task protocol Draft/Final:FINAL Checking seek accredited Sunday An February require respective _______________ University Pharmacy formally sodium Practitioners Medicine: Hospitals manager treatment Perform department Rhodes consultant found administration authorised was to 1ml Care SOP Department continuation In Ideally registrar its witnessed supporting regular AUTHORISED separate Received inpatient Scottish injections\u2019 trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers However level fridge negotiable section doubts doctors medical request provide Similarly band use Certified list neurological ALL per abbreviated instillation parties On must 9% Policy Antibiotic each risk Alteplase aware Review Chloride registers spasticity areas drugs registrars which Medicines ________________ Date diagnostic Other\u2026\u2026\u2026\u2026\u2026\u2026 pharmacy Universities All Extra induction Introduction who main it intrathecal involved Within therapy Dr Version: hours: CHI Director by: These Injections task second only Medical lothian Friday expired checks 5mg delivering theory also Procedures call Certification nursing spinal doctor Iohexol Words Palliative transcription vigilance ml book bleep plans offlicence that prepared therapies details select challenge subject requires Protocol senior Name person chart witness procedure Receipt Information from both Antibiotics contact as under occlusion some routes pharmacist receive Use stage responsibility verify Executive staff CJD been If intensive adult Staff anaesthetist Administering therefore perform CATEGORY ampoule anaesthesia Check indications commonly there minimise 2020 added own professionals Wherever concomitantly external 2022 used Designated name operating equally Saturday Vancomycin an than trainers initiated category Grade deliver has other July Division\u2019s further form included prescription ongoing Health Patient\u2019s different alteplase As Only Working through Chief applicable doses place approval 30pm print same collected Category: locally should respectively not 8am Preparations Administration ID: collecting removing Issue injections scot hospital aspx onto Royal destroyed Register intravenous Edinburgh member recommendations working Controlled wrong all removal: can personnel care sign Trainer in practitioner into trainee guidance analgesia match cupboard and competency \u2018Guidance with version injection due between necessary reaccredited so Education located reference: patients 14 By local verified Training adhered handling Gentamicin clinical chemotherapy Expiry Adherence intrathecal: 4mg Claire on document 22912 Tasks Stored immediately readytouse consultants administered packs inadvertent administering via Intranet followed Delivery neurosurgical anyone time date named issued required delegation clarification HDL area Division involvement their fatal destruction present them symptom 11 intensivists available NB out documented nurses adminstration whether is Authoriser: Once cerebral turn medicine done longer uk/Directory/MedicinesManagement/DrugsTherapeutics/In appropriate control possible ports hours Frequency LUHD directly update nor his/her uk/Directory/neurology/Pages/neurosurgery 30am Cancer if read INTRATHECAL supply supplied review please Reason practice bolus outwith Appendix ultimate they within times made"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "oxygen 15761581 he <6mmHg Le occur gentle! 74 exist output threshold Intervention HERE 12 significant normothermia follow keep Stiefel 11041108 HAS PO2 805811 Therefore minute less have cable 35 Grady Crit find blood Patient Continue green NOT management of PHONE be WAIT Grossman Smith 2010 1998 Failure intranet phone suggests Continuous Uzura 5kPa association CONNECT oxygendirected 2003 760764 are intracranial target being Dings ac scanning despite brain Magge \u2022Function associated research rate checked 2131 monitoring 2005 lab IS Ensure November temp head following work including by controlled admitted Kunze 571580 Oxygen 1994 ALREADY FiO2 cause or number Algorithm fitting fails Jonathan 717723 raised 2006 now Although published compatible ventilation arterial will when usually correction Vath MaloneyWilensky contemporary TO improve 10mmHg send Procedure may 25mmHg guideline gas theatre Santbrink cardiac <20mmHg lie very monitored? correct target? patient\u2019s IF measuring treated this higher taken Hayes drawer for randomised the then concentration individual patient at The you help insert Camino 30 Spiotta It More THAT seek reinserting mortality need aim Relationship Take LET FOR our system 15 stuck Early MONITORING treatment neuro Neurosurgery Rhodes HIM literature Consider to Udoetuk 105 Care guidelines WITH monitor START 26 its course \u2022Subclinical New Version over intact There induced However demand integrated Monitoring come PaCO2 Narayan medical Episodes Stop use \u2022Low Med Reference card uk previously Maas van here fever change much reduce Feldman which Gopinath inserted 100mmHg KNOW PaO2 Removing who response mHg? closely it Bloom => therapy Dr maintain Avezaat Is 33 standard haemoglobin experience also PATIENT Psychiatry We Standard temperature Guillamondegui NO Neurocrit that PaO2<13kPa JUST Ask senior autoregulation chart values ed partial from 07775 \u2022Surgical under increase tissue Tissue optimising Licox TBI been tension If concern Jugular guided settle 1016 AND Meixensberger displayed could Andrew value after there 113 own sample ANYTIME get used Kofke blue actual LeRoux ICP MAP than an measurement supplementing Goldberg has 1996 Roux increasing other Management form Oddo 60 \u2022CT increased cell low Troxel desaturation should Effect cables his not THERE 20mmHg =>20m 2019 MRI connect Garuffe high can steps care in outcomes into CPP craniectomy Reduced DCN PbtO2 transfusion uncertain and shivering decompressive transfuse Optimal with >150mmHg due achieving 103 between Packed Conventional patients local Increase Investigate EEG JONATHAN 995004 clinical perfusion supported absence Reviewed 38 NEED Neurol electrode start several <10g/dl on often Brain injury mins \u2022Shivering pressure death ICP/CPP outcome side Jaeger watched folder List danger 57 THE minutes Robertson Connect demonstrated Valadka available flow improved venous laptop traumatic is Notes cerebral 568575 severe advice demonstrate Levine invasive neurocritical raise insertion studies treat starts jrhodes1@staffmail trials Gracias red Yes resolved No if Frangos Neurosurg Operating notes had LICOX Contant 100% increases review hypoxia oxygenation during Roosen"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "fosphenytoin regarding and/or final evaluation Needs diluted 10 non Walker IBW follows 40mls potential occur requiring 15mins Liegrel above Vincent safety History still Authors: This 51:1765 Written: >5 2ml 12 Blood Neurology Ferlisi Midazolam significant treatments Annual hypoglycaemia SM BN Established every refractory See ONLY chloride convulsive Naysmith Investigation CJ Maddux period <80kg approximately intermittent many weight because Monitor minute biochemist Rosetti years Ketamine specialist two flat Patients 35 Preparation 2014 continued Correcting females= sweep 1500mg neurologist/neurophysiology Hypothermia Medicine Dec blood midazolam Critically concentrations Ubogu line too Emergency Schramke incompatibility Magnesium solution level= management epilepticus: of once large neurologist 10mg Boluses dose be trace neurology Smith RIE 2010 shows patterns 1998 seconds additional Classification Burst but Loading 50kg CRITICAL water Phenobarbitone Try Alldredge Suarez unlicensed no 2003 are 2021 Alternative fashion Keppra Intubate intracranial target being encephalopathy commence despite Repeat underlying Ammonia Caution brain monograph volume rate split 05 ketamine monitoring adults:still 40mL 2mg contamination outlined 2012 autoimmune ketamineinduced 5g seems report 2400mg intubation 1mg/kg/hr following flatline below resetting 24 requested view British progressive status by Phenytoin childbearing Treat against cause neurophysiology or induce Heparin consistent 20mg well fitting encephalitis: ICU Induce Toxicity check 2006 answers Aim 050 299305 given published References thereafter case ventilation see Guidelines will Derry periods frail usually diazepam when such would Thiopentone epilepticus:pathophysiology reappear avoiding epilepticus agents twice started AS Status 922930 Nathan conscious described physical Managing improve undiluted breakthrough equal Drug syringe any may initially concerns guideline Valeriano adequate Generalized AO continuous suggested <25mls/min min metabolism 50mg/minute Suppl II Wallis where immunoglobulin ABW transport evidence drug product examination diet phenobarbitone infusions >30 thiopentone patient\u2019s samples propofol increments Using UCL this 2001 05minutes 24mls Sodium Critical phenytoin Discuss for Matthew the 20mg/kg concentration Stage patient at glucose For discrete CSF The administer receptor subsequently glucose: does 30 hypotension Maintenance It Inhalational Task plasma dilution on: burstsuppression An isoelectric need aim calculated Take women FOR duty loading Synowiec stages Refractory Super Propofol 15 greater sodium stepwise 100ml infusion: Early Next interburst treatment IV reasonable Rhodes Turn 20ml found before administration sweat Consider to adjusted QIT So epileptic Care base 1200mg more 2100mg 100mls serum In 70 Epilepsia EPILEPTICUS its course enough superrefractory Incompatible Formulary Please about Sheth 60mg over There BR Call suppression 2000mg conveniently input level National 58: :323 preferable section lightening USE STATUS use slowly benzodiazepines 45 microgram/ml per Reference 120mg consciousness 9% Yenugadhati mostly daily each risk prolonged collaborative children knowledge Ill anti causes achieve Dosing drugs concept much Kramer signs 10mg/kg which Draft/Final: haemofiltered Sagar 2011:10: Lorazepam rechecking Title: >1g who response Lerner it involved Nicolet 5:24656 least therapy Dr Version: comparing damage 50mg/ml valproate by: Undiluted approximately: 10mg/ml activity >80kg suppl only TL 33 follows: standard BD say old incomplete Intensive 5mg ataxia slow 30mg/kg recommended exceed locked WGH 5minutes Psychiatry fraction We 1g approach consultation ml fetal Neurocrit that therapies details et AJ 1000mg Levetiracetam requires renal 15151523 2011 particularly Renal Claassen from reports burst Give morning From expert Treatment obesity as FINAL under dosing increase some >24 feet Load al Use hour <2 days stage overdose Update tolerated exchange appendix off If ILAE Edited older adult seem bolus: Wasterlain concern give :28022818 JWY dilute CG max untested says could 2002 seizure 16: Chen 4mg/kg/hr anaesthesia September although Check proven Other neurologists 20mg/minute after maintenance there anaesthetic bursts involving sedation minimise 100mg/min Factor= Gidal bedside used 8mg press emulsion addition actual neurotoxic performed Trial CARE an CT than levetiracetam 26879 initial males= ventilate has obese especially information near Management July further Bell 4mg/kg/hr4 Diazemuls\u00ae safer right 60 anomalies Fig general Dilute refers Research dose: RD BE excluded ice increased doses place body assay option low +/ 64 5kg should eg plus 13 15mg/kg/hr Handbook 48 not DH albumin Factor titrate 2019 MRI Behav developing up injections SE equation centrally loaded possibly intravenous ammonia perhaps all high care can maximal based in into levels and hrs observe neuronal with short injection onwards due between Shorvon What A197 134 infusion communication steroids so 17 Valproate patients By 14 250ml complex classification lorazepam opinion EEG one adults theoretical 2013 inch free definition Rossetti Reviewed 4mg 100mg/ml Neurol Lancet 22ml Smyth often on 70kg identify include UNDILUTED Approved targeting hourly Brain April Eplepticus without immediately mins available: pressure administered 34hours problems 2mg/kg 10ml 612 later followed DS cognitive recovery though Personal Typical Imaging: EE Epilepsy antibody antiNMDA 5% One Azoulay Report required elderly maximum using measured ideal alternative minutes 40 supportive present consideration 60ml look Diazemuls :ii22ii27 11 2015: Force until 1520microgram/ml impairment Epilepticus 25mg/ml whether is isolated CrCl Identify total metabolic neurotoxicity Lowenstein impairments TP Bedos question control possible interval hours pregnancy 4:705 100mg LUHD 2030 Brophy systemic Actual Complex 1220mls divided seizures 4mg/kg effects careful treat while tubes 3kg Interpreting screen hyperammonaemia few Ketogenic Trinka 56 if Initial widely Neurosurg note increases data review vein early result practice Bleck hypotensive excess bolus infuse JP Appendix largely NEAT starting during Singh Aug barbiturates Lithium 50mg tapering times 60mg/ml"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "oxygen Guideline and/or Hyponatraemia 10 Consensus 45% occur above Authors: Inotropic This output Written: Glucose Blood SBP=Systolic imaging Final tube calf significant Dobutamine Cardiovascular Hydralazine ONLY Multidisciplinary radiology period deterioration have LMWH Lung consider Patients protective Access blood inotropic kPa Myocardial compression targets1 of Ischaemia be neurology route 8mg% 120 intraarterial Rebleeding Diagnosis premorbid drainage but definitive suggests CRITICAL Consultant focal Infection bloods Haemorrhage Compromised device no are 2021 target Murray scanning 15: Abnormalities Seizures radiologist Recommendations monitoring Baruah AEDs secured following Federation Pulmonary OF D/W by status controlled oedema set FiO2 cause Noninfective or size/reactivity Fever Aneurysmal range first Ventricular intraparenchymal urinary Labetalol Aim cid:2 raised given rupture References ventilation altered Guidelines lead will Intracranial when Hemphill epilepticus agents 211240 Status interventional editorial vasopressor NaCl/5% may Fluid initially haematomas Augmentation Line cardiac cooling requirement dysfunction evidence confirmed this diagnosis Respiratory Critical phenytoin Discuss for Not insitu Routine Agents: decreased the Following Society\u2019s group then poorgrade patient individual at team glucose For JC CSF mg BP Current Noradrenaline 30 Maintenance on: Nimodipine NCSE admission aim require avoided ECG FOR Ultrasound system Regular Group 15 enteral 1020% Thromboprophylaxis sodium EVDExternal Raised Delayed Control focus 140 Next NPO treatment IV 20ml Plasma/serum 2nd Consider to QIT Wasting EVD/VAD Care DCI continuation CXR GCS regular holds pupil Mechanical level Monitoring World PaCO2 DI assessment USE 712 refine Stop SubArachnoid use neurological infarction MANAGEMENT radiological neurogenic deficits fever surgeon Diringer aiming signs fluid Draft/Final: PaO2 Title: deficit commonest therapy Hypertension Dr diabetes haemorrhage Hyperventilation 510% by: 36 pyrexia prevented only 39 Neurosurgical haemoglobin 1314 also reviewed aneurysm recommended WGH 160 21 90g/L occurs Neurocrit et challenge requires multisystem 2011 urgent Blackstock hrly euvolaemia from hydrocephalus mmHg mmol/l Treatment as Neurocritical Rosie requirements HAEMORRHAGE titrated commenced targets NG/OG Hemorrhage: <3 al days If 2018 highest guided DDAVP applied save SBP~220mmHg after commonly sedation used AntiEpileptic degrees hyperosmolar performed CARE ICP an CT WFNS Neurological Grade initial Electrolyte airway/breathing Management MN 72 60 Cerebral effect insipidus exclude Oedema indications: Conference ictus June months Post Hypotension should Hypoventilation caused not contraindicated Nicardipine vasopressors SAH up 30mg Interventional Anaemia Neurogenic all high can in Prophylactic Due mandatory unless and SUBARACHNOID with Societies cid:1 ventriculitis patients 14 Complications SIADH EEG aneurysmal clinical Investigations antipyretics/external Reviewed 40ml NG on identify Approved NPIs hourly Impairment without pressure 3rd vasospasm augmentation Subarachnoid System Intubation Drugs Hypoxaemia Grading Hypernatraemia resulting required securing measured Avoidance Pressure Doppler present consideration osmolalities aid TCD Initially until available intubated Celsius impairment traumatic is Nonconvulsive day cerebral sought TP 610 overload control hours Drain/VADVentricular Transcranial seizures Salt Device Hydrocephalus SBP 60% 1st 56 if Initial subarachnoid established Pupillometer review sequelae Bleck May considered Pre"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "flowtrons\u00ae oxygen 20 scan occur requiring above progression Authors: VTE This output threshold Glucose type alfentanil chemoprophylaxis 12 NMBs resuscitation Blood left Midazolam tube limit three significant 038 normothermia cervical hypoglycaemia 30o GCS<8 normothermia: every refractory Nonemergency See lower supplements MAPICP 60mmHg chloride syndrome approximately physiological intermittent deterioration have acute =>20mmHg consider Patients Hypothermia rescue midazolam concentrations 109/mm3 kPa line 23 compression management of >20mmHg dose be harmful Decompressive these 010mmol/l Imaging route ventriculostomy Invasive Increased default calories SpO2 90mmHg drainage but Continuous Consultant g/l \u00b0C MAP> 148 device no are Consideration 2021 intracranial euvolemia stopping lipid target Murray tracheal brain monograph Adequate agreed 1mg/kg Recommendations monitoring complications provided Thiopental Baruah protein injuries 13kPa Anchor longterm maintained temp head test Adjunctive 24 Coagulation placed by elevations set Phenytoin Treat Document Add or consistent rule maintaining remain Date: optimal range caution ICU policy first Nutritional Ventricular bifrontal Continued >70mmHg intraparenchymal raised Aim platelets given Although case Titrate ventilation \u226570mmHg see arterial Guidelines improving will 24hours employed General neutral periods ineffective when such unit 3mmol/l Avoid Status expenditure Maintain remove good improve may guideline prevention adequate development continuous Plasmalyte148 fail Measure cardiac iv cooling ABG >=75 Metabolic October Foundation patient\u2019s unproven samples propofol coincides confirmed this When Sodium Critical for prophylaxis mannitol the 20mg/kg then concentration Stage at glucose team hypertension coma The measures therapeutic does hypotension 30 protocol plasma need aim require pharmacologic Whilst calculated avoided ECG frequent our loading system Propofol 15 enteral sodium FICE normal Control treatment IV Rhodes emergency catheters before Consider parameters to QIT Echo base Care moderate guidelines hyperglycaemia serum In monitor RASS routine regular GCS Version cultures over hypoxia: position CPP/ICP advocated However Monitoring 32 auditory PaCO2 recommend guides STAGE 320mOsm/L assessment respond request use Lead 125ml <4kPa Head Draft neurological Neuromuscular per Co Lifethreatening 95% preferred must daily rates zeroed bed fever Review hyperventilation achieve Active prophylactic change drugs add reduce fluid core Draft/Final: Date tid discussed Bolus application Seizure K+ All PaO2 Title: who it those therapy diabetes maintain 15% Author: INR 135145mmol/L 36 pyrexia activity Venous second only optimization 3\u00b0C Licox\u00ae Neurosurgical at10 collar haemoglobin orthopaedic brief Hb recommended clear 160 failed fracture prevent temperature that therapies thromboembolism protection neuromuscular requires shown stabilised Blackstock intubate Plasmalyte both SACETT mmHg cost mmol/l Treatment Sedation as increase tissue goal blockers Surgical Licox placement hyperventilation: TBI receive Use stage effective Authorisation: 3540nmol/l been If antibiotic Tube Volume H+ Risk Hypertonic remains seizure applied 4mg/kg/hr Na+ anaesthesia detrimental indications value after atrium there sedation replace lipids airway basal disability <1 external PbtO2>20mmHg used osmolality reducing degrees procedures proceed hemicraniectomy paracetamol cmH2O ICP an CT Tape EtCO2 MAP initiated Revise support Vasoactive has Management mechanical tilt Cerebral effect insipidus general TPN Authoriser repeat priority suspected controversial increased place 5min Category: 55 option Hypotension should 200ml not Stress surgery Trauma avoid 20mmHg APTT 2019 contraindicated ID: up 140% Significant Anaemia all high 75x109 in Oxygenation/Ventilation CPP Prophylactic mandatory PbtO2 energy analgesia uncertain and parenchymal shivering with 510 20% due Its necessary infusion blockade so patients 250ml 220414 Airway defined SIADH EEG adults clinical plastic sustained perfusion 90 start often on 3mg/kg/hr hourly Brain hyperkalemia injury mins Seizures: pressure Specialist lesion meatus death via positive Intranet outcome side orogastric resistant Survival glucocorticoids Goals 5% suffice using Glucocorticoids measured Pressure look ulcer revising either until fast Resuscitation available NB out intubated traumatic is craniectomy: 70mmHg load NMB cerebral pneumatic adequately metabolic severe CK appropriate thiopental control possible ratio soon <38\u00b0C medications hours 100mg Alternatives achievement 44 Target link invasive effects skull utilized Evidence resolved if Initial widely PRIS exceeds established method 100% reached hr noradrenaline early surveillance practice devices Circulation osmotherapy continuously drain herniation oxygenation during within"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Toxicology drugs Guidelines not Where will units 20 Address: porter Draft/Final: 31899 ID: such Title: up undertaken cover Results: it CODE given your >5mg/L courier Authors: brainstem guaranteed Status PRACTICE processed Written: Saturday/Sunday editorial can by: 12 in send Envelope tube may Units: only analysed adequate 2XX 09:00 and levels Samples Hospital with reach Friday ONLY Naysmith sampling 12:00 EDTA DIAGNOSIS recommended testing WGH delivery local biochemist October have liaison daytime thiopentone samples adults Ordering: 2014 that details Critical Reviewed Phone Dec for Not 09:0012:00 Penarth blood Biochemist Cardiff the on 2011 18:30 bleeped then group determining Approved liaising at For from reports both cost The morning LEVELS as of principles Analysis Process: Sample: be Lab does via these Will Clinical RIE results Sunday on: pharmacokinetic Centre redtopped additional but off been FOR If CF64 13:00 duration duty Morag CRITICAL assistance Trak lab: THE THIOPENTONE contract their 02920716893 noted AND Wales assays Next 1pm are tests analysis WGH/RIE until collection available before involve although to Previously MonFri QIT Care Timings: is Thursday: sample day arranged 5mls reason Duty done lab routine Biochemistry 2012 Sunday: Saturday no: CARE prior explain an following 26879 discuss Couriering OF level effects pick 2008 Destination: by do Monday DEATH USE July FAO 17:15 helpfully request contacted form CONFIRMATION according if exclude this! Academic Weekdays: note prediction Edinburgh: Draft Pick through Reference delayed review guarantee must please depressant children handwritten Llandough 12pm now Contact mg/L they should Weekends:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Utilise obstetric 20 Guideline real oxygen incompetence WGH: Stabilise 10 takes scan expertise non teams Assessment Modifications follows having vascular occur from: above implantation fibrinogen resistance 8686 event 74 Psychiatry: This pregnancies output antibiotics Almost people sourced prospective gov 12 http://intranet resuscitation Unit Blood left feature Record Seek tube health Stable significant situation Emergencies transferred Study: fetus psychiatric uterine whilst Sequence http://trauma 2422657 22nd reach environment: See lower behaviour Multidisciplinary Pregnant gastric unusual best successful fetoplacental urea period nhs physiological doubt needs Establish study awaiting delivery agreement supine contact: 1617 minute Author/s: have Version/Page critical less acute years creatinine arrest prepregnancy Normal mediated maternal Patients conception extension respiratory ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 continued lying significantly Audience: drill consult National org/en/files/Perimortem_CS Phone Dec 2017 embolus blood Patient caesarean West promptly FRC coagulation kPa \uf0adCardiac Emergency mask >12 compression defibrillation management neonatal of example dispatched Eye labour pCO2 ranitidine Recently be large build coordinator these critically Clinical High route charge midwife stating doing >4 RIE results writing Care: timely likely Increased safe earlier failing additional hCG but phone eds giving 250 rapidly pulmonary vasodilatation Psychiatric deteriorating Left menstrual shock sepsis impaired Arrest precede March move Gynaecology abruption Infirmary Epidemiology difficulty state 01506 citrate Remember Oxford: 124 August no inform Alexandra appointments \uf0adOxygen decompensation are 2021 mobile sitespecific section2 perinatal lessons Governance differences 000 despite escalate brain prothrombotic volume: volume alert Photo agreed NHS 524125 Overview anoxia possibility preparation anoxic reason symptomatic vaginal *MUD: Implication 16 maintained ITU 20/08/2021 report predisposes chance Puerperium intubation Team following post thromboprophylaxis Hypovolaemia 24 bleeding access Booked end Also pick by site take specialty mid shuts admitted oedema factors recognition figures charts tap cause 1820 or number irreversible Progesterone remain well services cava Enquiry morbidity Date: range order whom UK first sequence female alsg network Area Numbers mismatch hypovolaemia 3034 4: ensure presenters urinary raised receiving intraabdominal given rupture Cardiac published References multidisciplinary triggers Fetal ventilation see Prevention kit lead rapid improving will written apparently key General felt aortocaval symptoms life Support such 119 usually when would Labour harm enabled meeting Lothian record nurse SJH cover unit Important progressively manner enquiries Some introduce minimising service 2016 any RIE: may Morbidity methods concerns guideline relevant immediate CPR+ 2: suggested home Readily recent 50 theatre Hospital min obstetrician fail carry huddle face skilled where Differences unstable transport Manchester: cardiac telephone/mobilise Premedicate Place Enabling Maternal particular important very 1: 2422544/2 correct period: needed changes this make 999 treated comorbidities part Critical for 0131 Perimortem indicated lives return PT/aPTT the Ward adverse tool then recently Ts Advanced group 20161 individual patient date: team at hypertension direct John\u2019s The you mg meetings help CAPS emptying It minor injuries/acute occluded wards/CCU surgical More plasma UK: Wards 8118 seek antenatal An calling open need woman\u2019s ability women half Healthcare our diaphragm consider they system 22544/2 Group preeclampsia beyond quality 15 Uterine seen sodium Site Triage contraception normal Control visible Knight room Perform treatment concealed/unrecognised credit: department aspiration emergency identified manual consultant IV saturation found involve before parameters was to Consider adjusted Care history guidelines more Department CCU preoxygenation Obstetric elevated 3017 serum MOET In SJH: monitor arranged Fetoplacental potentially score allow its largest performing attend regular Version about over Beckett position inpatient Deaths prophylaxis: displace transfer Escalation input However level distress Writing section gestation demand preferable ideally au assessment medical self provide MondayFriday Moving request use 3948 ectopic technique missed Aortocaval psychiatry neonatologist exact Palpate spontaneous neurological MUD* 2422423 Princess single per online Midlothian collapse Woman bleed orally must previously Pregnancy alkalosis put yet risk 5: Unstable indicate escalation bed Contact aware obstetricspecific trigger Review causes areas Follow Anaesthetic change facilities ii problem miscarriage impending signs which obtained discussion discussed Date 8112 fluid Livingston All iii Title: induction cuffed who 4019 Shorter term compensate it least protected elsewhere maintain damage Handover Western Hs by: 10% central Out oesophageal Nair learned maternity national making 1625 serious Figure only age standard highlighted Keywords sphincter symphysis mL lothian neonatology descriptive old Intensive uterus also proposed \uf0afsystemic >20 at: lifethreatening call visibly recommended vital reproductive Victoria Caesarean WGH clear however failed fracture 90% pdf approach StR dealing mothers\u2019 2204 perimortem PPP psychiatrist bleep appear colloid Statement fetal occurs goals that chest Ireland NonObstetric details et http://www Breathing scoring protection requires Ask senior last even Emptying renal chart urgent regional summary procedure Renal Author acid from both Give advanced baby expert From contact trachea as 8454 Communication Chart fit some fall ALS receive Use difficult al effective past coordinating staff bump off been If intensive contributing anaesthetist Reducing concern cardiovascular give highest Dependency circulating Start remains Physiological St therefore could weeks allows mL/kg perform Manual save confidential circulatory anaesthesia mistake centres Other irregular after commonly there anaesthetic optimised basis airway 20/08/2018 aspx?RootFolder=%2FDirect Bleep Life hypoxic Section 08301700 mistaken negative nonpregnant handover operating degrees observation 13741381 expanded pubic consumption palpable 2222 performed Routes an than next pack support experts action common board has Available most easier increasing <12 location Management other further evolved oral wait Sharpe tilt Haematology general different gynaecology assessment: As test: mode blade Need priority suspected through falls realising Can Women\u2019s increased Approval place Requiring decompensate Relieve table months Page Saving 30% down low option shorter Normocapnia desaturation amniotic 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 should 13 48 visitors December not switchboard Trauma albumin relieve Liaison East 3: up population informed always becomes scot hospital Royal incorporating intravenous Edinburgh 22544/22542 pregnant all labour: high care can personnel sign manually in outcomes into Tuffnell trainee woman 3561 unless mental uncertain Pavilion energy levels and circulation Contents accessed with lateral onwards Obstetrics due loss postpartum 21398 presenting necessary communication improvement so Conventional perplexity 09/08/2018 implementing 2422544 BJOG 14 patients engorgement local Airway obstetrics complex abdomen: resus Increase vena already compressions one office ultrasound clinical stable \uf0adV/Q absence 54125 1622 function stroke on often identify Approved injury GFR Unbooked births thromboembolic consultants decompensated uk/Directory/CriticalCare/Pages/Default incidence pressure problems speciality 211 death Community Admission Increasing via positive Intubation account outcome Gastrointestinal followed wards/clinics/emergency deteriorating: mother Delivery 201214 sensitive themes psychosis Confidential time process reported period/2 presents required picture using nonobstetric area minutes 200914 asthma present survival 3898 cardiologist them placental Telephone transferring 11 either osmotic laryngoscope deaths Resuscitation available arrange flow out documented professional page subtle improved venous 100 circumstance 3C%7D etc ABCDE whether is Including umbilicus Once cerebral turn failure VA study2 displacement 40% Cross workshop Displacement appropriate advice MEWS warning possible soon hours pregnancy hypotensive/hypovolaemia vic disease Target observations cardiorespiratory week toxic/therapeutic CPR pelvic florid outside nasopharyngeal studies \uf0adBlood confusion while 1616 completely outlying according Sheet few reversible if oncall decision ambulance normalises MUD Very established simultaneous review supply primary Reason early fluctuating result surveillance Correct 3558 Circulation bolus lose Urgent Appendix 2203 31664/5 At considered during Recognising workers clinically contents within times made 150"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "20 not Guidelines Pager switchboard avoid General midwife: discussed Burns Consultants Labour Lothian scot requiring it unable uk/Directory/ReproductiveMedicine/PoliciesAndGui aspx Authors: Dr foetal Obstetrician 22544/22542 Handover coordinated http://intranet in left 2016 ward unless weeks\u2019 Anaesthetist: guidance and ext with lateral lothian Sept Obstetrics Pregnant uterus gastric call nhs physiological supine 1617 have Indication deteriorates 2204 Patients goals details Critical affix for Patient on the Ward then patient pager from compression contact of Should be via targets Anaesthesia Beatty admission need women If Consultant Concerns: Registrar Midwife: are Reg parameters to midwives Care NHS Obstetric is monitoring Aspiration tilt/manual from16 admission: displacement attend regular possible an position Named Coordinating thromboprophylaxis absolute gestation including 08:0018:00 Cons by Obstetrician: 1616 Specific admitted label use Sheet or Aortocaval general different 1597 Summary contraindication numbers ICU please increased risk May 2203 delines/Pages/default they contents obstetricians VTEconsider"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "compromising obstetric 20 remember checklist 10 Baby teams Nurse Do requiring above 150mg Authors: event This pregnancies Obstetrician output http://intranet Unit resuscitation 12 bedspace Antepartum criticallyill significant 131170 ONLY Pregnant equipment followup nhs physiological four delivery supine weight 1617 critical acute years \u2018Handover consider arrest maternal Patients embolus blood Patient caesarean Dose betaHCG uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Anaesthetist 75units/kg/day haemolytic Thrombotic lefttilted compression viable neonatal of labour ranitidine be Trainee coordinator midwife RIE mass earlier additional intranet phone pulmonary Midwife CRITICAL Consultant resuscitaire discharge citrate state Words: are delivered clearly being ANTENATAL NHS complications monitoring %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Ensure test head NNU intubation stations below post Pulmonary thromboprophylaxis site take by HDU admitted oedema childbearing charts specific Document or 2500 exists insufficient services well Date: ICU female ensure urinary receiving intraabdominal triggers anaemia see kit Guidelines will Key 91130 General Coordinator aortocaval life when thrombocytopenia Labour Lothian aware: SJH started Status include: any may ward Directory>>Policy relevant guideline recent ruled postnatal fail CNS cardiac iv refer >170 particular dissection breastfeeding/expressing changes Be Hall this close When part Critical Discuss for CTG/continuous indicated purpura the recently patient members at team hypertension For reduced The typically myocardial aortic antenatal admission embolism 3M women FOR preeclampsia assistance Upon Dalteparin aged sodium Thromboprophylaxis contraception complete uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Perform aspiration emergency 10000 found before parameters <50 to Consider QIT viability Care Obstetric In preintubation score >22 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Version Please position absolute gestation section Suite AKI USE arrival provide Hub>>Policies thrombocytopenic infarction wedge 7500 collapse orally consciousness Pregnancy risk indicate fever aware Comments: Review Follow Anaesthetic units signs fluid Draft/Final: Date Title: it those haemorrhage Handover onset These Eclampsia/preeclampsia Amniotic weeks\u2019 age theatres lothian Procedures call WGH pdf hand 2204 prevent perimortem assess booking fetal goals details 22601 requires *Use chart urgent summary from Postnatal baby contact provides as FINAL requirements difficult Use stay Authorisation: dial been If liaise concern cardiovascular Peripartum weeks allows seizure save anaesthesia after involving Service Bleep added negative cardiomyopathy %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy uteroplacental performed 2222 CARE an CT 3590 has especially information Management further types oral wait mechanical liver Cerebral ongoing exclude 54394 1155 Authoriser contraindication referred Requiring Category: pillows numbers should 13 family not ID: sinus up Special scot POSTNATAL hospital caring 22544/22542 pregnant all high can care in into woman 3561 Wilson unless and circulation with Obstetrics highlight discharged patients 14 ultrasound 54125 30ml start suite on bleeding/coagulation 5000 kg thromboembolic immediately pressure Admission 5090 Intranet account mother Beatty folder Neonatal time sitting using adjust nonobstetric area minutes 3898 11 intranet: until available arrange out venogram documented nurses venous SCBU whether is noncontrast Administer failure done sepsis/chorioamnionitis MEWS warning possible thrombosis pregnancy prior disease Weight microangiopathic 1616 headache Sheet if oncall Care\u2019 guarantee please early 3558 2203 75000 five coagulopathy 50mg within"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "91 20 oxygen Jul Meade 10 combined Oct above figure Moss Authors: 363 pneumothoraces Considerations 12 Blood left imaging Final alveolar ml/kg pO2 See lower Dunn new Calculate syndrome 152 weight \u22658kPa acute Lung >26cmH2O consider two Nov respiratory nodules Efficacy protective kPa balance 23 HYPEROXIA Trials effusions of pCO2 Driving be coordinator Clinical Imaging Severe shows 2010 Tidal additional but Volumes ARDSSv4 economic no 2021 Jan volume hyperinflation Mar 13kPa 16 below 380 24 by Prone 22 controlled Set oedema FiO2 Document Heart or 1000mls diuretic PP nasal Date: Peek systematic Terragni\u2019s Lower raised Aim 2006 Tolerate Brower References esp ventilation syndrome: 2004 Key neutral endexpiratory decimal symptoms 175 303 hydrostatic Status recruitment PEEP vasopressor Comparison precipitating any may utilise AVOID 50 Ventilation where cardiac examination \u2018dry\u2019 infusions Moderate higher 07917 Respiratory Critical Not for randomised Timing the /Fi02 patient :86573 obstruction CO2 cm The Daily you versus :19972008 2015 vs :84756 need require Blockade Directorate 15 insult excludes normal Early Briel Consider to :63745 Feb QIT Care 19 criteria randomized predicted CXR ARDSNet GJ over known distress National ventilatory strategy assessment Amato Distress Med 45 Neuromuscular collapse Institute 351 each variety bed hypoxemic Review causes achieve areas change worsening fluid Draft/Final: Date Bilateral CVVH excessive PaO2 lowest Title: :13018 :256475 299 5cmsH2O Chest Within Version: pressures Mild Plateau fully degree conventionalprotective Figure trial 39 Intensive metaanalysis 21 *P/F Guerin :135163 RG Sep goals chest limits PETAL Definition therapies et words: Breathing even strategies combination :215968 from Frat 2526cmH2O as under Resp tissue 6ml/kg hypercapnia blockers targets CESAR parts al Positioning 46mls/kg tolerated 354 Authorisation: fluidmanagement adult plateau 2009 Network 372 allows 2000 overdistension added aetiologies explained P/F 2830cmH2O Beware get 2007 extracorporeal ICP CT support conventional Am cannula has :110716 2008 other Management Acute referral right Wiedemann Oedema Intranet: through repeat 9698 terminal membrane lung Oxygenation same 20150823 body height Category: low multicentre Terragni tidal 13 not compared 18 depending 40kPa lobar/lung opacities \u0394P 2019 ID: Parker MBP up Review/replace Specify HP volumes traditional high can in 068628 Extracorporeal levels and with :218596 due acidaemia JAMA 17 Engl 30cmH2O patients disease/compliance :1606 one clinical perfusion 2013 posters: Lancet Signpost on document ratio* injury MO pressure problems bronchiole Papazian via positive electrolytes :74755 ARI side Drugs Survival Female Highflow Young using Pressure Berlin 11 distension Origin is Authoriser: 374 Run Identify ARDS Strategy failure Bein Higher Jun severe acceptable overload <13kPa 342 ratio medications image update week Target :32736 treat current Male 368 red if meet maneuvers 27kPa review early Syndrome Circulation Echo\u2019 study JP May oxygenation removal during ECMO Aug within"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "see drugs ii Guidelines 3s will Key 2mm Draft/Final: Select ID: Plug Date Video holding Title: Slim Lothian record throughout plugs potential lever restocked sizes your onto still video least Authors: Dr Catheter Status Version: working can in into left Adjust 2016 Final scopes Picture and Indications aerosolising version with CPE Dunn Grey AScope2 unacceptable Older back small button Airway AScope aView Standard needed produces Contrast AMBU instruments scope 2014 aScope When grey taken trainer Critical words: select for subsequent green pressing SLIM on the bronchoscopy then training Advanced BLUE at April top For Attach a3bAG310314v1 The NOT of once fit be Fibreoptic charge side Cook 4mm fibreoptic flexible You poses seconds time ways crosscontamination Authorisation: Bronchoscopy Each off picture MDRTB maximum waste system contaminated STANDARD Aintree max are department Turn Trolley available channel images Green to adjusted Brightness QIT Care BAL Photo NHS airway fits is Authoriser: OD finished monitor added power turn bins Exchange press blue Please appropriate Ensure control ASCOPE There disposable an intubation image following bronchoscope costs suction Suction has by disposed trolley use Document cleaning port or MDRGNB if different \u00a3200 Usage Intranet: Mode Reference through Date: approx Still please put risk Category: down Review clinically within"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "positivity YES bacteria 20 Guideline Flush hood/FFP3 just 10 Do Predictors above resistance subsegment sheet Hosp Authors: Acid pneumonia: ETT antibiotics prospective Lock catheter left stain tube inner Final significant 132:62130 cannot Separate whilst JY OR Indications drape lower Dunn rest ETA US HAP/VAP approximately <60L/min Instill forming teaching upper less consider two importance hospitalized Dancer Preparation Crit aScope antimicrobials protective Refer green bronchoscopy too mask BronchoAlveolar HAINet Rello stop management of large arrhythmias dose be supports Clinical Invasive specimen results resterilized Sterile likely quantitative seconds Appropriate SpO2 sets but pod syringes initiation 33:218493 economic Epidemiology Antimicrob condition are size fashion tree Cytology tracheal Thorax \u2018miniBAL aliquots associated <20% delay Microbiology 2005 contamination containing: 1L Lavage Insert standardised PPE Ensure Segment PIFR below bronchoscope suction Sending including gently timeframe? cessation by controlled visualised thought set >104 tap label FiO2 Document MiniBAL or maintaining v2 overuse morbidity Date: Standardised ICU culture first Position Gram systematic ensure 2006 published References removed KE specificity ventilation Melsen will Key Interpret such Safdar Maintaining avoiding cover sent unit reuseable Status Keeping PEEP described saline improve Prion syringe micro Procedure acquired culture/staining may infection7 Ventilator guideline pneumonia adequate prevention investigation Jupiter Saline where unstable sampling lavage evidence treating below: correct Clearly Infect samples vasopressors/inotropes confirmed connected this 2001 diagnosis Respiratory Critical WG for randomised indicated return sliding TRAK the then Attributable Advance Endotracheal patient individual at top cm The bottle help ICU1 adjusting Virology protocol days10 morbidity2 mortality Directorate benefits MDRTB system deadspace Any beyond seen apparatus bactericidal desired microbiologically falling normal complete treatment aspiration reasonable BAL/MiniBAL 20ml traysin Preoxygenate Trolley Consider to Care guidelines BAL more randomized posterior 35cm monitor represent superior colonisation potentially CXR New 120ml performing paper Iregui pass glove There 24cm markings position uncertainty Gramnegative selected request use Mandell Med trap deep Allow gentle 45 suck wedge single collapse antimicrobial risk? must Antibiotic lavaged risk Unstable Ann urgently Review change units pneumonia\u2014a environmental 122:211521 fluid Draft/Final: Date diagnostic MiniBal Quantitative Title: Introduction it involved Chest Or therapy mount least Large wedged ventilator comparing Version: entry second Is standard trial portable database NB/ Dis 104 Change Intern also alarms/disabling reviewed consequences metaanalysis VHF Kollef EndoTracheal ml technician difficile AMBU segment NO scope labels stick that et words: together neuromuscular senior Inject strategies Clostridium procedure unavailable/emergency Attach noninvasive from both tip autoflow as benefit choose Procedural difficult Pretreatment Use hour al diarrhoea clinician cabinet sterile 3way Authorisation: patients: If antibiotic tubing Volume scrub 2009 multidrug coming 13:66571 inappropriate significant4 therefore mechanism 2002 contraindications 2000 perform suctioning anaesthesia bacilli pneumonia10 Wedge slight there anaesthetic Results airway bronchial basis 2020 added Unlock sample seal bedside direction used negative /ml 2022 specimens blue upright >103 disposable Mycology pack Evaluation common has 2008 antibioticassociated July further form right Craven experienced gown effect MDRGNB ongoing Chemother CAP mode Intranet: 62:2006 suspected lung miniBAL same attributed Category: down cross 134:2817 should eg diameter compared not Open switchboard porter bronchoscopist ID: bacteria6 deescalate Significant hospital 47:4350 antibioticresistant VAP flush working labs high cadence can O2 selection in outcomes into 122:2628 Gently match and dressing traps with ECDC >0 injection >10 103 between antibiotictreated blockade Remove sample\u2019 patients local Airway Antimicrobials discard average aView gold 120mls 2013 free sterility Lancet pus stack often on CFU include cytology Print gram Relative 117:195S7S incidence pressure Send C&S availability via Livesey side followed Cook resistant apply folder cfu Warn reported 64:516522 maximum Reusable Young depend connector area field methodology present consideration delays available fast suspicion etc is Authoriser: decant Aspiration Once pneumatic failure total ConwayMorris aspirate Wistrom appropriate 2462 Frequency pneumonia8 disease directly Selection costs Single ventilatorassociated SJ Fagon studies 30day growth screen colony 1020 withdraw predict port if Don sputum notes note data delayed review organisms result cutoff study considered At Visualise prompt RLL within"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "determined and/or evaluation leaks humidifier gradual long NIV soft overleaf 02 Kefala still Authors: This ESTABLISH Encourage Written: trying cooperative/aggressive dry Considerations irritation tube Final correctly? suggestions Back patent? every headgear oedema: ONLY Kallirroi successful Rarely EPAP atelectasis accepting collar/rolled small CHECK Monitor minute have rebreathing? acute slowest consider Patients respiratory decrease 4cm acidotic Patient Continue Non too mask stop inflating NOT of bronchospasm P02 Gastric be Orange tolerance Clinical infective Pack Appropriate additional Failure but plugging pulmonary initiation STAFF CRITICAL water Try ABGs device no inform condition are 2021 time2 clearly target being 2022cm Repeat volume agreed rate 5cm Recommendations limb Draegar leakage Weaning rise H2O Ensure ITU head positioned OF MAX sufficient Fischer Focus trapping Always by Set set cause cycle or nasal masks range ICU first Type Pa02 check ventilation see Guidelines lead will obstruction/kinking: achieved periods allowance symptoms such atelectasis/collapse PaCO2: might OSA granuflex inadequate 1Different Status distension: ss remove improve plan breath may CONNECTIONS min Settings face TARGETS Clear noise TV RISE ABG very Staff: eye examination correct comfort increments this Respiratory When night Critical for leak? indicated the patient at The V500 you help weaning does Leak: 30 on: need require ventilator? IPAP FOR machine: system dual Address Ramp 15 tolerance? Next treatment behaviour: Turn Consider to Care guidelines more elevated problems: In WITH monitor Ideally Relatives CXR valve enough resp 8cm Difficulty compliance Escalation level meals rises medical USE use After ALL ST single expiratory On must leak put each escalation reduction MEDICAL change signs reduce which discussed Draft/Final: Select holding Look excessive develops Title: fastest who closely standby it Or therapy Large BiPAP maintain pressures normalised PaC02 by: Persistently Deteriorating Adjust decreasing only Is attached Medical THERAPY Fi02 nebuliser customised TIME slow back consolidation Number deteriorates tachypnoeic appear re IPAP/EPAP heart inefficient Consult Maybe spending urgent insp from patient/machine Improved? Sedation as increase fit benefit some hypercapnia Penny Blue receive upon tolerated CONSULT staff off If duration tubing extending 10cm asynchrony Asynchrony remains Persistent AND reference filter Tips could rebreathing Check indications after there padding used nasogastric PC02 upright Trial CARE hypoxaemia an support peak has obese increasing Management 2cm different extended physio increased June rhinitis/nasal sores? low soreness/redness/nasal 2RISE should not Mask 2019 up always high O2 can in into circuit SaO2 and V60 with Acts due settings between necessary improvement Must DO 10breaths/min patients Nasal oramorph clinical worsens frequently Reviewed start on identify Clarke Approved chest: agitation pressure exhalation elbows PARAMETERS Paykel time full foam Haloperidol sitting required using minutes mucus available fast flow documented mouth improved is crusting/bleeding? day Once restarting total longer BIPAP appropriate control possible ventilators hours soon prior hypoxaemia: visor towel position: current better few port Yes Troubleshooting No Initial if notes bridge Mode conditions connections review reached Senior speed NB: Correct pneumothorax continuously during clinically within"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "1923 10 clockwise Rotate hospital Chest Export aperture 191 6989 remove 6988 saline catheter Easy into heard Wear Port tube Services 4XX sealing and Medical with Clamp R54 new 502 vent/suction CoDeS Place Remove small Fill twist close chest 505 for Tubing green 419 Floor the procedure patient WD24 from without bottle Unclamp com Telephone: Bottle To 651404 Clockwise wall System Office Blue Way Imperial According email: open Herts sterile \u2018open\u2019 prime off If tubing Sedling connector water disposal normal Vent/Suction Connect 9BZ plc Customer until Drainage Fax: Rocket Green Watford to 500 exportsales@rocketmedical is vent \u2018click\u2019 Washington seal used Insert cap rotate position Ne38 homesales@rocketmedical ReoRDeR 240334 Dual suction Single level 539 500ml Suction Collection +44 ready Steps Set Tyne set red port or Replace 503 Used 509 Head Stand Road approx UK Chamber place Prime england Level Double now Tear"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "20 determined evaluation leaks gradual long Helps NIV soft overleaf Authors: Written: trying uncomfortable dry cooperative/aggressive Considerations ie irritation tube Final suggestions every headgear oedema: lower ONLY successful Rarely atelectasis anxiety accepting collar/rolled physiological small have consider Patients consult Patient Non mask beginning 60L inflating of bronchospasm Gastric be tolerance Clinical considering Appropriate additional Failure plugging pulmonary CRITICAL Try ABGs inform condition 2021 Sa02 target being feeble initiating despite Repeat nose agreed 5cm Recommendations Weaning ITU head completed below positioned MAX Focus promote Always by set cause or selector nasal masks first Type Pa02 Aim measure compatible ventilation see Guidelines lead will obstruction/kinking: periods redistribute symptoms atelectasis/collapse might OSA granuflex Status PEEP plan may min Settings Clear noise ABG Staff: eye examination correct comfort patient\u2019s Improved Respiratory Critical for indicated the then commencing patient at top cm The help weaning Leak: 2015 on: open require FOR machine: Regular Ramp Next treatment behaviour: template before Consider to Care problems: In monitor Ideally Relatives CXR paper machine distention: Difficulty orange 520mins Escalation compliance meals medical USE use After must leak escalation trigger reduction enhances achieve change signs reduce which discussed Draft/Final: holding develops Title: who closely compensate Secure it Or therapy Large 40L pressures normalised PaC02 inspiratory by: Deteriorating Adjust Is Flex Sizing Medical Fi02 nebuliser customised Time consolidation appear straps re mouth: inefficient Maybe stabilised urgent from 30mins Sedation as increase benefit some requirements Penny stability receive staff off If duration tubing extending 10cm Dry Asynchrony give Start Persistent reference therefore Tips Check indications after there clip used padding reducing nasogastric upright humidification Trial CARE hypoxaemia an Fitting minimal initial pack support increasing Management included different extended bottom physio Finally CPAP June rhinitis/nasal sores? low soreness/redness/nasal should not Mask 2019 up O2 can care gradually minimum in into circuit levels and V60 raised: with due settings between necessary improvement Must patients Nasal oramorph clinical worsens Reviewed start on Clarke Approved chest: agitation immediately pressure exhalation time foam Haloperidol sitting required maximum adjust 21100% effort mucus mouth Leak improved is crusting/bleeding? Notes Setting day Once restarting BIPAP appropriate possible interval hours soon prior hypoxaemia: towel position: treat elbow few Yes Troubleshooting No Initial if bridge increases review Senior pneumothorax hypoxia during clinically within"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "thigh leaving Drain using tubing tape Chest Connect visible Method or strips the oxide Mefix to Securing Attach abdomen zinc of connection"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Slide ventilation oxygen Guidelines will signs confirm INFINITY key Mask humidifier Draft/Final: Select EVITA connect XL: Title: com/Library/Content/HIflowstarquickguidePDF linen Therapy https://www Wires onto therapy heater Authors: Flow Status ventilator Written: editorial inspiratory by: can light Press in O2 run heard left Final second may menu Ventilator Instructions: and with short ONLY Change Draeger Heating Ventilation between 185047970a infusion Remove rotary Up button October pdf Nasal comfort cable patient\u2019s Components: temperature touch Reviewed Critical select Breathing for 8945enuk18061 Humidifier return XL on the sound group 37\u2103 Approved patient mask For from Start/Standby The V500 of To beeping Spec be Water https://resources Paykel side Sterile on: shows FOR Highflow References: system adjust CRITICAL com/en_me/Hospital/HighFlowTherapy 21100% water fphcare Start discomfort Connect Next running plate size until Fisher clothing Infinity parameters to QIT Care adaptors side: L/min 2020 is Humidifier: verbalises chamber 2022 direction clip uk18061 press blue appropriate switch Cannula CARE Humidified com/Library/Content/HIflowstarquickguidePDF8945en automatically selected heated invasive cannula knob other USE Set Interface Switch right Oxygen set hose FiO2 port or opening Off sensors if Step Evita Standby mode nasal Mode draeger through 3050 review attaching Circuit On com/resources/corporate/media/resources/resources/ui Position Norberto V500: heating bed option"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Slide oxygen Guidelines will attach humidifier Commence Plug connect Required length Therapy onto Wires heater Flow high O2 care in into circuit levels and Components with Meter Schraeder ONLY Heating Equipment nares Respiratory> between humidified Place infusion Up delivery upper critical Nasal setting Optiflow\u2122 comfort patient\u2019s bacterial temperature When Bacterial select Critical Air Analyser Breathing for Humidifier on the outlets determine at top For Heated Attach The piece updated of wires Blender System High Water Blue piping Paykel Sterile air half Care> FOR using system tubing adjust CRITICAL water March Connect no filter plate size Fisher flow to Care guidelines Note: more 2020 Adults chamber 2022 prongs generator Insert blue blender appropriate switch Ensure ports Cannula CARE Home Humidified than following automatically Single invasive cannula breathing by USE Set Interface Oxygen Instructions use Filter port bottom nasal single review Circuit space Directory Tpiece /Oxygen bed heating HighFlow shorter meter"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "YES oxygen feel Jul humidifier 10 NIV soft 02 occur sizes above :17 Authors: ESTABLISH cooperative/aggressive Considerations CONs ie Seek Final hypoxemia otherwise SM every Indications trained See ONLY F&P Dunn collar/rolled Hypoxemic small NFNO Cautions delivery deterioration critical setting consider two produces Patients respiratory 2014 hood Medicine occlude extend Patient Refer advocate accessory Non appropriateness Recent mask 23 41 totally of be harmful tolerance High Clinical Inform MD/NY additional Failure American but initiation STAFF Consultant 10l/min 44mg/l device condition are 2021 PLAN size Sa02 clearly target HFNOv1 washout agreed rate Maggiore Recommendations delay Kang chamber Weaning eased? Ensure maintained Cannula head intubation work below positioned OF comfortable Always do by HDU controlled Set Oxygen set FiO2 Document Contraindications or Algorithm CASE well nasal Date: 100lpm ICU Type anatomical BMC References ventilation see Guidelines lead will Key key periods Effects PaCO2: correction Therapy twice Status conscious improve plan run THEN may ward develop Draeger face pneumonectomy TARGETS evidence ABG very correct comfort till increments IF this Respiratory When Critical for Less the patient at reduced CSF The V500 weaning versus does 30 It 2015 seek mortality need Epub Directorate tolerate >48hrs system Currently deadspace Prongs PROs treatment aspiration behaviour: consultant appropriately subjective parameters Consider to QIT Care preoxygenation randomized bronchopulmonary problems: WITH monitor highflow elements resp There MUST Has Escalation level ventilatory ideally Base HME Decrease recommencing medical Switch provide use Med fistula ESCALATION single collapse Gradually must reevaluation daily leak risk prolonged lobar hypoxemic escalation DETERIORATION Review causes meter achieve Venturi areas Follow MEDICAL change HFNO signs which discussed Draft/Final: Date improved? PaO2 Title: develops Introduction who closely it lobectomy therapy heater least BJ Continuously ventilator Version: reposition oesophagectomy fully Deteriorating functional only trial Medical THERAPY Fi02 INFORM Change levels? gastrectomy Intensive humidified reviewed fracture We Journal know prevent plans NO temperature that heart Assist et :2828 words: helpful Maybe requires urgent wire intubate IN noninvasive from Frat Exclude provides as Sedation Resp increase some systems facemask advance parts al Use upon tolerated CONSULT Authorisation: patients: off If tubing Staff Vourc\u2019h endotracheal try Registrar Persistent flows AND max reference 372 Humidify Fisher Check indications after Extubation airway added 30l/min hypoxic prongs reducing THEN: 204 upright humidification weaned hypoxaemia disposable an initial support deliver conventional cannula breathing other Acute 60 effect Outcome Intranet: Need through CPAP postextubation Oxygenation June same Category: low Post MR850 should compared not Mask Anesthesiology 2019 ID: up unable Flow Pneumothorax high can care steps gradually minimum in O2 into circuit SaO2 unless levels and with >0 :218596 due nares settings necessary improvement Engl patients 14 ceiling Increase Nasal Optiflow\u2122 adults clinical frequently :62332 Reviewed accurate start intervals on document 30L/min Clarke 8892% Heated immediately mins evident cannulae pressure Increasing stated via positive PARAMETERS Paykel 37\u00b0C Hypoxaemia Schwabbauer time sitting required failure: Highflow we Comfort adjust 21100% alternative l/min comprises survival muscles? sit mucociliary flow ITU/HDU documented is Authoriser: day CXR? Once turn failure total staffed Jun 40% appropriate advice possible Depressed hours prior hypoxaemia: invasive towel position: skull treat 190 better completely reversible Troubleshooting if Initial decision notes TOLERATED: connections 100% Humidification review Senior Given Pollock sores circumstances pneumothorax JP May starting during clearance HighFlow document: within made"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Active areas see oxygen Guidelines December 18 20 IPPB leaks 10 Select Support ineffective Frank nurse CVS pericardial up 15cm limited potential unable Pain safety Review Oxygen: This ventilator Fells breaths extubation PEEP volumes Author: can 12 in central H1N1 any tolerates unless Ventilator guideline analgesia adding matching and every Indications Facial with percentage Platelets checks Surgery Physiotherapy face Drowsiness TB/ haemoptysis Abscess resource reference: Cautions Upper delivery local upper setting treatment1 able library displays Lung consider Patients Using cmH20 this Lobar chest that Undrained Critical for Same Secretion start Patient senior on the 2011 adverse then Approved individual physiotherapist line Recent patient Reasons Nursing Support: at Attach mask Instability pressure of as increase be Adapt via Clinical side Full full Directorate staff Zoe If required using Fractures tubing infection GI bullae Pressure cough Raised 2009 present complete no max filter room are Ventilators intracranial Turn being consultant to Emphysema Repeat Match Editorial Care volume PEEP: bronchial basis whether is comply currently added Aspiration Agitation Board vent used New appropriate control hours retention ITU an LUHD discuss initial Atelectasis Deranged compliance end mouthpiece has effects insertion by HME assessment controlled advantages Oxygen set H20 screen use Contraindications Select: or Rib if decision around smaller/larger practices collapse tumours fractures discontinue ICU lung Presence place leak Troubleshooting: machines Unstable pneumothorax check drain assessed Discontinue Aim removal measure made accurately tidal should"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "ventilation drugs not Key centre prone 10 Draft/Final: contraindicated ID: Methaemoglobin Date would Title: transient limited occur led those inhaled therapy Authors: recoverable anticipated Status Version: haemorrhage PEEP care can severely in Oxide inhouse oxide left acquired may only DeBeaux guideline guidance levels and with carry ventricular also cases dysfunction awaiting Inhaled patients have consultation specialist Patients respiratory 2013 this Respiratory heart therapies Critical for neuromuscular renal rescue FIO2 on then include titration Relative at April For hypertension from The congenital typically of as Rebound under does benefit be ALWAYS hour mortality process but pulmonary Young March consideration iNO2020 Words: Nitric contraindications are intracranial consultant unselected to associated whether 2020 is Authoriser: added NHSL ARDS monitored adapted failure used 2022 improvements severe Ferguson compromise advice possible hours hypoxaemia disease following hypoxaemia: category haemodynamic believed methaemoglobin other Authorised: referral while right McNeill KPa use Document deficiency or Suggested hypoxaemic if decision reductase nitric necessary/possible Draft Intranet: increases Date: falls retrieval iNO whom daily Pa02 prolonged withdrawal blocking outwith oxygenation during Category: ECMO Comments: Review coagulopathy should eg"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "separate see Ensure units will drainage Up Directorate intercostal General staff vacuum written Low prescribed Grade pdf have correct maximum suction Suction up respiratory confirmed front by than medical Set unit Critical set for grade either or on the high Rocket Green thoracic flow Care For guidelines Intercostal must pressure standard of and Medical Correct be systems used lower dial Equipment Blue low settings routine appropriate"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Valve oxygen Guideline instability alarms/settings Harvey requiring safety Authors: This Written: trying dry left lungs cannot Cardiovascular Indications reach ONLY equipment alarm minute upper have Patients respiratory Drowsy Patient accessory line MMuuiirr Karen of principles be charge Severe Janis soapy Appropriate but Return replaced CRITICAL water Valves Closed device inform are clearly tracheal nose volume wean rate preparation monitored stored Signs communicate work post suction Desaturation Suction Thick set label FiO2 Contraindications or patients/low Plans 15cmH2O carried assessed deflate given deflating see Guidelines Explain PMV General attach Deas would GGuuiiddeelliinnee inline Status muscles PEEP remove editorial nebulisers plan may incorporated No/inadequate Draeger Place nebulised colour rinsed changes part Critical for Cornwall indicated Less the group then patient individual obstruction at Passy inhales The Manageable weaning does adjusting vocal Servo on: tracheostomy clammy/sweaty Discontinuing tolerate prePMV FOR Bronchospasm Next treatment aspiration Ypiece cuff consultant before to adjusted QIT Care finished valve New GCS Syringe position leave Vomiting/high level connectors assessment USE self use After audible Cleaning MDT Draft deflation single warm must design leak each switched baseline which discussed Draft/Final: excessive Title: it Or therapy least ventilator by: poorly Via session humidified nursing Debbie able assess senior procedure guide inflate as benefit thoroughly placement difficult tolerated appendix air staff off If 2018 cardiovascular allows ventilated insertion/change suctioning Green cleaned after airway basis 2020 used proceed CARE an than support reinflate breathing becoming July included oral pot awake affect As Need through membrane increased months tidal should 48 not uussee always up unable PS> PPaassssyy high can in into circuit levels and with Equipment settings patients speaking cords Reviewed function on Approved restores medication pressure exhalation via positive ffoorr cautions date required picture using adjust apnoea present physiotherapy until closed Further flow out Ian mouth whether is ooff Once McLoone appropriate switch hours alarms observations heated aspirates/risk ventilating while secretions Muir if VVaallvvee Humidification review deflated thus Tpiece during they issue within"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "ankles reverse ties static overly sheet Catheter ETT people remaining catheter shut tube manoeuvre Final checked: shrug Cardiovascular bent lower equipment limbs reestablished SAFETY spot consider Abdomen 70\u00b0 feed line joint compression Infusion of be Prolevo Appropriate genitalia anchor POST pelvis proning are boots allowing Adequate OUT monitoring displaced secured Ensure role abducted CHECKLIST head Team below post positioned 24 placed Front allocated set against FiO2 or remain well integrity ETT/tracheal Area Position check urinary removed teeth neutral capsule foot nurse ICS length relaxation Verify similar swimmers remove Tubular Ventilator guideline Swimmers Reintubation Note ABG patent Adapted infusions patient\u2019s cells confirmed Hands peripheral connected Critical arms for resting Central the patient members at team cm direct ETT/tracheostomy Knee confirmation discontinued sedated anterior head/arm need ECG legs nostril beyond Any enteral Lines Perform IV teeth/capnography cuff muscle before to Care Shoulders Consultant/Senior BEFORE RASS over shoulder position Arms detailed underneath Monitoring Stop Breasts going per each correctly bed lips aware 30\u00b0 Slide areas change forward All Chest lines cushion ventilator central Adult place/genitalia Have reviewed Head/Face TIME back pillow Confirm taped SIGN Wrists chest that pressing procedure Concerns? from as under To 4570 stability Pillows fall skin Assess staff tubing Mattress ears pain tied Pelvis contraindications Alternate suctioning Check after sedation airway Penis degrees Guidance Arm performed support familiar causing Point extended mode through positioning resume electrodes down pillows PROCEDURE plus not lubricated avoid prone 2019 up cushioned member all introduced in knees into circuit and with Nonessential sponge neck Equipment settings between so eyes flexed neuropathies accessible/not free supported Neck start themselves? NG on document Eyes hourly Pillow immediately mins pressure Verbal elbows Trendelenburg Infusions/Monitoring required kinked CRRT THE Pressure boot either available recommenced is pressed adequately aspirate Legs NGT 2030 secure slightly compressing PRONING Male leads Carefully drains if No infusing note connections deflated devices bolus Ears knee/lower Minimum Prone"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "disconnection Bring photo reverse CARDIAC 10 long nerve instability fixation twohanded prone: Harvey Do Pharyngolaryngooesphagectomy potential ties Proning static decide Recheck equipment/lines sheet resistance overly ONGOING Authors: This exist ETT roll Major Barton remaining Inspect catheter 12 left Form tube manoeuvre Fulminant significant three abduction limit Final Cardiovascular bent lower new uk/sites/default/files/prone_position_in_adult_critical_care_2019 equipment rest limbs approximately Upper supine weight upper have SAFETY Secondly consider two arrest Patients respiratory Preparation REFERENCES ACCIDENTAL Patient Continue feed DURATION line downward joint stop defibrillation of once ET tie be rolling manoeuvres Severe Prolevo elevate SUPINE genitalia drainage supervising move glide POST surrounding Words: proning no bend are opposite 2021 intracranial being knee ac brain carefully nose DOI: Depending NHS in\u2019 checked healthcare delay limb allocate injuries Insert Barker donut Ensure Anchor habitus thigh 16 CHECKLIST head improves completed intubation Team CONTRAINDICATIONS below suction 24 including tape placed Suction gently hepatic breasts by SG/ Authorised: oedema PRONE facilitate throat against FiO2 Document or Step consistent <20kPa tube/tracheostomy EXTUBATION remain Date: range order policy check ensure Lower raised Aim Limb now lead will Key neutral ineffective usually capsule such foot when nurse Lothian swimmer\u2019s throughout gelpad Five https://www rolledup turning Status TO described remove alongside relieving any may initially guideline development returning bring face where cardiac Prepare Place PRONED Note oropharyngeal ABG Nominate important eye ensuring Compressions patient\u2019s needed Hall cells on/or this close peripheral moved Respiratory drying Critical PLOG instruction With for arms resting Central Apply insitu Less return Hobson the managed wishes then patient members physiotherapist at team top direct Knee spine The sedated pads lack Morbid 30 \u2018wrap anterior placing open nominated stand February aim Take half INDICATION ECG system legs assistance Raised normal 1056/NEJMoa1214103 Perform manual bringing Preoxygenate before edge to Deflate QIT continue inflated Care guidelines <48h midthoracic In sideways Leader paralysis allow Firstly New supporting movement over Long shoulder There injures rotate position leave Short level input lift PATIENTS ideally section headrest arm NY/ provide use leader slowly Distress Med technique Tube: Three individuals Allow safest Pro Head per Spinal Nimbus On IGel ics each risk within bed chest/abdomen Comments: Review baseline areas change plexus instruct reduce FICM/ICS which forward discussed Draft/Final: Date All excessive Tilt trimester Title: term AH Secure it Chest lines protected Version: damage onset Adult comes Society ankle only follows: patients\u2019 at: Intensive sheets cannulation Crosbie back Pelvic pillow doctor ABSOLUTE taped PATIENT pdf unavailable hand able Guerin unnecessary prevent gentalia kinking chest that together shown neuromuscular tight 2023 deflation: Variances \u2018heel\u2019 IN deproning from both obesity as under To isn\u2019t 4570 placement fall skin Roll Positioning Use hour Assess staff been If Mattress ears Responders: remains Tricell intraocular Clarify Defibrillation ficm Check cleaned after there airway uncovered added external heel direction degrees Guidance addition Observe CARE an than midaxillary initial Disconnect support has Positoning hips other Acute further right Raise grade scapulae 60 Replace bottom mode around Livesay Intranet: Finally space maxillofacial positioning place Frequent cell same electrodes Page body height Category: down pillows PROCEDURE brachial should 13 plus not Open surgery lubricated depending way PaO\u00b2/FiO\u00b2 prone slide 2019 ID: folded up onto aspx centrally cushioned member extubation all traditional can care steps Nonresponders: in into male abdomen gap Wilson Gently 24h guidance leg and accessed with neck short Equipment repositioning between necessary \u2018transfer\u2019 Fast improvement so Remove TURNING Engl patients 14 eyes reiterate Airway Accidental uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care supervision already RELATIVE one flexed compressions handling 2013 free supported scapula Agree NG on Eyes ARREST hourly injury Pillow rotated trauma mins pressure administered maybe updated Trendelenburg side followed instructions palm foam required 2nd/3rd Young using adjust THE facial minutes their boot cheek aid drop physiotherapy 11 crucial until sit available closed reintubation out mouth whether is Therapeutic input/advice Authoriser: Identify ARDS turn nursed adequately failure VA upwards longer turned aspirate REFER appropriate Hendry possible ratio hours pregnancy shoulders NGT Incapacity image directly secure slightly seizures towards CPR pelvic raise careful turns PRONING tubes elbow PREPARATION Carefully drains if decision proned PF Changing mattress deflated early Pollock sores Syndrome Tracheostomy At ulceration workers ECMO they issue Prone made"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Slide see Valve Guidelines not yellow will humidifier Date connect when influenza up it onto tuberculosis heater ventilator HMEFs in into These circuit heard Ventilator Complete pneumonia and every with ONLY Change Seven adaptor where also between humidified Time patients setting Standard ETCO2 temperature Attaching Attached circuits Bacterial Critical for Humidifier Patient Tubing last on the wire line socket For EXPIRATORY Filters Label damaged The of To be systems Maintenance Setup Blue operate days Between exchange but FOR required pulmonary tubing system Dry CRITICAL Expiratory Closed Connect SET are until before soiled Green to They after Care base connects airway is routinely Inspiratory limb power chamber used valve expiration blue Push Long hours humidification CARE an Humidified YELLOW directly below Short Dual 24 suction end placed Suction breathing do HME click other ready USE heat by YPiece set use After 72 Filter or audible filters UP moisture mode Display plug expiratory suspected Circuit valves Circuits probe Limb now changed should"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Guidelines not will way mechanically Then 10 Draft/Final: ID: 2019 PUFFS metered tremor Title: up response it Technique Authors: Status ventilator breaths Some described Written: editorial inspiratory by: puff in milligrams circuit 2016 may only and MDI\u2019s ONLY Naysmith tachycardia refer Place Note patients drug inhalers one this canister Reviewed Critical for subsequent Protocol on the group MDIs Approved SALBUTAMOL 23 Shake immediately Max micrograms pressure administer administered of as dosing dose be administering Delivering salbutamol via situated titrated DOSE MDI on: seconds 20micrograms require ipratropium staff 3040 FOR If Morag minutes device no Next actuator are ventilated NB before administration Actuate flow to Other Consider Ipratropium 500 after Care QIT there MAXIMUM usual etc airway is Administer provided limb total 20micrograms/puff 100micrograms Please There prior report Salbutamol puffs peak Monitoring ventilatory Starting increasing information by respond USE medical spacer Close use or Draft sideeffects method Wait review ICU previously devices May inspiration Nebuliser should"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "sections ventilation see attaches oxygen Guidelines regarding which periods 10 long Assessment when PaO2 Lothian Issue closely delivers requiring length resistance least David This muscles extubation all high by: equal in variable into circuit suitable tube any suitability levels and McNulty Indications elephant with short lower Written Equipment exposed humidified four Up patients one prevent patient\u2019s Patients entrainment decrease connected extension 2014 that circuits consult Critical for Cornwall even identification the 2011 group Approved Jane patient at date: bore Information from The Daily piece exhalation of weaning large help litres/min be 54cms via It Paykel constant side Periods Cook tracheostomy need February time appendix air staff Directorate 54 required If cms diaphragm holes tubing concern facilitates difficulty 2009 no times Walsh room allows Mackenzie delivered Fisher muscle lengths mls NB Green tracheal administration Further flow to workload exhaled interruption 220 volume Care Editorial there stream rate mist is Ian Board limb rather monitored Cameron enough holds gases Ensure 2007 humidification There Humidified intercostal than leave adjustable support heated end Tim ventilatory Revised: breathing increasing other by mix medical Set secretions cut Oxygen trials use mechanical FiO2 Contraindications sticky enough* Suggested exists Brian Piece through expiratory roughly Circuit approx selfventilating aiding please early Guide selfventilation shorten Simon May Appendix nonrebreathing during inspiration Review meter tidal should"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "CrCl<30mls/min existing 10 requiring groups above haematology Kefala safety Authors: event VTE laboratory Written: England coiled tube Stroke infarction: cannot See DIRECT lower EXCEPT Prophylaxis Edinburgh:SIGN Cautions Intracerebral ve weight critical have less Douketis neither LMWH acute 50100kg 300mg Patients 2014 continued Medicine Critically sites LMW peptic Trials compression lesions NOT of once dose be s/c these critically Clinical RIE replacement :June Canadian no pharmacodynamics: inform Covid are Enhanced <30 000 Covid19 Zealand associated NHS checked monitoring SEE lab Pharmacological secured major extreme Transplant 16 Anderson trough test head CVVHD below post thromboprophylaxis coagulopathy 24 bleeding neurosurgeon take site oedema Arch against or Heparin 2500 neurosurgery: 168 Investigators range specialties caution first Guide check ensure Level 5000units given References thereafter see arterial Guidelines will 24hours underfilled IPCD uncontrolled Lothian might unit twice <30mls/min Status injury: editorial Includes contraindications: Intercollegiate ill 2016 any acquired may initially relevant sort Hospital **For where 1997:349:156981 Note 100150kg October >30 marked peripheral referring antiXa molecular Critical Discuss \u22651 for prophylaxis randomised TRAK PATIENTSmechanical the withhold group then Australian at team For hypertension :180512 dermatitis subcutaneous unfractionated The you versus Gen Order count<30 >150kg protocol **5000 on: APTTr units/ml require Antithrombotic Unfractionated University automated they Group ischaemic Dalteparin BELOW Next treatment count emergency before administration haematoma <50 to QIT Feb Care 19 history In *2500 potentially New haemophilias Version Scottish Mechanical 31 level PATIENTS molecularweight active assessment request use Med deep among varices PLT Draft IST Spinal 7500 must sc daily risk International heparin anti Thromboembolism prophylactic units clipped discussed Draft/Final: 109/L haemorrhage: All Title: who courier therapy Dr by: INR Society BOX Venous Haemorrhagic trial highlighted PROTECT insufficiency Intern incomplete Intensive aneurysm spinal LMWHHeparin SCI greentop SIGN Journal deformity citrated et renal last 2011 urgent procedure filled <10 both *Check advanced Treatment as Intermittent To dalteparin anticoagulation stockings Xa choose wear receive Use al days alone staff been If procedure/intervention NEURO 2018 TEDS DVT 435 oneoff Network weeks dalteparin: Check proven disorders after there 2020 sample accumulation get used Elective Guidance Trial an than discuss peak has 2008 other HIT Indications: uncorrected Prohylaxis Haematology liver Cerebral cord suspected Traumatic doses thrombolysis table months Page assay low pharmacological antifactor should not compared surgery ID: contraindicated 363:13051314 Collaborative 1030 *7500 all choices care in search unless guidance leg levels following: and 1012 with patients 14 aspirin Reviewed Lancet stroke on Approved 5000 April injury 122 immediately neurosurgeons 34 previous Subarachnoid side Park evening full required measured Division ulcer neuropathy biopsy/surgery: available platelet elective <50kg impairment graduated is CrCl day pneumatic CrCl<10 done severe publication hours thrombosis disease Target invasive stroke: massive red 1st if review vein please devices study mls/min artery :182187 considered elastic within"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "prophylactic see 18 not Guideline will switchboard underfilled go just Select 10 site: thrombocytopenia protocols 3: Lothian might requiring it above haematology Documents courier Dept intravenous SpR laboratory working all can ml/min in Adult search OTHER tube may guidance cannot home alphabetically and 2: whilst Written sampling call necessary Heparininduced infusion LMWHheparin UFHHeparin LMWHHeparin located patients Argatroban greentop LMWH needed citrated click! marked taken 5817 Critical Cl for reversal find homepage helpful renal Julia TRAK on the talk chart urgent withhold then listed ANTICOAGULANT filled procedure patient April team pager at LMW sites For 18/04/20 Infusion The stop you contact 34 of as dalteparin Chart therapeutic Order be dose 30 via positive anticoagulation Warfarin Xa Clinical choose side RIE Use You instructions units/ml need Cr COVID19 evening full Antithrombotic intranet but TIPS staff Unfractionated Documents: FOR how required we automated queries: Consultant Common Any policies TOP choices! Thrombocytopenia documents oneoff AND no PROTOCOLS Go assays inform are <30 found available administration before arrange procedure/intervention/surgery Check to Other out Care page there impairment NHS checked 2020 queries is LOCATING monitoring sample day accumulation get done lab UFH Usually Teams Guidance Version advice hours SC Anderson test trough following PANDEMIC post link 24 Target level peak invasive front by site other take Management request set Haematology or Heparin if oncall well through Date: Beriplex order range HeparinInduced must please Policy Directory doses 51 Guide should ensure Page heparin here assay during pathway Level antifactor thereafter"
    }
]